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1.1 Chemical Biology and its Educational Challenges  
Chemical biology applies chemical strategies to address biological questions at the molecular level. 
Importantly, the interaction between both disciplines must be understood synergistically.[1] Despite that 
this field is relatively young in many chemistry departments, in the 18th century Joseph Priestley 
performed first chemical biological experiments by studying the influence of different gases on plants 
and mice.[2] The characteristic interdisciplinary approach of working at the interface of chemistry and 
biology has a high potential to solve the complex modern problems, which remain untackable from the 
traditional single approach. To face these vital dilemmas, it is necessary to train the new-student 
generations by the implementation of interdisciplinary courses.[3] Chemical biology is the perfect field to 
tear the classical borders down and prepare the students for future challenges (Figure 1.1).[1,4] Over the 
last years, more and more courses in chemical biology are part of the curricula of the chemistry 
departments.[1,5] There are a handful of cohorts that additionally include research experiences increasing 
the motivation of the students and leading to positive learning outcomes.[6] However, such combination 
of research experiences in chemical biology are still rare and focus on single experiments. Through this, 
the whole picture of research is not clearly seen by the students. Consequently, a course, which 
combines all of these features is highly necessary. 
 
Figure 1.1. Schematic representation of the classical separated disciplines and taught subjects biology and chemistry 
in comparison to the approach in chemical biology, which combines the methods of both disciplines to result in an 
outcome which has the potential to solve complex modern problems. 
 
Still, cultural differences between biology and chemistry departments challenge the offer of joint 
chemical biology courses for both disciplines as well as the implementation of chemical biology 
educational programs. Thus, apart of organizational and administrative issues, which become complex 
between different faculties, many students are not well-prepared to enter interdisciplinary study 
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programs. Although chemistry and biology students successfully graduated in their field, few are familiar 
with concepts from both disciplines. Therefore, the instructors must be aware of these barriers and find 
a clever strategy to address and support both students at a similar extent, keeping the motivation high. 
Emerging from this approach, a new generation of students will be able to speak the language of 
chemistry and biology with equal fluency.[7,8] 
Following the crucial need of encouraging more students to be open to face future challenges and think 
more interdisciplinary, the implementation of new courses in chemical biology could help to push the 
university education system forward, sponsor the critical thinking of students and yield in successful and 
enhanced positive learning outcomes. 
 
1.2 Photosensitive Molecules in Chemical Biology 
At the beginning of life, there was light. Light was the energy for the first primitive reactions on earth[9], 
and it is still the power source involved in essential developmental biological processes such as photo-
synthesis.[10 , 11 ] The crucial role of photosensitive molecules in biological[10, 12 , 13 ] and non-biological 
processes[14,15] serve as inspiration for further innovative developments. In particular, the complexity of 
the biological processes cannot only be understood by the study of single separated components, but it 
requires to have tools at our disposal that allow the dynamic study of living systems itself as well as the 
relationship between each component. Spatial and temporal control would serve as key instruments to 
deepen our knowledge in complex biological systems. Light as a tool serves a fast, precise, controllable 
and inexpensive form of energy. Even in nature, light is the ideal trigger: for billions of years it has been 
used in photosynthesis and phenomena such as vision and the biological clock.[10,12,13] Today, not only 
chemists use the tool of light for numerous reactions[16,17], material science,[18,19] molecular motors[20,21,22] 
and photopharmacology,[23,24,25, 26] but also to understand the complexity of biological systems and 
modulate their functions. Therefore, innovative tools controlled by light, allow to study where, when 
and to what extent a biological process is started and stopped, to decipher the living systems at 
molecular level.[11,27] In the following chapters, different optochemical tools: photoactivatable (chapter 
1.2.1), photocaged (chapter 1.2.2) and photoswitchable molecules (chapter 1.2.3) as well as 
fluorophores (chapter 1.2.4) used for the study of biological functions are introduced.  
Activation of samples can be performed at different wavelengths. Light with shorter wavelengths (e.g. 
UV-light) has a short penetration depth and is high in energy, which is often harmful for biological 
systems. Light with longer wavelengths (visible light) serves an increasing penetration depth and 
decreases in energy, which makes it more suitable for biological samples.[28] Most known optochemical 
transducers — converters of signals into different outputs[29] — still rely on irradiation with UV-light 
limiting their application particularly for in vivo studies.[27] The demand on visible light probes is, 





1.2.1 Photoactivatable Molecules 
The term ‘photodynamic action’ dates back more than 100 years[30] and is, today, the key concept in 
photodynamic therapy (PDT),[31] which became a well-studied form of therapy against cancer and various 
non-malignant diseases including infections. Around 1900 in Munich, the medical student Oscar Raab 
discovered that when microorganisms were incubated with certain dyes, they could be killed by 
irradiation. He later discovered that apart of light, oxygen was necessary to observe the death of the 
microorganisms (Figure 1.2). 
 
Figure 1.2. Photodynamic therapy uses compounds capable of transforming molecular oxygen into toxic singlet 
oxygen upon irradiation, illustrated using a receptor.[25] 
 
Soon thereafter, similar approaches were used in cancer therapy.[30,31] In the 1970s the modern era of 
PDT started with the intense research efforts by Dougherty and co-workers.[31] He introduced a water-
soluble mixture of porphyrins called haematoporphyrin derivatives (HpD)[32] and porfimer sodium, a 
more purified form, known as photofrin.[ 33 ] Although having many disadvantages such as skin 
photosensitivity and inefficiency, photofrin is still the most often used photosensitizer (PS) today.[31,33] 
Mechanistically, PSs are excited by UV (280-400 nm) or visible light (> 400 nm)[34] into an orbital with 
higher energy. By intersystem crossing, the energy is transferred to molecular oxygen to form reactive 
oxygen species, which are cytotoxic to several biomolecules and cause cell death (chapter 1.2.4.1).[35] 
The most common PS scaffolds are tetrapyrrole-based such as porphoryns (Figure 1.3, compound 1) and 
similar derivatives like phthalocyanines (Figure 1.3, compound 2). Other examples entail both natural 
products such as hypericin (Figure 1.3, compound 3) and synthetic dyes like boron-dipyrromethene dyes 
(BODIPY, Figure 1.3, compound 4) and 4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein (rose bengal, 
Figure 1.3, compound 5).[31] The ideal PS should absorb between 600 nm and 800 nm to ensure deep cell 
penetration and bearing enough energy to produce singlet oxygen and reactive oxygen species (ROS). 
They should further exhibit low dark toxicity and a fast clearance from tissues to minimize side effects 
due to phototoxicity. An additional advantage of many PS is their high fluorescence quantum yield, which 
turn them into suitable ‘theranostic’ agents, a combination of diagnostics and therapeutics. It allows to 




Figure 1.3. Most common scaffolds of photosensitizers (PS): porphyrin, phthalocyanine, hypericin, boron-
dipyrromethene, 4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein.[31,36] 
 
Recent research approaches strive to develop innovative PS agents to reduce side effects, such as dark 
toxicity, and ensure selectivity.[37] These compounds have been classified depending on their mode of 
activation into environment-, enzyme- and nucleic acid-activatable photosensitizers.[38] 
 
Environment-activatable photosensitizers: A unique phenomenon of tumor cells is their low pH (6.5 to 
7.2) in extracellular tissues compared to normal tissues (pH ∼7.4).[39] This is due to the high activity of 
cancer cells. Thus, both glycolysis and plasma membrane proton pumps’s activity are enhanced, resulting 
in an enriched production of lactic acid, which, in turn, leads to the slightly acidic surrounding.[40 ] 
Therefore, PS with high fluorescence and singlet oxygen and ROS production at lower pH values, but a 
decreased activity at pH 7.4, would be appropriate for specific PDT and cancer imaging.[35] For example, 
Ju and co-workers designed a pH-sensitive aniline- based bromo-substituted aza-BODIPY-PS, which 
displayed fluorescence properties and sufficient singlet oxygen production for near-infrared cancer 
theranostics under acidic conditions (pH 4.5-5.0).[41,42] Thus, upon 808 nm laser irradiation of a mouse 
model, the direct monitoring of fluorescence of such compound allowed to observe a drastically 
decrease in tumor size. Whereas untreated tumor tissue displayed a fluorescence ratio at tumor to 
normal tissue of more than 10 fold, it decreased after the treatment down to a ratio of 1.4 fold. In 
addition, Wang and co-workers designed a water soluble supramolecular vesicle containing an iodinated 
BODIPY derivative, which underwent disassembly and consequently successfully released the 
chemotherapeutic selectively in the acidic surrounding of tumor cells.[43] This work suggested a promising 
drug nanocarrier, combining chemo- and photodynamic activities. A different strategy to initiate 
apoptotic cell death of cancer cells, using environment activatable PS, is the activation through 
glutathione (GSH).[44,45] GSH-levels are much higher in intracellular (10 mM) than in extracellular (2 µM) 
environments[46] and even higher in tumor tissues.[47] By cleaving disulfide bonds to caging groups,[44] or 
reduction or addition of the GSH to styryl double bonds,[45] the described quenched photosensitizers are 
reactivated. 
 
Enzyme-activatable photosensitizers: Overexpression of specific enzymes is often correlated to specific 
diseases,[48] so they can be used as PS activators. Whereas the PS will be active in tissues with the 
overexpressed enzyme, normal tissues will not be harmed. Especially high levels of proteases are 
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connected to numerous diseases, and the use of protease inhibitor therapeutics has been clinically 
approved for cancers, hypertension, myocardial infarction, periodontitis, AIDS, thrombosis, respiratory 
disease and pancreatitis.[38,49] One example using this approach in the context of PDT was described by 
Zheng and co-workers. They used a short peptide linker, which is caspase-3 cleavable, to connect a PS 
and a quencher. Their photoactivatable PS consisted of pyropheophorbide-α, a chlorophyll analogue, as 
the photosensitizer and a carotenoid as its quencher, connected through a specific bioactive peptide 
sequence. As the PS and quencher are held in close proximity by the peptide sequence, 1O2 generation 
and lifetime is decreased. Upon incubation with caspase 3, the linker was cleaved and singlet oxygen 
production enhanced.[50] It was demonstrated that through a modular approach by connecting the same 
PS and quencher through different protease cleavable peptide sequences, different targets could be 
easily addressed.[51,52] To circumvent the dependency on natural peptide folding for the efficiency of the 
quenching, a zipper molecular beacon was designed, bearing a polyarginine / polyglutamate electrostatic 
sequence close to the PS and the quencher. The formation of a zipper hairpin-linked fluorophore-
quencher pair brings both functionalities close to each other and ensures an efficient quenching.[53] 
 
Nucleic acid-activatable photosensitizers: Nucleic acids have successfully served to activate 
photosensitizers. Numerous diseases are connected to altered gene expression due to mutations in the 
DNA and besides nucleic acids are easily accessible by solid-phase synthesis. Therefore, precise control 
over nucleic acid-based processes bears a high potential. Nucleic acid activatable photosensitizers are 
able to recognize even single-base mutations and discriminate cells, expressing these specific genes.[38] 
Direct DNA binding by small molecule photosensitizers such as methylene blue display sequence-
selectivity in the singlet oxygen production with AT preference due to the quenching effects of the GC 
sequences.[54] Apart of this approach, different strategies for the sequence-specific targeting are known: 
one is the use of target hybridization strand displacement (Figure 1.4 A).[ 55 ] In this approach, a 
photosensitizer is linked to a nucleic acid sequence complementary to a target sequence, such as a mRNA 
linked to an overexpressed protein in cancer cells. Hybridization of this probe with a complementary 
sequence bearing a PS quencher results in an inactivated PS. However, in the presence of the specific 
RNA sequence, the sequence, linked to the photosensitizer is displaced and released, and the production 
of singlet oxygen is turned on. For precise control of this process, a well-chosen length of the 
oligonucleotides is necessary, whereas it is essential that the target strand has a higher affinity to the 
quencher oligonucleotide than to the one of the photosensitizer.[55] Another strategy applies molecular 
beacons (Figure 1.4 B).[56] These oligonucleotide approach consists of a short hybridized stem region, 
bearing both the photosensitizer and the quencher at its ends. These two strands are connected by a 
loop region, which is longer than the stem region and complementary to a specific target sequence.[56] 
Upon binding to the target sequence, the stem is dehybridized, and consequently, the PS activated. An 
example was applied for specifically targeting the cRAF-1 oncogene.[57] Incubation of cRAF-1 expressing 
cells with a molecular beacon, connected to a pyropheophorbide-a photosensitizer and a carotenoid 
quencher by a loop portion specific for the cRaf-1 oncogene, resulted in reduced viability of 38.0 ± 5.8%, 
which is in agreement with the positive control. Importantly, significant less efficacy (81.0 ± 4.6% 
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viability) was observed with an analogue scrambled loop-region. Aptamers are short oligonucleotides  
(< 100 bases), capable of binding to many types of different targets, such as small molecules (amino 
acids, antibiotics), proteins or nucleic acid structures, in the same high specificity and affinity range as 
antibodies.[58] They have been used for drug delivery and nanotechnology applications by targeting 
cancer-associated molecules.[59] Tan and coworkers designed a thrombin specific PS aptamer which is 
deactivated by carbon nanotubes. The carbon nanotubes can bind the aptamer through ionic 
interactions and is further able to quench the fluorescence of the PS. In the presence of the target, the 
nanotube dissociates from the aptamer, and the fluorescence increased up to 20-fold (Figure 1.4 C).[60] 
Further activation mechanisms for photosensitizers besides environmental effects, enzymes and nucleic 
acids, are the use of quantum dots[61] and nanoparticles.[62] 
 
 
Figure 1.4. Activatable photosensitizers based on a) reverse hybridization systems, b) molecular beacons and c) 
aptamers.[38,55,57,60,62] 
 
1.2.2 Photocaged Molecules 
One strategy for the controlled release of biologically active compounds is the utilization of photolabile 
protecting groups (PPGs), which can be removed in a photoreaction/photolysis by irradiation with light. 
PPGs were first described in the early 1960s by Barton,[63] Barltrop,[64] and Sheehan[65] and applied in 
organic synthesis. Their use for biological applications was introduced in 1976 by Engels and Schlaeger,[66] 
who synthesized a photoprotected cyclic adenosine monophosphate (cAMP), and successfully tested 
their ability to activate the cAMP-dependent protein kinase under irradiation. One year later, the word 
“caged” compound was coined by Hoffman and coworkers when they reactivated a sodium-potassium 
pump upon release of photoprotected ATP.[67] The definition of “caged compound” is controversial as it 
can easily be misinterpreted. The name itself reminds on a compound trapped inside of an actual cage, 
which is opened by light, instead of the covalently linked photolabile protecting group. Furthermore, 
literature searches can be complicated, as varying expressions such as “photoactivatable”, “light-
triggered” or “photocaged” are used, the protecting groups have structural similarity to many other 
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contexts, and the term “caged” is used in many different perspectives.[27, 68 ] There are several 
requirements for a suitable PPG depending on their application:[27,69] 
 
 strong absorbance at least over 300 nm, preferably in the visible light region, to not harm 
any biological components 
 the photoreaction should be fast, clean and with a high quantum yield for an efficient 
photoactivation 
 low intrinsic activity and stability under physiological conditions prior and during the 
photolysis 
 solubility in physiological conditions and capable of crossing biological barriers 
 its photolytical byproducts should be both transparent at the irradiation wavelength and 
non-toxic 
 ideally, kinetic values are known and the released compounds detectable, e.g. by 
fluorescence 
 
Since the introduction of “caged” compounds for biological applications 40 years ago, many different 
classes of photosensitive protecting groups with varying modifications were developed and applied to 
numerous systems.[68,69,70,71,72] In this chapter the existing classes and some examples are presented. 
 
1.2.2.1. Classes of Photolabile Protecting Groups 
The first and one of the most commonly used PPG for biological applications is the ortho-nitrobenzyl 
group (Figure 1.5, compound 6) and its derivatives, which are deprotected at λmax ≈ 400 nm with a release 
rate of 102 to 104 s-1. The main drawback of this PPG is the formation of a harmful nitrosoaldehyde as a 
byproduct after photolysis, whose aldehyde functionality can react with amines and its brown-colored 
degradation product acts as an internal filter.[68,69,73,74] Further modifications on the substituents of the 
ortho-nitrobenzyl facilitated absorbance over 400 nm[75,76] or could trap the formed nitrosoaldehyde.[77] 
Derivatives such as the ortho-nitrophenylethyl group (Figure 1.5, compound 7) were developed to speed 
up the reaction due to a differing release mechanism, forming a nitrosoketone upon deprotection.[68] 
Another common class of PPGs are coumarin derivatives (Figure 1.5, compound 8). They are deprotected 
at λmax ≈ 320-330 nm and characterized by fast release rates up to 1010 s-1,[78] improved stability and the 
possibility of monitoring the fluorescent byproduct.[68,79,80] Substituents on the coumarin core (Figure 
1.5, compound 8, R3 = Br, R4 = OMe, R5 = O) improved the solubility of the first generation compounds 
(Figure 1.5, compound 8, R3 = H, R4 = OMe, R5 = O).[69] Thiocoumarins (Figure 1.5, compound 8, R3 = H, R4 
= NEt2, R5 = S) enable uncaging in the 470-500 nm wavelength range.[81] Other examples for visible light 
PPGs are photolabile ruthenium complexes.[82,83] Quinones (Figure 1.5, compound 9)[84,85] and BODIPYs 
(Figure 1.5, compound 10)[86] are groups, which even allow the release of the protected compounds by 





Figure 1.5. Structural scaffold of common photosensitive protecting groups. LG = leaving group/compound of 
interest. R1 = H, OMe; R2 = H, Me; R3 = H, Br; R4 = OMe, NEt2; R5 = O, S. 
 
As mentioned before, the in vivo application of most photosensitive protecting groups is often restricted, 
because the photolysis involved harmful UV irradiation, and is, therefore, not fully biocompatible. The 
two-photon excitation uncaging strategy provides a suitable alternative to the normal single-photon 
excitation.[27] At high wavelengths, chromophores can simultaneously absorb two photons, resulting in 
a higher energetic state, which is about twice the frequency and often falls into the UV-region.[87,88] The 
resulting ability to apply red or near-infrared (NIR) light, allows the use of the phototherapeutic window 
between 650 and 950 nm,[69, 89 ] which is characterized by deep tissue penetration and low 
phototoxicity.[69] 
Having a large variety of different PPGs with different absorbance properties depending on their 
substituents allows designing orthogonal protection strategies. More recently, orthogonally addressing 
multiple PPGs were introduced in one single system, allowing to deprotect two functionalities 
independently by irradiation at different wavelengths. In 2000, Bochet described the first example of 
orthogonal release of PPGs, in which two carboxylic acids were protected with a 3,5-dimethoxybenzyl 
alcohol and a 2-nitro-4,5- dimethoxybenzyl alcohol.[90] Bochet studied their different deprotection speed 
in mixed solutions upon irradiation with 254 nm and 350 nm. A perfect selective deprotection was not 
achieved, due to partial overlapping of the two absorbance spectra. To overcome this limitation, the 
deprotection should be applied sequentially. As most compounds absorb in the UV-region, one must 
start with irradiation of the protecting group bearing the absorbance maximum at the higher 
wavelength. After complete uncaging of the first protecting group, the shorter wavelength can be 
applied to deprotect the second protecting group.[ 91 ] This approach was successful in several 
examples.[92,93,94] 
 
1.2.2.2. Applications of Photolabile Protecting Groups 
The application of photolabile protecting groups is nowadays spread over the whole field of chemical 
biology. Numerous examples are known to protect small molecules, peptides and proteins, or 
oligonucleotides: 
 
Small molecules: In particular, the pioneering caged ATP is the most common photocaged small molecule 
and even commercially available.[68,95] Young and Deiters developed a caged IPTG-version (Figure 1.6, 
compound 11) to control gene expression.[96] In a similar approach, Cambridge et al. used a caged 
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cyanodoxycycline (Figure 1.6, compound 12) in eukaryotes.[97] The use of the protected amino acid 
glutamate (Figure 1.6, compound 13) is an example of a small molecule in neurobiology and signaling 
pathways. Glutamate is responsible for the communication between neurons. Its commercially available 
version already allowed several investigations in neurosciences.[98,99] In combination with photocaged 
gamma-aminobutyric acid, an inhibitory neurotransmitter, it was possible to multimodular control the 
membrane potential of a single synapse.[ 100 ] Further examples are cyclic nucleotides,[ 101 ] 
phosphoinositols[102,103] or calcium, caged with photolabile chelators, as one of the most important 
carriers of chemical information.[104] One example of a photoactivatable small molecule interacting with 
DNA, is a photo-caged platinum(II) complex (Figure 1.6, compound 14) described by Franz and 
coworkers.[105] A nitrophenyl group is built into the backbone of a tetradentate ligand. The complexed 
platinum is unreactive towards ligand exchange. Upon UV-light irradiation, the ligand backbone is 
cleaved and the PtII complex can exchange ligands in a similar approach to cisplatin. In the dark, the 
caged complex showed no cytotoxicity towards human breast cancer MCF-7 cells, whereas upon 
irradiation it increased by 65%. Sugiyama and coworkers were able to introduce photocontrol into 
sequence-specific DNA alkylation.[106] By caging an alkylating group on a pyrrole and imidazole containing 
polyamide, which is known to target the DNA sequence-specifically, they were able to demonstrate their 
selective activation by UV irradiation both in vitro and in vivo. 
 
 
Figure 1.6. Examples of photocaged small molecules: caged IPTG, caged doxycycline, caged glutamate and caged 
platinum complex. 
 
Peptides and Proteins: The introduction of cages in peptides and proteins can affect their function, and 
consequently provides biological control.[27] For example, photoactivatable peptides and enzymes were 
used to control kinase activity,[107,108] liposomes[109] and neurotransmitters.[110] A different approach 
focused on photodegradable peptides, where an unnatural photolabile amino acid is introduced into the 
backbone of a bioactive peptide. Upon light irradiation, the peptide is cleaved which results in loss of 
activity.[ 111 , 112 ] By now, it is possible to introduce different photocages on many amino acids 
functionalities: the N-terminus,[113] acid-functionalities,[114] amides,[115] alcohols,[116,117] thiols[118] and 
amines.[109] On the level of proteins, there are different strategies to introduce the cages. The simplest 
one is to take advantage of the reactivity of a functional groups of the amino acid side chains, such as 
thiols due to their low abundance (<2%) in proteins and the highest nucleophilicity upon the amino acid 
side chain functionalities. Another possibility to address cages, are amines. They are also good reactants 
in nucleophilic substitutions, but rather common in proteins. Additional strategies apply unnatural amino 
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acids.[119] Another approach uses the multimeric properties of proteins. The chemical synthesis of one 
subunit of the protein allows the introduction of a caged moiety at a desired position. This subunit can 
then be used to replace the wild-type counterpart to yield the caged protein.[68] To introduce caged 
amino acids into larger proteins, Schultz et al. established a method, using a nonsense-codon and a 
corresponding tRNA, loaded with the caged amino acid.[118] 
 
Oligonucleotides: To introduce caging groups in oligonucleotides, they can be connected to the 
nucleobases to prevent Watson-Crick base pairing, on the ribose, the phosphodiester backbone or as an 
internal photocleavable linker.[27] Photocaged oligonucleotides can be used to regulate gene 
expression,[120,121] regulate aptamer activity[122] or cage molecular beacons.[123]  
 
1.2.3 Photoswitchable Molecules 
Photoswitchable molecules are compounds, which are able to isomerize between two or more different 
forms upon irradiation with a specific wavelength leading to different absorption spectra of their 
photostationary states.[29,124] Azobenzenes, stilbenes, diarylethenes and spiropyrans belong to the most 
common photoswitches and are described in more detail below. Due to the often non-invasive nature 
of light, they have been widely applied in the reversible optochemical regulation of biological systems[29] 
and serve as a scaffold for the field of photopharmacology.[25] Photopharmacology aims to face and 
improve pharmacological problems such as poor specificity, resulting in severe side effects, 
environmental toxicity and the growing problematic of resistance by introducing photoswitchable 
groups into the scaffold of the bioactive compounds to achieve control over the applied compounds.[26] 
The lack of controlling the activity of the drugs in space and time leads to those issues.  
 
1.2.3.1 Concepts 
To achieve the before mentioned selectivity, several strategies can be applied:[25] 1) by avoiding cross-
interactions to targets, which are absent in the human body;[ 125 ] 2) reducing off-target effects by 
selecting only targets, which are present in specific organs or overexpressed in a specific diseases, as 
immunotherapy;[126] or 3) local application, as it is performed in ophthalmology.[127] However, many 
diseases are difficult to combat, as their targets are expressed all over the body, in healthy and unhealthy 
cells.[126] To reduce side effects and to avoid off-targeting, photopharmacologists use light as the external 
trigger to control the activity of the bioactive molecule. Photoswitchable groups, introduced in the 
scaffold of the bioactive compound, can change its conformation upon irradiation. As the structure is 
most often directly linked to the dynamic and kinetic properties of the bioactive compounds, this 
approach allows a direct regulation of their therapeutic effect. As illustrated in Figure 1.7, 
photopharmacology is inspired by the more established photodynamic therapy, with the unique 
difference that the existence of the active compound can be regulated reversibly. Changing the 
conformation upon irradiation and thereby increasing the effective concentration of the active 
compound, has a direct and selective effect in the interaction with the receptor. Although, not yet being 
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Figure 1.7. Photopharmacology uses light to photocontrol the conformation of a drug that can only bind to the target 
in one state, illustrated using a receptor.[25] 
 
The dynamic regulation of the drug is obtained due to a reversible change in the structure of the 
photoswitch, resulting in the control of its properties. Photoswitches have already been incorporated 
into nucleic acids, the backbone of peptides, receptors and channels and were used to photoregulate 
enzyme activity as well as ligand binding to soluble proteins.[129]  
The design approach for photocontrollable tools to modulate biomacromolecular function was nicely 
summarized by Trauner et al.:[130,131,132] In a first attempt, the right photoswitch is selected. It is necessary 
to avoid phototoxicity and ensure a reliable isomerization over several cycles without affecting the 
integrity of the molecular transducer. Depending on the application, it might be advantageous to use a 
thermally instable photoswitch, which turns itself off in the absence of irradiation. In other cases, a 
thermodynamically stable photoregulator, whose activity is regulated by applying one specific 
wavelength, might be more suitable. Still, in the ideal case the conformation of the photoswitch changes 
completely between the two states. This is possible for those with areas of no spectral overlap for each 
conformation. These specific wavelengths can be used for irradiation to achieve high ratios for each 
isomer. Although this case is rare, it needs to be noted that even photoregulators with low isomer ratios 
in the 40/60 range can have pronounced biological effects.[130] Ideally, the photocontrollable moiety is 
introduced into the scaffold of the bioactive molecule giving the largest biological impact between the 
two conformers. Preferably, the isomerization changes completely between active and inactive. 
Furthermore, both states of the photoregulator must be soluble in the necessary media and efficient 
membrane permeability may be desirable, too. The new compound should not interfere with the applied 
assays, such as quench fluorescence, when needed. For in vivo application the cell penetration depth of 
the applied wavelengths needs to be considered.[130] Still, it needs to be noted that even 
photocontrollable compounds with a low penetration depth can have a pronounced effect in in vivo 
applications.[24] 
 
1.2.3.2 Classes of Photoswitches 
The most commonly used photoswitches are azobenzenes, stilbenes, spiropyranes, diarylethenes, 
thiophenefulgids and hemithioindigos (Figure 1.8). Each class of photoswitch has different properties, 
which are shortly summarized below. For all photoswitches, the influence of substituents on the 
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absorbance wavelength is strong.[129] The applications of azobenzenes, in the context of nucleic acids, 
are discussed in more detail below (chapter 1.2.3.3 and 1.2.3.4). 
 
Azobenzenes: Azobenzenes (Figure 1.8, compound 15) belong to the most commonly used 
photoswitches for oligonucleotide modification and biological application in general.[124] 
Functionalization of the aromatic rings allow ligation to different bioactive molecules, which is applied 
in this work for DNA binding molecules. 
 
Stilbenes: Structurally, stilbenes (Figure 1.8, compound 16) are closely related to azobenzenes and 
possess similar photochemistry.[ 133 ] The cis conformation is more stable and thermal cis/trans 
isomerization negligible at room temperature.[129] A major drawback is the tendency of stilbenes to 
undergo irreversible cyclization / oxidation of the cis isomer.[134] Whereas in the past, stilbenes were 
used for the photoregulation of oligonucleotides,[129] more recent examples are, due to the before 
mentioned drawbacks, relatively rare.[124] 
 
 
Figure 1.8. Molecular structures of the most commonly used photoswitches in their cis/trans or open/closed form: 




Spiropyrans: Upon irradiation with UV-light, the Cspiro-O bond of spiropyrans (Figure 1.8, compound 17) 
undergoes heterolytic cleavage and results in the open zwitterionic form, known as merocyanine. 
Irradiation with visible light or thermal energy leads back to the closed form.[136,137] Substitution of the 
spiropyrans and the used solvent have a high influence to the equilibrium of the two states.[138,139] Apart 
of the structural change, the polarity of the compound changes drastically upon ring opening, which 
influences the hydrophilicity / hydrophobicity.[140,141] Both forms exhibit a dramatically difference in DNA 
binding. Whereas the closed form is nonbinding, ring opening by UV irradiation leads to the form which 
is able to intercalate into the DNA bases.[142] 
 
Diarylethenes: The closed form of diarylethenes (Figure 1.8, compound 18) is caused by reversible, 
photochemically induced cyclization[129] of the hexatriene moiety in the open form. They are thermally 
stable, until electron-withdrawing groups are introduced on the aromatic rings.[143] Furthermore, they 
feature an immense resistance to fatigue with repetitions of switching cycles up to 1000 times.[144] 
 
Fulgides: The photochromic behavior of fulgides (Figure 1.8, compound 19, shown with thiophenes) 
equals the one of diarylethenes: reversible cyclization upon irradiation transforms the hexatriene into a 
cyclohexadiene ring.[145,146] Presence of a heteroaromatic ring or substitution on the C-atoms, forming 
the C-C-double bond, induces thermal irreversibility.[147,148] 
 
Hemithioindigos: Hemithioindigos (Figure 1.8, compound 20) undergo cis to trans isomerization of their 
olefinic bond, which changes the dipole moment of the molecule significantly.[149] The isomerization 
upon irradiation at 400-410 nm (cis to trans) and 480-490 nm (trans to cis) is reversible and stable over 
thousands of switching cycles.[149,150] Whereas the photoisomerization is a very fast process, the thermal 
trans to cis reisomerization, especially in organic solvents, is very slow.[129,150] 
 
1.2.3.3 Azobenzenes 
For the classical, unsubstituted azobenzene (Figure 1.8, compound 15), the trans isomer is the 
thermodynamically most stable form. It is a planar molecule with zero dipole moment. By irradiation 
with near-UV light, it can be isomerized into the cis form, which is nonplanar and has a dipole moment 
of ~ 3 D. The cis/trans ratio in the photostationary state is approximately 80/20.[124] Back isomerization 
is achieved by irradiation with light >460 nm or thermally resulting in a cis/trans ratio of approximately 
20/80.[124, 151 ] The UV-vis spectrum of azobenzene is characterized by two absorption bands 
corresponding to the π→π* and n→π* electronic transitions. The π→π* transition is usually in the UV 
region and the n→π* transition in the visible region. Whereas for the trans-isomer the π→π* absorption 
band is very intense, the n→π* band is much weaker, as this transition is not allowed due to symmetry 
rules. For the cis-isomer the π→π* absorption band is shifted to shorter wavelengths with decreased 
intensity and the allowed n→π* band shows increased intensity with respect to the trans-isomer (Figure 
1.9 B).[ 152 ] Aromatic ring substitution or expansion of the aromatic system, allows to shift theses 
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wavelengths into the visible light region,[153,154,155,156,157] which makes them suitable for even in vivo 
applications.[158] The wavelength shifts were based in splitting the n→π* absorption bands of the cis and 
trans isomer, which usually overlap in the 400-500 nm region (Figure 1.9 C). The separation of these two 
bands enables the irradiation of both forms with visible light.[157] 
However, as explained before (chapter 1.2), there is an interest in developing novel visible-light/NIR 
derivatives. The first examples were described by Herges and co-workers, who used an ethylene linker 
to covalently bridge the ortho-positions.[155] Through this modification, they achieved 
photoisomerization in both directions by the use of visible light and an almost complete photoconversion 
(100% trans to cis and 92% cis to trans).[155] Woolley and co-workers described, soon after that, a 
modification, bearing four methoxy-groups in the ortho-position of the azobenzene.[153] Their new azo-
derivative was regulated in the visible-light region, but possesses lower photoconversions (80% trans to 
cis and 85% cis to trans).[153] In 2012, Hecht and co-workers applied fluorine in ortho-positions of the 
azobenzene (oF4-Azo, Figure 1.9 A, compound 21). The electron withdrawing group reduced the electron 
density in the N=N bond and consequently lowered the n-orbital. In contrast to the before mentioned 
examples, the fluorine substituents are relatively small, which barely distort the planar geometry of the 
trans-azobenzene.[154] The modification leads to an overall blue-shift of the n→π* transition band of the 
cis-oF4Azo and a red-shift for the one of trans-oF4-Azo. The bands are now well separated (Figure 1.9 B) 
and the cis-conformation shows an immense thermal stability in DMSO at 25 °C with a half-life of 2 years. 
Further modifications in the para-position resulted in a n→π* band separation of 50 nm and high ratios 










Figure 1.9. a) Molecular structure of azobenzene (R = H) and F4-azobenzene (R = F), including their type of irradiation 
needed to switch between the two isomers. b) Absorbance spectra of trans (green) and cis (blue) azobenzene. c) 
Absorbance spectra of trans (green) and cis (blue) oF4-azobenzene.[157] 
 
1.2.3.4 Applications of Azobenzenes 
In this section the application of azobenzene-derivatives is limited to nucleic acids (DNA and RNA). This 
overview is clustered in different types of oligonucleotide modifications since the azobenzene moiety 
can be implemented as a nucleoside surrogate, attached to the nucleoside, as phosphate backbone linker 





Figure 1.10. Schematic representation of azobenzene-derivative implementation in different types of 
oligonucleotides: a) Azobenzenes as nucleoside surrogate, b) Azobenzenes attached to the nucleoside, c) Azobenzene 
as phosphate backbone linker and d) Azobenzene in non-covalent interaction with oligonucleotides.[124] 
 
Azobenzenes as nucleoside surrogates: The application of azobenzenes as nucleoside surrogates (Figure 
1.10 A) is the most successful and frequently applied method. In this approach, the azobenzene is 
attached to a linker molecule, which is introduced into the backbone of the oligonucleotide and replaces 
the nucleobase in this position. Depending on the conformation of the switch and the flexibility of the 
linker, the photoswitch can either intercalate between the neighboring bases or hang out of the 
strand.[124] The insertion of the photoswitchable nucleoside surrogate has a large impact in the stability 
of the formed duplex and was applied to influence enzyme regulation,[ 159 ] DNA[ 160 , 161 ] and RNA 
cleavage,[162 ] and peptide nucleic acid (PNA) activity.[163 , 164 ] Structurally, the azobenzene is usually 
connected to a diol linker in the solid-phase synthesis of oligonucleotides. For biological applications, the 
introduction of azobenzenes as nucleoside surrogates are limited to short oligonucleotides, as the 
implementation by PCR is limited until now.[124,165] Asanuma and co-workers found that the introduction 
of a thiol group in para and two methyl groups in ortho position of the azobenzene nucleoside surrogate 
shifts the absorption maximum into the visible light (λmax = 398 nm) and improves the thermal stability 
of the cis-isomer by 8-times.[166,167] This building block was introduced into a T7 promoter region involved 
in GFP expression. By controlling the melting of this region by light, the transcription by RNA polymerase 
could be photocontrolled.[168,169] 
 
Azobenzenes attached to the nucleoside: Here, the azobenzene is connected through a linker to a 
modified nucleoside before or after the oligonucleotide synthesis (Figure 1.10 B).[124] The length and type 
of the linker regulates, where the photoswitch is positioned. Connection to the C5-position of pyrimidine 
bases by linkers such as triazole and phenylacetylene for example, usually places the photoswitch into 
the major groove,[170,171,172] causing a relative low effect on the melting temperature. However, the exact 
mode of interaction is unknown and computational studies are rare.[124] 
 
Azobenzenes as phosphate backbone linkers: In this approach, the azobenzene is introduced into the 
backbone of the oligonucleotide (Figure 1.10 C). Most of these attempts aim to photocontrol the 
formation of oligonucleotide hairpins. Due to stacking of the photoswitch, melting temperatures are high 
and applications are, therefore, limited.[124] The azobenzene moiety is preferentially introduced as a diol. 
Since the trans-azobenzene is planar, the hairpins are usually built up that this isomer slides perfectly 
between the strands, whereas the cis conformation leads to destabilization.[173] One example of this 
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application was described by Wu, He and Tang, who prepared several light-switchable dumbbells  for the 
regulation of RNA digestion. The dumbbells were formed from antisense oligonucleotides and two short 
inhibitory sense strands, connected with an azobenzene linker. Whereas the hairpin is stabilized in the 
trans state, destabilization melting occurs in the cis form, and consequently hybridization to target RNA 
and its following digestion.[174] 
 
Azobenzenes in non-covalent nucleotide interactions: In a similar approach to photopharmacology, non-
covalent binding photoswitches allow an on/off reversibility (Figure 1.10 D). Whereas in the trans-form, 
the planar conformation of azobenzenes result in π-stacking with the bases of the oligonucleotides, the 
bent cis-conformation leads to steric hindrance and lower binding affinities. To enhance double-stranded 
(ds) DNA binding, azobenzenes are usually functionalized with cationic ends, to increase electrostatic 
interaction with the phosphate backbone of the DNA.[124] The cationic azobenzene AzoDiGua (Figure 
1.11, compound 22) has been used to influence duplex stability.[ 175 ] The terminal guanidinium 
functionalized azobenzene intercalates as trans-AzoDiGua into the DNA, strongly stabilizes the DNA 
double helix and increased its melting temperature by several ten degrees. Upon UV-irradiation, which 
leads to the cis-isomer, ejection of AzoDiGua is induced, which results in a significant decrease of the 
melting temperature of up to 18 °C.[175] Azobenzene molecules have also been employed as DNA/RNA 
condensation agents.[176] The azobenzene trimethylammonium bromide surfactant AzoTAB (Figure 1.11, 
compound 23) is a well-studied photoswitchable compacting agent, whose hydrophobic trans-form 
triggers ten times more compacted DNA. Irradiation with UV-light and the formation of the cis-isomer 
relaxes the DNA again.[176] AzoTAB was further demonstrated to reversibly inhibit RNA production, 
resulting in a photoreversible GFP production[177] and was used for gene silencing.[178] 
 
 
Figure 1.11. Molecular structure of AzoDiGua[175] and AzoTAB.[176]  
 
1.2.4 Fluorophores 
Photosensitive molecules can be used to visualize biological processes apart from controlling biological 
functions as in the case of photoactivatable, photocaged and photoswitchable compounds. These type 
of molecules are known as fluorophores. Fluorophores are compounds capable to emit fluorescence 
upon irradiation with a specific wavelength.[179] In this chapter, the concept of fluorescence (chapter 
1.2.4.1), the classes of the main fluorophores (chapter 1.2.4.2) small-molecule fluorophores (chapter 





1.2.4.1 Concept of Fluorescence 
The phenomenon of fluorescence can best be described in a Jablonski diagram (Figure 1.12). It is divided 
into three different stages: the excitation, the internal conversion and the fluorescence emission. During 
the excitation, energy in form of a photon supplied by an external source such as a lamp or a laser is 
absorbed by the fluorophore. This process creates an excited electronic singlet state (S1’), which in the 
next step undergoes an internal conversion to yield in the relaxed singlet excited state (S1). In the last 
step, the fluorophore returns back to its ground state (S0), by emitting a photon, which is observed as 
fluorescence. Due to the energy difference of the S1’ and S1 state, the energy of this photon is lower than 
the absorbed one, resulting in a longer wavelength. The difference in energy or wavelength between the 
excited and the emitted photon is called stokes shift. Apart from returning to the ground state by 
fluorescence, the relaxed singlet excited state (S1) can undergo non-radiative decay, transfer its energy 
to another molecule in a Förster Resonance Energy Transfer (FRET) or perform an intersystem crossing 
to emit phosphorescence or transform molecular oxygen into singlet oxygen (chapter 1.2.1).[180,181] 
 
 
Figure 1.12. Jablonksi diagram showing the process of fluorescence and other energy emitting phenoma after 
excitation of a photon by a fluorophore. 
 
1.2.4.2 Classes of Fluorophores 
The first studies in the field of fluorescence were performed on the molecule quinine (Figure 1.13, 
compound 24). Later, such compound did not only become an important molecule in organic chemistry 
but also in medicinal chemistry. Thus, quinine is a drug against malaria.[182,183] Interestingly, William 
Perkin’s attempt to synthesize quinine by oxidative dimerization of N-allyltoluidine in 1856, and similarly 
oxidizing aniline, accidentally resulted in the first synthetic dye: mauveine[183] (Figure 1.13, compound 
25). His initial studies laid the basis for the discovery of the main fluorophore classes during the next 
decades (Figure 1.13 and Figure 1.3): xanthenes (compound 26) such as fluorescein (ca. 1871, compound 
27) and rhodamines (ca. 1887, compound 28); coumarins (ca. 1884, compound 29); phenoxazines (ca. 
1903, compound 30), cyanines (ca. 1924, compound 31) and BODIPYs (ca. 1968, compound 4).[182,184] 
Since then, there have been intense efforts to overcome the problems of these first generation 
fluorophores such as low photostability and intensity, as well as high hydrophobicity. The improvements 
resulted in excellent stains like the highly used “Alexa Fluor” dyes developed by Molecular Probes[185] 
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and sulfoindocyanine succinimidyl esters (CyDyes) from Alan Waggoner.[186] These modern compounds 
can be modified to specifically target organelles, indicate ions or be used for imaging studies in living 
cells.[182] Apart from small molecules, fluorescent proteins are widely used in biological and medical 
imaging approaches. Having fluorescent-labeled proteins at the disposal, allowed biologists to synthesize 
fluorophore fusions. Subsequent advances in fluorescent proteins have replicated many of the 
properties once unique for small-molecule stains.[182] In the following chapters, the main classes of small-
molecule fluorophores and the class of fluorescent proteins are described in detail. 
 
 
Figure 1.13. Molecular structure of the first fluorescent dye quinine (24), the first synthetic dye mauveine (25) and 
examples for the main classes of present fluorophores: xanthenes (26, X = O, X = NR2), fluorescein (27), rhodamine 
(28), coumarin (29), phenoxazine (30) and cyanine (31).[182] 
 
1.2.4.3 Small-Molecule Fluorophores 
Several fluorophores were already introduced in the previous chapters, as some additionally function as 
photosensitizers or caging groups. Here, the main dye classes and their key characteristics are presented: 
 
Coumarins: Coumarins (Figure 1.13, compound 29) are a large class of natural products and 
pharmaceuticals,[187] which further present a suitable photolabile group. Derivatives as the thiocoumarin 
afford red-shifted cages (chapter 1.2.2).[81,188] Heteroatom substitution of the coumarin core on the 
phenolic ring yields highly fluorescent molecules.[179] 7-hydroxy-4-methylcoumarin (4-MU), for example, 
absorbs UV- and emits blue light under basic conditions, because the deprotonated hydroxyl group 
enlarged the conjugated π-system.[189] Halogenation of 4-MU[189] on the phenolic ring, which lowers the 
pKa of the hydroxyl group, or the related 7-amino derivative are less pH sensitive.[190] N-acylation or N-
alkylation of 7-amino-coumarins cause hypsochromic and bathochromic shifts and serve compounds 
with new properties. Coumarins find broad applications in chemical biology from assaying enzyme 




Xanthenes: Fluorescent compounds containing the xanthene moiety, a three membered ring structure 
bearing an oxygen in the central ring (Figure 1.13, compound 26), serve a large class of fluorophores. 
Fluoresceins, rhodamines and phenoxazines are common members and described in more detail.[179] 
Fluorescein (Figure 1.13, compound 27) remains the dye of choice in modern biochemical, biological and 
medicinal research laboratories. In its dianionic open form it is highly fluorescent, bearing a pKa of 6.4 
and an immense quantum yield of 0.95.[179,188,191] Fluorination of fluorescein reduces the pKa, while 
keeping good quantum yields, which results in more photostable and less pH sensitive derivatives.[192] 
Other modifications such as the replacement of the xanthene oxygen of fluorescein (λmax = 490 nm; Ф = 
0.95) with a gem-dimethyl (carbofluorescein: λmax = 567 nm; Ф = 0.62) or a dimethylsilyl group 
(silafluorescein: λmax = 598 nm; Ф = 0.42) results in a red-shifted emission, but comes along with a 
decrease in quantum yield.[179] The introduction of locking groups on the phenolic oxygen connected as 
esters or ethers can modulate the equilibrium between open and closed form of fluoresceins. This 
strategy is used to prepare “caged” probes (chapter 1.2.2) or fluorogenetic substrates for many 
enzymes.[188,193] Several indicators for biological relevant ions were developed by modification of the 
fluorescein scaffold with chelating ligands.[194,195] One example is the calcium indicator Fluo-3, which is 
widely used in high-throughput screening to measure calcium ion fluxes in live cells.[196] 
Rhodamines, the amino derivatives of fluoresceins (Figure 1.13, compound 28), display a low pH 
sensitivity (pKa 4-5)[197] and tunable properties depending on the N-alkylation pattern.[179] Rhodamine 
110, the simplest member of the class, exhibits similar fluorescence properties as fluorescein and is 
broadly used as fluorescent label.[198] The locked N-acyl rhodamine 110 is applied for measuring enzyme 
activity[ 199 ] and as activatable label in advanced fluorescence microscopy.[ 200 ] Replacement of the 
xanthene oxygen with carbon, silicon, germanium or tin shifts the spectral properties to higher 
wavelength due to the stabilization of the π-system LUMO and was applied in cells and whole 
animals.[201,202] Introduction of morpholine and piperidine substituents allow the access to cell type-
specific fluorescent stains.[ 203 ] By pairing the rhodamine with the fluorescein dye, FRET-based 
experiments are possible and commonly applied in DNA sequencing.[179] 
Phenoxazines (Figure 1.13, compound 30) possess next to the xanthene oxygen an additional nitrogen 
atom in the central ring. This additional nitrogen atom results in a bathochromic shift compared to 
xanthene.[188] They are sensitive to the polarity of the medium and find applications as histochemical 
stains, lasers and fluorescent probes.[188,204] One representative of this class is resorufin, which is pH 
sensitive with a pKa of 5.8.[205] Its locked derivatives serve as enzyme substrates[206] and photoactivatable 
compounds.[207] As it also undergoes facile redox chemistry and as well the reduced as also the oxidized 
form are non-fluorescent, it can be applied as a substrate for e.g. peroxidases[208] or as a cell-viability 
stain. Resazurin, another phenoxazine derivative, is reduced to its fluorescent analog inside living 
cells.[209] 
 
BODIPYs: BODIPYs, (Figure 1.3, compound 4) possess characteristics such as neutral charge, a small 
stokes shift, lipophilicity and an environment independent fluorescence.[184] Especially their halogenated 
derivatives further serve as good photosensitizers. Its higher photostability compared to fluorescein 
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turns it into a suitable dye for many applications.[184,188] Especially as a fluorescent label, it serves highly 
useful in several analysis techniques.[210] To adjust its spectral properties it can be modified in numerous 
positions.[179] 
 
Cyanines: Cyanine dyes (Figure 1.13, compound 31) are molecules bearing a polymethine chain between 
two heterocyclic nitrogens (e.g. R2N-(CH=CH)n-CH=N+R2).[179] Numerous examples of cyanine dyes were 
developed during the last decades, offering emission properties over the whole visible spectra (Figure 
1.14).[ 211 ] They usually have high extinction coefficients (e.g. Cy3: ε = 130000 M-1cm-1), excellent 
photostability[188] and are used as labels,[212] DNA stains[213] and membrane potential sensors.[214,215] The 
most common examples are the CyDyes, which are based on a sulfoindocyanine structure. Their different 
derivatives are named after their number of carbon atoms between the dihydroindole units. A higher 
number of methine carbons enlarge the π-system, which results in higher emission wavelength. For 
example, Cy3 emits at 568 nm, Cy5 at 672 nm and Cy7 at 788 nm. Further fine tuning of the spectral 
properties can be performed by changing the type of aromatic rings or its substituents.[179] The 
combination of CyDyes can be used as FRET pairs.[216] 
 
 
Figure 1.14. Emission spectra of different cyanine dye dimer derivatives, displaying their broad application range 
with emission spectra over the whole visible spectrum.[211] 
 
1.2.4.4 Fluorescent Proteins 
The first discovered fluorescent protein was the green fluorescent protein (GFP) in the 1960s during 
studies on the bioluminescent properties of aequorea victoria jellyfish. Shimomura and coworkers 
isolated the bioluminescent protein aequorin, which was named green fluorescent protein.[217 ] The 
fluorescent proteins (FP) are ~ 25 kDa in size.[224] Whereas the whole protein consists out of an extreme 
rigid β-barrel-fold of 11 β-sheets and a central α-helix,[218] the principle chromophore is formed out of 
few crucial amino acids in the center of the β-barrel: after folding of the protein, the amide-nitrogen of 
glycine at the position 67 forms in a nucleophilic attack to the carbonyl of serine at the position 65 an 
imidazolinone, followed by dehydration. Dehydrogenation of the α-β-bond of tyrosine at position 66 sets 
the aromatic ring of the tyrosine into conjugation with the imidazolinone, which leads to the 






Scheme 1.1. Mechanism for the formation of p-hydroxybenzylideneimidazolinone out of the amino acid residues 
Ser65, Tyr66 and Gly67. These residues undergo cyclization, dehydration and a final dehydrogenation.[219] 
 
Analysis of over 100 naturally occurring chromophore variants demonstrated that only four amino acids 
are highly conserved: glycine at the position 67 and tyrosine at the position 66 to form the chromophore 
itself and arginine at the position 96 and glutamic acid at the position 222 as catalytic residues located 
in close proximity to the formed chromophore.[220] 
It was 30 years later when GFP had been cloned[221] and used as a fluorescent tag in bacteria gene 
expression,[222] when it became a unique tool for biological and medical imaging approaches. Since then, 
protein engineering based on GFP assisted in improving and varying the biochemical properties. 
Nowadays, fluorescent proteins cover the emission range over the whole visible spectrum.[223,224] These 
achievements were recognized by the Noble Prize in 2008.[225] Protein engineering of the remaining 
residues of the protein changed the local surrounding of the chromophore, yielding in broad variations 
in spectral characteristics, photostability, acid resistance and other physical properties.[224] Further 
explorations of marine organisms such as the mushroom anemone discosoma striata and the sea 
anemone entacmaea quadricolor even resulted in orange, red and far-red FPs.[223] The FP fused to 
another protein allows its own study of localization, movement and turnover. By addressing specific cell 
organelles it further enables visualization of their morphology, fusion and fission and segregation during 
cell division. They are applied for cell and tissue labeling and are used to label whole organisms, which 
allows the discrimination between transgenic and wild-type organisms. They enable visualization of 
enzymatic activity (e.g. kinases) or measurements for ion, metabolite and messenger concentrations 
(e.g. H+, Ca2+, Cl-, H2O2, cAMP).[224] By the use of different FP, FRET experiments open further possibilities 
to study phenomena such as protein-protein-interactions.[226] Even though brighter fluorescent proteins 
were found in sharks,[227] the need for genetic manipulation and factors such as brightness and stability, 






1.2.4.5 dsDNA Sensors 
Many fluorescent sensors are based on environment sensitive fluorophores capable to interact with the 
dsDNA. They display low intrinsic fluorescence in aqueous media and a large fluorescence increase 
(fluorogenic dyes) or color change (solvatochromic dyes) upon DNA binding due to changes in the 
microenvironment such as polarity, viscosity and molecular order.[228] The dependence of fluorescence 
intensity on the surrounding environment can be reasoned by charge-transfer, intramolecular proton 
transfer, conformational changes, ground-state isomerization or aggregation effects of the fluorescent 
probe.[228] In the case of most dsDNA sensors, aggregation is often the reason for the decreased 
fluorescence in aqueous solution. The flat aromatic π-system of the sensors has a high tendency to form 
non-fluorescent H-aggregates.[229] In polar solvents, such as water, the aggregation-based quenching is 
favored. In contrast, in apolar solvents or environments such as inside the DNA, the dyes can 
disassemble, to yield fluorescence. The aggregation can be intramolecular as seen for the cyanine dye 
oxazole yellow dimer (YOYO-1) or intermolecular in monomeric dyes such as thiazole orange (TO).[228,230] 
One of the most popular and widely used dsDNA sensors is ethiudium bromide (EtBr, Figure 1.15, 
compound 36). It was one of the first commercially available dyes and is comparably inexpensive. By 
intercalating into the DNA, the microenvironment of the stain is changed and its fluorescence turned-
on. This property is mainly used in gel electrophoresis to visualize dsDNA. In addition, the low intrinsic 
fluorescence allows the use without gel distaining. The toxicity for living systems reasoned the use of 
pretended safer, but more expensive DNA stains. However, it was shown that ethidium bromide is not a 
human mutagen and alternatives are sometimes even more toxic.[231,232] 
 
                  
Figure 1.15. Left: Molecular structure of ethidium bromide. Right: agarose gel after gel electrophoresis stained with 
ethidium bromide. Stained lanes are a 100 bp ladder (Fermentas, Germany) and 494 bp and 734 bp PCR product 
samples.[233] 
 
4’,6’-diamidino-2-phenylindole dihydrochloride hydrate (DAPI, Figure 1.16, compound 37) is a blue 
emitting stain that binds into the minor groove of the DNA and allows in vitro and in vivo staining. It 




               
Figure 1.16. Left: Molecular structure of DAPI. Right: Confocal image of DAPI stained HeLa cells as bright field, DAPI-
stained and merge picture.[234] 
 
A rather modern DNA stain is represented by SYBR Green, a thiazole orange derived compound.[235] Its 
manufacturer Molecular Probes offers two different versions for DNA and RNA staining. It stains gels 
more sensitive than EtBr and reveals a supposed lower mutagenicity. These advantages come along with 
a high increase in costs.[231] 
SyTO-9, a different dye manufactured by Molecular Probes, is a green-fluorescent nucleic acid stain for 
live and dead eukaryotic cells, as well as gram-positive and gram-negative bacteria. It displays a low 
intrinsic fluorescence with a quantum yield less than 0.01, which is strongly enhanced upon nucleic acid 
binding with quantum yields higher than 0.4.[236,237] All structural features of the compound are strongly 
protected by a patent. SyTO-9 was used to label live bacteria for macrophage uptake assays.[238,239] 
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Photosensitive molecules have revolutionized Molecular Biology since they allow the visualization, 
control and manipulation of biological functions by a non-invasive source: light. Nowadays 
photoresponsive compounds are spread over many fields of life science research. Their importance was 
further highlighted by several Noble Prizes: in 2016 Sauvage, Stoddart and Feringa were awarded for the 
design and synthesis of molecular machines, in 2014 Betzig, Hell and Moerner for the development of 
super-resolved fluorescence microscopy and in 2008 Shimomura, Chalfie and Tsien for the discovery, 
development and implementation of the green fluorescent protein (GFP). Despite many different 
strategies using photoactivatable, photocaged and photoswitchable molecules have been established 
for both optochemical control of biological processes and their visualization over the last decades, there 
are still limitations (chapter 1.2). Consequently, there is a "call to arms" for chemical biologists to 
synthesize novel improved molecules and develop innovative tools to understand biology at molecular 
level and, therefore, move life science research into a new era. In this thesis we aim to synthesize novel 
photosensitive molecules capable of opening new venues to visualize and control biological phenomena, 
which to date were not accessible. In different projects we intent to develop novel fluorophores for the 
study of multidrug resistant bacteria, engineer visible-light photoswitches to control epigenetic 
processes (Figure 2.1) and transfer these interdisciplinary approaches into the class room. 
 
Figure 2.1. Photosensitive tools for the visualization, control and manipulation of biological functions by light. In the 
context of this thesis, photosensitive molecules were used to target nucleic-acid based processes. 
 
1) Synthesis and study of new fluorophores capable of labeling multidrug-resistant bacteria with low 
cytotoxicity to enable real-time assays 
The growing number of multidrug-resistant bacteria has become a significant problem and received the 
highest research priority by the World Health Organization. New solutions to combat against them, are 
urgently required, and research is lagging. Fluorescence labeling studies would provide more in-depth 
knowledge and will help to find solutions to fight back. The most established method to visualize 
biological functions in biomedical research is the implementation of GFP and its derivatives. However, 
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many important organisms have been difficult to modify, including many multidrug-resistant bacteria 
due to the impossibility of select their transformants carrying the GFP-coding transgene with antibiotics. 
Therefore, studies with fluorescence tagged multidrug-resistant bacteria, especially in the host cell 
interplay are rare. The implementation of small-molecule nucleic acid stains to avoid the need for genetic 
manipulation has been so far limited to compounds with high cytotoxicity, or a low labeling efficiency in 
antibiotic sensitive bacteria (chapter 1.2.4.5). In this project we aimed at the design, synthesis and study 
of novel fluorophores to label multidrug-resistant bacteria efficiently without affecting their viability to 
allow real-time studies. 
 
2) Synthesis and study of visible-light photoswitches for the control of DNA-based epigenetic processes 
The lack of specificity is a big issue in pharmacology, which often results in severe side effects, 
environmental toxicity and drug-resistance. Photopharmacology aims to overcome this challenge by 
using photoswitchable molecules. Additionally, these compounds will help to better understand 
biological pathways as the reversible control in space and time allows precise activation/deactivation of 
the desired targets. The reversible regulation of DNA-based biological processes were, so far, mainly 
accessed by the use of classical azobenzenes. Their implementation demands the use of UV light, which 
is harmful. To evade this great problem, we planned to introduce new visible-light photoregulators to 
control nucleic acid binding. They would allow to reversibly regulate the exposure of DNA and, in turn, 
study and control genome functions in physiological as well as disease contexts. In this thesis, we aim to 
develop specific methodologies to access and study these regulators to get deeper insights into 
photopharmacology of nucleic-acid based processes. 
 
3) Bringing the big picture of epigenetic research into an interdisciplinary chemical biology course 
Chemical biology is a highly interdisciplinary area. Despite such approaches are more and more common 
in research, the implementation in education is still rare. Therefore, we planned to extrapolate the 
intrinsic nature of chemical biology to an interdisciplinary course for chemistry and biology master 
students to give them the real-world picture of science and highlight the importance of collaborative 







3.1 English Summary 
This thesis presents the synthesis of novel photoresponsive DNA-binding agents as well as their 
application for both visualization and control of biological processes. In addition, the implementation of 
an innovative course to transfer the interdisciplinary research culture of chemical biology to education 
is reported. This cumulative dissertation is mainly composed of four chapters, each of them dealing with 
either published or submitted articles under revision. An introduction, motivation and outlook are 
included, too. 
The first article is published in Angewandte Chemie International Edition, and describes the development 
of a new far-red fluorescent DNA binder, 6-TramTO-3, as an alternative chemical tool to the green 
fluorescent protein (GFP) for interaction studies of live multidrug-resistant pathogens and host cells. 
Thus, the derivatization of thiazole orange (TO) resulted in a new cyanine dye, 6-TramTO-3, whose 
spectroscopic properties were analyzed. DNA binding analysis by UV-vis, fluorescence and CD 
spectroscopy was performed to study the interaction mode upon addition to DNA. Initially, fluorescence 
confocal microscopy, FACS and growth curve analysis with live E. coli displayed an efficient staining of 
more than 90% and no effect on the bacterial viability. Importantly, 6-TramTO-3 overcomes common 
limitations of other frequently used fluorophores like ethidium bromide, carboxyfluorescein succinimidyl 
ester and SyTO-9, such as low staining efficiency and cytotoxicity without genetic manipulation. 
Encouraged by these unique properties, we tested 6-TramTO-3 with antibiotic-sensitive and multidrug-
resistant Klebsiella pneumoniae strains. 6-TramTO-3 conferred both strains a highly specific red-
fluorescent shift with 91% and 87% in the 652-671 nm red2 channel without observable cytotoxic effects. 
Next, we performed phagocytosis assays with human macrophages, which revealed a different strain 
behavior for the first time. Besides the publication, an European patent was filed (18174086.1 – 1011) 
and numerous collaborations with universities, research institutes and companies were initiated to apply 
6-TramTO-3 in different contexts. 
The second article is published in Organic & Biomolecular Chemistry, and presents ortho-tetra-
fluoroazobenzene derivatives as DNA intercalators for photocontrol of DNA and nucleosome binding 
upon visible-light irradiation. Its use is less harmful to biological systems and therefore, preferred over 
UV-light, which is needed for the most known nucleic acid targeting photoswitchable systems. Thus, the 
introduction of such moiety in the backbone of the minor groove binder netropsin added dynamic 
control and changed the recognition mode. UV-vis, HPLC and NMR analysis demonstrated the 
photoisomerization of the new compounds by visible light. DNA-binding analysis conducted by UV-vis, 
fluorescence and CD spectroscopy revealed an intercalating binding mode in the low nM-region with 
differences between isomers. Finally, the use of the new derivative as a light-controllable nucleosome 
binder was explored. The different binding affinities observed on free DNA were corroborated for the 
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nucleosomal DNA. Interestingly, electromobility shift assays and dynamic light scattering experiments 
proved that when the compound is in its trans-form, it intercalated into the nucleosomal DNA, induced 
distortion, which further led to disruption of the nucleosomes. These findings will help to introduce 
photochemical control to pave the way to altering nucleosome-based processes by light. 
The third chapter of this thesis is a submitted manuscript to the journal Organic Letters under revision 
and deals with a novel synthetic approach to access pyrrole-imidazole (Py-Im) DNA binding polyamides 
based on 4-methyltrityl (Mtt) solid-phase peptide synthesis (SPPS). Commonly Py-Im polyamide hairpins 
are synthesized by Boc- and Fmoc- SPPS. New Mtt-protected pyrrole and imidazole building blocks were 
synthesized with higher yields than the Boc- and Fmoc-analogues. Their implementation could 
successfully be shown by the synthesis and study of a DNA-binding polyamide applying all Mtt-building 
blocks. Our methodology is orthogonal to Fmoc and will allow the implementation of base labile 
compounds and other sensitive groups in Py-Im polyamide chemistry affording novel polyamide 
conjugates. In a further attempt, it was already possible to use the new building blocks for the 
introduction of a photoswitchable compound into the polyamide-hairpin backbone, which will access 
the introduction of dynamic and spatial control in the level of sequence specific DNA binding in biological 
assays. 
The fourth chapter is a submitted manuscript to the Journal of Chemical Education under replied revision, 
in which a novel course for master students in chemistry and biology is introduced to fill the missing gap 
between cutting-edge interdisciplinary research and education of future scientists. In other words, our 
course aimed at bringing the authentic “big picture” of science by the combination of lectures, a 
discovery-based research laboratory and science communication. The students experienced the 
advantages of collaborative work, wrote a short article and were guided in the design and defense of 
their own research proposals in chemical biology. Evaluation of the course clearly proved that the course 
fosters cooperative research relationships between biology and chemistry students, provides a unique 
and genuine research experience and increased the students’ interest in interdisciplinary approaches 






3.1 Zusammenfassung in deutscher Sprache 
In der vorliegenden Thesis werden die Synthese innovativer photoregulierbarer DNA-bindender 
Verbindungen sowie deren Anwendung zur Visualisierung und Steuerung biologischer Prozesse 
vorgestellt. Darüber hinaus wird über die Implementierung eines neuartigen Kurses zur Übertragung der 
interdisziplinären Forschungskultur der Chemischen Biologie auf die Lehre berichtet. Diese kumulative 
Dissertation besteht hauptsächlich aus vier Kapiteln, die sich jeweils mit veröffentlichten oder in Revision 
stehenden Artikeln befassen. Zudem umfasst die Arbeit eine Einleitung, eine Motivation und je Kapitel 
einen Ausblick. 
Der erste Artikel wurde in der Angewandten Chemie International Edition veröffentlicht und beschreibt 
die Entwicklung einer neuen tiefrot fluoreszierenden DNA-bindenden Verbindung 6-TramTO-3 als 
alternatives chemisches Instrument zum Grün-Fluoreszierenden-Protein (GFP) für Interaktionsstudien 
mit lebenden multiresistenten Krankheitserregern und Wirtszellen. Basierend auf der Grundstruktur des 
Thiazoloranges (TO) wurde ein neuer Cyaninfarbstoff, 6-TramTO-3, entwickelt, dessen spektroskopische 
Eigenschaften untersucht wurden. Eine DNA-Bindungsanalyse durch UV-vis-, Fluoreszenz- und CD-
Spektroskopie wurde durchgeführt, um den Bindungsmodus nach Zugabe von DNA zu untersuchen. 
Konfokale Fluoreszenzmikroskopie, FACS und Wachstumskurvenanalyse mit lebenden E. coli zeigten eine 
effiziente Färbung von 93% und keinen Einfluss auf die Lebensfähigkeit der Bakterien. Entscheidend 
dabei ist, dass 6-TramTO-3 die üblichen Problematiken anderer häufig verwendeter chemischer 
Fluorophore wie Ethidiumbromid, Carboxyfluorescein-Succinimidylester und SyTO-9, wie geringe 
Färbungseffizienz und Zytotoxizität ohne genetische Manipulation überwindet. Aufgrund dieser 
herausragenden Eigenschaften haben wir 6-TramTO-3 im Weiteren mit Antibiotika-sensitiven wie auch 
multiresistenten Klebsiella pneumoniae-Stämmen getestet. 6-TramTO-3 verlieh beiden Stämme eine 
hochspezifische rot-fluoreszierende Verschiebung mit 91% und 87% in den 652-671 nm roten Kanal, 
ohne die Viabilität zu beeinflussen. Als nächstes führten wir Phagozytosetests mit menschlichen 
Makrophagen durch, wobei erstmalig ein unterschiedliches Wirtsverhalten gezeigt werden konnte. 
Neben der Veröffentlichung des Fachartikels wurden ein europäisches Patent angemeldet 
(18174086.1 - 1011) und zahlreiche Kooperationen mit Universitäten, Forschungsinstituten und 
Unternehmen initiiert, um 6-TramTO-3 in diversen Zusammenhängen anzuwenden. 
Der zweite Artikel wurde in Organic & Biomolecular Chemistry veröffentlicht und stellt ortho-
Tetrafluorazobenzolderivate als DNA-Interkalatoren für die photokontrollierbare Bindung an der DNA 
und den Nukleosomen durch Bestrahlung mit sichtbarem Licht vor. Dieses ist für biologische Systeme 
weniger schädlich und daher UV-Licht vorzuziehen, welches für die die Regulierung der bekanntesten 
photoschaltbaren nukleinsäurebindenden Systeme benötigt wird. Die Einführung einer solchen Einheit 
in das Grundgerüst des kleine Furchen bindenden Netropsins führt zu einer dynamischen Kontrolle und 
änderte den Erkennungsmodus. UV-Vis-, HPLC- und NMR-Analyse zeigten die Photoisomerisierung der 
neuen Verbindungen. Eine DNA-Bindungsanalyse mittels UV-Vis-, Fluoreszenz- und CD-Spektroskopie 
ergab einen interkalierenden Bindungsmodus mit Affinitäten im niedrigen nM-Bereich und 
Unterschieden zwischen den Isomeren. Schließlich wurde die Verwendung des neuen Derivats als 
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lichtkontrollierbare nukleosomenbindende Substanz untersucht. Die bei freier DNA beobachteten 
unterschiedlichen Bindungsaffinitäten wurden für die nukleosomale DNA bestätigt. Interessanterweise 
zeigten Elektromobilitäts-Shift-Untersuchungen und dynamische Lichtstreuungsexperimente, dass die 
trans-Form der Verbindung eine Aufweitung der nukleosomalen DNA induzierte, die zur Entwindung der 
Nukleosomen führte. Diese Erkenntnisse werden dazu beitragen, eine photochemische Kontrolle 
einzuführen, um den Weg zur Veränderung von nukleosomenbasierten Prozessen durch Licht zu ebnen. 
Das dritte Kapitel dieser Arbeit ist ein in Revision stehendes Manuskript im Journal Organic Letters und 
befasst sich mit einem neuartigen Syntheseansatz der Pyrrol-Imidazol (Py-Im)-DNA-bindende Polyamide 
auf der Basis von 4-Methyltrityl (Mtt) Festphasenpeptidsynthese (SPPS) zugänglich macht. Üblicherweise 
werden Py-Im-Polyamid-Haarnadeln durch Boc- und Fmoc-SPPS synthetisiert. Neue Mtt-geschützte 
Pyrrol- und Imidazol-Bausteine wurden mit höheren Ausbeuten als die entsprechenden Boc- und Fmoc-
Analoga synthetisiert. Ihre Anwendung konnte durch die Synthese und Untersuchung eines DNA-
bindenden Polyamids unter Einsatz der Mtt-Bausteine erfolgreich gezeigt werden. Unsere Methode ist 
orthogonal zu Fmoc und ermöglicht die Implementierung basenlabiler Verbindungen und anderer 
empfindlicher Gruppen in der Py-Im-Polyamidchemie, wodurch neue Polyamidkonjugate erhalten 
werden können. In einem weiteren Versuch war es bereits möglich, die neuen Bausteine für die 
Einführung einer photoschaltbaren Verbindung in das Polyamid-Haarnadel-Rückgrat zu verwenden, die 
die Einführung von dynamischer und räumlicher Kontrolle der sequenzspezifischen DNA-Bindung in 
biologischen Untersuchungen ermöglicht. 
Das vierte Kapitel ist ein in bearbeiteter Revision stehendes Manuskript im Journal of Chemical 
Education, welches einen neuartigen Kurs für Masterstudenten in den Fächern Chemie und Biologie 
vorstellt, um die vorhandene Lücke zwischen interdisziplinärer Spitzenforschung und der Ausbildung 
künftiger Wissenschaftler zu schließen. Mit anderen Worten, der Kurs zielte darauf ab, durch die 
Kombination von Vorlesungen, einem entdeckungsbasierten Forschungslaborkurses und 
wissenschaftlicher Kommunikation das authentische „Gesamtbild“ der Wissenschaft zu vermitteln. Die 
Studierenden erlebten die Vorteile von Kollaborationen, verfassten einen kurzen Artikel und wurden bei 
der Konzeption und Präsentation ihrer eigenen Forschungsvorschläge in der Chemischen Biologie 
angeleitet. Die Evaluation des Kurses zeigte eindeutig, dass die Lehrveranstaltung kooperative 
Forschungsbeziehungen zwischen Biologie- und Chemiestudenten fördert, ein einzigartiges und echtes 
Forschungserlebnis bietet und das Interesse der Studierenden an interdisziplinären Ansätzen und 
gemeinsamer Arbeit erhöht. Das Kurs- und Bewertungsmaterial wird zugänglich sein, um andere 
interdisziplinäre Wissenschaftsbereiche zu inspirieren ähnliche Kurse durchzuführen. 
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4.1 A Far-Red Fluorescent DNA Binder for Interaction Studies of Live 




Turning the light on: The fluorescent labeling agent 6-TramTO-3 was developed for real‐time analysis of 
bacterial infection. This far‐red fluorescent nucleic acid stain efficiently labeled bacteria through DNA 
binding without affecting their growth or viability. Staining of Klebsiella pneumoniae, a major threat to 
hospitalized patients, uncovered different interaction strategies of antibiotic‐resistant and antibiotic‐
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A Far-Red Fluorescent DNA Binder for Interaction Studies of Live
Multidrug-Resistant Pathogens and Host Cells
Leon N. Schulte+, Benedikt Heinrich+, Harshavardhan Janga, Bernd T. Schmeck, and
Olalla V#zquez*
Abstract: Transgene expression of green fluorescent protein
(GFP) has facilitated the spatiotemporal investigation of host–
pathogen interactions; however, introduction of the GFP gene
remains challenging in drug-resistant bacteria. Herein, we
report a novel far-red fluorescent nucleic acid stain, 6-
TramTO-3, which efficiently labels bacteria through a DNA
binding mode without affecting growth and viability. Exem-
plarily, we stained Klebsiella pneumoniae, a major threat to
hospitalized patients, and deciphered divergent interaction
strategies of antibiotic-resistant and antibiotic-sensitive Kleb-
siella strains with immune cells. 6-TramTO-3 constitutes an
off-the-shelf reagent for real-time analysis of bacterial infec-
tion, including strains for which the use of genetically encoded
reporters is not feasible. Eventually, our approach may aid the
development of strategies to combat a major worldwide health
threat: multidrug-resistant bacteria.
The discovery, characterization, and implementation of the
green fluorescent protein (GFP) has unquestionably revolu-
tionized modern molecular cell biology, and was recognized
by the Nobel Prize in Chemistry in 2008.[1] Nowadays, GFP
derivatives are widely used as fluorescent reporters to study
biological processes at the cellular and molecular level. In the
case of bacterial infection, we and others have used GFP for
fluorescence labeling of bacteria to study host–pathogen
interactions with unprecedented sensitivity down to single-
cell resolution.[2] These novel approaches have the potential
to transform our understanding of bacterial strategies to
override host immunity but currently rely on genetic manip-
ulation. Unfortunately, several important organisms have
remained difficult to modify for fluorescent-protein expres-
sion, in particular the growing number of multidrug-resistant
bacteria posing an emerging threat to patients in clinics
worldwide. Specifically, these strains may acquire resistance
to the antibiotics used to select transformants carrying the
fluorescent-protein transgene. Thus, the investigation of host-
cell interplay with drug-resistant bacteria by means of
fluorescence labeling has lagged behind.
Excessive use of antibiotics has propelled the spread of
multidrug-resistant bacteria at alarming rates.[3] As a conse-
quence, incremental failure of antimicrobial treatment in
patients leads to increased fatality rates due to the systemic
spread of bacteria and organ failure. Among a number of
major disease-causing agents, Klebsiella pneumoniae has
received highest research priority by the World Health
Organization owing to rapid acquisition of novel resistances.[4]
New research tools compatible with resistant bacteria, such as
fluorescence-labeling approaches, are urgently required.
Detailed investigation of the disease-causing strategies of
drug-resistant bacteria interacting with their hosts will assist
rational drug design[5] and may eventually reduce fatality
rates of infected patients.
Herein, we report the synthesis and applicability of novel
far-red fluorescent DNA cyanine dyes for straightforward live
bacterial cell labeling, allowing subsequent infection studies.
We identified 6-TramTO-3 as a vital dye, conferring bacteria
fluorescence staining without compromising microbial
growth. We exemplify our approach with Escherichia coli as
well as antibiotic-resistant and antibiotic-sensitive K. pneu-
moniae strains. Importantly, our results reveal differential
strategies of the examined strains in their interaction with
primary human host cells.
In the past decades, chemical biology has made great
strides towards the development of fluorescent small mole-
cules as alternatives to genetically encoded fluorescent
reporters. Particularly in the context of inflammation, fluo-
rophores have recently been shown to selectively track[6] or
report the activity[7] of phagocytic immune cells, such as
macrophages. These cells play a major role in the clearance of
bacteria in a process referred to as phagocytosis. For the study
of bacteria–phagocyte interactions,[8] fluorescein derivatives
have been used in bacteria uptake assays,[9] though they tend
to suffer from quenching in environments with low pH values.
Nanospheres may fluorescently label living bacteria, although
the consequences for bacterial viability are unclear.[10]
BODIPY derivatives have been used to stain obligate intra-
cellular bacteria, however with high background due to host-
cell co-staining[11] and continuous fluorescence emission
independent of target structure binding. Light-up DNA
binders have been used instead, but at the expense of
compromising bacteria viability.[12] For example, live bacterial
cells have been labeled for macrophage uptake assays with
the nucleic acid stain SyTO-9TM.[ 9e, 13] However, reduced
colony formation by the stained bacteria was observed,[9e]
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indicative of toxicity, which compromises the use of SyTO-9TM
as a vital dye for pathogen–host investigations. Taking SyTO-
9TM as a starting point, and due to the excellent spectroscopic
properties of such cyanine compounds,[14] we aimed at the
synthesis of a versatile azide-functionalized unsymmetrical
NIR cyanine dye, 6-AzTO-3, based on classical thiazole
orange (TO) and related compounds.[15] To increase both
solubility and affinity, we also prepared two amino deriva-
tives: 6-NH2TO-3 and 6-TramTO-3 (Figure 1; see the Sup-
porting Information for compound synthesis).
Initially, we evaluated whether our compounds and other
common fluorophores for biological research, such as ethid-
ium bromide (EtBr), carboxyfluorescein succinimidyl ester
(CFSE), or SyTO-9TM, could enable fluorescent labeling of
live E. coli without affecting viability. The bacterial culture
medium was supplemented directly with the candidate
compounds, and E. coli growth was monitored over time
(Figure 2; see also Figure S43A in the Supporting Informa-
tion). At mid-exponential growth phase, fluorescence labeling
was determined by fluorescence-activated cell sorting (FACS)
analysis. Importantly, none of the standard fluorophores
(EtBr and CFSE) was found eligible for bacterial vital
staining at 2.5 mm : Despite being compatible with bacterial
growth, CFSE hardly labeled bacteria at all, whereas EtBr did
not confer a pronounced fluorescence shift in the red/green/
yellow emission bands commonly used in FACS (see Fig-
ure S43B). As a possible explanation, EtBr displays intrinsic
membrane impermeability in living cells at low concentra-
tions.[14b] Interestingly, SyTO-9TM, which conferred efficient
green-fluorescence labeling, delayed bacterial growth sub-
stantially. Moreover, cross-emission into the yellow and red
spectrum was observed, rendering combination of SyTO-9TM
with other fluorophores difficult. Importantly, all our novel
cyanine dyes conferred a highly specific red-fluorescence shift
of live bacteria in the 652–671 nm red2 channel, as deter-
mined by FACS (Figure 2; see also Figure S43B) and
microscopy (see Figure S41). Notably, the compound 6-
TramTO-3 was fully compatible with normal bacterial
growth in liquid medium (Figure 2) and on solid medium
(see Figure S44B), thus suggesting no effects on viability.
Importantly, 6-TramTO-3 fluorescence labeling remained
stable over several hours after shifting the bacteria into dye-
free media (see Figure S45). Consequently, we selected 6-
TramTO-3 as the most promising candidate for further
spectroscopic characterization as well as DNA-binding-affin-
ity, sequence-selectivity, and activity studies with antibiotic-
sensitive and antibiotic-resistant bacteria.
In aqueous solution, 6-TramTO-3 shows long-wavelength
maxima of excitation and emission (633 and 645 nm, respec-
tively; see Figure S24B) and low intrinsic fluorescence (FF =
0.005). Remarkably, upon the addition of double-stranded
calf thymus DNA (dsDNACT), the fluorescence emission
intensity increased dramatically (> 25-fold; FF = 0.27), and
emission was stable over several hours (see Figures S27–S29).
Interestingly, this fluorescence increase outcompetes that
observed for EtBr under the same conditions (Figure 3A).
Furthermore, the 6-TramTO-3 emission maximum was found
to be shifted to the far-red part of the spectrum, which
enabled 6-TramTO-3 detection in the FACS red2 fluores-
cence channel. Our results also suggest the implementation of
Figure 1. A) Schematic representation of growth-compatible bacterial
labeling for host–pathogen studies: Live bacteria cells are labeled with
far-red fluorescent dyes and subsequently added to host-cell cultures.
Host cells containing bacteria may be identified by FACS or microsco-
py for detailed host–pathogen interaction analysis. B) Chemical struc-
ture of the synthesized and tested far-red dyes.
Figure 2. A) Optical density (OD600 nm) of E. coli LB cultures supple-
mented with dimethyl sulfoxide (DMSO; light-gray line with dots), 6-
TramTO-3 (black line with squares), CSFE (gray line with rhombuses),
or Syto-9TM (gray line with triangles) over time. Mean data points and
standard deviations are derived from three independent experiments.
B) Representative dot plots of bacteria, including quantification from
three independent experiments (see Figure S48C), from (A) sampled
at OD600 nm = 2.0 and analyzed by FACS in the red1, red2, green, and
yellow channels.
Figure 3. A) Fluorescence emission spectra in Tris buffer (pH 7.6) and
50 mm KCl at 20 8C of a 1 mm solution of: 6-TramTO-3 alone (black
line with black squares), 6-TramTO-3 in the presence of dsDNACT
(15 equiv; black line with black dots), EtBr alone (gray line with white
squares), and EtBr in the presence of dsDNACT (15 equiv; gray line
with white dots). Insert shows gel staining of different dsDNAs with 6-
TramTO-3 ; lines 1–3: circular bacterial dsDNA; lines 4–6: linearized
bacterial dsDNA; both in amounts of 1000, 500, and 100 ng. B) Emis-
sion profiles at 647 nm for titrations of 6-TramTO-3 with: dsDNACT
(black line with squares), dsDNAhGC (gray line with triangles), and
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6-TramTO-3 as a replacement for EtBr to post-stain DNA in
gel electrophoresis (Figure 3A; see also Figure S39).
To obtain more information on the affinity and selectivity
of 6-TramTO-3–DNA binding, we performed fluorescence
titrations with dsDNACT and hairpin oligonucleotides con-
taining either the sequence ATTA (dsDNAhAT) or GGCCC
(dsDNAhGC). In all cases, the addition of DNA resulted in
a progressive increase in fluorescence emission (Figure 3B).
The rise in the emission at 647 nm could be fitted to
a simplified 1:1 binding model, resulting in the corresponding
apparent dissociation constants. The calculated affinity of 6-
TramTO-3 for dsDNACT (KD = (19.5: 2.6) mm) is reminiscent
of previously obtained results for DNA intercalators, such as
EtBr (KD = 15 mm), methylene blue (KD = 46 mm), and acri-
dine orange (KD = 36 mm) with the same DNA.
[16] Further-
more, thermal melting experiments showed significant
dsDNACT stabilization upon 6-TramTO-3 binding (DTm =
5 8C). 6-TramTO-3 displays a higher affinity for both hairpin
oligonucleotides than for dsDNACT. Analysis of the apparent
dissociation constants of 6-TramTO-3 for dsDNAhAT and
dsDNAhGC (KD = (0.114: 0.03) mm, KD = (0.104: 0.054) mm,
respectively) indicates non-sequence-specific binding, further
supporting the intercalation binding mode.[17] The slightly
lower fluorescence intensity observed with dsDNAhGC might
be explained by photoinduced electron transfer (PET) in GC-
rich sequences.[18] Next, to better understand the binding
mode of 6-TramTO-3, we carried out absorbance titrations
(Figure 4a). The addition of dsDNACT (< 2.5 equiv of DNA)
caused a dramatic change in the absorption spectrum: A
102 nm blue shift of the absorption maximum of 6-TramTO-3
was observed, and was also found to be temperature-
dependent (see Figure S37). Further increments in the
number of equivalents of DNA promoted a new response:
a red-shifted transition with a maximum intensity at 631 nm.
This result points to a half-intercalating binding mode.
Circular dichroism (CD) experiments corroborated the
suggested binding modes (Figure 4B). Taken together, our
findings show that 6-TramTO-3 behaves as a novel DNA-
intercalating dye compatible with bacterial cell growth,
conferring fluorescence labeling at an emission wavelength
suitable for routine FACS analysis.
Having established an assay for fluorescence labeling of
live E. coli cells, we tested the applicability of 6-TramTO-3 for
the staining of clinically relevant bacteria that are hard to
modify genetically owing to resistance to selection antibiotics.
A lack of genetic tools has hampered studies on the
interaction of such strains with host cells by standard
methods, such as fluorescence microscopy or FACS. To test
whether our dye could overcome this current limitation, we
focused on the major human pathogen K. pneumoniae. To this
end, antibiotic-resistant and antibiotic-sensitive K. pneumo-
niae were cultured and compared with E. coli. Resistance to
standard antibiotics was confirmed by spotting bacterial
dilutions onto solid medium (Figure 5A). Whereas multi-
resistant K. pneumoniae were insensitive to kanamycin,
ampicillin, and chloramphenicol, both E. coli and the other
K. pneumoniae strain were sensitive to all three antibiotics.
All bacterial strains were successfully fluorescently labeled
(Figure 5B; see also Figure S44A) and grew normally in the
presence of 6-TramTO-3 (see Figure S44B,C). Thus, 6-
TramTO-3 does not disturb bacterial growth and overcomes
the current lack of a universal fluorescence-labeling approach
for multidrug-resistant pathogenic bacteria.
After demonstrating the successful fluorescence labeling
of multiresistant microbes, we sought to evaluate the use of 6-
TramTO-3 in studies addressing the interaction of these
bacteria with host cells. Bacterial infections typically occur
through ingestion or inhalation and subsequent colonization
of the mucosal surfaces of the lung or gastrointestinal tract.
Resident immune cells, such as macrophages, may phagocy-
tose and neutralize bacteria or signal to the environment to
prevent them from causing disease.[19] In a proof-of-principle
experiment we examined the interaction of E. coli and both
Klebsiella strains with primary human macrophages through
bacterial labeling with 6-TramTO-3. Nonpathogenic E. coli
have previously been shown to be readily phagocytosed by
macrophages.[20] Consequently, the E. coli strain used in this
study was readily taken up in coculture experiments, as
indicated by a red shift of approximately 26 % of the
macrophages (Figure 6A,B). Importantly, phagocytosis rates
Figure 4. A) UV/Vis spectra of 12.3 mm solutions and B) CD spectra of
36.9 mm solutions of: 6-TramTO-3 alone (black dotted line), 6-TramTO-
3 in the presence of increasing amounts of dsDNACT (<2.5 equiv;
black lines), and 6-TramTO-3 in the presence of increasing amounts of
dsDNACT (>2.5 equiv; gray lines) in Tris buffer (pH 7.6) with 50 mm
KCl at 20 8C. All data are mean values derived from three independent
measurements.
Figure 5. A) Indicated dilutions of bacteria sampled at OD600 nm = 2.0
were spotted onto LB solid medium without antibiotics (LB) or
supplemented with ampicillin (LB Amp), kanamycin (LB Kan), or
chloramphenicol (LB Cm), followed by outgrowth for 48 h. E.co =
E. coli ; K.pnR =multiresistant K. pneumoniae ; KpnS =antibiotic-sensitive
K. pneumoniae. B) Representative dot plots of FACS analysis (red2 and
green channel) of all three strains in the presence of DMSO or 6-
TramTO-3, sampled at OD600nm = 2.0, including quantification from
three independent experiments (see Figure S48A).
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obtained with 6-TramTO-3-labeled E. coli matched results
obtained with yellow fluorescent protein (YFP) expressing
E. coli (see Figure S46), thus confirming the reliability of our
cyanine dye approach.
Separation of 6-TramTO-3-positive from 6-TramTO-3-
negative (unstained) macrophages by FACS and subsequent
quantitative real-time PCR (qRT-PCR; Figure 6D) con-
firmed that the red-shifted population comprised macro-
phages that had taken up bacteria. Interestingly, in Klebsiella-
exposure experiments only approximately 4 % of the macro-
phages took up the antibiotic-resistant strain, whereas
approximately 0.2% took up the antibiotic-sensitive strain
(Figure 6A,B), as confirmed by FACS and qRT-PCR. Intri-
guingly, the antibiotic-resistant strain was found to be
encapsulated, whereas the antibiotic-sensitive strain does
not possess a capsule (see Figure S47). This result implies that
besides the capsule, Klebsiella may employ further means to
prevent phagocytic uptake.
To trace the fate of macrophages with phagocytosed
bacteria, co-staining with the yellow-fluorescent cell-death
stain propidium iodide was performed. As compared to the
macrophage subpopulation without intracellular bacteria
(lower-left quadrants in Figure 6A), the macrophage subpo-
pulation with phagocytosed E. coli or sensitive and multi-
resistant K. pneumoniae (upper-left quadrants in Figure 6A)
in the same culture dish preferentially entered cell death
(Figure 6C). This result is in line with the reported role of
macrophages in digestion and subsequent self-degradation as
part of bacterial clearance.[21]
Together these observations suggest that the examined
Klebsiella strains adopt different virulence strategies:
Whereas the encapsulated, multidrug-resistant strain evades
clearance by antimicrobial compounds, but only partially
evades phagocytosis, the antibiotic-sensitive strain has
learned to cope with clearance by immune cells, such as
macrophages. Follow-up investigations using 6-TramTO-3 to
screen uptake rates of non-encapsulated K. pneumoniae
strains by macrophages may reveal novel virulence factors
involved in the evasion of phagocytosis by this major
pathogen. To the best of our knowledge, no direct comparison
of the interaction of antibiotic-resistant and antibiotic-sensi-
tive pathogens with human immune cells has been provided
previously by means of fluorescence labeling (Figure 7).
In conclusion, we synthesized and studied a novel far-red
fluorescent cyanine derivative, 6-TramTO-3, for live bacte-
rial-cell tracking. 6-TramTO-3 is a fluorescent light-up probe
with an up to 27-fold signal increase in the presence of
dsDNA and no apparent effects on bacteria viability. We
demonstrated efficient labeling of multidrug-resistant bacte-
ria, the fluorescence tagging of which by genetic manipulation
is not feasible. Thereby, our exemplary investigations with
pathogenic microbes revealed divergent interaction modes of
multiresistant and antibiotic-sensitive Klebsiella bacteria with
human macrophages. We anticipate that our approach will
open the door to further advanced applications, such as dual
RNA-Seq[2b] or single-cell RNA-Seq,[2c] to understand the
disease strategies of antibiotic-resistant bacteria, an emerging
worldwide threat.
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Figure 6. A) Representative dot plots of human macrophages exposed
to 6-TramTO-3-labeled bacteria; the observed shift into the red channel
is indicative of bacterial uptake. B) Quantification of red-shifted macro-
phages. Data are derived from five independent experiments. C) Quan-
tification of propidium iodide (PI)-positive macrophages with (red-
shifted) or without bacteria (unshifted). D) Experimental scheme and
qRT-PCR using RNA from both fractions to determine the relative
abundance of human U6 snRNA versus bacterial housekeeper RNA
GyrA. E.co.= E. coli ; K.pnR = multiresistant K. pneumoniae ;
K.pnS = antibiotic-sensitive K. pneumoniae. Statistical significances
were evaluated using a one-way Anova (B) or a two-tailed Student t-
test (C). * P,0.05; ** P,0.01.
Figure 7. Model illustrating the observed interaction of antibiotic-
sensitive and antibiotic-resistant bacteria with human macrophages.
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Abstract: Transgene expression of green fluorescent protein (GFP) has facilitated the spatio-temporal investigation of host-pathogen 
interactions; however, the introduction of the GFP gene remains challenging in drug-resistant bacteria. Herein, we report a novel far-red 
fluorescent nucleic acid stain, 6-TramTO-3, which efficiently labels bacteria through a DNA binding mode without affecting growth and viability. 
Exemplarily, we stained Klebsiella pneumoniae, a major threat to hospitalized patients, and deciphered for the first time, divergent interaction 
strategies of antibiotic-resistant and -sensitive Klebsiella strains with immune cells. 6-TramTO-3 constitutes an off-the-shelf-reagent for real-
time analysis of bacterial infection, including strains where the use of genetically-encoded reporters is not feasible. Eventually, our approach 
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Experimental Procedures 
Materials and Experimental Procedures 
All commercially purchased reagents were used without further purification as delivered from the corresponding company. The 
respective reagents were purchased from the following companies: lepidine, N,N'-diphenylformamidine, 2-methylbenzothiazole, 
ethyliodide, copper powder, triphenylphosphine, DMSO for molecular biology, ethidium bromide, potassium chloride, 2,6-lutidine and 
DNA hairpins from Sigma Aldrich (USA), tris(2-carboxyethyl)phosphine (TCEP), acetic anhydride, copper(II) sulfate, 
Tris(hydroxymethyl)aminomethane (Tris) and sodium chloride from Carl Roth (Germany), nigrosin and crystal violet from Merck 
(Germany), sodium azide, and propargylamine from Acros Organics (Belgium), triethylamine and acetonitrile (MeCN) from VWR (USA), 
dibromohexane from Alfa Aesar (USA), copper(I) bromide from Santa Cruz Biotechnology (USA), trifluoroacetic acid (TFA) from abcr 
(Germany), Atto 655 NHS-ester from Atto-tec (Germany), SYTO-9TM nucleic acid stain from Life Technologies (USA), 
carboxyfluorescein N-succinimidyl ester (CFSE) from Thermo Fisher (Germany), CSL 1kb DNA ladder from Cleaver Scientific (UK) and 
calf thymus DNA (dsDNACT) and Alexa Fluor
® 647 C2-maleimide was purchased from Invitrogen (USA). Water was purified with a milli-
Q Ultra Pure Water Purification System (TKA, Germany). 
High-Performance Liquid Chromatography (HPLC) 
For preparative purposes, a PLC 2020 Personal Purification System (Gilson) with a preparative Nucleodur C18 HTec-column (5 µm, 
250 x 16 mm; Macherey & Nagel) using an isocratic regime during the first five minutes for column equilibration, followed by a linear 
gradient 5% to 75% B in 30 min, for both compounds: 6-TramTO-3 (2) and 6-NH2TO-3 (3), with a flow rate of 10 mL/min at 25°C was 
used. The detection was carried out by measuring the absorption at wavelengths: 220 nm and 300 nm. Milli-Q water (A) and MeCN (B) 
were employed as eluents with an addition of 0.1% of TFA for both solvents. 
For analytical purposes, an Agilent 1260 Infinity II HPLC-System (Agilent Technologies) with an EC 125/2 Nucleodur 100-C18 ec 
column (Macherey & Nagel) using an isocratic regime during the first five minutes for column equilibration, followed by a linear gradient 
5% to 75% B in 30 min with a flow rate of 0.2 mL/min at 55°C was used. The detection was carried out by measuring the absorbance 
at a wavelength of 660 nm for the NIR cyanine dye derivatives 1, 2 and 3. In all cases, milli-Q water (A) and MeCN (B) were employed 
as eluents with an addition of 0.05% of TFA for A and 0.03% for B.  
Below the HPLC chromatograms of the synthesized NIR cyanine dyes used in the bacteria cell-based experiments: 
 
 
Figure S1: Structure of 6-AzTO-3 (1) used in the bacteria cell-based assays and its corresponding HPLC chromatogram. 
 
 
Figure S2: Structure of 6-TramTO-3 (2) used in the bacteria cell-based assays and its corresponding HPLC chromatogram. 




Figure S3: Structure of 6-NH2TO-3 (3) used in the bacteria cell-based assays and its corresponding HPLC chromatogram. 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
All NMR spectra were automatically measured at 300 K either in a Bruker AV III HD 300 MHz at a frequency of 300 MHz (1H) or 75 MHz 
(13C) or in a Bruker AV III HD 500 MHz at a frequency of 500 MHz (1H) or 125 MHz (13C). All chemical shifts (δ) are relative to 
tetramethylsilane (TMS), i.e. δ(TMS) = 0 ppm. As internal standards, deuterated chloroform (CDCl3), dimethyl sulfoxide (DMSO) with 
TMS were used. Solvent shifts (ppm): δ(CHCl3) = 7.26 ppm (
1H), δ(CHCl3) = 77.16 ppm (
13C), δ(DMSO) = 2.50 ppm (1H), δ(DMSO) = 
39.52 ppm (13C).[1] The assignment of each signal was based on two-dimensional nuclear magnetic resonance spectroscopy (2D NMR) , 
i.e. heteronuclear single quantum coherence (HSQC), heteronuclear multiple bond correlation spectroscopy (HMBC) and correlation 
spectroscopy (COSY).  
Mass Spectrometry 
Electrospray ionization mass spectrometry (ESI-MS) was performed on a Finnigan LTQ-FT (Thermo Fischer Scientific). EI-MS was 
performed on an AccuTOF GCv (JEOL). 
Fluorescence Measurements 
Fluorescence measurements and titrations were performed on a Jasco FP-6500 spectrofluorometer equipped with a Thermo Haake 
WKL 26 water recirculator at 20°C. Unless otherwise noted, a 1400 µL fluorescence cuvette of HellmaAnalytics (104F-QS) was used 
and the measurements were performed with the following settings: increment: 1.0 nm; integration time: 0.2 s; speed: 500 nm/min; 
sensitivity: medium; excitation slit width: 3 nm; emission slit width: 3 nm; excitation wavelength 610 nm. The emission spectra were 
recorded from 625 to 750 nm at 20°C. From all spectra, the corresponding background signal was subtracted.  
 
The used hairpin double-stranded DNAs: dsDNAhAT and dsDNAhGC had the following sequences: 
 
Table S1. Binding sites and sequences of DNA hairpins, which were used for fluorescence titrations experiments. 
DNA binding site sequence (5’ – 3’) 
dsDNAhAT ATTA GGCGATTACAGCTTTTTGCTGTAATCGCC 
dsDNAhGC GGCCC GGCAGGCCCAGCTTTTTGCTGGGCCTGCC 
 
Fluorescence Quantum Yield  
Fluorescence intensity values for the quantum yields were determined on an ISS PC1 spectrofluorometer with an ISS 11650 lamp 
connected to an ISS Simpson model 109 and an ISS 80011 photomultiplier connected to a MGW Lauda K2R D and an Amherst 
Scientific Corp. 7600F for cooling. A VWR Refrigerated Circ 1160S was connected for the cooling of the cuvette chamber. It was 
measured in a 1400 µL fluorescence cuvette of HellmaAnalytics (104F-QS) at 25°C using the following settings: increment: 2.0 nm; 
integration time: 1.0 s; excitation slit width: 0.25 mm; emission slit width: 0.5 mm; excitation wavelength 590 nm. The emission spectra 
were recorded from 610 to 750 nm. From all spectra the corresponding background signal was substracted. Absorbance values were 
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measured on a Jasco V-650 UV-Vis Spectrophotometer equipped with a Jasco PAC-743 temperature controlled cell holder and a 
Julabo F250 cooling system. UV-Vis titration measurements were performed in a 1400 µL quarz cuvette with a pathlength of 1 cm at 
25°C using the following settings: increment: 1.0 nm; bandwidth: 1.0 nm; scanning speed: 1000 nm/min; scanning mode: continuous. 
From all values, the corresponding background signal was substracted. The values for the reference compounds were measured in 
duplicates, the ones for 6-TramTO-3 with and without dsDNACT in triplicates. The quantum yields of 6-TramTO-3 with (30 eq) and 
without dsDNACT were determined in 10 mM Tris pH 7.6 and 50 mM KCl. All measurement were following the procedure of Horiba
[2] 
and using the equation:  
 







2 )  (S1) 
 
where Φ = fluorescence quantum yield, η = refractive index of the used solvent, Grad = gradient from the plot of integrated fluorescence 
intensity vs absorbance and the subscripts ST and X denote standard and tested sample.  
 
As reference compounds, Atto 655 in PBS pH 7.4 (Φ = 0.30) [3] and Alexa Fluor® 647 in 50 mM potassium phosphate pH 7.2 and 
150 mM NaCl (Φ = 0.33)[4] were used. All solvents were degased before use.  
UV-VIS Measurements 
UV-Vis titration measurements were performed on a Jasco V-650 UV-Vis spectrophotometer equipped with a Jasco PAC-743 
temperature controlled cell holder and a Julabo F250 cooling system to maintain the temperature constant at 20°C during the 
measurements. UV-Vis titration measurements were performed in a 500 μL quarz cuvette with a pathlength of 1 cm at 20°C. The 
absorbance spectra were recorded from 400 nm to 800 nm. 
The concentration determination and measurement of full UV-Vis spectra were performed on a Tecan 20M at room temperature. The 
measurements were performed in a 1400 μL quarz cuvette with a pathlength of 1 cm in a volume of 1 mL. 
CD Measurements 
CD titration measurements were performed on a Jasco J-810 Spectropolarimeter equipped with a Jasco CDF-426S peliter controller 
and a Thermo Haake WKL 26 water recirculator at 20°C using a 350 µL CD cuvette of HellmaAnalytics (110-QS) at a concentration of 
36.9 μM of 6-TramTO-3 in 10 mM Tris pH 7.6 and 50 mM KCl. The settings were: range from 750-450 nm, speed of 100 nm/min, 
response of 4 s, band width of 10 nm and a data pitch of 1 nm. The measurement was performed 2 min after the addition of dsDNACT. 
Each measurement consisted of a mean of 5 measurements. Three independent measurements were performed.  
Thermal Melting Analysis 
Thermal melting analysis was performed on a Jasco J-810 spectropolarimeter equipped with a Jasco CDF-426S peliter controller and 
a Thermo Haake WKL 26 water recirculator. It was measured at a concentration of 45 μM of dsDNACT with and without 1.8 μM of 6-
TramTO-3 in 10 mM Tris pH 7.5. The measurement was performed at 260 nm, with a response of 2 s, a band width of 10 nm, from 40-
95°C, a slope of 2°C/min. Three independent measurements were recorded and the intensity normalized.  
Gel Electrophoresis 
Gel electrophoresis was performed with a Mini-Sub® Cell GT Cell (Biorad, USA) system with a power supply: MP-300V (Major Science, 
USA), for 75 min at 25°C with constant 80 V. For the experiments, 6 µL of 1000 ng, 500 ng and 100 ng of dsDNAbc and dsDNAbl in 
TAE, containing 10% glycerol were loaded. As DNA ladder, CSL 1kb ladder was used. The gel was resolved in 1% agarose gel using 
TAE as a running buffer and analyzed by post-staining with either 1 µM of 6-TramTO-3, or 1 µM ethidium bromide in TAE buffer. The 
gel was visualized using a Typhoon TRIO Variable Mode Imager (Amersham Biosciences, UK). To visualize the gel stained by 6-
TramTO-3, we used: the emission filter 670 BP 30 Cy5, the red laser (633 nm), PMT 400, pixel size 25 microns and normal sensitivity. 
For the case of the gel stained ethidium bromide, we used: no filter, an ECL + Excitation, PMT 400, pixel size 25 microns and a normal 
sensitivity. 
Bacteria and Host Cell Culture 
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Bacteria Culture and Staining / Destaining Experiments 
Escherichia coli (E. coli) NEB5α (New England Biolabs) and antibiotic-resistant (Prof. Jörg Vogel, Würzburg) and –sensitive (Prof. 
Reinier Mutter, Marburg) Klebsiella pneumoniae (K. pneumoniae) were cultured in Luria-Bertani (LB) solid medium (LB-Agar) over-
night at 37°C. For staining, growth curve analysis and replating experiments bacteria were suspended in LB liquid medium at an 
OD600 nm of 1.0 and 800 µL were transferred into a culture tube containing 7.2 mL of LB liquid medium supplemented with DMSO or 
candidate dyes (2.5 µM final concentration) followed by continuous shaking at 180 rpm and 37 °C. Density of bacterial cultures was 
measured using an Ultrospec 10 Cell Density Meter with 600 nm LED source (Amersham Biosciences). To address destaining of 6-
TramTO-3 labelled bacteria over time cells grown till an OD600 nm of 2 in the presence of the dye (2.5 µM final concentration) were 
washed five times with phosphate buffered saline (PBS) and resuspended in 8 ml fresh LB medium (without 6-TramTO-3) or added 
into X-Vivo15 host cell medium (without 6-TramTO-3) in 6-well culture dishes as described below (host cell culture). LB-cultures were 
placed back into the shaking incubator and X-vivo15 medium cultures were placed into the host cell incubator for the remainder of the 
experiment. For bacterial re-plating experiments bacteria were sampled at OD600 nm = 2.0 and 5 µL of indicated dilutions in LB-medium 
were spotted onto LB-agar plates (Fig. 5) or 100 µL were plated onto LB-agar plates followed by incubation at 37°C until colonies 
became visible. For generation of YFP-expressing Escherichia coli cells the strain introduced above (NEB5α) was chemically 
transformed with the pUCP20-eYFP plasmid (a gift from Mariette Barbier (Addgene plasmid # 78466) using the CaCl2-method. 
Bacteria Capsule Staining 
5 µl bacteria suspension grown till OD600 nm of 2 were placed on a microscopy slide and mixed with 1 µl nigrosin solution (100 mg 
nigrosin + 5 µl formalin per ml H2O). Bacteria/nigrosin mixture was spread out into a film and air-dried. The slide was then saturated 
with crystal violet solution (5 mg crystal violet + 200 µl methanol per 1 ml H2O) and after 1 min of incubation carefully rinsed with water. 
The slide was again air-dried and analyzed on an AXIO Vert.A1 wide-field microscope (Zeiss) at 63x magnification. 
Host Cell Culture and Exposure to Bacteria 
For primary human macrophage cultures buffy coats from blood donations were loaded onto LymphoprepTM gradient medium 
(Fresenius Kabi) followed by centrifugation. The peripheral blood mononuclear cell band was isolated from the gradient and monocytes 
were enriched using CD14 MACS beads (Miltenyi) according to the manufacturer ’s instructions. To differentiate monocytes into 
macrophages cells were cultured in 6-well plates (800.000 cells/mL) in 2 mL X-Vivo 15 medium (Lonza) supplemented with 5 % fetal 
bovine serum (Biochrom) and 15 ng/mL recombinant human GM-CSF (Preprotech). 
On day 7 macrophages were considered terminally differentiated and treated with stained bacteria. To this end bacteria stained as 
described above or modified for YFP expression were sampled at an OD600 nm = 2.0 and washed five times with phosphate buffered 
saline (PBS). After the last wash bacteria were brought to an OD600 nm of 2.0 and 16 µL, equivalent to 16.000.000 bacteria were added 
to each well to achieve a multiplicity of infection of 20. Culture plates were then centrifuged for 10 min at 250 g and 37°C to establish 
physical contact between macrophages and bacteria. Subsequently, culture plates were transferred back into a 37°C incubator with 
CO2 atmosphere for the remainder of the stimulation period. 
Fluorescence Microscopy 
Cell Preparation 
For microscopic analysis, bacterial cells cultures were taken up in PBS and added onto an IBIDI 8-wells glass bottom plate pre-coated 
with poly-L-lysine. After 10 min of incubation non-adherent bacteria were washed away with PBS and remaining bacteria were layered 
with a film of PBS, followed by microscopic analysis. 
Macrophage cells were grown and stimulated with bacteria as described above but grown in 35 mm IBIDI µ-Dish (800.000 cells per 
dish in 2 mL of culture medium). 
Microscope Settings 
For acquisition of confocal images, we used an LSM880 Laser Scanning Confocal Microscope (Zeiss, Germany). Images were acquired 
with a 63X 1.4 oil immersion objective, fluorescence excitation was obtained using the 633 nm laser line, fluorescence emission was 
detected in the 633-695 nm range. For the images of bacteria alone, pixel size is 0.05 microns and image size is 27.1X27.1 microns. 
For the images of macrophages co-incubated with bacteria, pixel size is 0.13 microns and image size is 135.0X135.0 microns, z-scaling 
is 0.5 microns. 




Bacteria and macrophages were washed with PBS prior to flow cytometry and analysed using a Guava easyCyte flow cytometer 
(Millipore). FCS3.0 files were analysed using Flowing Software (http://flowingsoftware.btk.fi/). Cells were first gated in the forward- / 
side-scatter plot to exclude debries, followed by quadrant gating in plots using the fluorescence channels as shown. For live/dead cell 
discrimination cells in PBS were supplemented with 0.4 μL/mL propidium-iodide (5 mg/ml solution) followed by 5 min incubation on ice. 
Propidium iodide signal was recorded in the yellow channel. 
Cell Sorting 
For separation of macrophages containing or not containing bacteria cells were washed twice with PBS, removed from the culture 
dishes using a rubber scraper and sorted using an Aria III Fluorescence Activated Cell Sorter (BD) with 100 µm nozzle and cooling. 
Sorting was performed with no more than 1000 events per second and ‘Single Cell’ purity setting. 
Quantitative Real-Time PCR 
For quantitative real-time PCR (qRT-PCR) analysis cell pellets were dissolved in Trizol reagent (Thermo Fisher) and RNA was extracted 
with chloroform. RNA from the aqueous phase was precipitated with isopropanol and washed once with 70% ethanol. Air-dried RNA 
was resuspended in water and treated with DNaseI (Thermo Fisher) according to the manufacturer’s instructions. RNA was extrac ted 
with 25:24:1 phenol, chloroform, isoamylalkohol (Roth) and precipitated with 30:1 ethanol, sodium-acetate (3M, pH5.5). RNA-pellet 
was washed once with 70% ethanol, air-dried and resuspended in double-distilled water. Nucleic acid concentration was determined 
using a Nanodrop-2000 spectrometer. 
To determine U6 and GyrA gene expression RNA samples were subjected to qRT-PCR analysis using the POWER SYBR Green RNA-
to-CT kit (Thermo Fisher) according to the manufacturer’s instructions and a QuantStudio3 device (Applied Biosystems). Primer 
sequences (ordered from Metabion) were: U6 forward: GCTTCGGCAGCACATATACTAAAAT, U6 reverse: 
ATATGGAACGCTTCACGAATTTG, GyrA forward: TTACACCGGTCAACATTGAGG, GyrA reverse: TTCATGGCGTAAAGTACGCG. 
Gene expression differences were calculated based on the Threshold-Cycle (CT) values according to the 2-ΔΔCT formula.[5] 
Bacterial DNA Preparation 
To obtain pure DNA for staining experiments chemically competent E. coli NEB5α cells were transformed with pUC18 plasmid DNA by 
heat-shock (42°C, 120 seconds) and subsequently shifted to LB medium containing Ampicillin (100 µg/ml). After shaking for 12 h at 
37°C and 180 rpm bacteria were pelleted by centrifugation and pUC18 plasmid DNA was isolated using the Plasmid Pure column 
purification kit (Macherey Nagel) according to the manufacturer’s instructions. For experiments with linearized bacterial DNA pUC18 
plasmid DNA was incubated overnight with KpnI restriction enzyme (Thermo Fisher) at 37°C, followed by purification using the GeneJet 
PCR purification kit (Thermo Fisher) according to the manufacturer’s instructions. Linearized DNA was eluted from the purification 
column with double-distilled water.  
SUPPORTING INFORMATION          
60 
Synthesis  
Below, it is shown the followed retrosynthetic approach for the preparation of the cyanine dye derivatives: 6-AzTO-3 (1), 6-TramTO-3 
(2) and 6-NH2TO-3 (3). The building block compounds (5), (6), (9) were synthesized according to the literature. Their analytical data 
were consistent with such literature. Compounds (7), (10) and (11) were commercially available. Other intermediates and finals 
compounds were synthesized following the procedures described below. 
 
Figure S4. Retrosynthetic approach for the preparation of the cyanine dye derivatives 6-AzTO-3 (1), 6-TramTO-3 (2) and 6-NH2TO-3 (3). 
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Synthesis of the Quinolinium Iodide (5) 
 
Figure S5. Synthesis route of quinolinium iodide (5) starting from lepidine (7). 
 
1-ethyl-4-methylquinolin-1-ium iodide (6): Following the procedure of PENG et al.,[6] lepidine (7, 143 mg, 1.00 mmol) was dissolved 
in toluene (1 mL) and ethyl iodide (0.10 mL, 1.25 mmol) was added. The mixture was refluxed in a sealed tube for 8 h. The resulting 
solid was crushed, washed several times with ethyl ether and dried under vacuum to yield the desired product 6 without further 
purification (280 mg, 0.94 mmol, 94%) as a green solid. Rf=0.35 (CH2Cl2/MeOH 10:1); 1H NMR (300 MHz, [D6]DMSO, 25°C): δ=9.42 
(d, 1H, 3J(H,H)=6.0 Hz; H-1), 8.60 (d, 1H, 3J(H,H)=8.9 H; H-6), 8.55 (d, 1H, 3J(H,H)=8.6 Hz; H-3), 8.26 (dd, 1H, 3J(H,H)=8.9 Hz, 
3J(H,H)=8.6 Hz; H-5), 8.01 – 8.11 (m, 2H; H-1 and H-4), 5.05 (q, 2H, 3J(H,H)=7.2 Hz; H-8), 3.01 (s, 3H; H-7), 1.59 (t, 3H, 
3J(H,H)=7.2 Hz; 
H-9); 13C NMR (75 MHz, [D6]DMSO, 25°C): δ=158.3 (Cq), 148.1 (CH), 136.5 (Cq), 135.1 (CH), 129.5 (CH), 128.9 (Cq), 127.1 (CH), 
122.8 (CH), 119.2 (CH), 52.5 (CH2), 19.6 (CH3), 15.2 (CH3); HRMS-ESI+ (m/z): [M]
+ calcd for C12H14N, 172.1121; found, 172.1122.
 
 
(E)-1-ethyl-4-(2-(phenylamino)vinyl)quinolin-1-ium iodide (5): Following a procedure of KISHINO et al.,[7] the iminium salt 6, (200 mg, 
0.67 mmol) and N,N’-diphenylformamidine (131 mg, 0.67 mmol) were mixed under vigorous stirring at 160°C for 30 min. The mixture 
was allowed to cool down to 25°C. The resulting solid was crushed and washed several times with ethyl ether. The crude product was 
recrystallized from ethanol. The crystallization was completed within one night at 0°C. The precipitate was filtered off and washed with 
ethanol and ethyl ether to yield the desired product 5 (169 mg, 0.42 mmol, 63%) as a brown solid. Rf=0.33 (CH2Cl2/MeOH 10:1); 1H 
NMR (300 MHz, [D6]DMSO, 25°C): δ=10.94 (s, 1H; NH), 8.89 (d, 1H, 3J(H,H)=12.5 Hz; H-8), 8.69 (d, 1H, 3J(H,H)=7.1 Hz; H-1), 8.32 
(d, 1H, 3J(H,H)=8.6 Hz; H-6), 8.22 (d, 1H, 3J(H,H)=8.7 Hz; H-3), 8.15 (d, 1H, 3J(H,H)=7.1 Hz; H-2), 8.05 (dd, 1H, 3J(H,H)=8.7 Hz, 
3J(H,H)=7.3 Hz; H-4), 7.81 (dd, 1H, 3J(H,H)=7.3 Hz, 3J(H,H)=8.6 Hz; H-5), 7.39 – 7.48 (m, 4H; H-9, H-10, H-12 and H-13), 7.13 (dd, 
1H, 3J(H,H)=7.2 Hz, 3J(H,H)=7.2 Hz; H-11), 6.74 (d, 1H, 3J(H,H)=12.5 Hz; H-7), 4.70 (q, 2H, 3J(H,H)=7.2 Hz; H-14), 1.48 (t, 3H, 
3J(H,H)=7.2 Hz; H-15); 13C NMR (75 MHz, [D6]DMSO, 25°C): δ=153.9 (Cq), 145.8 (CH), 143.3 (CH), 139.9 (Cq), 137.4 (Cq), 134.0 
(CH), 129.6 (3C; CH), 127.3 (CH), 125.0 (CH), 123.8 (CH), 123.8 (Cq), 118.3 (CH), 116.6 (CH), 109.9 (CH), 95.9 (CH), 49.8 (CH2), 
14.8 (CH3); HRMS-ESI+ (m/z): [M]
+ calcd for C19H19N2, 275.1543; found, 275.1545. 
  
SUPPORTING INFORMATION          
62 
Synthesis of the N-alkylated Benzothiazolium Intermediate (8)  
 
 
Figure S6. Synthesis route of N-alkylated benzothiazolium intermediate (8) starting from 1,6-dibromohexane (11) and 2-methylbenzothiazole (10). 
 
1,6-diidohexane (9): Following the procedure of SCHEUFFLER et al.[8] 1,6-dibromohexane (11, 20.0 mL, 130 mmol) was dissolved in 
acetone (500 mL) and potassium iodide (65.7 g, 396 mmol) was added. The suspension was refluxed overnight. After full conversion 
of the starting material the solvent was removed under reduced pressure. The remaining solid was resuspended in chloroform and 
filtered. The resulting solution was washed with destilled water; the aqueous layer was extracted once more with chloroform. The 
combined organic layers were dried over magnesium sulfate and the solvent was removed under reduced pressure to yield the desired 
product 9 without further purification (39.8 g, 118 mmol, 91%) as a pale orange liquid. Rf=0.86 (n-pentane); 1H NMR (300 MHz, CDCl3, 
25°C): δ=3.19 (t, 4H, 3J(H,H)=7.0 Hz; H-1 and H-6), 1.79 – 1.89 (m, 4H; H-2 and H-5), 1.39 – 1.47 (m, 4H; H-3 and H-4); 13C NMR 
(75 MHz, CDCl3, 25°C): δ=33.3 (2C; CH2), 29.5 (2C; CH2), 6.8 (2C; CH2); HRMS-EI+ (m/z): [M]
+ calcd for C6H12I2, 337.90284; found, 
337.90185. 
 
3-(6-iodohexyl)-2-methylbenzo[d]thiazol-3-ium (8): Under inert atmosphere, 2-methylbenzothiazole (10, 500 µL, 3.93 mmol) was 
added to 1,6-diidohexane (9, 3.24 mL, 19.7 mmol) and stirred at 110°C for 21.5 h. The reaction mixture was cooled to 25°C over 30 min 
and cooled for another 1 h at 4°C. The precipitate was filtered off and washed with cold ethyl ether to yield the desired product 8 
(730 mg, 2.03 mmol, 52%) as pale orange solid. Rf=0.39 (CH2Cl2/MeOH 10:1); 1H NMR (300 MHz, [D6]DMSO, 25°C): δ=8.45 (d, 2H, 
3J(H,H)=8.0 Hz; H-4), 8.35 (d, 2H, 3J(H,H)=8.5 Hz; H-1), 7.89 (dd, 2H, 3J(H,H)=8.5 Hz, 3J(H,H)=7.2 Hz; H-2), 7.80 (dd, 2H, 
3J(H,H)=8.0 Hz, 3J(H,H)=7.2 Hz; H-3), 4.70 (t, 2H, 3J(H,H)=7.8 Hz; H-5), 3.28 (t, 2H, 3J(H,H)=6.8 Hz; H-10), 3.22 (s, 3H; H-11), 1.80 – 
1.91 (m, 2H; H-6), 1.71 – 1.80 (m, 2H; H-9), 1.36 – 1.53 (m, 4H; H-7 and H-8); 13C NMR (75 MHz, [D6]DMSO, 25°C): δ=177.1 (Cq), 
140.8 (Cq), 129.4 (CH), 129.1 (Cq), 128.1 (CH), 124.6 (CH), 116.9 (CH), 49.1 (CH2), 32.6 (CH2), 29.4 (CH2), 27.6 (CH2), 24.7 (CH2), 
16.9 (CH3), 8.8 (CH2); HRMS-ESI+ (m/z): [M]
+ calcd for C14H19INS, 360.0277; found, 360.0275. 
  





Figure S7. 1H NMR and 13C NMR spectra of the compound (8). 
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Figure S8. COSY-NMR spectra of the compound (8). 
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Figure S9. HMBC-NMR spectra of the compound (8). 
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Synthesis of the Azido Cyanine Dye Derivative 6-AzTO-3 (1)  
 
Figure S10. Synthesis route of azido cyanine dye 6-AzTO-3 (1) starting from N-alkylated benzothiazolium intermediate (8) and quinolinium iodide (5). 
 
4-((1E,3Z)-3-(3-(6-azidohexyl)benzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)-1-ethylquinolin-1-ium iodide (1): The quinolinium (5, 
250 mg, 0.62 mmol) and thiazolium (8, 303 mg, 0.62 mmol) were dissolved in dichloromethane (1.5 mL) and methanol (1.5 mL). Acetic 
anhydride (585 µL, 6.20 mmol) and triethylamine (605 µL, 4.36 mmol) were added and the resulting mixture was heated at 30°C for 
one min. Afterwards, the reaction flask was wrapped in aluminum foil and stirring in the dark at 25°C for another 1.5 h, then the solvent 
was removed. The crude was washed with destilled water, dissolved in dichloromethane, dried over magnesium sulfate and purified by 
flash column chromatography (allox, MeOH in CH2Cl2: 0% → 0.1% → 0.2% → 0.3% → 0.4%). Under inert atmosphere, the obtained 
product was dissolved in DMF (3 mL) and sodium azide (53.0 mg, 0.82 mmol) was added. The resulting mixture was heated at 50°C 
for 18.5 h. The solvent was removed and the product purified by flash column chromatography (allox, MeOH in CH2Cl2: 0% → 0.1% → 
0.2% → 0.3% → 0.4%) to yield the desired product (1, 130 mg, 0.22 mmol, 35%) as blue solid. Rf=0.37 (CH2Cl2/MeOH 10:1); 1H NMR 
(300 MHz, [D4]MeOD, 25°C): δ=8.32 (d, 1H, 3J(H,H)=8.4 Hz; H-18), 8.05 (d, 1H, 3J(H,H)=7.2 Hz; H-15), 7.96 (dd, 1H, 3J(H,H)=12.3 Hz, 
3J(H,H)=13.3 Hz; H-12), 7.75 – 7.78 (m, 2H; H-20 and H-21), 7.51 – 7.56 (m, 2H; H-4 and H-19), 7.49 (d, 1H, 3J(H,H)=7.2 Hz; H-14), 
7.26 (dd, 1H, 3J(H,H)=8.2 Hz, 3J(H,H)=7.2 Hz; H-2), 7.16 (d, 1H, 3J(H,H)=8.2 Hz; H-1), 7.12 (dd, 1H, 3J(H,H)=7.9 Hz, 3J(H,H)=7.2 Hz; 
H-3), 6.95 (d, 1H, 3J(H,H)=13.3 Hz; H-13), 6.43 (d, 1H, 3J(H,H)=12.3 Hz; H-11), 4.40 (q, 2H, 3J(H,H)=7.2 Hz; H-16), 4.10 (t, 2H, 
3J(H,H)=7.8 Hz; H-5), 3.30 – 3.33 (m, 2H; H-10), 1.73 – 1.79 (m, 2H; H-6), 1.58 - 1.65 (m, 2H; H-9), 1.46 – 1.53 (m, 7H; H-7, H-8 and 
H-17); 13C NMR (75 MHz, [D4]MeOD, 25°C): δ=163.2 (Cq), 152.4 (Cq), 145.1 (CH), 142.8 (Cq), 142.4 (CH), 139.3 (Cq), 134.4 (CH), 
128.7 (CH), 127.6 (CH), 126.8 (CH), 126.4 (Cq), 126.0 (Cq), 125.3 (CH), 123.4 (CH), 118.2 (CH), 113.1 (CH), 110.6 (2C; CH), 99.8 
(CH), 52.4 (CH2), 50.9 (CH2), 47.0 (CH2), 29.8 (CH2), 28.3 (CH2), 27.6 (CH2), 27.3 (CH2), 15.0 (CH3); tR=33.3 min (5% to 75% B in 
30 min); HRMS-ESI+ (m/z): [M]+ calcd for C27H30N5S, 456.2216; found, 456.2215. 
 




















































SUPPORTING INFORMATION          
68 
 
Figure S12. 13C-NMR spectrum of 6-AzTO-3 (1). 
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Figure 13. COSY-NMR spectrum of 6-AzTO-3 (1)  
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Figure S14. HMBC-NMR spectrum of 6-AzTO-3 (1). 
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Synthesis of the Amine Cyanine Dyes: 6-TramTO-3 (2) and 6-NH2TO-3 (3)  
 
Figure S15. Synthesis route of the amine cyanine dyes 6-TramTO-3 (2) and 6-NH2TO-3 (3) starting from azido cyanine dye 6-AzTO-3 (1). 
 
4-((1E,3Z)-3-(3-(6-(4-(aminomethyl)-1H-1,2,3-triazol-1-yl)hexyl)benzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)-1-ethylquinolin-1-
ium iodide (6-TramTO-3): Under inert atmosphere, azido derivative cyanine dye 6-AzTO-3 (3, 49.0 mg, 84.0 µmol) was dissolved in 
ethanol (415 µL) and propargylamine (10.7 µL, 168 µmol), copper powder (6.4 mg, 101 µmol) and copper sulfate (100 mM, 42 µL, 
4.20 µmol) were added. The resulting mixture was stirred for 39 h, filtered and the solvent was removed. The product was purified by 
preparative HPLC (5 -75%) to yield the desired product (2, 20.5 mg, 27.8 µmol, 33%) as blue solid. Rf=0.08 (CH2Cl2/MeOH 10:1); 1H 
NMR (300 MHz, [D6]DMSO, 25°C): δ=8.48 (d, 1H, 3J(H,H)=8.4 Hz; H-18), 8.45 (d, 1H, 3J(H,H)=7.2 Hz; H-15), 8.31 (s, 2H; NH2), 8.09 
– 8.18 (m, 3H; H-12, H-21 and H-22), 7.97 (dd, 1H, 3J(H,H)=8.4 Hz, 3J(H,H)=7.3 Hz; H-20), 7.86 – 7.88 (m, 2H; H-4 and H-14), 7.71 
(dd, 1H, 3J(H,H)=8.4 Hz, 3J(H,H)=7.3 Hz; H-19), 7.58 (d, 1H, 3J(H,H)=8.2 Hz; H-1), 7.48 (dd, 1H, 3J(H,H)=8.2 Hz, 3J(H,H)=7.2 Hz; H-
2), 7.31 (dd, 1H, 3J(H,H)=8.0 Hz, 3J(H,H)=7.2 Hz; H-3), 7.13 (d, 1H, 3J(H,H)=13.2 Hz; H-13), 6.50 (d, 1H, 3J(H,H)=12.3 Hz; H-11), 4.61 
(q, 2H, 3J(H,H)=7.2 Hz; H-16), 4.40 (t, 2H, 3J(H,H)=7.1 Hz; H-10), 4.22 (t, 2H, 3J(H,H)=7.6 Hz; H-5), 4.09 – 4.13 (m, 2H; H-23), 1.79 – 
1.86 (m, 2H; H-6), 1.68 – 1.76 (m, 2H; H-9), 1.44 - 1.49 (m, 5H; H-8 and H-17), 1.29 – 1.36 (m, 2H; H-7); 13C NMR (75 MHz, [D6]DMSO, 
25°C): δ=160.9 (Cq), 150.5 (Cq), 144.0 (CH), 142.3 (CH), 141.5 (Cq), 140.1 (Cq), 137.7 (Cq), 133.5 (CH), 127.7 (CH), 126.7 (CH), 125.3 
(CH), 124.8 (Cq), 124.3 (Cq), 124.2 (2C; CH), 122.7 (CH), 117.9 (CH), 112.5 (CH), 110.0 (CH), 109.5 (CH), 98.5 (CH), 49.4 (2C; CH2), 
45.5 (CH2), 34.0 (CH2), 29.7 (CH2), 26.9 (CH2), 25.6 (CH2), 25.5 (CH2), 14.8 (CH3); tR=24.2 min (5% to 75% B in 30 min); HRMS-ESI+ 
(m/z): [M]+ calcd for C30H35N6S, 511.2638; found, 511.2641.  
 
mono(4-((1E,3Z)-3-(3-(6-ammoniohexyl)benzo[d]thiazol-2(3H)-ylidene)prop-1-enyl)-1-ethylquinolinium) mono(2,2,2-
trifluoroacetate) (6-NH2TO-3): Azido derivative cyanine dye (3, 40 mg, 87.6 µmol) was dissolved in acetonitrile (600 µL) and a solution 
of TCEP in milli-Q water (0.44 M, 600 µL, 263 µmol) was added. The resulting mixture was stirred for 2 h at 60°C afterwards it was 
purified by preparative HPLC (5 -75%) to yield the desired product (3, 31.5 mg, 57.8 µmol, 66%) as blue solid. Rf=0.05 (CH2Cl2/MeOH 
10:1); 1H NMR (500 MHz, [D6]DMSO, 25°C): δ=8.43 – 8.52 (m, 2H; H-15 and H-18), 8.13 – 8.20 (m, 1H; H-12), 8.10 (d, 1H, 
3J(H,H)=8.6 Hz; H-21), 7.97 (dd, 1H, 3J(H,H)=7.7 Hz, 3J(H,H)=8.6 Hz; H-20), 7.86 – 7.92 (m, 2H; H-4 and H-14), 7.67 - 7.79 (m, 4H; H-
19 and NH3), 7.60 (d, 1H, 
3J(H,H)=8.0 Hz; H-1), 7.49 (dd, 1H, 3J(H,H)=7.3 Hz, 3J(H,H)=8.0 Hz; H-2), 7.31 (dd, 1H, 3J(H,H)=7.3 Hz, 
3J(H,H)=7.5 Hz; H-3), 7.14 (d, 1H, 3J(H,H)=13.2 Hz; H-13), 6.52 (d, 1H, 3J(H,H)=12.2 Hz; H-11), 4.61 (q, 2H, 3J(H,H)=7.2 Hz; H-16), 
4.24 (t, 2H, 3J(H,H)=7.1 Hz; H-5), 2.75 – 2.82 (m, 2H; H-10), 1.69 – 1.78 (m, 2H; H-6), 1.52 - 1.58 (m, 2H; H-9), 1.37 – 1.50 (m, 7H; H-
7, H-8 and H-17); 13C NMR (125 MHz, [D6]DMSO, 25°C): δ=158.1 (Cq), 150.5 (Cq), 144.0 (CH), 142.3 (CH), 141.5 (Cq), 137.7 (Cq), 
133.5 (CH), 127.7 (CH), 126.7 (CH), 125.3 (CH), 124.7 (Cq), 124.3 (Cq), 124.2 (CH), 122.7 (CH), 118.0 (CH), 112.5 (CH), 110.3 (CH), 
109.5 (CH), 98.4 (CH), 49.4 (CH2), 45.5 (CH2), 38.7 (CH2), 26.9 (CH2), 26.9 (CH2), 25.6 (2C; CH2), 14.8 (CH3); tR=23.5 min (5% to 75% 
B in 30 min); HRMS-ESI+ (m/z): [M]+ calcd for C27H32N3S, 430.2311; found, 430.2302. 
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Figure S17. 13C-NMR spectrum of 6-TramTO-3 (2). 
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Figure S18. COSY-NMR spectrum of 6-TramTO-3 (2). 
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Figure S19. HMBC-NMR spectrum of the 6-TramTO-3 (2). 
  































































Figure S21. 13C-NMR spectrum of 6-NH2TO-3 (3). 
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Figure S22. COSY-NMR spectra of 6-NH2TO-3 (3). 
 




Figure S23. HMBC-NMR spectra of 6-NH2TO-3 (3). 
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Results and Discussion 
Excitation and Emission Spectra of the NIR Cyanine Dye Derivatives 
For each cyanine dye derivative: 6-AzTO-3, 6-TramTO-3 and 6-NH2TO-3, the excitation and emission spectra of a 10 µM solution of 
the corresponding compound in 1 mL of 10 mM Tris pH 7.6 and 50 mM KCl were measured. The excitation spectra were recorded at 
an emission of 670 nm in a rage from 500 – 660 nm (slit 5/10 nm), while the emission spectra were measured at an excitation of 590 nm 








Figure S24. Excitation (black line) and emission (red line) spectra of 10 µM solution of cyanine dye: a) 6-AzTO-3; b) 6-TramTO-3 and c) 6-NH2TO-3 in 1 mL 10 mM 
Tris pH 7.6 mM and 50 mM KCl at 20°C. 
Fluorescence Emission of the NIR Cyanine Dye Derivatives with(out) dsDNACT 
We compared the fluorescence properties of different cyanine dyes: 6-AzTO-3, 6-TramTO-3 and 6-NH2TO-3 in presence of double-
stranded calf thymus DNA (dsDNACT). The emission spectra of a 1 µM solution of the corresponding compound in 120 µL of 10 mM 
Tris pH 7.6 and 50 mM KCl were measured in presence and absence of 15 µM dsDNACT. A 100 µL fluorescence cuvette of 




Figure S25. Emission spectra of 1 µM solution of cyanine dye in presence and absence of 15 µM dsDNACT. All spectra were measured in 120 µL 10 mM Tris pH 
7.6 and 50 mM KCl at 20°C: 6-AzTO-3 is shown in blue; 6-TramTO-3 is shown in red and 6-NH2TO-3 is shown in black. 
Fluorescence Titrations of 6-TramTO-3 
All fluorescence titrations followed the same procedure: to 1 mL of 1 μM solution of corresponding cyanine dye derivative in 10 mM 
Tris pH 7.6 and 50 mM KCl aliquots of a stock solution of the corresponding annealed DNA (dsDNAhAT and dsDNAhGC = 435 µM; 
dsDNACT = 0.65 mM) were successively added and the fluorescence spectra were recorded in a range from 625-750 nm after 1 min of 
each addition. For each compound three independent measurements were carried out. The fluorescence emission plotted is the 
resulting mean of the three independent measurements. 









Figure S26. Fluorescence spectra of the titration of 6-TramTO-3 with a) dsDNACT; b) dsDNAhAT; c) dsDNAhGC. All spectra were measured of a 1 µM solution of 
cyanine dye in 10 mM Tris pH 7.6 mM and 50 mM KCl at 20°C.  
The stability of 6-TramTO-3 fluorescence signal was studied in presence and absence of dsDNACT. Emission spectra of a 2.5 µM 
solution of 6-TramTO-3 in 10 mM Tris pH 7.6 and 50 mM KCl (total volume 1 mL) were measured in presence and absence of 37.5 µM 
dsDNACT. The fluorescence spectra were recorded in a range from 625-750 nm with slits of 3/5 nm for the sample without dsDNACT 
and slits of 3/3 nm for the sample with dsDNACT and measuring at one hour intervals for 5 hours. Incubation of the samples was 







Figure S27. Fluorescence spectra of 6-TramTO-3 a) alone; b) with 37.5 µM dsDNACT after incubation at 20°C. All spectra were measured of a 2.5 µM solution of 







Figure S28. Fluorescence spectra of 6-TramTO-3 a) alone; b) with 37.5 µM dsDNACT after incubation at 37°C. All spectra were measured of a 2.5 µM solution of 




The fluorescence intensity at the maximum (647 nm) of each spectrum was plotted against the time intervals. Mean values from three 
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Figure S29. Fluorescence stability of 6-TramTO-3: alone (black triangles) or with 37.5 µM dsDNACT (black squares) after incubation at a) 20°C and b) 37°C.  
Binding Affinity Determination by DynaFit 
For the determination of the binding affinity, the maximum of each fluorescence spectrum (647 nm in the case of dsDNACT, 647 nm in 
the case of dsDNAhAT and 650 nm in the case of dsDNAhGC) was plotted against the added dsDNA concentration. The mean values 
from three independent measurements with its standard deviation is shown. The KD-value and its standard deviation was determined 








Figure S30. Calculated binding affinities from the fluorescence spectra of the titration of 6-TramTO-3 with a) dsDNACT; b) dsDNAhAT; c) dsDNAhGC. 
 
Table S2. Determined binding constants of 6-TramTO-3 with dsDNACT, dsDNAhAT and dsDNAhGC. 
DNA binding affinity [µM] 
dsDNACT 19.5 ± 2.6  
dsDNAhAT 0.114 ± 0.03 
dsDNAhGC 0.104 ± 0.054 
 
All binding affinities were determined by fitting the obtained experimental data in the DynaFit 4.0 software. The program is available 
free of charge for academical use at http://www.biokin.com/dynafit/[9] In this program it is necessary to create scripts containing 
information about the chemical model underlying the experimental data, the concentration of the fixed component, determined 
spectroscopic data of the titration and information about the location of files. An example of a script is shown below with c omments (in 
italic) about the purpose of the keywords. 
 
[task]   
   task = fit         nature of the calculation performed by Dynafit 
   data = equilibria 
[mechanism]        simple 1:1 binding model 
   P + LL <==> P.LL : KdL dissociation  indicates that it is a dissociation constant 
[constants]         initial KD-value for iteration 
   KdL = 2 ?        the ? indicates that this value will be optimized 
[concentrations] 
   LL = 1         fixed concentration of the cyanine dye derivative 
[responses] contribution to the spectroscopic signal (adjustable parameters, as is specified 
by the question mark after the numerical value) 
   LL = 5.8 ?        fluorescence intensity of the dye alone 
   P.LL = 155.8 ?        fluorescence intensity of the saturated DNA / dye signal 
[data]         location of files and information about the data 
   variable P        indicates the species that changes its concentration 
   file ./Measurements/data/BH574_mean.txt   path of the experimental data file 
[output] 
   directory ./Measurements/output/BH574_mean  path indicating the location of the output file 
[end] 
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Fluorescence Quantum Yield  
The slopes for the determination of the quantum yields and their calculated quantum yield values are summarized in table S3.  
 
Table S3. Determined slopes and corresponding quantum yields for the two reference compounds Alexa Flour® 647 and Atto 655 and for 6-TramTO-3 with and 
without dsDNACT. 
dye slope mean reference dye quantum yield  quantum yield (lit.) 
Alexa Fluor® 647 52937300 
51185000 Atto 655 0.32 0.33[4] 
Alexa Fluor® 647 49432700 
Atto 655 48486000 
47618300 Alexa Fluor® 647 0.31 0.30[3] 
Atto 655 46750600 
6-TramTO-3 alone 792132 
809683 Alexa Fluor® 647 0.0052  6-TramTO-3 alone 822593 
6-TramTO-3 alone 814323 
6-TramTO-3 + DNA 41583400 
42097433 Alexa Fluor® 647 0.27  6-TramTO-3 + DNA 41800000 
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Concentration Determination  
For the accurate determination of our compounds 6-TramTO-3 the extinction coefficient was calculated. A specific amount (< 2.00 mg) 
of the compound was weighted on a Mettler Toledo XP6 and dissolved in a known amount of milli-Q water. Increasing amounts of such 
stock solution were added into a 1 mL cuvette filled with 1 ml of milli-Q water. The corresponding absorbance of each addition was 
measured on a Tecan Spark 20M at the maximum at 625 nm and without exceeding 10% of the initial volume. In all the cases the 
absorbance was between 0.1 and 1 AU to be in concordance with Lambert-Beer law.[10]  
A = ε l c   (S2) 
In this equation: A = absorbance of the solution; l = length of the cuvette; c = concentration; ε = molar extinction coefficient. 
 
Figure S31. UV-Vis spectrum of a 10 µM solution of 6-TramTO-3 in 1 mL 10 mM Tris pH 7.6 and 50 mM KCl. 
 
 
The lineal regression of the obtained absorbance measurements versus the concentrations of 6-TramTO-3 allowed us to obtain the 
molar extinction coefficient. These measurements were repeated three times independently i.e. from three different stock solutions. 









Figure S32. Determination of the extinction coefficient of compound 6-TramTO-3 in milli-Q water. The absorbance maximum at 625 nm was plotted against the dye 
concentration. Three independent measurements are shown with the calculated extinction coefficient and their corresponding regression value (R2). The mean 
extinction coefficient and the standard deviation of 6-TramTO-3 is 59403 ± 646 M-1cm-1. 
 
 
The mean extinction coefficient and the standard deviation of 6-NH2TO-3 and 6-AzTO-3 were determined following the above described 
procedure. The extinction coefficient of 6-NH2TO-3 was determined in milli-Q water, whereas the extinction coefficient of 6-AzTO-3 
was determined in DMSO due to its low aqueous solubility. Figure S30 shows the corresponding UV-Vis spectra in 1 mL 10 mM Tris 
pH 7.6 and 50 mM KCl at a dye concentration of 10 µM. For the spectrum of 6-AzTO-3 1% of DMSO was added for a better solubility. 
Figure S31 and Figure S32 show the lineal regressions from the three independent measurements. Table 4 summarized the molar 
extinction coefficient obtained. 







Figure S33. a) UV-Vis spectra of compound 6-AzTO-3 in 1 mL 10 mM Tris pH 7.6 and 50 mM KCl at a dye concentration of 10 µM and 1% DMSO. b) UV-Vis 










Figure S34. Determination of the extinction coefficient of compound 6-AzTO-3 in DMSO. The absorbance maximum at 639 nm was plotted against the dye 
concentration. Three independent measurements are shown with the calculated extinction coefficient and their corresponding regression value (R2). The mean 










Figure S35. Determination of the extinction coefficient of compound 6-NH2TO-3 in milli-Q water. The absorbance maximum at 625 nm was plotted against the dye 
concentration. Three independent measurements are shown with the calculated extinction coefficient and their corresponding regression value (R2). The mean 
extinction coefficient and the standard deviation of 6-NH2TO-3 is 90043 ± 418 M-1cm-1. 
 
Table S4. Determined mean extinction coefficients and standard deviations of 6-AzTO-3 in DMSO and 6-TramTO-3 and 6-NH2TO-3 in water.  
 6-AzTO-3 in DMSO 6-TramTO-3 in water 6-NH2TO-3 in water 
mean 110203 ± 1577 M-1cm-1 59403 ± 646 M-1cm-1 90043 ± 418 M-1cm-1 
 
Syto-9TM was used as a 3.34 mM DMSO stock commercial solution. For EtBr the extinction coefficient ε480nm = 5600 M
-1cm-1[11] was 
used. dsDNACT was purchased as a solution of 15.4 mM solution. 
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For the determination of the concentration of the hairpin DNAs, the purchased lyophilized DNA was dissolved in milli-Q water, heated 
to 95°C for 10 min and slowly cooled down to r.t. Their molar extinction coefficients were determined by using the following formula:[12] 
 
𝜀260𝑛𝑚 = {(8.8 ∗ #𝑇) + (7.3 ∗ #𝐶) + (11.7 ∗ #𝐺) + (15.4 ∗ #𝐴)} ∗  0.8 ∗  10
3  𝑀−1𝑐𝑚−1       (S3) 
 
In the formula # = number of nuleobases determined throughout the DNA sequence, T = thymine, C = cytosine, G = guanine, A = 
adenine 
UV-Vis Titrations  
UV-Vis titration measurements were performed at a concentration of 12.3 μM of the dye in 10 mM Tris pH 7.6 and 50 mM KCl. 
Increasing aliquots of a 1.54 mM and 15.4 mM stock solutions of dsDNACT were successively added and the absorbance spectra were 
recorded in a range from 400-800 nm after 1 min of each addition. Three independent measurements were carried out. The presented 









Figure S36. UV-Vis spectra of the titrations of a 12.3 µM solution of 6-TramTO-3 in 10mM Tris pH 7.6 and 50mM KCl with increasing amounts of dsDNACT where 
a) the equivalents of dsDNACT are: 0, 0.4, 0.7, 1.1, 1.5, 2.3; b) the equivalents of dsDNACT are: 2.3, 3.0, 3.8, 5.3, 6.8, 10.5, 18.0, 25.5, 40.6, 55.6, 70.6 and c) is the 
combined titration of a and b. 
 
We recorded the temperature dependence of the sample: to get a strong signal at 523 nm, a 12.3 µM solution of 6-TramTO-3 in 10 mM 
Tris pH 7.6 and 50 mM KCl was prepared and 7.5 µM dsDNACT added. The measurement was started at a temperature at 2°C and the 
temperature increased in 4°C steps. After the device reached the set temperature we waited for 2 min before measurement. Figure 
S34 shows the change of the UV-Vis spectra with increasing temperature. Further, the signal at 523 nm and 625 nm were plotted 








Figure S37. Temperature dependence of the UV-Vis signal of 6-TramTO-3 in 10 mM Tris pH 7.6 and 50 mM KCl with 7.5 µM dsDNACT. a) full UV-Vis spectra with 
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CD Measurements 









Figure S38. CD spectra of the titrations of a 36.9 µM solution of 6-TramTO-3 in 10mM Tris pH 7.6 and 50 mM KCl with increasing amounts of dsDNACT where a) 
the equivalents of dsDNACT are: 0, 0.4, 0.8, 1.2; b) the equivalents of dsDNACT are 2.4, 4.9, 9.8, 20.3 and 40.7 c) is the complete titration  
Gel Electrophoresis 






Figure S39. 1% agarose gel electrophoresis with 1000 ng, 500 ng and 100 ng of dsDNAbc and dsDNAbl. CSL 1kb DNA ladder was used as a reference. The gel was 
run for 75 min at 25°C at 80 V and post stained with either a) 1 µM of 6-TramTO-3 in TAE buffer or b) 1 µM ethidium bromide in TAE buffer. 
Thermal Melting Analysis 
Figure S40 shows the determined melting point for dsDNACT with and without addition of 6-TramTO-3. 
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Figure S40. Melting temperature measurements of 45 μM dsDNACT with and without addition of 1.8 μM 6-TramTO-3 in 10 mM Tris pH 7.5. The melting points were 
calculated to be 68.12°C for dsDNACT alone and 72.66°C for dsDNACT with addition of 6-TramTO-3. 
Fluorescence Microscopy 
Figure S41 shows confocal microscopy pictures of 6-TramTO-3 labeled E. coli bacteria attached on an IBIDI 8-wells glass-bottom plate 
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Figure S42 shows confocal microscopy pictures of macrophages exposed to bacteria stained with 6-TramTO-3 (bright field, red channel, 
merged image), including z-stacks (Z). 
 






























     



















Figure S42. Confocal microscopy of bacteria and macrophages stained with 6-TramTO-3. Shown are a) bright field; b) red channel; c) merged image at different 
Z-stacks 
Additional Cell-Based Assays 
Figure S43 shows the growth of E. coli in the presence of the indicated fluorescence dyes (a) and the fluorescence shift of the bacteria 




Figure S43. a) E. coli was grown in the presence of the indicated dyes and the optical density (OD600) was determined at various time-points. Mean values and 
standard-deviations from three independent experiments are shown. b) Fluorescence shift of E. coli cells grown in the presence of the indicated dyes was recorded 
by flow-cytometry at an optical density of 2.0 in the indicated channels, including quantification from independent experiments (Figure S48). 
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Figure S44 shows the labelling of antibiotic-resistant and -sensitive Klebsiella pneumoniae strains with 6-TramTO-3 (a), the 
quantification of colonies formed by DMSO- or 6-TramTO-3 labeled bacteria on solid agar (b) and Klebsiella growth in the presence of 




Figure S44. a) Klebsiella pneumoniae strains (R = resistant, S = sensitive) were grown in the presence of DMSO or 6-TramTO-3 and fluorescence shift of cells in 
the indicated channels at an optical density of 2.0, including quantification from independent experiments (Figure S48), was recorded by flow-cytometry. b) 24 h 
after plating of E. coli and K. pneumoniae strains sampled at and optical density of 2.0, grown in the presence of DMSO or 6-TramTO-3, onto LB solid agar plates 
colony forming units per ml of culture were determined (Y-axis). Error bars represent the standard deviation derived from three independent experiments. c) K. 
pneumoniae (R = resistant, S = sensitive) was grown in the presence of DMSO or 6-TramTO-3 and the optical density (OD600nm) was determined at various time-
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Figure S45 shows the change in fluorescence intensity and percentage of red-shifted bacteria during staining of Escherichia coli with 
6-TramTO-3 and upon shift into dye-free LB-medium or X-Vivo-15 macrophage medium.  
 
a)                                        b)                                                c) 
Figure S45. a) Escherichia coli cultures were grown for 4 h (≈ OD600nm = 2.0) in the presence of 2.5 µM 6-TramTO-3 and bacterial red fluorescence staining was 
determined at the indicated time-points by FACS (upper row: Red2 vs Green channel scatter plots; lower row: histogram plots with cell number vs Red2 fluorescence). 
Quantification of the percentage of bacteria in the red gate and the fold-change in fluorescence intensity compared to unstained bacteria is provided on the right 
hand side. b) Same as a) but upon shift of 6-TramTO-3 labelled E. coli at OD600nm = 2.0 into dye-free X-Vivo-15 macrophage culture medium. c) Same as a) but 
upon shift of 6-TramTO-3 labelled E. coli at OD600nm = 2.0 into dye-free LB medium. Mean values and individual data points from three independent experiments 
are shown. 
SUPPORTING INFORMATION          
93 
Figure S46 shows the development of a fluorescent macrophage side-population upon exposure to 6-TramTO-3-, YFP- or 6-TramTO-
3/YFP double-positive bacteria. 
 
Figure S46. a) Macrophages were stimulated with un-labeled, 6-TramTO-3 labeled, YFP-expressing or 6-TramTO-3/YFP double-positive Escherichia coli for 2 and 
4 h. Samples of stimulated macrophage cultures were recorded by FACS and representative dot-plots (Red2 versus Yellow channel) are shown. b) Quantification 
of the percentage of macrophages with phagocytosed bacteria as reported using 6-TramTO-3-, YFP- or 6-TramTO-3/YFP-labeled bacteria at 2 and 4 h post onset 
of the co-culture experiment. Mean values and individual data points from three independent experiments are shown. 
Figure S47 shows the presence of a capsule in the antibiotics-resistant K. pneumoniae strain but not in the E. coli or antibiotics-sensitive 
strain. 
 
Figure S47. Bacteria were stained with nigrosin and crystal violet and pictures were recorded at 63x magnification by widefield microscopy a) E. coli = E. coli; b) 
K.pnR = multiresistant K. pneumoniae; c) KpnS = antibiotic-sensitive K. pneumoniae 
 
  
SUPPORTING INFORMATION          
94 
Figure S48 shows the quantification plots of independent measurements of the FACS experiments   
 
Figure S48. a) Quantification of bacterial 6-TramTO-3 labeling data from Fig. 5 (panel B, right hand side) and Fig. S44 (panel A, upper row). b) Quantification of 
bacterial labeling data from Fig. S43 (panel B). c) Quantification of bacterial labeling data from Fig. 2 (panel B, upper row). 6-TramTO-3 was detected in the red2 
channel, CSFE and SyTO9TM in the green channel. All data represent mean values and standard deviations derived from three independent experiments. 
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4.1.1 Conclusion 
A new far-red fluorescent DNA stain, 6-TramTO-3, was synthesized and studied as a vital dye for bacteria 
tracking in host-cell interaction studies. 6-TramTO-3 is a cyanine dye derivative, which labels bacteria 
fast and efficiently without the need for genetic manipulation or effects on their viability. So far, neither 
fluorescent proteins, nor commercial dyes were able to stain multidrug-resistant bacteria. We 
demonstrated the applicability of 6-TramTO-3 in FACS analysis and confocal fluorescence microscopy 
and, for the first time, showed different interaction behavior of multidrug-resistant and antibiotic-
sensitive Klebsiella strains during phagocytosis by human macrophages. Our new off-the-shelf reagent 
may help to identify unknown disease-causing strategies, permitting improved drug-design against 
multidrug-resistant bacteria. We believe that future developments will show the utility of 6-TramTO-3 in 
many different microorganisms allowing phagocytosis studies with other hosts. The synthesis and study 
of new TramTO-derivatives could enable multicolor labeling and grant deeper understanding of its mode 
of action and the reason for its lack of toxicity in our bacterial experiments. 
 
4.1.2 Further Developments and Outlook 
Additional experiments with 6-TramTO-3 were performed, and supplementary biological and chemical 
approaches are currently under investigations. We were interested in exploring new green and yellow 
emitting TramTO derivatives to provide multiple color staining. We further aimed to gain insights into 
the nontoxic behavior of the dye in bacterial labeling experiments by derivatization of the triazole group 
of 6-TramTO-3. To access a green fluorescent version of TramTO, we designed the analogue bearing only 
one instead of three carbons in the methine-bridge. We expected to observe a change in the 
spectroscopic properties as the one reported from thiazole orange-3 (TO-3) to TO-1.[1,2] At the same time, 
we wanted to verify the role of the side-chain triazole moiety in the non-toxic behavior. Scheme 4.1.1 
illustrates the synthetic pathway for the new green-fluorescent dye 6-TramTO-1. In a nucleophilic 
aromatic substitution of benzothiazole A1 to the quinoline A2, the TO-1 backbone was formed. In a SN2-
reaction, the side chain iodine was replaced by an azide. The azide derivative A4 serves as the starting 
material in a click reaction with propargylamine, to yield the final compound 6-TramTO-1 A6. 
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Scheme 4.1.1. Synthesis path for the green emitting TramTO derivative 6-TramTO-1 (A6). 
 
Analytical data and a figure of the 1H-NMR spectra of 6-TramTO-1 (Figure 4.1.1) are given below: 
1H-NMR (500 MHz, DMSO-d6, δ): 8.75 (d, 1H, J = 8.8 Hz, H-16), 8.67 (d, 1H, J = 7.2 Hz, H-13), 8.29 (br s, 
3H, NH3+), 8.17 (d, 1H, J = 8.8 Hz, H-19), 8.10 (s, 1H, H-20), 8.05 (dd, 1H, J = 7.9 Hz, J = 0.9 Hz, H-4), 8.01 
(m, 1H, H-17), 7.80 – 7.75 (m, 2H, H-1, H-18), 7.61 (m, 1H, H-2), 7.45 – 7.41 (m, 2H, H-3, H-12), 6.94 (s, 
1H, H-11), 4.66 (q, 2H, J = 7.2 Hz, H-14), 4.63 (t, 2H, J = 7.4 Hz, H-10), 4.37 (t, 2H, J = 7.0 Hz, H-5), 4.12 – 
4.06 (m, 2H, H-21), 1.83 – 1.75 (m, 4H, H-6, H-9), 1.54 – 1.46 (m, 5H, H-8, H-15), 1.36 – 1.28 (m, 2H, H-7). 
13C-NMR (125 MHz, DMSO-d6, δ): 159.4 (Cq), 148.7 (Cq), 144.0 (CH), 140.0 (Cq), 136.9 (Cq), 133.3 (CH), 
128.2 (CH), 126.9 (CH), 125.7 (CH), 124.5 (CH), 124.3 (Cq), 124.1 (2C, CH, Cq), 123.9 (Cq), 123.0 (CH), 118.0 
(CH), 113.0 (CH), 108.3 (CH), 87.6 (CH), 49.5 (CH2), 49.3 (CH2), 45.6 (CH2), 33.9 (CH2), 29.6 (CH2), 26.8 
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Next, we preliminary investigated growth, viability and labeling efficiency studies with 6-TramTO-1 in 
E. coli and Klebsiella strains.I For both strains and as already observed for 6-TramTO-3 the growth curves 
overlay the ones of the negative DMSO control with just a very slight growth delay, suggesting the same 





Figure 4.1.2. Optical density (OD600 nm) of a) E. coli and b) K. pneumoniae LB cultures supplemented with DMSO (red 
line with dots) and 6-TramTO-1 (blue line with dots) over time. These preliminary results were obtained once. 
 
Regarding the labeling efficiency, under the same conditions as with 6-TramTO-3 in FACS analysis, 
incubation with 6-TramTO-1 resulted in a shift of E. coli. population in all channels, except the Red2-
channel (652-671 nm), but only 59% of the cells into the yellow channel (570-596 nm). This observation 
is in agreement with previous results from the green emitting dye SyTO-9. Unfortunately, in the case of 
Klebsiella, hardly any labeling could be observed with 6-TramTO-1 (Figure 4.1.3 and Figure 4.1.4). Further 
experiments need to be performed to explain the lack of labeling. 
 
 
Figure 4.1.3. Representative dot plots of E. coli after incubation with DMSO (left) and 6-TramTO-1 (right), including 
quantification from one experiment. Bacteria were sampled at OD600 nm = 2.0 and analyzed by FACS in the red1, red2, 
green and yellow channels. 
 
                                                             
I FACS and growth curve analysis were performed by Jun.-Prof. Dr. Leon Schulte, iLung Institute for 
Lung Research, Marburg. 
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Figure 4.1.4. Representative dot plots of K. pneumoniae after incubation with DMSO (left) and 6-TramTO-1 (right), 
including quantification from one experiment. Bacteria were sampled at OD600 nm = 2.0 and analyzed by FACS in the 
red1, red2, green and yellow channels. 
 
Preliminary staining experiments with fixed HeLa cellsII (Figure 4.1.5) revealed comparable good labeling 
results of the green fluorescent dye 6-TramTO-1 in comparison to the far-red labeling dye 6-TramTO-3. 
As expected, both dyes stain the nucleus of the HeLa cells. Present studies focus on the verification by 






Figure 4.1.5. Fluorescence microscopy images of fixed HeLa cells, incubated with 5 µM a) 6-TramTO-3 and  
b) 6-TramTO-1 in DPBS. 
 
Inspired by the described findings, current investigations target the decoding of the role of the triazole 
in the binding mode and especially the non-toxic behavior of the TramTO derivatives. We, therefore, 
plan to synthesize various 6-TramTO-1 and 6-TramTO-3 versions with a short (Cn with n = 2) and a long 
(Cn with n = 6) side chain, connecting different functional groups (Figure 4.1.6). Additionally, an expected 
yellow emitting triazole-dye (Figure 4.1.6, compound A8, expected λEm emission = 601 nm)[3] was 
designed and will be synthesized. Further attempts face the specific targeting of mitochondria by 
connecting a triphenylphosphine moiety[4] or a mitochondira-penetrating peptide[5] to the TramTO-
derivatives. All of these compounds, including 6-TramTO-1, will be analyzed in spectroscopic binding 
                                                             
II Cell preparation and fluorescence microscopy were performed by Greta Linden, AK Vázquez, Philipps-
Universität Marburg. 
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Figure 4.1.6. Planned scaffolds for in-depth understanding of triazole role in the TramTO dyes. Compound A8 
represents a planned expected yellow emitting version. 
 
To broaden the field of applications of 6-TramTO-3, several collaborations have been established. All 
collaborators plan to test our compounds in different systems. The following list gives an overview of the 
present collaborators and their planned research projects: 
 
1) Roy Gross, Julius-Maximilians-University Würzburg: “Characterization of the interaction of the 
etiological agent of whooping cough Bordetella pertussis with human 3D airways models.” 
2) Mariana Pinho, University NOVA de Lisboa: “Use of far-red fluorescent nucleic acid staining 
compound 6-TramTO-3 to label DNA in live Straphylococcus aureus cells.” 
3) Rolf Müller, Helmholtz Institute for Pharmaceutical Research Saarland: “Labeling of different 
bacterial species with 6-TramTO-3 for the use in host cell and zebrafish embryo infection models.” 
4) Ralf Ehricht, Leibniz-Institute of Photonic Technology Jena: “Live staining of gram-negative 
antibiotic-resistant bacteria.” 
5) Pierre Cosson, Centre Médical Universitaire Geneva: “Fluorescence labeling of different bacteria 
(Klebsiella, E. coli, P.aeruginosa, B.subtilis) and their application in phagocytosis studies.” 
6) Raphaël Georges Duval, Nanogalenix (company) in Switzerland: “Labeling of harmful bacteria; 
targeting specific tissues such as solid tumors or cells; labeling parasites or other types of living 
species in the µm/mm range.” 
7) Peter Graumann, Philipps-University Marburg: “Spatial distribution of the signal recognition particle 
in bacteria.” 
8) Torsten Waldminghaus, Max Planck Institute for Terrestrial Microbiology Marburg: “Quantification 
of DNA in gram-negative bacteria with Flow Cytometry.” 
9) Pierre Stallforth, Leibniz-Institute for Natural Product Research and Infection Biology Jena: “Labeling 
of various bacteria that interact with soil amoebae for monitoring the transition to the fruiting 
bodies.” 
4. Cumulative Part 
100 
10) Cynthia Sharma, Julius-Maximilians-University Würzburg: “Investigation of host-pathogen 
interactions using fluorescence-based sorting and imaging techniques.” 
11) Knut Drescher: Philipps-University Marburg: “6-TramTO-3 as a fluorescent dye for the investigation 
of bacterial biofilm studies.” 
 
4.1.3 Author Contribution 
The initial idea of 6-TramTO-3 resulted from an azide functionalized version 6-AzTO-3, I was preparing to 
selectively mark the nucleosome by click reaction. I synthesized and fully characterized 6-AzTO-3, and 
also the two amine derivatives 6-NH2TO-3 and 6-TramTO-3, including all previous synthetic 
intermediates. I performed their spectroscopic analysis (absorbance and fluorescence spectra) and 
determined their extinction coefficients. Of the most promising compound 6-TramTO-3, I determined 
the quantum yields and melting temperature with and without DNA, and fully characterized its complex 
binding mode to DNA by fluorescence titrations with calf thymus, AT-and GC-rich DNA, circular dichroism 
and absorbance spectroscopy. I further evaluated temperature-dependent DNA binding. Additionally, I 
demonstrated the application of 6-TramTO-3 as a DNA stain in gel electrophoresis.  
Fluorescence microscopy measurements were assisted by Dr. Gabriele Malengo (Synmikro, Marburg). 
Bacterial labeling studies with multidrug resistant and sensitive strains, and following phagocytosis 
studies were performed by Jun.-Prof. Dr. Leon Schulte and Harshavardhan Janga (iLung Institute for Lung 
Research, Marburg). Jun.-Prof. Dr. Olalla Vázquez had the role of corresponding author, was leading or 
involved in all the 14-role taxonomy for author-contribution assignment.[6] 
Under the supervision of Jun.-Prof. Dr. Olalla Vázquez, I further developed the project after the 
publication, such as the design, synthesis and study of new TramTO derivatives or guided students into 
the topic. The initial synthetic derivatization of 6-TramTO-1 was performed together with Dr. Rashmi 
Sharma (DAV University, Jalandhar, Punjab, India; DFG-project VA 1002/3-1).  
Finally, some of the named collaborations were the result of discussions after my flash communication 
at the 6th European Chemical Biology Symposium in Madrid in April 2019 and a talk I gave within the 
Synmikro cluster in July 2019 in Marburg. 
 
Marburg,  
     Jun. Prof. Dr. Olalla Vázquez  Benedikt Heinrich 
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4.2 ortho-Fluoroazobenzene Derivatives as DNA Intercalators for 






We report a high-affinity photoswitchable DNA binder, which displays different nucleosome-binding 
capacities upon visible-light irradiation. By electromobility shift assay and dynamic light scattering 
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ortho-Fluoroazobenzene derivatives as DNA  
intercalators for photocontrol of DNA and  
nucleosome binding by visible light† 
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We report a high-affinity photoswitchable DNA binder, which dis-
plays different nucleosome-binding capacity upon visible-light 
irradiation. Both photochemical and DNA-recognition properties 
were examined by UV-Vis, HPLC, CD spectroscopy, NMR, FID  
assays, EMSA and DLS. Our probe sets the basis for developing new 
optoepigenetic tools for conditional modulation of nucleosomal 
DNA accessibility. 
Over the last decades, a large number of studies have estab- 
lished that the organization of eukaryotic DNA, by proteins  
and RNAs, into a nucleoprotein complex referred to as chroma-
tin is key to regulate genome functions.1 The most abundant 
chromatin proteins are the histones. These proteins tightly  
wrap DNA into a “beads-on-a-string”-like structure. Each ‘bead’ 
is referred to as a nucleosome and comprises a histone  
octamer around which about 150 base pairs (bp) of DNA are 
wrapped. On average, nucleosomes are separated by about  
50 bp of free (also called “linker”) DNA.2 This entails that  
about 75% of our DNA is wrapped around histones. This 
nucleosomal organization restricts access to DNA considerably. 
As a result, nuclear processes such as DNA repair, replication 
and transcription largely depend on enzymes that can change 
nucleosomal DNA accessibility.3-5  
Hence, the ability to control chromatin compaction and, in 
turn, DNA accessibility using small molecules may provide us 
with means to study and, conceivably, control (at least some) 
genome functions, in physiological as well as disease contexts. 
So far, the use of small-molecule probes as complementary  
tools to classic chromatin biochemical approaches has  
strongly contributed to deciphering epigenetic mechanisms  
 
and strengthened our understanding of genome regulation. 
However, this approach has mainly been limited to enzyme 
inhibitors6-9 and altering nucleosome accessibility has largely 
been disregarded. Indeed, while there is just a handful of 
examples of compounds capable of targeting nucleosomal  
DNA, to our knowledge, none of these molecules allow spatio-
temporal control of nucleosome binding.10-15  
Reversible photoresponsive molecules, which have demon-
strated their potential in diverse areas (material science,16-17 
molecular motors18-20 photopharmacology,21-24 molecular 
containers,25 etc.) represent a very promising chemical 
alternative to optogenetics.26,27 However, the implementation  
of photoswitchable genome regulators has been very scarce  
and again only focused on histone-modifying enzymes, so  
far.28-30 Therefore, we designed and synthesized a novel 
photoswitch, which allows light-driven DNA and nucleosome 
binding and we studied the consequences of this interaction  
(Fig. 1a). 
The ability of externally controlling DNA-associated pro-
cesses by switching the state of a photochromic DNA binder  
has previously been demonstrated.31,32 However, such  
examples are mainly restricted to the use of azo-modified DNA 
binders, which involve undesirable UV irradiation.33-38 There  
are several strategies to synthesize azobenzene photoswitches 
that undergo isomerization upon visible-light irradiation.39-42  
For example, the Hecht group has recently optimized the pro-
perties of the classical azobenzenes by introducing σ-electron-
withdrawing fluorine atoms in ortho position to the azo- 
benzene unit. Such substitution leads to visible-light switches 
with high photoconversions and very long-lived cis-  
isomers.43,44 Furthermore, to our knowledge, photoswitchable 
DNA binders have never been used in the context of the 
nucleosome. Consequently, inspired by the natural DNA minor 
groove binder netropsin (1), we synthesized and studied two 
water-soluble photosensitive pyrrole hybrids that have identi- 
cal number of N-methyl pyrrole rings as netropsin, but incor-
porate an ortho-fluoroazobenzene scaffold between the pyrrole 
backbone and also vary in terms of their net charge at physiologi-  
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Fig. 1 (a) Outline of the photocontrollable nucleosome targeting  
approach based on light-visible photoswitchable DNA binders. (b)  
Structure of the studied molecules, highlighting the key synthetic build- 
ing blocks. 
 
cal conditions: F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) 
(3) (Fig. 1b). 
The synthesis of F4Azo-(PyDp)2 (2) and F4Azo-(PyDp) 
(PyOMe) (3) was straightforward through one-pot condensation 
between the previously reported building blocks: 4,45 5,43,44  
and 6.46 (Fig. 1 & Schemes S1-S4†). Once synthesized, their 
photochemical behaviour was investigated in detail. Thus, the 
ortho-fluoroazobenzene building block 5 alone and also in 
presence of the pyrrole moieties showed the expected absorp-
tion bands: intense band at λmax = 319 nm assigned to the π →  
π* transition together with a weaker one due to a n → π* and 
significant intensity decrease of the π → π* band with a slight 
increase of the n → π* one under 405 nm and 520 nm  
irradiation, respectively (Fig. S21b†). Nevertheless, the direct 
insertion of the azophenyl derivative into the pyrrole backbone 
affected the parental spectra, as observed for related com-
pounds.47 Irradiation of F4Azo-(PyDp)2 (2) entails fast spectro-
scopic changes.48 Thus, upon irradiation with 520 nm there is  
a clear intensity decrease between 287 nm and 500 nm, the  
λmax is slightly shifted to 278 nm and a new partly overlapping 
band at λmax = 420 nm can be detected (Fig. 2a). The photosta-
tionary state is reached after just 2 minutes of irradiation. We 
also demonstrated the reversibility of the photoisomeriztion for 
up to 16 cycles without any significant photobleaching (Fig. 2b). 
We next determined the isomer ratios at the photostation- 
ary state as well as the lifetime of the isomers by integrating  
the peak area of the HPLC chromatograms at the isosbestic  
point (287 nm). As expected, the trans-isomer was the thermo-
dynamically stable species (trans/cis ratio 92:8; Fig. S23a†) 
Importantly, the thermal relaxation of the cis-isomer was slow 
(cis/trans ratio 77:23, after 9 hours stored in the dark, Fig. 3), 
which enabled both DNA and nucleosome binding experiments. 
Unfortunately, F4Azo-(PyDp)(PyOMe) (3) did not show  
any major change by neither UV-Vis spectroscopy nor HPLC 
 
Fig. 2 (a) UV-Vis spectra of a 20 μM solution of F4Azo-(PyDp)2 (2) in 10 mM 
Tris buffer pH 7.6, 50 mM KCl and DMSO (98:2), initially at the 
thermodynamic state (blue) and after successive irradiation intervals at 
520 nm (green). (b) Reversible photochromism upon alternating 
irradiation at 520 nm (green) and 405 nm (blue) measured at 335 nm. 
Represented data are calculated from three independent experiments. 
 
 
Fig. 3 Evaluation of the cis-isomer stability of F4Azo-(PyDp)2 (2) in  
10 mM Tris buffer pH 7.4, 10 mM NaCl and DMSO (95:5) by HPLC after 
initial irradiation at 520 nm for 2 min (time 0h). Samples were stored in 
total darkness. HPLC chromatograms were recorded after the listed  
times. Represented data are a set, which is representative of the 
measurements from three independent experiments. 
 
(Fig. S20 & S23b†). This forced us to use 1H-NMR analysis for 
further investigations (Fig. 4). Thus, the trans/cis ratios were 
calculated by the integration of the aromatic proton signals 
(6.8 ppm—8.1 ppm). Gratifyingly, in the case of F4Azo-(PyDp)2 
(2) we corroborated the same ratio as the one obtained by  
HPLC (trans/cis ratio 93:7 and 30:70 for the trans- and cis- 
state, respectively). In addition, 1H-NMR studies revealed that, 
indeed, the photochemical behaviour of F4Azo-(PyDp)(PyOMe) 
(3) is analogue to F4Azo-(PyDp)2 (2) (trans/cis ratio 97:3 and 
27:73 for the trans- and the cis-state, respectively). 
Once the photoisomerization was fully characterized, we 
explored whether the two compounds are able to interact with 
DNA and whether their isomers displayed any differences in 
DNA-binding affinity. Thermal melting experiments are the 
most common methodology used for the evaluation of DNA 
interactions; however, we observed decomposition at high 
temperatures (Fig. S36†). Consequently, we performed a fluo-
rescent intercalator displacement (FID) assay49 compatible  
with the isomerization. We also compared our results with the 
minor groove binder netropsin (1). Thiazole orange (TO) was 
chosen as intercalator since its excitation and emission hardly 
affect the trans/cis isomerization (Fig. S34†). This experiment 
relies on a decrease of fluorescence due to the displacement of  
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Fig. 4 Selected aromatic region of the 1H-NMR spectra (300 MHz) of a 4 mM solution of (a) F4Azo-(PyDp)2 (2) and (b) F4Azo-(PyDp)(PyOMe) (3) in  
DMSO-d6 after irradiation to the trans- (top) and cis-isomer (bottom). Aromatic protons are marked in colours in the spectra and molecules.  
 
DNA-bound TO by the competitive binder. Therefore, we first 
determined the apparent binding constant of TO in presence  
of a hairpin oligonucleotide, which contains the sequence  
ATTA (dsDNAhAT) with the HypSpec software. Subsequently we 
simulated the species distribution for the obtained binding 
constant (KD = 59.8 ± 13.1 nM) by using the HySS software.  
The affinity of TO to dsDNAhAT enabled FID experiments at low 
μM range with more than 95% of TO-DNA complex in our 
experimental conditions (Table S4†), which assures the  
reliability of the assay. Typical fluorescence quenchers such as 
DABCYL or BHQ-1 are provided with the diazenyl functional 
group (R-N=N-R’), therefore we initially performed control 
competition assays in presence of increasing amounts of 5 to  
rule out artefacts due to quenching effects (Fig. S38†). As 










Fig. 5 (a) Competitive displacement analysis of a 6 μM TO solution in  
20 mM NaH2PO4 pH 7.4, 100 mM NaCl and 1 μM of dsDNAhAT with: 
netropsin (1, orange stars); F4Azo-(PyDp)2 isomers (trans-2 dark blue 
squares; cis-2 dark green squares) and F4Azo-(PyDp)(PyOMe) (trans-3 
light blue triangles; cis-3 light green triangles); (b) sequence-selectivity 
analysis of netropsin (1, stars) trans-F4Azo-(PyDp)2 (trans-2, squares) in 
presence 6 μM TO solution in 20 mM NaH2PO4 pH 7.4, 100mM NaCl  
and 1 μM of dsDNAhAT (blue) or dsDNAhGC (brown). Represented data 
and standard deviations are mean values calculated from thre indepen-
dent experiments. Data points were fitted with HypSpec, using multi-
variant factor analysis to obtain globally optimized parameters. Lines 
are “eye-guides” for assistance in visualizing the binding curves. 
(PyOMe) (3) were able to efficiently replace the bound TO from 
the DNA. The obtained data suggested binding modes beyond 
the 1:1 stoichiometry. For the mathematical analysis of the  
FID assays, the experimental data were fitted globally (all wave-
lengths simultaneously) with HypSpec. These experimental  
data fitted the model adequately (Fig. S33†). 
The analysis of the apparent dissociation constants indi- 
cated that both photoswitchable compounds have high DNA-
binding affinity in the nM range (Table 1). Importantly, for  
both azobenzene derivatives (2 and 3), the binding capacity of 
their isomers is different. This demonstrates a conformation-
dependent binding mode. In each pair, the trans-isomer is  
always the best binder, which is in agreement with other pre- 
vious examples of azobenzene derivatives.33-38 Furthermore, 
upon addition of the netropsin (1) control, the emission inten- 
sity of DNA-Bound TO also decreased significantly. The faster 
saturation of the netropsin (1) in comparison with our photo-
switchable binders, together with the fact that its binding  
curve does not also appear to follow a standard isotherm may  
be indicative of different binding modes. It was expected that 
netropsin (1), as a minor groove binder, could not fully dis- 
place the intercalator TO and reach saturation.50 The binding 
curve of netropsin (1) with a hairpin oligonucleotide contain- 
in  the sequence GGCCC (dsDNAhGC) displayed the standard 
 
Table 1 Binding affinities derived from FID experiments with selected 
hairpin oligonucleotide (dsDNAh). 
Compound dsDNAh site KD (nM) 
Netropsin (1) ATTA 10 ± 1 
Netropsin (1) GGCCC n. c. 
cis-F4Azo-(PyDp)(PyOMe) (cis-3) ATTA 82 ± 6 
trans-F4Azo-(PyDp)(PyOMe) (trans-3) ATTA 54 ± 3 
cis-F4Azo-(PyDp)2 (cis-2) ATTA 108 ± 14 
trans-F4Azo-(PyDp)2 (trans-2) ATTA 60 ± 1 
trans-F4Azo-(PyDp)2 (trans-2) GGCCC 13 ± 1 
   n.c. represents not calculated. 
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isotherm for non-specific interaction i.e. proportional to the 
concentration of added ligand (Fig. 5b). 
To get additional insight into its binding mode, we per-
formed exemplarily selectivity experiments with F4Azo-(PyDp)2 
(2) and the additional hairpin dsDNAhGC (Fig. 5b) as well as 
circular dichroisim (CD) experiments (Fig. 6). 
Regarding selectivity, F4Azo-(PyDp)2 (2) showed a slight 
preference for dsDNAhGC. Of note, all the obtained binding 
constants were derived from indirect assessments, based on  
the TO affinity to the corresponding dsDNA and its loss of 
fluorescence when it is displaced by a new binder. Therefore,  
the technique is limited to compounds with binding affinities  
in the same rage. In addition, ligand-induced condensation or 
interference with the fluorescence could not be discriminated 
from the actual fluorescence loss due to displacement, which 
may explain non-standard isotherms. Consequently, these values 
are, strictly speaking, estimations. Despite these  
inherent drawbacks, the FID assay is a straightforward method 
for the comparative characterization of DNA-recognition by the 
azobenzene derivatives on the one hand, and on the other  
hand, by the netropsin (and compounds with similar binding 
modes). 
The CD experiments of F4Azo-(PyDp)2 (2) with the double-
stranded calf thymus DNA (dsDNACT) confirmed a non-covalent 
interaction beyond the external non-specific electrostatic 
association with the DNA phosphates. Therefore, the observed 
interaction differs from the cationic polyamines such as sper-
mine and spermidine.51 The CD spectra of the dsDNACT alone 
showed the characteristic bands of the canonical B-DNA con-
formation (Fig. 6, grey line): a positive band at 275 nm and a 
negative one at 245 nm of similar intensity.52 F4Azo-(PyDp)2 (2) 
is achiral and, hence, optically inactive (Fig. 6, black line). 
However, when increasing amounts of F4Azo-(PyDp)2 (2) were 
added to the dsDNACT, induced circular dichroic (ICD) signals 






Fig. 6 CD spectra of a 50 μM solution of dsDNACT in 20 mM NaH2PO4  
pH 7.4, 100 mM NaCl with increasing amounts of the F4Azo-(PyDp)2 
isomers: (a) trans-2, blue; (b) cis-2, green. F4Azo-(PyDp)2 amounts: 0 eq 
(grey circles); 0.16 eq (light squares); 0.5 eq (diamonds); 1.1 eq (tri-
angles) and 2.8 eq (dark squares). Black line represents the CD spectra 
of a 142 μM (equivalent to 2.8 eq in the titration) solution of F4Azo- 
(PyDp)2 isomers under the same conditions: (a) trans-2 (diamonds); (b)  
cis-2 (triangles). Represented data are mean values calculated from two 
independent experiments; buffer subtracted; eq means equivalents:  
mol of compound 2 per mol of dsDNACT. 
Intriguingly, the addition of F4Azo-(PyDp)2 (2) induced a  
remarkable dose-dependent increase in magnitude of the  
signal in the region of 240-480 nm with a clear negative peak  
at 310 nm. Importantly, the two isomers cis-2 and trans-2 
behaved differently in the CD experiments under the same 
conditions. In particular, the ICD signals are more pro- 
nounced with trans-2 than with cis-2, which is concurrent with 
our previous FID experiments (as described above). 
To understand the observed CD signature, we performed 
UV-Vis titrations (Fig. 7). We observed that the addition of 
F4Azo-(PyDp)2 (2) promoted a red shift of the absorbance 
maximum of the dsDNACT and a new partly overlapped band  
at 420 nm, as in the CD spectra. However, the CD band at  
310 nm was not clearly detected in our UV-Vis measurements. 
Other azo-modified polyamines displayed CD signals at  
∼310 nm in presence of DNA but, to our knowledge, always  
with positive ellipticity.34,53 However, it has been reported that 
strong insertion of intercalators into the DNA causes a red-
shifted band with high negative CD signals between 240 nm  
and 340 nm,54 which is consistent with our observations. 
All together our results have shown that F4Azo-(PyDp)2 (2) 
is a photoswitchable molecule capable of interacting with the 
DNA through a conformation-dependent binding mode. 
Finally, we explored the possibility of using F4Azo-(PyDp)2  
(2) as a controllable nucleosome binder using visible light. For 
this endeavour, we first reconstituted nucleosome core par- 
ticles (NCP) using chicken erythrocyte histones55 and the  
Widom 601 DNA, which forms a stably positioned nucleo-
somes.56 We next used native gel electrophoretic mobility shift 
assays (EMSA) to analyse nucleosome reconstitution efficiency. 
We also used EMSA to assess nucleosome integrity after incu-
bating nucleosomes with increasing amounts of either netrop- 
sin (1) or F4Azo-(PyDp)2 (2) for three hours. As shown in Fig. 8, 
low concentrations of the minor groove binder netropsin (up  
to 4 eq) do not affect the nucleosome integrity. In the pres- 
ence of high netropsin concentrations, the bands became  
very diffuse and consequently barely detectable. This phenom-
enon may be due to the formation of many different species 




Fig. 7 UV-Vis spectra of a 12.5 μM solution of dsDNACT  in 20 mM  
NaH2PO4 pH 7.4, 100 mM NaCl with increasing amounts of the F4Azo-
(PyDp)2 isomers: (a) trans-2, blue; (b) cis-2, green. F4Azo-(PyDp)2  
amounts: 0 eq (grey circles); 0.16 eq (light squares); 0.5 eq (diamonds); 
1.1 eq (triangles) and 2.8 eq (dark squares). Represented data are calcu-
lated from three independent experiments; buffer was subtracted; eq 
means equivalents: mol of compound 2 per mol of dsDNACT. 
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Fig. 8 Evaluation of the interaction of DNA binders with Widom 601 
nucleosome core particle (NCP). All experiments were performed with  
300 nM NCP and 55 nM dsDNA as control in 10 mM Tris buffer pH 8,  
1 mM EDTA, 50 mM NaCl and DMSO (90:10) and analyzed by ethidium 
bromide staining, after electrophoresis: (a) netropsin interaction: lane 1: 
dsDNA; lanes 2-9: NCP + [netropsin] = 0, 32, 16, 8, 4, 2, 1, 0.5 eq.; (b)  
F4Azo-(PyDp)2 (2) interaction: lane 7: NCP; lane 6: dsDNA; lane 1-5:  
NCP + [cis-2] = 0.5, 0.25, 0.13, 0.06, 0.03 eq.; lane 8-12: NCP + [trans- 
2] = 0.5, 0.25, 0.13, 0.06, 0.03 eq. DMSO stocks of F4Azo-(PyDp)2 (2)  
were irradiated before EMSA; (c) F4Azo-(PyDp)2 (2) interaction with  
in situ irradiation: lane 1: dsDNA; lane 2: NCP; lane 3-4: control with  
previous irradiation of NCP + [cis-2] = 0.5, 0.25 eq.; lane 5-6: control  
with previous irradiation of NCP + [trans-2] = 0.5, 0.25; lane 7-9 in situ 
irradiation at 405 nm for 10 s of NCP + [cis-2] = 0.5, 0.25, 0.13 eq.; (d)  
effect of irradiation at 405 nm on NCP: lane 1: dsDNA; lane 2: NCP; lane  
3-7: NCP after 1 s, 5 s, 10 s, 30 s, 60 s irradiation. Eq. means equivalents:  




gates, which may be too big to enter the gel. Interestingly, the 
binding of our molecule F4Azo-(PyDp)2 (2) apparently triggered 
this effect at lower concentrations than netropsin, despite having 
the same net charge (Fig. 8a & b). Importantly, there  
was a noticeable difference between isomers. In particular, the 
intensity of the nucleosome band abruptly ceased to be detect-
able in the presence of 0.5 eq. of the trans-2, while at the same 
concentration, the cis-2 failed to fully alter the nucleosome  
band. Furthermore, the fact that we circumvented the use of 
strong UV light, for the isomerization, facilitated the in situ 
application. Thus, the same procedure was repeated but now 
performing the irradiation in situ: after incubating the cis-2 for  
1 h with the nucleosome, the samples were irradiated at  
405 nm for 10 s, in a single isomerization cycle. As a control,  
we also included both isomers irradiated prior to the nucleo- 
some incubation. Gratifyingly, we observed that the in situ 
formed trans-2 showed a higher impact than the parental cis-2. 
Of note, no irradiation effect on the nucleosome was detect- 
able (Fig. 8d).  
To complement the EMSA studies and gain preliminary 
insights into the effect of F4Azo-(PyDp)2 (2) on the NCPs, we 
performed dynamic light scattering (DLS) measurements. 
Nucleosomes are colloidal particles of 11 nm wide,59 and 
alterations in their hydrodynamic size can assist in the charac-
terization of the interaction with small molecules. In this ana- 
lysis, we used NCP at 2μM concentration, employing plasmids 
containing multiple repeats of the Widom 601 sequence for 
large-scale DNA isolation.60 As shown in Fig. 9, the particle 
size of the NCP is consistent with previous reports.61,62 
Increasing amounts of F4Azo-(PyDp)2 (2) clearly change  
the size distribution resulting in larger particles than the 
canonical NCP (Fig. 9a). This effect was reproducible and, 
interestingly, changes were already detectable from the first 
F4Azo-(PyDp)2 addition (0.06 eq.), although no alterations in  
the EMSA bands were observable under the same conditions at 
this concentrations (Fig. S46a†). This was also contrary to the 
case of the netropsin, where low concentrations did not affect  
the size of the particle (Fig. S42 & S46d†). Therefore, as 
expected, the insertion of F4Azo-(PyDp)2 (2) caused higher 
structural distortion than for the minor groove binder 1. To study 





Fig. 9 Effect of F4Azo-(PyDp)2 on: (a) nucleosome (NCP); (b) dsDNA601  
at 2 μM concentration in 10 mM Tris 1 mM EDTA pH 8.0 and 50 mM 
NaCl monitored by dynamic light scattering (DLS). F4Azo-(PyDp)2 (2) 
amounts: 0 eq. (grey); 0.06 eq. (green); 0.13 eq. (blue); 0.25 eq. (black)  
and 0.5 eq. (red); (c) effect of MgCl2 on NCP at 2 μM concentration in 
3.5 mM Tris 0.35 mM EDTA pH 8.0 monitored by DLS. MgCl2 concen-
trations: 0 mM (grey); 2.5 mM (green); 3.75 mM (blue); 5 mM (black); 
10 mM (red). Intensity statistics of 10 measurements. Represented data 
are a representative one of two measurements from independent 
experiments; eq means equivalents (mol of compound per mol of base  
pair) Represented data are a set, which is representative of the measure-
ments from two independent experiments. 
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via nucleosome disassembly, we performed control experi 
ments with the analogue set-up but using the dsDNA  
employed for the nucleosome assembly (dsDNA601) instead of 
the whole NCP, as well as, the precipitated NCP in presence of 
magnesium chloride; and histone octamer alone. However, the 
latter protein complex did not display any DLS signal under  
these conditions. 10 mM of magnesium chloride promoted  
the precipitation of the NCP (Fig. S43 & S46c†) and the appear-
ance of single peak of higher size than the NCP alone but  
smaller than the one obtained with highest concentrations  
of F4Azo-(PyDp)2 (2) (342 nm versus 3580 nm, respectively). 
Interestingly, the incubation of dsDNA601 in presence of  
F4Azo-(PyDp)2 (2) (Fig. 9b) displayed DNA-higher order struc-
tures, as reported with other cationic molecules63-65 such as 
polyamines, surfactants, etc. Qualitatively, the distribution of  
the peaks obtained from this titration were similar to the one 
observed in the presence of NCP (Fig. 9a). Therefore, these  
DLS data suggest that, first, the F4Azo-(PyDp)2 (2) intercalates 
into the nucleosomal DNA inducing distortions, which lead to 
the formation of high size aggregates. These observations are 
consistent with the hypothesis that nucleosome distortion 
subsequently leads to disruption. Future experiments will  
be required to fully characterize these alterations and their 
kinetics. 
In summary, we have designed, synthesized and studied a 
novel photoswitchable ortho-fluoroazobenzene DNA binder: 
F4Azo-(PyDp)2. We also demonstrated that its DNA interaction 
depends on the conformation, which, importantly, can be con-
trolled by visible-light. Furthermore, our study establishes the 
possibility of performing photocontrollable nucleosome  
binding. To our knowledge this is the first time that nucleo- 
some targeting is externally modulated by visible-light photo-
switches. We believe that this approach uncovers the possi- 
bility of using photosensitive chemical tools to alter nucleo-
some-based processes. At this point, it is impossible to predict 
whether our molecule can preferentially impact specific cell 
functions. It is more plausible that, if appropriately taken up  
by cells, the molecule would alter cell functions randomly,  
since F4Azo-(PyDp)2 (2) only shows a slight sequence binding 
preference. Thus, future directions may include the develop-
ment of sequence-specific nucleosome binders to potentially 
control cell functions specifically via modulation of DNA tran-
scription and/or repair processes. 
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APS ammonium persulfate 
AU arbitrary unit 
bp base pair 
CD circular dichroism 
d doublet 
DIPEA N, N-diisopropylethylamine 
DLS dynamic light scattering 
DMAP 4-(dimethylamino)pyridine 
dNTP deoxyribonucleotide triphosphate  
Dp N,N-dimethyl-1,3-diaminopropane  
dsDNACT double-stranded calf thymus DNA 
dsDNAhAT double-stranded DNA hairpin with the consensus sequence ATTA 
dsDNAhGC double-stranded DNA hairpin with the consensus sequence GGCCC 
E.coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
EGTA ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid 
EI emission intensity, electron ionization 
EMSA electrophoretic mobility shift assay 
ESI-MS electrospray ionization mass spectroscopy 
EtBr ethidium bromide 
FID fluorescence intercalator displacement 
HATU hexafluorophosphate azobenzotriazole tetramethyl uronium 
HF high-fidelity 
HMBC heteronuclear multiple bond correlation spectroscopy 
HRMS high resolution mass spectroscopy 
HSQC heteronuclear single quantum correlation spectroscopy 




NMR nuclear magnetic resonance 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PMSF phenylmethane sulfonyl fluoride 
ppm part per million  
Py pyrrole 
Rf retention factor 





TBE tris/borate/EDTA buffer 
TEMED tetramethylethylenediamine 
TMS trimethylsilyl protecting group 




δ chemical shift 





Materials and Experimental Procedures 
All commercially purchased reagents were used from the following companies without further purification: trichloroacetyl 
chloride, thionyl chloride, DMSO for molecular biology, potassium chloride, APS, Igepal CA630, EGTA, citric acid, CM-
Sephadex, potassium acetate, primers and DNA hairpins from Sigma Aldrich (USA); iron(II) sulfate heptahydrate, acetic 
anhydride, Tris, boronic acid, 19 : 1 acrylamide : bisacrylamide, TEMED, sucrose, adenine, potassium dihydrogen phosphate 
and DIPEA from Carl Roth (Germany); sodium hydroxide, potassium hydroxide, EDTA, ethidium bromide, dipotassium 
hydrogen phosphate, ethanol absolute, PEG 6000, isoamyl alcohol and nitric acid from Merck (Germany); potassium 
permanganate, N,N-dimethyl-1,3-diaminopropane (Dp), spermidine, spermine, sodium citrate, calcium chloride and Pd/C 
from Alfa Aesar (USA); DMF peptide grade and HATU from Iris Biotech (Germany); phusion polymerase and 5X HF buffer from 
New England Biolabs (USA); 4-bromo-2,6-difluoroaniline from Fluorochem (UK); copper (I) cyanide and heparin sodium salt 
from TCI (Japan), N-methyl pyrrole (Py) and glycerol from Acros Organics (Belgium); DMAP and PMSF from Fluka (USA); 
agarose, dNTPs and calf thymus DNA from Invitrogen (USA); sodium chloride from VWR (USA); sodium dihydrogen phosphate 
from Grössing GmbH (Austria); netropsin from Santa Cruz Biotechnology (USA); MNase (LS004797) from Worthington (USA); 
phenol, sodium dodecyl sulfate, RNAse (A3832,0050) and glucose monohydrate from PanReac Applichem ITW Reagents 
(USA); sodium acetate from Riedel de Haen (Germany); glacial acetic acid and EcoRV from Fisher Scientific (USA) and HT Gel 
from Biorad (USA). Water was purified with a milli-Q Ultra Pure Water Purification System (TKA, Germany). 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
All NMR spectra were automatically measured at 300 K either in a Bruker AV III HD 300 MHz at a frequency of 300 MHz (1H) 
or 75 MHz (13C) or in a Bruker AV III HD 500 MHz at a frequency of 500 MHz (1H) or 125 MHz (13C). All chemical shifts (δ) are 
relative to tetramethylsilane (TMS), i.e. δ(TMS) = 0 ppm. As internal standards, deuterated chloroform (CDCl3), dimethyl 
sulfoxide (DMSO) with TMS were used. Solvent shifts (ppm): δ(CHCl3) = 7.26 ppm (1H), δ(CHCl3) = 77.16 ppm (13C), δ(DMSO) 
= 2.50 ppm (1H), δ(DMSO) = 39.52 ppm (13C).[i] Coupling constants are given in Hz. The assignment of each signal was based 
on two-dimensional nuclear magnetic resonance spectroscopy (2D NMR), i.e. heteronuclear single quantum coherence 
(HSQC) and heteronuclear multiple bond correlation spectroscopy (HMBC). Unless otherwise noted, the NMR tubes were 
Wilmad NMR tubes (WG-5-7E; OD: 4.947±0.019 mm; ID: 4.1 mm; length 7). For analytical purposes the photoswitchable 
ortho-fluorazobenzene-pyrrole hybrids were fully characterized as their E-isomers. The symbol * represents Z-isomer signals 
in the spectra. For the isomerization studies also the Z-isomer was analyzed. 
 
High Performance Liquid Chromatography (HPLC) 
For preparative purposes, a PLC 2020 Personal Purification System (Gilson) with a preparative Nucleodur C18 HTec-column 
(5 µm, 250 x 16 mm; Macherey & Nagel) using an isocratic regime during the first five minutes, for column equilibration, 
followed by a linear gradient 5% to 60% B in 40 min for compounds 2 and 17 and a linear gradient 5% to 75% B in 30 min for 
compound 3 with a flow rate of 10 mL/min at 25°C was used. The detection was carried out by measuring the absorption at 
wavelengths: 220 nm and 260 nm. Milli-Q water (A) and MeCN (B) were employed as eluents with an addition of 0.1% of TFA 
in both solvents. 
For analytical purposes, an Agilent 1260 Infinity II HPLC-System (Agilent Technologies) with either an EC 125/2 Nucleodur 
100-C18 ec column (Macherey & Nagel) with a flow rate of 0.2 mL/min for purity analysis or an eclipse XDB-C18 (5 µm, 4.6 x 
150 mm, Agilent) with a flow rate of 1.0 mL/min for switching studies using with an isocratic regime during the first five 




Electrospray ionization mass spectrometry (ESI-MS) was performed on a Finnigan LTQ-FT (Thermo Fischer Scientific). EI-MS 
was performed on an AccuTOF GCv (JEOL). 
 
UV-Vis Spectroscopy 
UV-Vis measurements were performed on a Tecan 20M at room temperature using a quartz cuvette (Hellma Analytics; 104-
QS) with a pathlength of 1 cm in a volume of 1 mL. The represented measurements were always buffer substracted. 
 
Fluorescence Spectroscopy 
Fluorescence measurements were performed on a Jasco FP-6500 spectrofluorometer equipped with a Thermo Haake WKL 
26 water recirculator at 20°C. Unless otherwise noted, fluorescence cuvette (Hellma Analytics; 104F-QS) was used. The 
measurements were performed with the following settings: increment: 1.0 nm; integration time: 0.2 s; speed: 500 nm/min; 
sensitivity: medium; excitation slit width: 3 nm; emission slit width: 5 nm; excitation wavelength 490 nm. The emission 
spectra were recorded from 510 to 700 nm at 20°C. From all spectra, the corresponding background signal was subtracted. 
Measurements were performed in triplicates. The represented measurements were always buffer substracted. 
 
Circular Dichroism 
CD titration measurements were performed on a Jasco J-810 Spectropolarimeter equipped with a Jasco CDF-426S peliter 
controller and a Thermo Haake WKL 26 water recirculator at 20°C using a CD cuvette (Hellma Analytics; QS 0.200). The settings 
were: range from 550-230 nm, speed of 100 nm/min, response of 0.25 s, band width of 2 nm and a data pitch of 1 nm. The 
represented measurements were always buffer substracted. 
 
Dynamic Light Scattering 
Dynamic Light Scattering (DLS) measurements were performed on a Malvern Instruments (UK) Zetasizer Nano ZS equipped 
with a 10 mW HeNe laser at a wavelength of 633 nm. Measurements were performed at 25°C using an UVette (Eppendorf; 
0030106300). The settings were: material: protein (RI 1.450, absorbance 0.001); dispersant: viscosity 0.8812 cP, RI 1.331; 
equilibration time: 180 s; cell: disposable cuvette ZEN0040; measurement: measurement angle: 173° backscatter (NIBS 
default), measurement duration: number of runs 10, run duration 10 s. The corresponding hydrodynamic diameter were then 




The retrosynthesis of the photoswitches is illustrated for the E-isomer because it is the most stable thermodynamically. 
 
Scheme S1: Retrosynthetic approach for the preparation of the flourazobenzene derivatives F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) (3). 
 
Synthesis of the Symmetrical ortho-fluorazobeneze-4,4’-dicarboxylic acid (F4Azo-diacid, 5) 
This synthesis was reported before by Hecht et al.[ii,iii] Such procedure is based in the preparation of the symmetrical ortho-
fluorazobeneze-4,4’-diester (F4-diester, 14).[ii] We followed the same approach with minor modifications. 
 
 
Scheme S2: Synthesis route of F4Azo-diacid (5) starting from 4-bromo-2,6-difluoroaniline (9). 
 
4-amino-3,5-difluorobenzonitrile (11): 4-bromo-2,6-difluoroaniline (9, 5.00 g, 24.0 mmol) and CuCN (6.45 g, 72.0 mmol) 
were dissolved in DMF (50 mL) and heated to 160°C for 16 h. The mixture was poured into saturated Na2CO3 (250 mL), filtered 
and the precipitate washed with EtOAc. The organic phases were washed with NH3 12% aqueous solution and dried over 
MgSO4. The crude product was purified by column chromatography (CH2Cl2/n-pentane 2:1) to yield the desired product (11, 
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2.29 g, 14.9 mmol, 62 %) as a white solid. Rf = 0.39 (CH2Cl2/n-pentane 2:1); δH(300 MHz; CDCl3; Me4Si) 7.13 (2 H, dd, 3JHF 6.0, 
4JHH 2.3, H-1 and H-2), 4.29 (2 H, br s, NH2); δC (75 MHz; CDCl3; Me4Si) 152.3 (Carom.), 149.0 (Carom.), 129.8 (Carom.), 118.0 (CN), 
115.7 (CH), 115.4 (CH); 98.4 (Carom.) HRMS-EI+ (m/z): [M]+ calcd for C7H4F2N2, 154.03425; found, 154.03252. 
 
4-amino-3,5-difluorobenzoic acid (12): 4-amino-3,5-difluorobenzonitrile (11, 2.25 g, 14.6 mmol) was suspended in 1M NaOH 
(80 mL) and refluxed overnight. The reaction mixture was cooled to r.t. and acidified with 1M HCl. The resulting precipitate 
was dissolved in EtOAc, dried over MgSO4, filtered and the solvent removed under reduced pressure to yield the desired 
product (12, 2.20 g, 12.7 mmol, 87 %) as a white solid. Rf = 0.93 (EtOAc/formic acid 1:0.02); δH(300 MHz; [D6]DMSO; Me4Si) 
12.68 (1 H, s, COOH), 7.39 (2 H, dd, 3JHF 7.2, 4JHH 2.4, H-1 and H-2), 6.05 (2 H, s, NH2); δC (75 MHz; [D6]DMSO; Me4Si) 166.0 
(COOH), 151.3 (Carom.), 148.2 (Carom.), 130.6 (Carom.), 115.7 (Carom.), 112.3 (CH), 112.1 (CH); HRMS-ESI- (m/z): [M]- calcd for 
C7H4F2N1O2, 172.0216; found, 172.0217. 
 
ethyl 4-amino-3,5-difluorobenzoate (13): 4-amino-3,5-difluorobenzoic acid (12, 1.90 g, 11.0 mmol) was dissolved in EtOH 
(40 mL) and conc. H2SO4 (4 mL) and refluxed for 5 h. Conc. H2SO4 was added and the reaction mixture refluxed for 1 h. The 
mixture was neutralized with sat. NaHCO3, extracted with CH2Cl2, the organic phases dried over MgSO4, filtered and the 
solvent removed under reduced pressure to yield the desired product (13, 2.07 g, 10.3 mmol, 94 %) as a pale brown solid. 
Rf = 0.29 (CH2Cl2/n-pentane 1:1); δH(300 MHz; CDCl3; Me4Si) 7.53 (2 H, dd, 3JHF 7.2, 4JHH 2.1, H-1 and H-2), 4.33 (2 H, q, 3JHH 
7.1 Hz, H-3), 3.86 (2 H, br s, NH2), 1.37 (3 H, t, 3JHH 7.1, H-4); δC (75 MHz; [D6]DMSO; Me4Si) 165.3 (CO), 152.4 (Carom.), 149.3 
(Carom.), 128.9 (Carom.), 118.8 (Carom.), 112.8 (CH), 112.6 (CH), 61.2 (CH2), 14.5 (CH3); HRMS-ESI+ (m/z): [M]+ calcd for 
C9H9F2N1O2H, 202.0674; found, 202.0675. 
 
diethyl 4,4'-(diazene-1,2-diyl)-bis(3,5-difluorobenzoate) (14): ethyl 4-amino-3,5-difluorobenzoate (13, 1.36 g, 6.76 mmol) 
was dissolved in CH2Cl2 (115 mL) and KMnO4 (11.5 g, 73.0 mmol) and FeSO4 x 7H2O (11.5 g, 41.2 mmol) were added. The 
reaction mixture was refluxed overnight and filtered over celite. The solvent was removed under reduced pressure and the 
crude purified by column chromatography (CH2Cl2/n-pentane 1:1) to yield the desired product (14, 452 mg, 1.13 mmol, 34 %) 
as an orange solid. Rf = 0.75 (CH2Cl2); HRMS-ESI+ (m/z): [M]+ calcd for C18H14F4N2O4H, 399.0962; found, 399.0963. 
E-isomer: 
δH(300 MHz; CDCl3; Me4Si) 7.74 (4 H, d, 3JHF 8.9, H-1, H-1’, H-2 and H-2’), 4.43 (4 H, q, 3JHH 7.1, H-3 and H-3’), 1.43 (6 H, t, 3JHH 
7.1, H-4 and H-4’); δC (75 MHz; CDCl3; Me4Si) 163.8 (2 C, CO), 156.9 (2 C, Carom.), 153.4 (2 C, Carom.), 134.0 (2 C, Carom.), 133.9 
(2 C, Carom.), 114.2 (2 C, CH), 113.9 (2 C, CH), 62.3 (2 C, CH2), 14.3 (2 C, CH3). 
 
4,4'-(diazene-1,2-diyl)-bis(3,5-difluorobenzoic acid) (5): diethyl 4,4'-(diazene-1,2-diyl)-bis(3,5-difluorobenzoate) (14, 449 mg, 
1.13 mmol) was dissolved in THF (25 mL) and KOH (228 mg, 4.06 mmol) dissolved in H2O (13 mL) was added. The reaction 
mixture was stirred for 1 h and acidified with 1M HCl. The formed precipitate was filtered and dried on the freeze-dryer 
overnight to yield the desired product (5, 362 mg, 1.06 mmol, 94 %) as a pale orange solid. Rf = 0.63 (EtOAc/formic acid 
1:0.02); HRMS-ESI- (m/z): [M]- calcd for C14H5F4N2O4, 341.0191; found, 341.0203. 
 
E-isomer: 
δH(300 MHz; [D6]DMSO; Me4Si) 13.84 (1 H, br s, COOH), 7.80 (4 H, d, 3JHF 9.3 Hz, H-1, H-1’, H-2 and H-2’); δC (75 MHz; 
[D6]DMSO; Me4Si) 164.5 (2 C, CO), 156.0 (2 C, Carom.), 152.5 (2 C, Carom.), 135.2 (2 C, Carom.), 133.0 (2 C, Carom.), 114.0 (2 C, CH), 




Synthesis of Pyrrole Monomers Py(Dp) (8) and Py(OMe) (7) 
This synthesis was reported before by Dervan et al.,[iv] Lown et al.[v] and Pindur et al.,[vi] Such procedure is based in the 
preparation of the nitro pyrrole methylester 7.[iv] We followed the same approach with minor modifications. 
 
Scheme S3:  Synthesis route of O2N-Py-OMe (7) and O2N-Py-Dp (8) starting from N-methylpyrrole (10). 
 
2,2,2-trichloro-1-(1-methyl-1H-pyrrol-2-yl)ethan-1-one (15): Under inert atmosphere, to a solution of trichloroacetyl 
chloride (2.80 mL, 25.0 mmol) in Et2O (5.00 mL), a solution of N-methylpyrrole (2.20 mL, 25.0 mmol) in Et2O (5.00 mL) was 
added at 0 °C over 1 h. The reaction mixture was stirred overnight at r.t. and neutralized with K2CO3 solution. It was extracted 
with Et2O, dried over MgSO4 and the solvent removed under reduced pressure to yield the desired product (15, 4.67 g, 
20.6 mmol, 82 %) as brown solid. Rf = 0.60 (n-pentane / EtOAc 1:1); δH(300 MHz; [D4]MeOD; Me4Si) 7.46 - 7.42 (2 H, m, H-1 
and H-3), 6.30 (1 H, dd, 3JHH 4.3, 3JHH 2.5, H-2), 3.91 (3 H, s, H-4); δC (75 MHz; [D4]MeOD; Me4Si) 171.8 (CO), 135.3 (CH), 123.6 
(CH), 120.7 (Cq), 109.1 (CH), 96.0 (CCl3), 36.2 (CH3); HRMS-EI+ (m/z): [M]+ calcd for C7H6Cl3N1O1, 225.95932; found, 225.95978. 
 
2,2,2-trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)ethan-1-one (16): Under inert atmosphere, to a solution of 2,2,2-trichloro-
1-(1-methyl-1H-pyrrol-2-yl)ethan-1-one (1.50 g, 6.62 mmol) in Ac2O (8.00 mL, 84.6 mmol), conc. HNO3 (0.60 mL, 14.4 mmol) 
was added at -40°C over 30 min. The reaction mixture was slowly warmed up to r.t. and stirred overnight. It was neutralized 
with Na2CO3 solution, extracted with EtOAc, washed with brine, the organic phases dried over MgSO4 and the solvent 
removed under reduced pressure to yield the desired product (16, 1.24 g, 4.56 mmol, 69 %) as brown solid. Rf = 0.16 (n-
pentane / EtOAc 10:1); δH(300 MHz; [D6]DMSO; Me4Si) 8.56 (1 H, d, 4JHH 1.6, H-2), 7.80 (1 H, d, 4JHH 1.6, H-1), 4.00 (3 H, s, H-
3); δC (75 MHz; [D6]DMSO; Me4Si) 172.8 (CO), 134.2 (Cq), 132.5 (CH), 120.6 (Cq), 116.3 (CH), 94.5 (CCl3), 50.0 (CH3); HRMS-
EI+ (m/z): [M]+ calcd for C7H6Cl3N2O3, 270.94440; found, 270.94291. 
 
methyl 1-methyl-4-nitro-1H-pyrrole-2-carboxylate (7): To a solution of 2,2,2-trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-
yl)ethan-1-one (16 ,4.72 g, 17.4 mmol) in MeOH (58.0 mL) DMAP (212 mg, 1.74 mmol) was added and stirred at r.t. for 72 h. 
The solvent was removed and the crude product purified by column chromatography (n-pentane / EtOAc 4:1 → 1:1)  to yield 
the desired product (7, 2.57 g, 14.0 mmol, 80%) as yellow solid. Rf = 0.16 (n-pentane / EtOAc 10:1); δH(300 MHz; [D6]DMSO; 
Me4Si) 8.27 (1 H, d, 4JHH 2.0, H-2), 7.30 (1 H, d, 4JHH 2.0, H-1), 3.92 (3 H, s, H-3), 3.80 (3 H, s, H-4); δC (75 MHz; [D6]DMSO; 
Me4Si) 159.8 (CO), 134.2 (Cq), 129.4 (CH), 122.6 (Cq), 111.5 (CH), 51.7 (CH3), 37.4 (CH3); HRMS-ESI+ (m/z): [M]+ calcd for 
C7H8N2O4H, 185.05623; found, 185.05665. 
 
1-methyl-4-nitro-1H-pyrrole-2-carboxylic acid (17): To a solution of methyl 1-methyl-4-nitro-1H-pyrrole-2-carboxylate (7 , 
2.00 g, 10.9 mmol) in MeOH (25.0 mL) 1M NaOH (15mL) was added and the reaction mixture stirred at r.t. overnight and 
heated at 60 °C for 1 h. Afterwards, it was extracted with EtOAc and washed with saturated NaHCO3. The aqueous phases 
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were acidified with 2M HCl, extracted with EtOAc, the organic phases dried over MgSO4, filtered and the solvent removed 
under reduced pressure to yield the desired product (17, 1.77 g, 10.4 mmol, 95%) as pale yellow solid. Rf = 0.33 (EtOAc/formic 
acid 1:0.02); δH(300 MHz; [D6]DMSO; Me4Si) 13.11 (1 H, s, COOH), 8.21 (1 H, d, 4JHH 2.1, H-2), 7.25 (1 H, d, 4JHH 2.1, H-1), 3.91 
(3 H, s, H-3); δC (75 MHz; [D6]DMSO; Me4Si) 160.9 (CO), 134.0 (Cq), 129.1 (CH), 123.8 (Cq), 111.4 (CH), 37.4 (CH3); HRMS-ESI- 
(m/z): [M]- calcd for C6H5N2O4, 169.0255; found, 169.0257. 
 
N-(3-(dimethylamino)propyl)-1-methyl-4-nitro-1H-pyrrole-2-carboxamide (8): To a solution of 1-methyl-4-nitro-1H-pyrrole-
2-carboxylic acid (17, 674 mg, 3.96 mmol) in CH2Cl2 (13.5 mL) and DMF (112 µL), SOCl2 (2.88 mL, 39.6 mmol) was added slowly 
at 0 °C. The reaction mixture was warmed up to r.t. and stirred for another 6 h. The solvent was removed under reduced 
pressure. At 0 °C under inert atmosphere, the crude was dissolved in DMF (2.70 mL) and N,N-dimethyl-1,3-diaminopropane 
(18, 1.10 mL, 8.71 mmol) added dropwise. The reaction mixture was warmed to up to r.t. and stirred for 16 h. Deionized 
water was added to be extracted with EtOAc. The organic phases were washed with saturated NaHCO3, dried over MgSO4, 
filtered and the solvent removed under reduced pressure. The crude product was purified by column chromatography (CH2Cl2 
/ MeOH / TEA 10:1:0.5%) to yield the desired product (8, 642 mg, 2.52 mmol, 64%) as pale yellow solid. Rf = 0.07 (CH2Cl2 / 
MeOH / TEA 10:1:0.5%); δH(300 MHz; [D4]MeOD; Me4Si) 7.82 (1 H, d, 4JHH 1.9, H-2), 7.27 (1 H, d, 4JHH 1.9, H-1), 3.95 (3 H, s, 
H-3), 3.33 (2 H, t, 3JHH 7.0, H-4), 2.41 (2 H, t, 3JHH 7.6, H-6), 2.27 (6 H, s, H-7 and H-7’), 1.84 – 1.72 (2 H, m, H-5); δC (75 MHz; 
[D4]MeOD; Me4Si) 162.9 (CO), 136.2 (Cq), 128.4 (CH), 127.9 (Cq), 108.5 (CH), 58.2 (CH2), 45.4 (2C, CH3), 38.7 (CH3), 37.9 (CH2), 
28.1 (CH2); HRMS-ESI+ (m/z): [M]+ calcd for C11H18N4O3H, 255.1452; found, 255.1457. 
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Synthesis of photoswitchable ortho-fluorazobenzene-pyrrole hybrids: F4Azo-(PyDp)2 (2) and 
F4Azo-(PyDp)(PyOMe) (3)  
This synthesis relies on the condensation reactions between the F4Azo-diacid (5) and the reduced pyrrole derivatives. 
 
Scheme S4: Synthesis route of photoswitchable fluorazobenzene dimers F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) (3) starting from F4Azo-diacid (5), O2N-Py-
Dp (8) and O2N-Py-OMe (7). 
 
4,4'-((4,4'-(ethene-1,2-diyl)bis(3,5-difluorobenzoyl))bis(azanediyl))bis(N-(3-(dimethylamino)propyl)-1-methyl-1H-pyrrole-
2-carboxamide) (2): Compound 8, (78.1 mg, 0.31 mmol) and Pd/C 10% dry (50.0 mg, 64.0% w/w) was suspended in THF 
(3.0 mL) and stirred under H2 atmosphere for 2 h. The reaction mixture was filtered over celite and the solvent removed 
under reduced pressure. F4Azo-diacid (5, 50.0 mg, 0.15 mmol) and HATU (117 mg, 0.31 mmol) were dissolved in THF (400 µL) 
and DIPEA (107 µL, 0.61 mmol) added. The reaction mixture was stirred for 75 min before the reduced pyrrole 8 dissolved in 
THF (700 µL) was added. After stirring for 4.5 h, the solvent was removed and the crude purified by preparative HPLC (5 - 60% 
over 40 min) to yield the desired product as its TFA salt (2, 68.8 mg, 0.07 mmol, 47%) as orange solid. tR = 22.6 min (5% to 




δH(500 MHz; [D6]DMSO; Me4Si): 10.69 (2 H, s, NH-3 and NH-3’), 9.58 (2 H, br s, NH+-12 and NH+-12’), 8.26 (2 H, t, 3JHH 5.9, 
NH-7 and NH-7’), 7.96 (2 H, s, H-1 and H-1’ / H-2 and H-2’), 7.92 (2 H, s, H-1 and H-1’ / H-2 and H-2’), 7.33 (2 H, d, 4JHH 1.7, H-
4 and H-4’), 6.99 (2 H, d, 4JHH 1.7 Hz, H-5 and H-5’), 3.86 (6 H, s, H-6 and H-6’), 3.26 (4 H, dt, 3JHH 6.3, 3JHH 5.9, H-8 and H-8’), 
3.04 – 3.14 (4 H, m, H-10 and H-10’), 2.79 (12 H, s, H-11, H-11’, H-11’’ and H-11’’’), 1.79 – 1.92 (4 H, m, H-9 and H-9’); δC 
(125 MHz; [D6]DMSO; Me4Si) 161.5 (2 C, CO), 160.0 (2 C, CO), 156.2 (2 C, Cq), 152.7 (2 C, Cq), 138.5 (2 C, Cq), 131.9 (2 C, Cq), 
123.1 (2 C, Cq), 121.5 (2 C, Cq), 118.7 (2 C, CH), 112.5 (2 C, CH), 112.1 (2 C, CH), 104.5 (2 C, CH), 54.8 (2 C, CH2), 43.4 (4 C, CH3), 
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difluorobenza- mido)-1-methyl-1H-pyrrole-2-carboxylic acid (19): Compound 6, (16.2 mg, 0.06 mmol) and Pd/C 5% dry 
(20.0 mg, 123% w/w) was suspended in THF (3.0 mL) and stirred under H2 atmosphere for 2 h. The reaction mixture was 
filtered over celite and the solvent removed under reduced pressure. F4Azo-diacid (5, 50.0 mg, 0.15 mmol) and HATU 
(33.5 mg, 0.09 mmol) were dissolved in THF (10 mL) and DIPEA (85.0 µL, 0.49 mmol) added. The reaction mixture was stirred 
for 50 min before the reduced pyrrole 8 dissolved in THF (1.50 mL) was added. After stirring for 1.5 h, the solvent was 
removed and the crude purified by preparative HPLC (5 - 60% over 40 min) to yield the desired product as its TFA salt (19, 
19.7 mg, 0.03 mmol, 47%) as orange solid. tR=24.2 min (cis), 24.6 min (trans) (5% to 75% B in 30 min); HRMS-ESI+ (m/z): [M]+ 
calcd for C25H24F4N6O4H, 549.1868; found, 549.1883.  
E-isomer: 
δH(500 MHz; [D6]DMSO; Me4Si) 13.95 (1 H, s, COOH), 10.68 (1 H, s, NH-3), 9.48 (1 H, br s, NH+-12), 8.27 (1 H, t, 3JHH 5.8, NH-
7), 7.94 (1 H, s, H-1 / H-2), 7.92 (1 H, s, H-1 / H-2), 7.83 (1 H, s, H-1b / H-2b), 7.81 (1 H, s, H-1b / H-2b), 7.32 (1 H, d, 4JHH 1.9, 
H-4), 6.99 (1 H, d, 4JHH 1.9, H-5), 3.85 (3 H, s, H-6), 3.28 – 3.22 (2 H, m, H-8), 3.11 – 3.06 (2 H, m, H-10), 2.79 (6 H, s, H-11 and 
H-11’), 1.88 – 1.81 (2 H, m, H-9); δC (125 MHz; [D6]DMSO; Me4Si) 164.5 (COOH), 161.4 (CO), 159.9 (CO), 155.5 (Cq), 155.3 
(Cq), 153.5 (Cq), 153.3 (Cq), 138.7 (Cq), 134.9 (Cq), 133.2 (Cq), 131.8 (Cq), 123.0 (Cq), 121.4 (Cq), 118.7 (CH), 114.1 (CH), 113.9 








          





























Figure S10: HMBC-NMR spectrum of trans- F4Azo-(PyDp)(COOH) (19).
131 
(E)-3-(4-(4-((2,6-difluoro-4-((5-(methoxycarbonyl)-1-methyl-1H-pyrrol-3-yl)carbamoyl)phenyl)diazenyl)-3,5-difluorobenza-
mido)-1-methyl-1H-pyrrole-2-carboxamido)-N,N-dimethylpropan-1-aminium (3): Compound 7, (4.40 mg, 24.1 µmol) and 
Pd/C 5% dry (6.00 mg, 136% w/w) was suspended in THF (3.0 mL) and stirred under H2 atmosphere for 2 h. The reaction 
mixture was filtered over celite and the solvent removed under reduced pressure. F4Azo-(PyDp)(COOH) (19, 12.0 mg, 
21.9 µmol) and HATU (9.16 mg, 24.1 µmol) were dissolved in THF (400 µL) and DIPEA (12.6 µL, 72.3 µmol) added. The reaction 
mixture was stirred for 4 h before the reduced pyrrole 7 dissolved in THF (600 µL) was added. After stirring for 2.5 h, the 
solvent was removed and the crude purified by preparative HPLC (5 - 75% over 30 min) to yield the desired product as its TFA 
salt (3, 5.40 mg, 6.76 µmol, 31%) as orange solid. tR=27.9 min (5% to 75% B in 30 min); HRMS-ESI+ (m/z): [M]+ calcd for 
C32H32F4N8O5H, 685.2505; found, 685.2532. 
E-isomer: 
δH(500 MHz; [D6]DMSO; Me4Si) 10.66 (1 H, s, NH-3 / NH-3b), 10.63 (1 H, s, NH-3 / NH-3b), 9.24 (1 H, br s, NH+-13), 8.25 (1 H, 
t, 3JHH 5.7, NH-8), 7.94 (2 H, s, H-1 / H-2 / H-1b / H-2b), 7.91 (2 H, s, H-1 / H-2/ H-1b / H-2b), 7.56 (1 H, d, 4JHH 1.8, H-4b), 7.31 
(1 H, d, 4JHH 1.8, H-4), 7.00 (1 H, d, 4JHH 1.8, H-5 / H-5b), 6.99 (1 H, d, 4JHH 1.8, H-5 / H-5b), 3.88 (3 H, s, H-6), 3.86 (3 H, s, H-6b), 
3.76 (3 H, s, H-7), 3.30 – 3.22 (2 H, m, H-9), 3.13 – 3.03 (2 H, m, H-11), 2.80 (3 H, s, H-12 / H-12’), 2.79 (3 H, s, H-12 / H-12’), 
1.91 – 1.78 (2 H, m, H-10); δC (125 MHz; [D6]DMSO; Me4Si) 161.9 (CO), 161.2 (CO), 160.5 (CO), 160.4 (CO), 156.0 (2C, Cq), 
153.9 (2C, Cq), 138.8 (2C, Cq), 132.4 (2C, Cq), 123.5 (Cq), 122.6 (Cq), 122.0 (Cq), 121.7 (CH), 119.6 (Cq), 119.2 (CH), 112.9 (2C, 
CH), 112.7 (2C, CH), 109.0 (CH), 104.9 (CH), 55.3 (CH2), 51.6 (CH3),  42.7 (2C, CH3), 36.8 (CH3), 36.7 (CH3), 36.0 (CH2), 25.2 (CH2). 
 
 
Figure S11: HPLC chromatogram of F4Azo-(PyDp)(PyOMe) (3). 
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Figure S13: 13C-NMR spectrum of trans- trans- F4Azo-(PyDp)(PyOMe) (3). 
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Figure S14: HSQC-NMR spectrum of trans- trans- F4Azo-(PyDp)(PyOMe) (3). 
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For the accurate concentration determination of the compounds: F4Azo-(PyDp)(PyOMe) (3) and F4Azo-(PyDp)2 (2) their 
extinction coefficient in DMSO at room temperature was calculated. A specific amount (1.00 - 2.00 mg) of the corresponding 
compound was weighted on a Mettler Toledo XP6 micro balance and dissolved in a known volume of DMSO. Increasing 
amounts of such stock solution were added into a cuvette filled with 1 mL of DMSO. The corresponding absorbance of each 
addition was measured on a Tecan Spark 20M at the individual maximum and without exceeding 10% of the initial volume. 
In all the cases the absorbance was between 0.1 and 1 AU to be in concordance with Lambert-Beer law.[vii]  
A = ε l c        (S1) 
In this equation: A = absorbance of the solution; l = length of the cuvette; c = concentration; ε = molar extinction coefficient. 
Below the UV-Vis spectrum of a 24 µM concentration of the compound F4Azo-(PyDp)(PyOMe) (3) in DMSO (Figure S16). The 
lineal regression of the obtained absorbance measurements versus the concentrations of the F4Azo-(PyDp)(PyOMe) allowed 
us to obtain the molar extinction coefficient (Figure S17). This experiment was repeated three times independently i.e. from 
three different stock solutions.  
 
 









Figure S17: Determination of the extinction coefficient of compound F4Azo-(PyDp)PyOMe) (3) in DMSO. The absorbance maximum at 287 nm was plotted against 
the F4Azo-(PyDp)(PyOMe) concentration. Three independent measurements are shown with the calculated extinction coefficient and their corresponding 
regression value (R2). The mean extinction coefficient and the standard deviation of F4Azo-(PyDp)(PyOMe) (3) is 30167 ± 285 M-1cm-1. 
 
Below the UV-Vis spectrum of a 24 µM concentration of the compound F4Azo-(PyDp)2 (2) in DMSO (Figure S18). The lineal 
regression of the obtained absorbance measurements versus the concentrations of F4Azo-(PyDp)2 (2) allowed us to obtain 
the molar extinction coefficient (Figure S19). This experiment was repeated three times independently i.e. from three 















Figure S19: Determination of the extinction coefficient of compound F4Azo-(PyDp)2 (2) in DMSO. The absorbance maximum at 284 nm was plotted against the 
dimer concentration. Three independent measurements are shown with the calculated extinction coefficient and their corresponding regression value (R2). The 
mean extinction coefficient and the standard deviation of F4Azo-(PyDp)2 (2) is 31933 ± 484 M-1cm-1. 
 
Table S1 summarized the obtained molar extinction coefficient for both compounds. 
 
Table S1: Determined mean extinction coefficients and standard deviations of F4Azo-(PyDp)(PyOMe) (3) and F4Azo-(PyDp)2 (2) in DMSO at r.t. 
 F4Azo-(PyDp)2 in DMSO (284 nm) F4Azo-(PyDp)(PyOMe) in DMSO (287 nm) 
mean 31933 ± 484 M-1cm-1 30167 ± 285 M-1cm-1 
 
In general during the concentration determination, the absorption values were subtracted against the corresponding buffer 
solution. For thiazole orange, we used the extinction coefficient from the literature in DMSO: ε503nm = 63000 M-1cm-1[viii].  
For the concentration determination of the hairpin DNAs, the purchased lyophilized DNA was dissolved in Milli-Q water, 
heated to 95°C for 10 min and slowly cooled down to room temperature. Their molar extinction coefficients were determined 
by using the following formula:[ix]  
 
𝜀260𝑛𝑚 = {(8.8 ∗ #𝑇) + (7.3 ∗ #𝐶) + (11.7 ∗ #𝐺) + (15.4 ∗ #𝐴)} ∗  0.8 ∗  10
3 𝑀−1𝑐𝑚−1       (S2) 
 
In the formula # = number of nucleobases determined throughout the DNA sequence, T = thymine, C = cytosine, G = guanine, 








Table S2. Binding sites, sequences and extinction coefficients of DNA hairpins, which were used for fluorescence titrations experiments . 
DNA binding site sequence (5’ – 3’) extinction coefficient at 260 nm 
dsDNAhAT ATTA GGCGATTACAGCTTTTTGCTGTAATCGCC 238400 M-1 cm-1 
dsDNAhGC GGCCC GGCAGGCCCAGCTTTTTGCTGGGCCTGCC 225920 M-1 cm-1 
 
The nucleic acid concentration after the PCR was determined on a NanoDrop 2000 spectrometer (Thermo Scientific) by 
measuring the absorbance at 260 nm and using the extinction coefficient in water for double-stranded DNA (50 ng*cm/µL).[x] 
dsDNACT was purchased as a solution of 15.4 mM concentration. 
The concentration of the nucleosomes in 10 mM Tris 1 mM EDTA pH 8.0 and 50 mM NaCl were also determined on the 
NanoDrop using the extinction coefficient from the literature: ε260nm = 1880000 M-1cm-1.[xi] 
 
 
Photoisomerization of F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) (3) 
A 405 nm LED lamp (Roschwege Star UV 405-03-00-00, 405 nm, 700 mA, 3.5 V, Poptisch = 670 mW) was used for the irradiation 
at 405 nm and a 520 nm LED lamp (Roschwege Star LSC-G 520 nm, 1A, 3.8 V, 87 Im, 130°) was used for irradiation at 520 nm. 
For the irradiation at 520 nm a filter (FGL515 – Ø25 mm OG515 Colored Galss Filter, 515 nm longpass, Thorlabs) was further 
attached to the lamp. 
For the F4Azo-derivatives, the trans-isomer is the thermodynamically most stable form,[iii] which was also yielded from the 
synthesis as the major product. The photostationary states were studied by UV-Vis spectroscopy, RP-HPLC and by NMR. All 
photosiomerization measurements were performed in the dark.  
 
UV-Vis Characterization 
For the characterization of the photoisomerization of the compound F4Azo-(PyDp)(PyOMe) (3) via UV-Vis measurements, a 
solution of 20 µM of 3 in 10 mM Tris pH 7.6, 50 mM KCl and DMSO (98:2) (total volume 1 mL) was irradiated for 1 min at 
405 nm to ensure complete conversion to the trans state. Afterwards, to obtain the cis isomer such solution was irradiated 
at 520 nm at different time intervals: 10 s / 30 s / 1 min / 2 min / 3 min / 5 min / 10 min. As seen in figure S20, after 10 min 
of continuous irradiation no significant spectroscopic changes could be observed. Afterwards this solution was irradiated at 
the time intervals: 5 s / 10 s / 30 s / 1 min / 1.5 min / 2 min / 2.5 min / 3 min at 405 nm, which brought the characteristic 
trans-isomer spectrum (Figure S20B). No significant spectroscopic changes were observed after 3 min. The represented data 









Figure S20: UV-Vis spectra of 20 µM of F4Azo-(PyDp)(PyOMe) (3) in 10 mM Tris, pH 7.6 50 mM KCl and DMSO (98:2). A) 1 min irradiation at 405 nm followed by 
successive time interval (10 s / 30 s / 1 min / 2 min/ 3 min / 5 min / 10 min) irradiation at 520 nm. B) Final irradiation conditions of A, followed by successive time 
interval (5 s / 10 s / 30 s / 1 min / 1.5 min / 2 min / 2.5 min / 3 min) irradiation  at 405 nm.  
 
We further recorded DMSO subtracted absorbance spectrum of: a) a 40 µM solution of O2N-Py-Dp (8) in 10 mM Tris pH 7.6, 
50 mM KCl and DMSO (98:2); b) 20 µM solution of F4Azo-(COOH)2 (5) in the trans and the cis-state in 10 mM Tris 50 mM pH 









Figure S21: A) UV-Vis spectra of 40 µM O2N-Py-Dp (8) in 10 mM Tris pH 7.6, 50 mM KCl and DMSO (98:2). B) UV-Vis spectra of 20 µM F4Azo-(COOH)2 (5) in 10 mM 
Tris pH 7.6 , 50 mM KCl and DMSO (98:2). The green spectra shows the compound in the cis-state, which was achieved by irradiating of the sample for 2 min at 
520 nm. The blue spectra shows the compound in the trans-state, which was achieved by irradiating the sample for 10 s at 405 nm C) UV-Vis spectra of a mixture 
of 40 µM O2N-Py-Dp (8) and 20 µM F4Azo-(COOH)2 (5) in 10 mM Tris pH 7.6, 50 mM KCl and DMSO (98:2). The green spectra shows the compound in the cis-state, 
which was achieved by irradiating the sample for 2 min at 520 nm. The blue spectra shows the compound in the trans-state, which was achieved by irradiating 
the sample for 10 s at 405 nm. 
 
We further recorded the spectra of the trans- and the cis-isomer of a 20 µM solution of F4Azo-(PyDp)2 (2) in DMSO under the 
same conditions, which spectra is shown in figure S22. 
 
 
Figure S22: UV-Vis spectra of 20 µM of F4Azo-(PyDp)2 (2) in DMSO. The blue spectra shows the spectra of the trans-isomer, which was achieved by 1 min 
irradiation at 405 nm. The green spectra shows the spectra of the cis-isomer, which was achieved by irradiation at 520 nm for 2 min. 
 
The procedure of the absorbance titrations was: addition of increasing amounts of a 2.73 mM F4Azo-(PyDp)2 solution in DMSO 
to solution of 12.5 µM dsDNACT in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl in the corresponding cuvette. The stock solution of 
F4Azo-(PyDp)2 was irradiated for 10 s at 405 nm to measure the trans-derivative or 2 min at 520 nm to measure the cis-
derivative. Solutions were kept in the dark and the measurement performed in the absence of light. Small aliquots of the 
compound stocks were stepwise added and the fluorescence spectra recorded after an incubation time of 3 min. The 




For the characterization of the photoisomerization of the compounds via RP-HPLC measurements, a solution of 50 µM of 
each compound in 10 mM Tris pH 7.4, 10 mM NaCl and DMSO (95:5) was irradiated for 10 s at 405 nm to obtain the trans-
isomer and for 2 min at 520 nm to obtain the cis-isomer and 30 µL were injected into the RP-HPLC. The photostationary states 
reached upon irradiation were determined by integration of the peak areas in the HPLC chromatogram at 287 nm (isosbestic 
point). In the case of F4Azo-(PyDp)2 (2) it was possible to detect both isomers by RP-HPLC, in the case of F4Azo-(PyDp)(PyOMe) 
(3) it was not possible to separate both isomers by RP-HPLC and analyze their photoisomerization. The represented data 
shows a representative one of three measurements from independent experiments. Figure S23 shows the corresponding RP-












For the characterization of the photoisomerization of the compounds via NMR, a solution of 2 mg of each compound was 
dissolved in DMSOd6 to give a 4 mM solution and their 1H-NMR spectra was measured in a brown NMR tube (Rotilabo-NMR 
tube, Carl Roth) to get the spectrum of the thermodynamically more stable trans-isomer. To get the spectrum of the cis-
isomer the solution was irradiated for 2 min at 520 nm, transferred into the Rotilabo-NMR tube and its 1H-NMR spectra was 
measured. In the case of F4Azo-(PyDp)(PyOMe) (3) another spectrum after irradiation for 4 min at 520 nm was recorded, to 
ensure the maximum conversion after 2 min of irradiation, which was determined for F4Azo-(PyDp)2 (2) as sufficient. The 
trans/cis-ratio was calculated by integration of the proton signals of the pyrroles and the aromatic protons of the tetra-ortho-
fluorazobenzenes. The represented data shows a representative one of three measurements from independent experiments. 
 
 
DNA Binding Experiments  
DNA binding affinities were determined via fluorescence intercalation displacement (FID) titrations. To a solution of hairpin 
DNA, thiazole orange (TO) was added yielding in a fluorescence increase upon binding to the DNA. Addition of our compounds 
led to a decrease of fluorescence due to the displacement of the fluorescent TO. The affinity of TO to the respective hairpin 
DNA, allows the determination of the binding affinity of our molecules through the fluorescence decrease measurements.[xii] 
We decided to use TO instead of EtBr, as it gives a much higher fluorescence increase upon DNA binding and therefore, 
allowed to use smaller slits sizes in our FID assay. This results in less light exposure of our samples and a lower probability of 




To determine the binding affinity of TO to the hairpin DNAs, titrations were performed in 20 mM NaH2PO4 pH 7.4, 100 mM 
NaCl (total volume 1 mL) at a constant TO concentration of 1 µM. Small aliquots of DNA stocks (50 µM and 500 µM) were 
stepwise added and the fluorescence spectra recorded after an incubation time of 3 min. The corresponding spectra are 
buffer subtracted and show the mean out of three independent measurements. The maximum at 530 nm was plotted versus 
the added amount of DNA. Represented data are mean values calculated from three independent experiments. The binding 
affinity was calculated using the program HypSpec using the non-corrected measured spectra.  
 
The following figures show the recorded mean fluorescence spectra of TO with dsDNAhAT and dsDNAhGC and its maximum 







Figure S24: A) Mean fluorescence spectra of a 1 µM solution of TO in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl with increasing amounts of dsDNAhAT. B) Fluorescence 
intensity maximum at 530 nm plotted against the concentration of added DNA. Represented data are mean values and their standard deviation calculated from 







Figure S25: A) Mean fluorescence spectra of a 1 µM solution of TO in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl with increasing amounts of dsDNAhGC. B) Fluorescence 
intensity maximum at 530 nm plotted against the concentration of added DNA. Represented data are mean values and their standard deviation calculated from 
three independent experiments. 
Using the program HypSpec and setting the number of reagents to 2, the corresponding binding affinities were calculated out 
of the non-corrected measured spectra and summarized in table S5 (Section Binding Affinity Calculation by HypSpec). 
 
Once the KD of TO to the hairpin DNAs was determined, we performed the FID titrations to determine the KD of the 
compounds. Varying from the described procedure above, the slits for the displacement titrations were excitation slit width: 
3 nm; emission slit width: 3 nm. Titrations were performed in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl (total volume 1 mL) at a 
TO concentration of 6 µM and a hairpin concentration of 1 µM, which equals the ideal dye:bp-DNA ratio of 1:2.[xii,xiv] 
Compound solutions were prepared as a DMSO stock with a concentration of 250 µM and 1 mM. These stock solutions were 
irradiated for 10 s at 405 nm to measure the trans-derivative or 2 min at 520 nm to measure the cis-derivative. Netropsin 
was prepared as DMSO stocks with the same concentrations, but not irradiated. Solutions were kept in the dark and the 
measurement performed in the absence of light. Small aliquots of the compound stocks were stepwise added and the 
fluorescence spectra recorded after an incubation time of 3 min. The corresponding spectra are buffer subtracted and show 
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the mean out of three independent measurements. The maximum at 530 nm was plotted against the added amount of 
compound. In the plot of the fluorescence intensity against the added compound concentration, the mean value and its 
standard deviation was calculated out of three independent measurements. The binding affinity was calculated using the 
program HypSpec and setting the number of reagents to 3, using the non-corrected measured spectra.  
 
The following figures show the recorded mean fluorescence spectra of the FID titrations of TO and dsDNAhAT with F4Azo-









Figure S26: dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: mean 
fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of F4Azo-
(PyDp)(PyOMe) (3) in A) trans- conformation and B) cis- conformation. C) Fluorescence intensity maximum at 530 nm plotted against the concentration of added 
compound. Represented data are mean values and their standard deviation calculated from three independent experiments.  Squares show the plot of F4Azo-









Figure S27: dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: mean 
fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of F4Azo-
(PyDp)2 (2) in A) trans- conformation and B) cis-conformation. C) Fluorescence intensity maximum at 530 nm plotted against the concentration of added 
compound. Represented data are mean values and their standard deviation calculated from three independent experiments . Squares show the plot of F4Azo-







Figure S28: A) dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: 
mean fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of 
netropsin. B) Fluorescence intensity maximum at 530 nm plotted against the concentration of added compound. Represented data are mean values and their 




Using the program HypSpec the corresponding binding affinities were calculated out of the non-corrected measured spectra 
and summarized in table S6 (Section Binding Affinity Calculation by HypSpec). 
 
To check for the selectivity of the binder, F4Azo-(PyDp)2 (2) in the trans-conformation and netropsin were used in a FID 







Figure S29: A) dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhGC solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: 
mean fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhGC solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of 
trans-F4Azo-(PyDp)2. B) Fluorescence intensity maximum at 530 nm plotted against the concentration of added compound. Represented data are mean values 







Figure S30: A) dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhGC solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: 
mean fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhGC solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of 
netropsin. B) Fluorescence intensity maximum at 530 nm plotted against the concentration of added compound. Represented data are mean values and their 
standard deviation calculated from three independent experiments. 
 
Using the program HypSpec the corresponding binding affinities were calculated out of the non-corrected measured spectra 
and summarized in table S7 (Section Binding Affinity Calculation by HypSpec). 
 
 
Complex Formation Calculation by HySS2009 
To have reliable results from the FID assays, all intercalation sites must be occupied with the minimal presence of free 
molecule in solution to maintain background fluorescence low and fluorescence decrease sufficiently large to give an 
adecuate dynamic range.[xiv] To validate whether the used conditions during the FID are appropiated, we simulated how much 
percentage of TO-DNA complex is formed at the initial point of our FID assays by using the software Hyperquad Simulation 
and Speciation, HySS2009 (Protonic Software).[xv] We analyzed calf thymus DNA and DNA hairpins. The simulation mode was 
used, the number of reagents was set to 3 (TO, DNA, analyzed compound) and protons set to be absent. The input of the 
program was the concentration of the species and the binding constant of the TO-DNA complex, which was set to be constant. 
The binding affinity of the TO-DNA complex for the hairpin DNAs was determined experimentally (see table S3) and the one 
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for calf thymus DNA was KD = 3.16 µM.[xvi] The percentage of formed complex was obtained from simulated graph. Table S3 
shows the percentage of the calf thymus DNA-TO complex at different concentrations and ratios of both. We were not able 
to find suitable low micromolar concentrations resulting in a complex formation >95%. For the DNA hairpins, which are 
classically used in FID assays[xii] we were able to reach complex formations >95% with the conditions which were later applied. 
The complex percentages with the hairpin DNAs are shown in table S4. 
 
 
Table S3: Simulated calf thymus DNA-TO complex percentages with different concentrations and ratios of calf thymus DNA and TO. The given percentages were 
simulated by using the program HySS2009. 
































Table S4: Simulated hairpin DNA-TO complex percentages with different concentrations and ratios of hairpin DNAs and TO. The given percentages were simulated 
by using the program HySS2009. 
DNA concentration  TO concentration [µM] TO-DNA-complex 












Binding Affinity Calculation by HypSpec 
Binding affinities were calculated by using the software HypSpec2014 (Protonic Software).[xvii] For the calculation of the 
binding affinities of TO to the hairpin DNAs, the number of reagents was set to 2 (TO and DNA), assuming a 1:1 binding mode. 
The fluorescence spectra of TO alone under the same conditions as described above was measured and due to its low intensity 
(see figure S31) only the spectra of the TO-DNA-complex was set to have a fluorescence spectra. All other spectra were 
assumed to be none. pH readings were set to be absent. The spectra of the fluorescence measurements, including the 
concentration of each reagent at each measurement point was prepared in an extra file and loaded into the program. The 
binding affinity of the TO-DNA-complex was refined, aiming the lowest sigma value, assuring that the molar absorbances are 
positive and the percentage of the formed complexes and free reagents make sense. Represented data are mean values 
calculated from three independent experiments. Figure S32 shows exemplary one out of the three binding affinity 











Figure S32: Representative plots of the binding affinity determination of TO to A) dsDNAhAT and B) dsDNAhGC at the wavelength of the maximum of 530 nm. 
Shown are in black the intensities experimentally determined at different concentrations of dsDNA and in red the corresponding fit performed by HypSpec.  
Table S5: Determined mean KD-values and standard deviations of TO to dsDNAhAT and dsDNAhGC.  
 TO to dsDNAhAT TO to dsDNAhGC 
Mean KD value 59.8 ± 13.1 nM 11.6 ± 3.8 nM 
 
For the calculation of the binding affinities of F4Azo-(PyDp)(PyOMe) (3) and F4Azo-(PyDp)2 (2) in the trans- and cis-
conformation it was proceeded like described above, but the number of reagents was set to 3 (TO, DNA and compound 2 or 
3). Only the spectra of the TO-DNA-complex was set to have a fluorescence spectra, as the spectrum of TO alone is very low 
compared to the recorded ones (see fig. S321). The binding affinity of the TO-DNA complex was set to constant using the 
constant value, which was calculated above (table S5). The binding affinity of the binder-DNA complex was refined like 
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described above. For the case of the netropsin (1) the best fit was obtained using the data up to 2 µM concentration; higher 
concentrations suggest different binding modes. 
Represented data are mean values calculated from three independent experiments Figure S33 shows exemplary one out of 
the three binding affinity determination fits of HypSpec at a wavelength of the maximum of 530 nm. Table S6 and S7 















Figure S33: Representative plots of the FID binding affinity determination of A) trans-F4Azo-(PyDp)2 to dsDNAhAT, B) cis-F4Azo-(PyDp)2 to dsDNAhAT, C) trans-F4Azo-
(PyDp)2 to dsDNAhGC, D) trans-F4Azo-(PyDp)(PyOMe) to dsDNAhAT, E) cis-F4Azo-(PyDp)(PyOMe) to dsDNAhAT and F) netropsin to dsDNAhAT, at the wavelength of the 
maximum of 530 nm. Shown are in black the intensities experimentally determined at different concentrations of DNA and in red the corresponding fit performed 
by HypSpec.  
 
Table S6: Determined mean KD-values and standard deviations of F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) (3) as their trans- and cis-isomer and netropsin to 
dsDNAhAT. Binding affinities were calculated using the program HypSpec. 
 F4Azo-(PyDp)(PyOMe) (3) F4Azo-(PyDp)2 (2) netropsin 
 trans cis trans cis  
Mean KD value 53.6 ± 2.8 nM 81.5 ± 6.6 nM 59.9 ± 1.2 nM 108.3 ± 14.9 nM 9.9 ± 0.6 nM  
 
 
Table S7: Determined mean KD-values and standard deviations of F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) (3) in their trans- and cis-conformation to 
dsDNAhGC. n.c. stands for non-calculated. 
 F4Azo-(PyDp)2 trans netropsin 




Control Experiments with F4Azo-(PyDp)2 (2) 
To ensure the stability of the trans- and the cis-state of F4Azo-(PyDp)2 (2) during the measurements, we further performed 
several control experiments. 
To show the stability of the isomers of the compound F4Azo-(PyDp)2 (2) during the FID measurement, a solution of 50 µM of 
2 in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and DMSO (95:5) (total volume 500 µL) was irradiated in a cuvette for 10 s at 
405 nm or 2 min at 520 nm to achieve the maximum cis/trans or trans/cis conversion. All solutions were kept in the dark and 
the measurements performed in the absence of light. The cuvette was placed into the fluorimeter and the temperature 
adjusted to 20 °C. One sample was taken and 30 µL injected into the HPLC. The cuvette was placed back in the fluorimeter, 
which is used in the FID measurements. 5 fluorescence measurement points were performed and a new 30 µL sample was 
taken to inject into the HPLC. The same procedure was repeated after 10 and 15 measurement points. Figure S34 illustrates 







Figure S34: RP-HPLC chromatogram of F4Azo-(PyDp)2 (2) show the stability after irradiation at A) 405 nm for 10 s and B) 520 nm for 2 min and their corresponding 
trans/cis-ratio during the FID measurements. Samples were taken before the measurement and after 5, 10 and 15 measurement points. Represented data are a 
representative one of three measurements from independent experiments 
 
To analyze the stability of both isomers of F4Azo-(PyDp)2 (2) during the gel mobility shift assay, a solution of 50 µM of F4Azo-
(PyDp)2 (2) 1X SDB (10 mM Tris, 1 mM EDTA pH 8.0, 50 mM NaCl) and DMSO (95:5) was irradiated for 10 s at 405 nm or 2 min 
at 520 nm to achieve the maximum cis/trans or trans/cis conversion. Afterwards it was stored in total darkness at r.t. and RP-






Figure S35: RP-HPLC chromatogram of F4Azo-(PyDp)2 (2) under mobility shift assay conditions show the dark stability after irradiation at A) 405 nm for 10 s and 
B) 520 nm for 2 min and their corresponding trans/cis-ratio after several time points. Represented data are a representative one of three measurements from 
independent experiments 
 
To analyze the thermal stability of F4Azo-(PyDp)2 (2), a solution of 50 µM of F4Azo-(PyDp)2 (2) in 10 mM Tris pH 7.4, 10 mM 
NaCl  
and DMSO (95:5) was irradiated for 30 s at 405 nm to achieve the maximum cis/trans conversion. Afterwards the temperature 
was increased with 0.5°C/min and RP-HPLC chromatograms, under the same conditions as before, were recorded after 





Figure S36: RP-HPLC chromatogram of F4Azo-(PyDp)2 (2) after several temperature points. Represented data are a representative one of three measurements 
from independent experiments 
 
 
To check how much the DMSO influences the FID measurements, a FID measurement, like described above was performed, 
but adding DMSO instead of the DMSO stocks of the compounds to the solution of 6 µM of TO and a 1 µM of dsDNAhAT in 
20 mM NaH2PO4 pH 7.4, 100 mM NaCl (total volume 1 mL). The maximum at 530 nm was plotted against the added amount 
of compound, which equals the added DMSO amount. In the plot of the fluorescence intensity against the added compound 
concentration, the mean value and its standard deviation was calculated out of three independent measurements. The plots 







Figure S37: A) dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: 
mean fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of 
DMSO. B) Fluorescence intensity maximum at 530 nm plotted against the concentration of added compound, which equal the added amount of DMSO. Mean 
values with their standard deviation are shown. Represented data and standard deviations are calculated from three independent experiments 
 
To rule out quenching effects, the influence of the added F4Azo-(COOH)2 (5) was checked, by following the same procedure 






Figure S38: : A) dashed line: mean fluorescence emission spectra of a 1 µM TO and 6 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Solid lines: 
mean fluorescence emission spectra of solutions of a 6 µM TO and 1 µM dsDNAhAT solution in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl and increasing amounts of 
F4Azo-(COOH)2 (5). B) Fluorescence intensity maximum at 530 nm plotted against the concentration of added compound. Mean values with their standard 






For the characterization of the binding of compound F4Azo-(PyDp)2 (2) via circular dichroism, a solution of 50 µM dsDNACT in 
20 mM NaH2PO4 pH 7.4, 100 mM NaCl was prepared in the corresponding cuvette and measured. Solutions of F4Azo-(PyDp)2 
were prepared as a DMSO stock with a concentration of either 250 µM or 1 mM. These stock solutions were irradiated for 
10 s at 405 nm to measure the cis-derivative or 2 min at 520 nm to measure the trans-derivative. Solutions were kept in the 
dark and the measurement performed in the absence of light. Small aliquots of the compound stocks were stepwise added 
and the fluorescence spectra recorded after an incubation time of 3 min. The corresponding spectra are buffer subtracted 
and show the mean out of two measurements. Figure S39 shows the CD spectra of the calf thymus DNA after buffer 
subtraction. Represented data are mean values calculated from two independent experiments. 
 
 
Figure S39: Buffer subtracted CD spectra of a 50 µM solution dsDNACT in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Represented data are mean values calculated 
from two independent experiments. 
 
We further recorded the CD spectra of a solution of 5 µM dsDNAAT and dsDNAGC in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. 
The procedure were equal the described above. The corresponding spectra are buffer subtracted. Represented data are mean 






Figure S40: : Buffer subtracted CD spectra of a 5 µM solution of A) dsDNAAT and B) dsDNAGC in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl. Represented data are mean 
values calculated from two independent experiments 
 
We further titrated the DNA with increasing amount of spermine. The procedure and concentrations were equal the 





Figure S41: Buffer subtracted CD spectra of the titrations of a 50 µM solution dsDNACT in 20 mM NaH2PO4 pH 7.4, 100 mM NaCl with increasing amounts of 





In order to study the effect of trans-F4(PyDp)2 (trans-2) and netropsin on the hydrodynamic diameter of the nucleosome and 
the nucleosomal DNA we performed DLS measurements. 100 µL of a 2.00 µM nucleosome stock or nucleosomal DNA in 
10 mM Tris 1 mM EDTA pH 8.0 and 50 mM NaCl was prepared in the corresponding cuvette and measured. Stocks of trans-
F4(PyDp)2 (trans-2, 1.41 mM, 2.94 mM and 5.88 mM) and netropsin (5.88 mM and 11.76 mM) in DMSO were prepared. For 
every addition, stock volumes of 1.25 µL were stepwise added and the spectra recorded after an incubation time of 3 min. 
Represented data are a representative one of two measurements from independent experiments. Figure S42 shows the DLS 







 Figure S42: DLS signals of a solution of a) 2 µM nucleosome and b) 2 µM nucleosomal DNA in 10 mM Tris 1 mM EDTA pH 8.0 and 50 mM NaCl with increasing 
amounts of netropsin, where the equivalents in bp are 0 (grey), 0.25 (green), 0.5 (blue) and 1.0 (black) eq. Represented data are a representative one of two 
measurements from independent experiments. 
 
For the precipitation by MgCl2, the nucleosome stock was prepared in 3.5 mM Tris 0.35 mM EDTA pH 8.0. For every addition, 
MgCl2 stock volumes (62.5 mM and 125 mM) in MilliQ water of 1.25 µL were stepwise added and the spectra recorded after 
an incubation time of 3 min.  
To find out at which MgCl2 concentration the nucleosome precipitates, the solutions were analyzed before spectroscopically 
on a NanoDrop 2000 spectrometer (Thermo Scientific) by measuring the absorbance at 260 nm. Different amounts of MgCl2 
were added, the samples incubated for 20 min at r.t. and centrifuged for 20 min at 14000 rpm at r.t. The absorbance at 









For the nucleosome assays nucleosomal DNA was produced by polymerase chain reaction (PCR) or in a large scale by alkaline 
lysis and the histone octamers extracted from chicken blood. Both were assembled to nucleosomes using salt gradient 
dialysis. To study the effect of our molecules to the nucleosome, Mobility Shift Assays were performed.  
 
Nucleosomal DNA 
The nucleosomal DNA (dsDNA601) was obtained in two different ways either in a small scale by PCR, which was used for the 
assembly of nucleosomes and the EMSA studies or in a big scale by a large scale plasmid preparation and further EcoRV-digest 
for the assembly of higher concentrated nucleosomes, which was used for the DLS experiments. 
 
Small scale: 
The Plasmid pGEM-3z/601 (Addgene plasmid # 26656, deposited by Jonathan Widom) was used as nucleosomal DNA 
template. This plasmid was replicated in DH5 alpha cells to facilitate long-term storage and sequencing, Thus, this plasmid 
was diluted from an initial concentration of 1.1 μg/μL to a final one of 0.1 μg/μL. 0.5 μL of this solution (containing 50 ng of 
the plasmid) was added to 50 μL of competent cells (E. coli DH5 alpha). The cells were then transferred into a 2 mm-gap 
cuvette for electroporation at 2.5 kV with a 5.8 ms pulse. 1 mL of LB medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L 
NaCl) was added to the cells immediately, and the cells were recovered by incubation at 37°C and 800 rpm for 1 h. Afterwards, 
cells were plated onto ampicillin containing agar, and grown overnight at 37°C. A streak of bacteria was transferred into 5 mL 
of LB medium containing ampicillin, and grown for 24 h at 37°C and 200 rpm. For long-term storage, 300 μL glycerol (80%) 
was added to 700 μL of the bacterial culture, mixed and shock-frozen in liquid nitrogen, after which the glycerol stock was 
stored at -80°C. The plasmid for amplification was performed from 4 mL of bacterial culture with a GenElute HP Plasmid 
Miniprep Kit (Sigma Aldrich) by following the manufacturer’s instructions. The plasmid was eluted in 50 μL millipore water. 
Afterwards, the plasmid was amplified by polymerase chain reaction (PCR). The reagents described in table S8 were mixed 
and the PCR run with the temperature program indicated in table S9. After finishing the PCR cycles, the products were purified 
using a GenElute PCR CleanUp Kit (Sigma Aldrich) and eluted with water. The DNA concentration was determined by 





Table S8: List of reagents used for the polymerase chain reaction of Widom 601 DNA. 
reagent amount 
HF buffer 1X 
DMSO 3% 
dNTPs 200 µM each 
forward primer 0.5 µM 
reverse primer 0.5 µM 
plasmid pGEM-3z/601 1 ng/µL 
phusion polymerase 1 U / 50 µL 
 
Table S9: Temperature program for the polymerase chain reaction of Widom 601 DNA. 
initial denaturation 98 °C / 30 s 
denaturation 98 °C / 8 s 
annealing 60 °C / 20 s 
elongation 72 °C / 10 s 
number of cycles  30 
final elongation 72 °C / 4 min 
 4 °C / hold 
 
Table S10: primer sequences used in the polymerase chain reaction of Widom 601 DNA. 
primer sequence 
forward primer CCTGGAGAATCCCGGTGC 




The Plasmid pUC-19/16x601 (deposited by Ji-Joon Song) was used as nucleosomal DNA template. This plasmid was replicated 
in DH5 alpha cells and grown on agar plates as described above. A streak of bacteria was transferred into 6 mL of LB medium 
containing ampicillin, and grown for o/n at 37°C and 200 rpm. 1 mL each was transferred into 1 L of LB medium containing 
ampicillin, and grown for o/n at 37°C and 200 rpm. The alkaline lysis plasmid preparation was performed following a protocol 
of Luger et al.[xviii] For the purification of the insert, 5.44 mg plasmid at a concentration of 1.0 µg/mL in 10 mM Tris HCl pH 8.5 
10 mM MgCl2 100 mM KCl and 0.1 mg/mL BSA was treated with 700 U EcoRV (Thermo Fisher) at 37°C o/n and additional 70 U 
EcoRV for 7 h at 37°C. The purification was performed following the same protocol as described above. As a final purification 
step, gel filtration was included. SEC was performed on an Äkta FPLC system (Amersham Biosciences) equipped with pump 
P-920, mixer M-925, sample injection valve INV-907, fraction collector Frac-950, monitor UPC-900 and remote connector CU-
950, controlled via Unicorn V5.0 software, using a Superdex 200 10/300 GL-column by GE Healthcare with a flow of 
0.5 mL/min in 10 mM Tris 1 mM EDTA pH 8.0 and 150 mM NaCl. Detection was executed at a wavelength of 254 nm. The final 
product fractions were concentrated using a 10000 MWCO Amicon Ultra-15 Centrifugal Filter (Merck).  
 
 
Native Polyacrylamide Gel Electrophoresis 
To analyze molecular weights of DNA and nucleosomes and to perform the EMSA, native polyacrylamide gel electrophoresis 
(native PAGE) was performed. Polyacrylamide gels were prepared as 5% gels in 0.5X TBE (10 mM Tris, 45 mM borate, 1 mM 
EDTA). Therefore, 1.875 µL 40% acrylamide solution (19 : 1, acrylamide : bisacrylamide) was diluted in 0.5X TBE to a total 
volume of 15 mL. The reaction was started by addition of 150 µL of an APS solution (10% in water) and 7.5 µL TEMED. The 
mixture was immediately poured into commercially available gel cassettes (glas, 1.00 mm, Biorad) placed in a Tetra Cell 
Casting Stand (Biorad), where wells were created by comb insertion. After complete polymerization (approximately 40 min), 
the comb was removed, the glass plates and wells washed with MilliQ water and the cassette placed into an electrophoresis 
chamber filled with 0.5X TBE. The wells were flushed with the running buffer by pipette. After adding 0.1 volumes glycerol to 
the samples, 20 µL containing 0.06 µM DNA or 0.27µM  nucleosomes were loaded into the wells. The gel was run at 90 V for 
40 min in a Ready Gel Cell (Biorad) using a Power Pac 300 (Biorad). The gel was poststained for 15 min in an ethidium bromide 
solution (50 µL of 0.1% solution in 100 mL 0.5X TBE buffer) and visualized under UV-light using a ChemiDoc MP Imaging 
System (BioRad). 
 
Histone Octamer Extraction 
Chicken erythrocyte histone octamers were extracted from chicken blood, following a procedure of Smale et al.[xix] Divergent 
to the protocol, the lysis of the chicken erythrocyte nucleis and the final removal of the DNA was modified. The lysis of the 
chicken erythrocyte nuclei was performed by sonication 5 times 30 s at 30% with a Sonopuls Ultrasonic Homogenizer HD 
2200 (Bandelin) with 2 min rest in between on ice until all clumps were converted into a homogeneous solution. To remove 
remaining DNA from the chicken histones, purification by hydroxyapatite chromatography did not yield in sufficiently pure 
histone octamers, but remaining DNA. For further purification, the solution was concentrated to 3.5 mg/mL and treated 3 
times with 5 mL HT Gel (Biorad). Before use, the HT Gel was washed with wash buffer and then added to the histone solution. 
After incubation for 3 h at 4°C, the HT Gel was centrifuged and the supernatant collected. Purity was checked by 6% stacking 
and 15% running SDS-PAGE. Staining was performed with coomassie. To verify the absence of DNA, a gel performed in the 




Figure S44: SDS-PAGE of the purified histone octamers.  
 
 
Reconstitution of Nucleosome Core Particles 
Nucleosome core particles were reconstituted by salt gradient dialysis.[xix] A test assembly to experimentally verify the amount 
of chicken histones necessary. to nucleosome reconstitution was performed in a final concentration of 1 µg DNA per 30 µL 
reaction volume. Such DNA amount was mixed in 1X SDB (10 mM Tris, 1 mM EDTA pH 8.0 and 2 M NaCl) with chicken histone 
octamers at different concentrations: volumes between 9.75 µL and 11.25 µL in 0.25 µL steps of a histone octamer stock of 
47 µg/mL were added. These solutions were given in dialysis cells (Nadir-dialysis tubing, cellulosehydrate, molecular weight 
cut-off: 10 – 20 kDa, Carl Roth) and dialyzed in 1X SDB for 1 h. The NaCl concentration was step-wise reduced (2 M → 1 M → 
500 mM → 50 mM; dialysis time each 1 h) while keeping the other buffer components constant. The final dialysis step was 
performed for 16 h. The nucleosomes were taken out of the dialysis chamber, centrifuged at 10000 rpm for 2 min and the 
supernatant analyzed by EMSA. Figure S45 shows the native PAGE gel electrophoresis mobility shift assay (EMSA) analyzed 
by EtBr-staining of the test assembly, were conditions 3 were found to be the ideal conditions. 
 
 
Figure S45: EMSA results showing the test assembly of the nucleosome. Experiments were carried out with 0.06 µM of free DNA or 0.27 µM of nucleosome. All 
experiments were carried out in the following buffer solution: 10 mM Tris, 1 mM EDTA pH 8.0 and 50 mM NaCl. 1 marks the free DNA, 2-8 mark the test assembly 
conditions of 1 µg DNA mixed with 9.25, 9.50, 9.75, 10.00, 10.25, 10.50, 10.75 µL of a histone octamer stock of 47 µg/mL. 
For the large scale nucleosome assembly, the optimal conditions from above were used to assemble enough nucleosomes. 
The assembly was performed under the same concentrations and conditions, but in a reaction volume of 600 µL. Purity of 
the reconstituted nucleosome core particles was checked by EMSA. 
For higher concentrated nucleosomes, which were necessary for DLS, nucleosomes were reconstituted at a concentration of 




Gel Electrophoresis Mobility Shift Assay (EMSA) 
To verify nucleosome stability  after incubation with F4Azo-(PyDp)2 (2) and F4Azo-(PyDp)(PyOMe) (3) EMSA was performed. 
To 20 µL of a 0.3 µM solution of nucleosomes (40 µM bp after DMSO stock addition) in 10 mM Tris pH 8.0, 1 mM EDTA and 
50mM NaCl, stock solutions of the compound (2) or (3) were added in the dark. Stock solutions were prepared in DMSO and 
irradiated for 10 s at 405 nm or 2 min at 520 nm to obtain the trans- or cis-isomer. Solutions were kept in the dark and the 
measurement performed in the absence of daylight. Dilution rows were prepared and 2 µL of these stocks added to the 
nucleosomes. The DMSO stocks had an end concentration of 1.76, 0.88, 0.44, 0.22, 0.11, 0.055, 0.028, 0.014 mM (this equals 
4, 2, 1, 0.5, 0.25, 0.13, 0.06, 0.03 eq in bp). As controls, 55 nM free DNA (8 µM bp) and 0.27 µM nucleosome (40 µM bp) in 
10 mM Tris, 1 mM EDTA pH 8.0 and 50mM NaCl and DMSO (90:10) were prepared. The solutions were incubated for 3 h at 
r.t., 2 µL glycerol added and the samples loaded on the native PAGE gel, run and stained with EtBr. 
We further incubated the nucleosome with netropsin under the same conditions and same concentrations  but without 
irradiation as well as using higher concentrations of netropsin with the DMSO stocks having an end concentration of 14.1, 
7.04, 3.52, 1.76, 0.88 mM (this equals 32, 16, 8, 4, 2 eq in bp). 
We further performed the nucleosome binding assys with in situ irradiation. For this purpose we chose conditions with a 
clear  difference in nucleosome stability for the trans- and cis-isomer of F4Azo-(PyDp)2 (2). Following the procedure described 
above we incubated two reference samples of 40 µM bp nucleosome with 0.5 and 0.25 eq of F4Azo-(PyDp)2 (2) in trans- and 
cis-conformation for 3 h. Another three nucleosome samples were incubated with 0.5, 0.25 and 0.13 eq of F4Azo-(PyDp)2 (2) 
in cis-conformation for 1 h, irradiated these samples for 10 s at 405 nm and incubated for another 2 h.  
 
To validate the influence of the irradiation during the in situ irradiation experiment on the nucleosome binding, we prepared 
samples of 40 µM bp nucleosome in 20 µL 10 mM Tris, 1 mM EDTA pH 8.0 and 50mM NaCl and added 2 µL of DMSO. The 





EMSA Controls of the DLS 
During the measurements of the DLS, aliquots of each concentration steps were taken, to analyze them by EMSA. 2 µL of the 
2 µM solution were mixed with 0.5 µL of glycerol and loaded on a 5% native PAGE 0.5X TBE. The gel was performed like 














Figure S46: EMSA results showing the NCP after incubation with a) trans-F4(PyDp)2, c) MgCl2 and d) netropsin at different concentrations and the free nucleosomal 
DNA after incubation with b) trans-F4(PyDp)2 and e) netropsin at different concentrations. Molar equivalents of the compounds per mol bp are in a and b) 0, 0.06, 
0.13, 0.25 and 0.50 eq;in d) and e) 0, 0.25, 0.50, 1.0 eq. MgCl2 concentrations in c) are 0, 2.5, 3.75, 5.0, 10.0 mM. 2 µL aliquots of the sample were taken during 
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4.2.1 Conclusion 
In this chapter we described the synthesis and study of a novel photoswitchable DNA binder. The 
interaction of this ortho-tetra-fluoroazobenzene derivative with dsDNA as well as the nucleosome is 
visible-light controllable. To the best of our knowledge, it is the first example of a visible-light mediated 
nucleosome binder. Such compound may lay the ground for the development of new approaches to 
externally control epigenetic processes. However, the unspecific DNA binding of our compound would 
likely alter cell functions randomly. Therefore, future directions aim the design and study of sequence 
specific photocontrollable DNA and nucleosome binders to add specificity to our initial external control 
mechanism. 
 
4.2.2 Further Developments and Outlook 
After the photoswitchable nucleic-acid binder F4Azo-(PyDp)2 was analyzed towards its photophysical and 
DNA-binding properties, further studies were performed to gain a deeper insight into the process of 
nucleosome disassembly. Additional dynamic light scattering (DLS), size exclusion chromatography (SEC) 
measurements and gel electrophoresis were accomplished with F4Azo-(PyDp)2, EtBr and netropsin. In 
the case of EtBr, the addition of increasing amounts of compound to the nucleosome resulted in a shift 
of the size distribution to larger particles (Figure 4.2.1 A). Still, these particles were smaller than the 
formed ones upon addition of F4Azo-(PyDp)2. This is consistent with previous gel electrophoresis 
studies,[1,2] which suggested that the intercalation of EtBr into the DNA led to a structural distortion and, 
in turn, disassembly of the nucleosomes. In contrast to our new photoswitchable compound, EtBr 
formed smaller aggregates. Whereas addition of 0.5 eq of our described compound in the trans-form to 
2 µM nucleosome in 10 mM Tris 1 mM EDTA pH 8.0 and 50 mM NaCl formed particles >1000 nm, 
addition of EtBr under the same conditions, resulted in particles <100 nm. Addition of EtBr to free 
nucleosomal DNA (Figure 4.2.1 B) did not lead to differences in the DLS, as the induced structural 
distortion did not result in a detectable difference in the particle size. However, loading the DLS samples 
on a control electrophoresis gel, demonstrated increased smearing of the band upon higher EtBr 
concentrations which was congruent with the described structural distortion and formation of many 
different species through unspecific electrostatic interaction.[4] Subsequent addition of stoichiometric 
amount of histone octamers to the EtBr-DNA particles formed larger particles of 1000 nm. It was 
additionally tested, to reproduce the large agglomerates induced by the addition of F4Azo-(PyDp)2 to 
nucleosomes. By final addition of histones to F4Azo-(PyDp)2-treated free DNA this could be proven. As 
seen in Figure 4.2.1 C, the difference upon histone addition to the DNA aggregates at the highest F4Azo-
(PyDp)2 concentration of 1 µM, did not show a significant difference. The reason might be that already 
dsDNA alone formed large aggregates at this binder concentration. Addition of F4Azo-(PyDp)2 in the cis-
form, led to slightly smaller agglomerates than the one induced by the trans isomer. Irradiation of this 
samples for 10 s at 405 nm formed the trans isomer in situ and led to slightly higher aggregates then 
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before (Figure 4.2.1 D). This behavior is in agreement with the azobenzene trimethylammonium bromide 











Figure 4.2.1. DLS signals of a solution of a) 2 µM nucleosome and b-d) 2 µM nucleosomal DNA in 10 mM Tris 1 mM 
EDTA pH 8.0 and 50 mM NaCl with in a and b) increasing amounts of EtBr, where the equivalents in bp are 0 (grey), 
0.13 (green), 0.25 (blue), 0.50 (black) and 1.0 (red). In b) subsequently 1.0 eq histone octamer was added (violet). In 
c) increasing amounts of F4Azo-(PyDp)2 as the trans isomer and in d) increasing amounts of F4Azo-(PyDp)2 as the cis 
isomer were added, where the equivalents in bp are 0 (grey), 0.06 (green), 0.13 (blue), 0.25 (black) and 0.5 (red). In 
c) subsequently 1.0 eq histone octamer was added (violet) and in d) the sample was subsequently irradiated for 10 s 
at 405 nm (violet). 
 
Moreover, size exclusion chromatography (SEC) measurements with nucleosomes after addition of  
F4Azo-(PyDp)2, EtBr and netropsin were recorded as an attempt for detecting the free nucleosomal DNA 
after addition of F4Azo-(PyDp)2 to nucleosomes, and consequently verify the disassembly instead of 
simple precipitation. Whereas in the case of EtBr, the disassembly could be visualized by gel 
electrophoresis, this could not be shown for F4Azo-(PyDp)2. For SEC measurements, nucleosomes at a 
concentration of 2 µM in 10 mM Tris 1 mM EDTA pH 8.0 and 150 mM NaCl were centrifuged after one 
hour of addition of the corresponding compound to remove precipitated particles and the supernatant 
injected. After verifying that aprotinin has no effect on the nucleosomes, it was used as size standard by 
addition before the centrifugation. Before, it was shown experimentally that aprotinin has no effect on 
the nucleosomes. As seen in Figure 4.2.2, SEC is a less sensitive detection method than gel 
electrophoresis and DLS. Only traces of free DNA could be detected for the EtBr treated samples at a 
ratio of 0.50 eq. For all the other samples no free DNA could be detected, and in the case of F4Azo-
(PyDp)2 the difference between the cis and the trans isomer could not even be visualized. However, the 
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general trend of increasing aggregation, which led to precipitation, could be confirmed by the decreasing 











Figure 4.2.2. SEC chromatograms of a solution of 2 µM nucleosome and 1 mg/mL aprotinin in 10 mM Tris 1 mM 
EDTA pH 8.0 and 150 mM NaCl after addition of increasing amounts of a and b) F4Azo-(PyDp)2, c) EtBr and d) 
netropsin, an incubation time of 1 h and subsequent injection of the supernatant after centrifugation. Added 
equivalents and the addition of the trans or cis isomer in a and b) are indicated in the corresponding chromatograms. 
 
This additional development of the photoswitchable DNA binder points at visible-light mediated dynamic 
control of sequence-specific DNA binders. However, the Fmoc-approach based solid phase synthesis of 
pyrrole and imidazole polyamide hairpins is not compatible with base labile compounds such as ortho-
fluoroazobenzene. It was possible to develop a compatible solid phase based procedure to access 
photoswitchable polyamide hairpins. The next chapter of this thesis presents the synthesis of new Mtt-
protected monomers and their application in polyamide synthesis. 
 
4.2.3 Author Contribution 
The idea for this article resulted from the attempt to introduce real-time manipulation and dynamic 
control in pyrrole-imidazole (PyIm) polyamide hairpins. Due to low yields in solid phase approaches after 
introduction of ortho-fluoroazobenzene, and the need of intensive optimization, we decided to 
synthetize photoswitchable-netropsin derivatives in solution as a contingent plan. We foresaw that these 
molecules should be interesting per se. Therefore, I planned and synthesized different photoswitchable 
molecules based on the minor groove binder netropsin. The solution-synthesis approach provided us 
with sufficient amount to fully characterize the DNA binding. I planned and conducted all experiments 
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myself. I analyzed the switching behavior of the new molecules by RP-HPLC, UV-vis spectroscopy and 
NMR. I improved and performed dsDNA binding studies, such as melting temperature analysis, 
fluorescence intercalation displacement measurements, circular dichroism titrations and UV-vis 
spectroscopy titrations. The binding affinities, I analyzed with the programs HypSpec and HySS. To 
conduct the experiments on the nucleosome, I optimized and performed the extraction of chicken 
erythrocyte histone octamers from chicken blood. Literature based protocols had to be modified and 
sharpened at different stages to yield sufficient amount of histones. The DNA, which wraps around the 
histone proteins to form the nucleosome, I initially produced in small scale by PCR and afterwards I 
conducted a large scale preparation by employing plasmids with multiple repeats of the Widom 601 
sequence. Nucleosomes were assembled after being introduced by Dr. Karim Bouazoune (Institute of 
Molecular Biology and Tumor Research, Marburg). He supported us with fruitful discussions on biological 
issues during the manuscript preparation. I carried out all the electromobility shift assays and dynamic 
light scattering (DLS) measurements once instructed by Mathias Wojcik and Prof. Dr. Udo Bakowsky. 
Jun.-Prof. Dr. Olalla Vázquez had the role of corresponding author, was leading or involved in all the 14-
role taxonomy for author-contribution assignment.[5] 
 
Marburg,  
     Jun. Prof. Dr. Olalla Vázquez  Benedikt Heinrich 
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4.3 4-Methyltrityl (Mtt)-Protected Pyrrole and Imidazole Building 






DNA-binding polyamides are synthetic oligomers consisting of the repetition of pyrrole/imidazole units 
with high specificity and affinity for double-stranded (ds)DNA. To increase the synthetic diversity of these 
compounds and their conjugates, we report a novel methodology based on 4-Methyltrityl (Mtt)-solid-
phase peptide synthesis (SPPS), which is milder than the conventional Fmoc- and Boc-SPPS. Also, our 
building blocks are more synthetic accessible than the standard ones. We demonstrate the robustness 
of this approach by the preparation and study of a hairpin containing all precursors. Importantly, our 
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ABSTRACT: DNA-binding polyamides are synthetic oligomers consisting of the repetition of pyrrole/imidazole units with high specificity 
and affinity for double-stranded (ds)DNA. To increase the synthetic diversity of these compounds and their conjugates, we report a novel 
methodology based on 4-methyltrityl (Mtt)-solid-phase peptide synthesis (SPPS), which is milder than the conventional Fmoc- and Boc-SPPS. 
Also, our building blocks are more synthetic accessible that the standard ones. We demonstrate the robustness of this approach by the prepara-
tion and study of a hairpin containing all precursors. Importantly, our strategy is orthogonal to Fmoc-SPPS, compatible with sensitive molecules 
and it could be readily automatized.
The discovery of the dimeric interaction of distamycin A in the 
DNA minor groove1 paved Dervan’s way for the development of 
programmable hairpin pyrrole-imidazole (Py-Im) polyamides ca-
pable of specifically targeting double-stranded (ds) DNA se-
quences.2-7 During the last two decades, the vast repertoire of syn-
thesized polyamides has demonstrated the implementation of the 
Dervan hairpins as a powerful tool to interfere with DNA-
dependent processes and their potential in medicine as therapeu-
tics. Thus, these modular probes have been involved in gene ex-
pression,8-10 epigenetic control,11-14 DNA replication,15 DNA over-
winding/underwinding.16 Furthermore, polyamides have been 
conjugated to fluorophores for screenings and diagnosis.17-20 Cur-
rently, more complex functionalization has been reported to im-
prove or diversify the use of these molecules10, 14, 21-22 
Nowadays solid-phase peptide synthesis (SPPS) is the method 
of choice for the preparation of Py-Im polyamides. To date, the 
strategies have been restricted to the use of tert-butyloxycarbonyl 
(Boc)23-25- and fluorenylmethyloxycarbonyl (Fmoc)24, 26-
protecting groups for the N-methyl pyrrole and N-methyl imidaz-
ole amino acids. However, the increasing complexity of the poly-
amide conjugates demands alternative approaches to expand the 
scope of the reactions as well as the functionalities used in the syn-
thesis of hairpin batteries. For this purpose, we envisaged using the 
4-methyl trityl (Mtt) group as the amino-protecting group of the 
pyrrole/imidazole building blocks (Figure 1). Indeed, Mtt-pro-
tecting group does not only allow milder deprotection procedures 
as the ones involved in Boc chemistry (2% TFA/DCM for Mtt ver-
sus 80% TFA/DCM/0.5M PhSH for Boc), but also it is orthogo-
nal to the Fmoc-based synthesis as well as compatible with a broad 
palette of building reactions.27 
 
 
Figure 1. ImPyPyIm-γ-PyImImPy-β-Dp (1) prepared from Mtt-
SPPS and Fmoc-SPPS. The colors highlight the different building 





























































































Herein, we describe the preparation of Mtt-protected pyrrole 
(2) and imidazole (3) monomers for Py-Im polyamide SPPS. Our 
straightforward synthesis results in higher yields than those used 
for the Fmoc- and Boc-analogues. In addition, we report the pro-
cedure to yield the dimeric Mtt-protected Py-Im building block 
(4) to counter the synthetic difficulty from the electron-deficient 
nucleophilic imidazole amine.28 The Mtt-protected γ-aminobu-
tyric acid (5) as a turn unit of the hairpin was synthetized too. We 
exemplified our approach with the synthesis of a Py-Im polyamide 
containing all our new Mtt-proctected compounds: ImPyPyIm-γ-
PyImImPy-β-Dp (1) and compared the synthetic efficiency of this 
methodology to that of the “conventional” Fmoc-SPPS. 
The synthesis of the Mtt-protected precursors is shown in 
Scheme 1. The transformation of the corresponding commercially 
available NO2-Py/Im-OMe compounds (10 and 12, respectively) 
into the desired Mtt-protected Py/Im amino acids (2 and 3, re-
spectively) was carried out in a two-step procedure. Thus, palla-
dium-catalyzed reductive chemistry followed by in situ protection 
of the resulting amine with Mtt-Cl, and subsequent ester hydroly-
sis afforded the Mtt-protected monomers with excellent yields: 
84% for Mtt-Py-OH (2) and 68% for Mtt-Im-OH (3). Comparing 
the synthetic accessibility of our Mtt-protected Py/Im monomers 
to that of the previous reported, ours have higher yield than the 
Boc- and Fmoc-protected analogues23, 26 (64% for Boc-Py-OH and 
42% for Boc-Im-OH; 58% for Fmoc-Py-OH and 30% for Fmoc-
Im-OH). Furthermore, both the Mtt-PyIm-OH dimer and Mtt-γ-
OH turn motif were prepared following the same reaction se-
quence from the previous reported NO2-PyIm-OMe23 and the 
commercial available methyl γ-aminobutyrate hydrochloride 
(Scheme S4). 
 
Scheme 1. Synthesis of the Mtt-protected Py/Im monomers 
 
 
The different π-electron density of the N-heterocycles entails a 
distinct reactivity towards the Mtt deprotection by using TFA. As 
expected, in the case of the electron-rich pyrrole the Mtt group was 
more acid-labile. Thus, in presence of 0.1% TFA for 3 min the re-
moval of the protecting group of Mtt-Py-OMe was almost com-
plete while the electron-deficient imidazole analogue required 
2.0% TFA for 3 min for the efficient cleavage. In figure 2, a zoom-
in of the 1H-NMR spectra of the Mtt-methyl group in its bound 
and free form is shown at different TFA concentrations in CDCl3. 
At higher TFA concentrations, the signals are low-field shifted, 
which is in agreement with our observations of the 1H-NMR spec-
tra of Mtt-Cl under the same conditions (Figure S50) as well as 
reported trityl derivatives.29-30 The two different peaks for the free 
Mtt-methyl group can be reasoned by an equilibrium with TFA 






Figure 2. a) Reaction scheme of the Mtt deprotection; b) zoom-in of 
the aliphatic region of the 1H-NMR spectra of Mtt-Py-OMe (11) and 
c) Mtt-Im-OMe (13) in CDCl3 at 25°C after addition of different 
amounts of TFA and incubation for 3 min. The signals of the methyl 
of the Mtt-protecting group are marked in the scheme and the corre-
sponding NMR spectra. The small free Mtt signal in b) at 0% TFA is 
due to acid traces in CDCl3. 
For testing the applicability of our Mtt-protected compounds 
for Py-Im SPPS, we next synthesized a Dervan hairpin 
(ImPyPyIm-γ-PyImImPy-β-Dp, 1) containing all of them (Figure 
1). For comparison we prepared the same sequence using the 
Fmoc-protected compounds too. Our strategy offers a mild alter-
native to the current protocols, which must be particularly inter-
esting for basic-sensitive conjugates and those susceptible to 
strong acidic conditions or nucleophilic attack. Along these lines, 
the conventional N,N-dimethylaminopropylamine (Dp) aminoly-
sis used as final cleavage26 (68 eq, 55 °C, 18 h) was exchange for a 
controlled amide bond formation in solution in both synthesis. 
The implementation of Mtt-SPPS was straightforward using the 
same coupling and capping conditions as the ones described in the 
Fmoc-SPPS9 except the deprotection step. Thus, 2% TFA in 
CH2Cl2 for 20 min served as a base-free alternative to release the 
reactive amine, instead of the 20% piperidine in DMF used in 
Fmoc-SPPS. The aromatic amine and the color of the pyrrole and 
imidazole prevent the use of both the ninhydrin33 and the TNBS 
test34 to monitoring the progress of the coupling reactions. How-
ever, stepwise cleavage of a sample of resin and reverse phase 
(RP)-HPLC analysis verified high yields till the incorporation of 
the turn amino acid (>95%) (Figure S64). We observed that, un-
like the Fmoc-γ-OH, the coupling of the Mtt-γ-OH did not occur 













i) Pd/C, H2, MeOH, rt

















ii) 1M LiOH, 
     1,4-dioxane, rt
iii) Pd/C, H2, EtOAc/EtOH, rt
   Mtt-Cl, py, CH2Cl2, rt
iv) 1M KOH, 









eq DIPEA. NMR experiments revealed that the electron-rich pro-
tecting group Mtt increased the nucleophilicity of the secondary 
amine yielding the corresponding deactivated Mtt-butyrolactam 
(Scheme S6, Figure S58-S63) in presence of HATU and DIPEA 
(pKa = 10.75).35 Indeed, the acetylated polyamide starting material 
was the only product detected in the HPLC chromatogram(Figure 
S65a). However, the use of weaker bases such as NMM (pKa = 
7.38)36and pyridine (pKa = 5.21)36 reduced the intramolecular de-
activation and allowed the successful coupling obtaining the de-
sired product with 10% and 65% yield, respectively (Table 1, Entry 
B & C). Coupling with PyBOP increased the amount of desired 
product up-to 75% (Table 1, Entry G) and corroborated the gen-
eral tendency observed with the different bases. Importantly, due 
to the Mtt orthogonality to Fmoc synthesis, the co-synthesis with 
Fmoc-γ-OH was possible too. 
 
Table 1. Tested conditions for the Mtt-γ-OH (5) incorporation.a 
# coupling reagent base yield/% 
A 4 eq HATU 12 eq DIPEA <5 
B 4 eq HATU 12 eq NMM 10 
C 4 eq HATU 12 eq pyridine 65 
D 4 eq HATU 8 eq pyridine 63 
E 4 eq PyBOP 12 eq NMM 42 
F 4 eq PyBOP 8 eq NMM 52 
G 4 eq PyBOP 8 eq pyridine 75 
a Reaction conditions: 4 eq Mtt-γ-OH (0.3M in NMP), 4 eq cou-
pling reagent and 8 or 12 eq base were pre-incubated for 3 min and 
coupled for 1 h. After capping, cleavage and HPLC analysis, yields 
were calculated by integration of the peak areas with an intensity 
>10% related to the highest peak in the chromatogram. 
 
After the incorporation of the turn motif, the rest of the cou-
plings proceeded as expected for both protocols. Once all the syn-
thesis steps were completed, the Py-Im polyamide was cleaved 
from the resin, which resulted in a single peak in the RP-HPLC 
chromatogram (Figure S43 & S44). ImPyPyIm-γ-PyImImPy-β-
COOH 35 yields were comparable via both methodologies. Dp 
was placed in solution at the C-terminus of the polyamide to in-
crease the affinity (Scheme S5).25 
Finally, we tested the affinity and specificity of ImPyPyIm-γ-
PyImImPy-β-Dp (1) by thermal denaturation analysis. These 
spectroscopic measurements were performed on 
 
Figure 3. Melting curves of a 1 µM duplex dsDNA solution in 10 mM 
NaH2PO4 pH 7.4: 5′-GGTAGCCGTACC-3′ (blue) or 5′-
GGTAGCTGTACC-3′ (red) in presence (straight) and absence 
(dotted) of 1.2 µM ImPyPyIm-γ-PyImImPy-β-Dp (1). 
12-mer dsDNA duplexes with the sequences 5′ -
GGTAGCCGTACC -3′ and 5′ - GGTAGCTGTACC -3′, which 
contain the target and a single mismatch binding site, respectively. 
Satisfactorily, our Py-Im polyamide (1) has higher thermal stabili-
zation value in the presence of the target dsDNA than the mis-
matched one (DTm of 6.6 °C versus DTm of 1 °C). 
In conclusion, this work represents the first report of Mtt-pro-
tected pyrrole and imidazole building blocks for DNA-binding 
polyamides. Our monomers are accessible with the higher yields 
than those use in the conventional Boc- and Fmoc-SPPS. We 
demonstrate the utility of this methodology by the synthesis and 
study of a DNA-binding hairpin bearing all types of Mtt-protected 
compounds needed. This approach is both orthogonal to Fmoc-
SPPS and compatible to sensitive groups. Therefore, we foresee 
that our Mtt-SPPS will increase the synthetic diversity in Py-Im 
polyamide chemistry affording novel bifunctional polyamide con-
jugates. In addition, it could be readily adapted to automated syn-
thesis. 
ASSOCIATED CONTENT  
Supporting Information 
Experimental procedures, spectroscopic and analytical data of all new 
compounds are provided as well as additional experiments. The Sup-




* E-mail: olalla.vazquez@staff.uni-marburg.de 
ORCID 
Benedikt Heinrich: 0000-0002-9074-5983 
Olalla Vázquez: 0000-0002-7555-1865 
Notes 
The authors declare no competing financial interest. 
ACKNOWLEDGMENT  
We thank Abbas Sajediabkenar for his contribution in the synthesis of 
several starting materials. We further thank Prof. Dr. Armin Geyer and 
Dr. Xiulan Xie for the helpful NMR discussions. We acknowledge the 
Deutsche Forschungsgemeinschaft (DFG) for co-financing the Ac-
cuTOF GCv 4G (JEOL) Time of Flight (TOF) mass spectrometer 
(grant: INST 160/622-1 FUGG to U. Linne). 
 
REFERENCE 
1. Pelton, J. G.; Wemmer, D. E., Proc Natl Acad Sci U S A 1989, 86 
(15), 5723-7. 
2. Dervan, P. B., Bioorg Med Chem 2001, 9 (9), 2215-35. 
3. Dervan, P. B.; Burli, R. W., Curr Opin Chem Biol 1999, 3 (6), 
688-93. 
4. White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. 
B., Nature 1998, 391 (6666), 468-71. 
5. Yu, Z.; Pandian, G. N.; Hidaka, T.; Sugiyama, H., Adv Drug Deliv 
Rev 2019, 147,66-85 
6. Kawamoto, Y.; Bando, T.; Sugiyama, H., Bioorg Med Chem 
2018, 26 (8), 1393-1411. 
7. Blackledge, M. S.; Melander, C., Bioorg Med Chem 2013, 21 
(20), 6101-14. 
8. Hargrove, A. E.; Martinez, T. F.; Hare, A. A.; Kurmis, A. A.; 





9. Yang, F.; Nickols, N. G.; Li, B. C.; Marinov, G. K.; Said, J. W.; 
Dervan, P. B., Proc Natl Acad Sci U S A 2013, 110 (5), 1863-8. 
10. Yu, Z.; Guo, C.; Wei, Y.; Hashiya, K.; Bando, T.; Sugiyama, H., J 
Am Chem Soc 2018, 140 (7), 2426-2429. 
11. Taniguchi, J.; Feng, Y.; Pandian, G. N.; Hashiya, F.; Hidaka, T.; 
Hashiya, K.; Park, S.; Bando, T.; Ito, S.; Sugiyama, H., J Am Chem Soc 2018, 
140 (23), 7108-7115. 
12. Pandian, G. N.; Taniguchi, J.; Junetha, S.; Sato, S.; Han, L.; Saha, 
A.; AnandhaKumar, C.; Bando, T.; Nagase, H.; Vaijayanthi, T.; Taylor, R. 
D.; Sugiyama, H., Sci Rep 2014, 4, 3843. 
13. Patel, S.; Pongkulapa, T.; Yin, P. T.; Pandian, G. N.; Rathnam, 
C.; Bando, T.; Vaijayanthi, T.; Sugiyama, H.; Lee, K. B., J Am Chem Soc 
2015, 137 (14), 4598-601. 
14. Pandian, G. N.; Shinohara, K.; Ohtsuki, A.; Nakano, Y.; 
Masafumi, M.; Bando, T.; Nagase, H.; Yamada, Y.; Watanabe, A.; Terada, 
N.; Sato, S.; Morinaga, H.; Sugiyama, H., Chembiochem 2011, 12 (18), 
2822-8. 
15. Martinez, T. F.; Phillips, J. W.; Karanja, K. K.; Polaczek, P.; 
Wang, C. M.; Li, B. C.; Campbell, J. L.; Dervan, P. B., Nucleic Acids Res 2014, 
42 (18), 11546-59. 
16. Wang, C. C.; Dervan, P. B., J Am Chem Soc 2001, 123 (36), 
8657-61. 
17. Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, 
W. G., Jr.; Dervan, P. B., Proc Natl Acad Sci U S A 2004, 101 (48), 16768-73. 
18. Han, Y. W.; Sugiyama, H.; Harada, Y., Biomater Sci 2016, 4 (3), 
391-9. 
19. Chenoweth, D. M.; Viger, A.; Dervan, P. B., J Am Chem Soc 
2007, 129 (8), 2216-7. 
20. Bando, T.; Fujimoto, J.; Minoshima, M.; Shinohara, K.; Sasaki, 
S.; Kashiwazaki, G.; Mizumura, M.; Sugiyama, H., Bioorg Med Chem 2007, 
15 (22), 6937-42. 
21. Han, Y.-W.; Tsunaka, Y.; Yokota, H.; Matsumoto, T.; 
Kashiwazaki, G.; Morinaga, H.; Hashiya, K.; Bando, T.; Sugiyama, H.; 
Harada, Y., Biomaterials Science 2014, 2 (3), 297-307. 
22. Minoshima, M.; Bando, T.; Shinohara, K.; Sugiyama, H., Nucleic 
Acids Symp Ser (Oxf) 2009,  (53), 69-70. 
23. Baird, E. E.; Dervan, P. B., Journal of the American Chemical 
Society 1996, 118 (26), 6141-6146. 
24. Fang, L.; Yao, G.; Pan, Z.; Wu, C.; Wang, H. S.; Burley, G. A.; Su, 
W., Org Lett 2015, 17 (1), 158-61. 
25. Belitsky, J. M.; Nguyen, D. H.; Wurtz, N. R.; Dervan, P. B., 
Bioorg Med Chem 2002, 10 (8), 2767-74. 
26. Wurtz, N. R.; Turner, J. M.; Baird, E. E.; Dervan, P. B., Org Lett 
2001, 3 (8), 1201-3. 
27. Chouikhi, D.; Ciobanu, M.; Zambaldo, C.; Duplan, V.; 
Barluenga, S.; Winssinger, N., Chemistry 2012, 18 (40), 12698-704. 
28. Wetzler, M.; Wemmer, D. E., Org Lett 2010, 12 (15), 3488-90. 
29. Hojo, M.; Ueda, T.; Yamasaki, M., J Org Chem 1999, 64 (13), 
4939-4942. 
30. Kobayashi, N., B Chem Soc Jpn 2002, 75 (1), 1-19. 
31. Shahsavari, S. C., J.; Wigstrom, T.; Gooding, J.; Gauronskas, A.; 
Fang, S., Tetrahedron Lett. 2016, 57 (34), 3877-80. 
32. Feigel, M. K., H., Angew. Chem. Int. Ed. Engl . 1977, 16 (4), 256-
7. 
33. Sarin, V. K.; Kent, S. B. H.; Tam, J. P.; Merrifield, R. B., Anal 
Biochem 1981, 117 (1), 147-157. 
34. Hancock, W. S.; Battersby, J. E., Anal Biochem 1976, 71 (1), 
260-4. 
35. Boncel, S. S., K.; Hefczyc, Barbara; Walczak, K. Z. , Beilstein J. 
Org. Chem. 2011, 7, 173–8. 







4-Methyltrityl (Mtt)-Protected Pyrrole and Imidazole Building 




Benedikt Heinrich and Olalla Vázquez 
  
168 
TABLE OF CONTENT 
 
ABBREVIATIONS ....................................................................................................................... 169 
General Methods and Materials ................................................................................................... 171 
Nuclear Magnetic Resonance Spectroscopy (NMR) ................................................................... 171 
High Performance Liquid Chromatography (HPLC) ................................................................. 171 
Mass Spectrometry ..................................................................................................................... 172 
UV-Vis Spectroscopy .................................................................................................................. 172 
FT-IR Spectroscopy ................................................................................................................... 172 
Synthesis in Solution ..................................................................................................................... 173 
Synthesis of Pyrrole Monomers Nitro-Py-OMe (10), Fmoc-Py-OH (6) and Fmoc-PyIm-OH(8) 173 
Synthesis of Imidazole Monomer Fmoc-Im-OH (7) ................................................................... 176 
Synthesis of ImPy-OH (31) and Fmoc-γ-OH (9) ........................................................................ 179 
Synthesis of Mtt-building blocks ................................................................................................ 181 
NMR and IR spectra of new compounds ..................................................................................... 185 
Solid Phase Peptide Synthesis ....................................................................................................... 206 
Manual Solid Phase Protocol for Peptide Synthesis ................................................................... 206 
Synthesis and Characterization Data of the Polyamides ............................................................ 207 
Concentration Determination ....................................................................................................... 209 
Thermal Melting Analysis ............................................................................................................ 210 
Stability of the Mtt-building blocks .............................................................................................. 211 
Additional Experiments ................................................................................................................ 217 
Synthesis of Mtt-butyrolactam (36) ............................................................................................ 217 
Test Implementation of Mtt-γ-OH .............................................................................................. 221 







A adenine, absorbance  
aq aqueous 
arom aromatic 






CI chemical ionization 







dsDNA double-stranded DNA 
EI electron ionization 
ESI electrospray ionization 
Fmoc fluorenylmethyloxycarbonyl  
FT-IR fourier-transform infrared spectroscopy 
G guanine 
HATU hexafluorophosphate azobenzotriazole tetramethyl uronium 
HMBC heteronuclear multiple bond correlation spectroscopy 
HOBt 1-hydroxybenzotriazole 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
HSQC heteronuclear single quantum correlation spectroscopy 
Im imidazole 





m  multiplet, medium  
Mtt 4-methyltrityl 
NMM 4-methylmorpholine 




ppm parts per million 
Py pyrrole 
PyBOP (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate 
q quartet 
Rf retention factor 
RP reverse-phase 
s  singlet, strong 
SPPS solid phase peptide synthesis 




Tm melting temperature 
TMS trimethylsilyl 





γ γ-aminobutyric acid 
δ chemical shift 
ε extinction coefficient 
171 
General Methods and Materials  
All commercially purchased reagents were used from the following companies without further 
purification: trichloroacetyl chloride, N-methylimidazole, fuming nitric acid, thiophenol, 1-
hydroxybenzotriazole hydrate, PyBOP, DMSO for molecular biology and ssDNAs from Sigma Aldrich 
(USA); sodium hydroxide, potassium hydroxide and concentrated nitric acid from Merck (Germany); 
DMF peptide grade, HATU, piperidine and NMP from Iris Biotech (Germany); DIPEA, acetic 
anhydride and Fmoc-Cl from Carl Roth (Germany); Pd/C, 4-methylmorpholine, 4-aminobutanoic acid 
and N,N-dimethyl-1,3-diaminopropane from Alfa Aesar (USA); pyridine, triethylamine, cesium 
carbonate, acetonitrile and sodium chloride from VWR (USA); 4-methyltrityl chloride, FmocOSu and 
(Boc)2O from Fluorochem (UK); OxymaPure and DIC from Carbolution (Germany); N-methyl pyrrole 
and benzyl bromide from Acros Organics (Belgium); trifluoroacetic acid from abcr (Germany); 
dimethylamino pyridine and N,N’-dicyclohexylcarbodiimide from Fluka (USA); sodium bicarbonate 
from PanReac AppliChem (Germany), reverse phase filter cartridges Oasis HLB 20cc from Waters 
(Germany) and TG R PHB resin from Rapp Polymere (Germany). Water was purified with a milli-Q 
Ultra Pure Water Purification System (TKA, Germany). For aqueous solutions for reaction deionized 
water was used. The buffer for thermal melting analysis was prepared with milli-Q water. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
All NMR spectra were automatically measured at 300 K either in a Bruker AV III HD 300 MHz at a 
frequency of 300 MHz (1H) or 75 MHz (13C) or in a Bruker AV III HD 500 MHz at a frequency of 
500 MHz (1H) or 125 MHz (13C). All chemical shifts (δ) are given in ppm and are relative to 
tetramethylsilane (TMS), i.e. δ(TMS) = 0 ppm. As internal standards, deuterated chloroform (CDCl3), 
deuterated methanol (CD3OD), dimethyl sulfoxide (DMSO) with TMS were used. Solvent shifts (ppm): 
δ(CHCl3) = 7.26 ppm (
1H), δ(CHCl3) = 77.16 ppm (
13C), δ(CH3OH) = 3.31 ppm (
1H), δ(CH3OH) = 
49.00 ppm (13C), δ(DMSO) = 2.50 ppm (1H), δ(DMSO) = 39.52 ppm (13C).[i] The assignment of each 
signal was based on two-dimensional nuclear magnetic resonance spectroscopy (2D NMR), i.e. 
heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond correlation 
spectroscopy (HMBC). TopSpin was used to analyze the spectra. 
 
High Performance Liquid Chromatography (HPLC) 
For preparative purposes, a PLC 2020 Personal Purification System (Gilson) with a preparative 
Nucleodur C18 HTec-column (5 µm, 250 x 16 mm; Macherey & Nagel) using an isocratic regime during 
the first five minutes, for column equilibration, followed by a linear gradient 5% to 50% B in 30 min 
with a flow rate of 10 mL/min at 25 °C was used. The detection was carried out by measuring the 
absorption at wavelengths: 220 nm and 304 nm. Milli-Q water (A) and MeCN (B) were employed as 
eluents with an addition of 0.1% of TFA in both solvents. 
For analytical purposes, an Agilent 1260 Infinity II HPLC-System (Agilent Technologies) was used 
with an eclipse XDB-C18 column (5 µm, 4.6 x 150 mm, Agilent). The flow rate was 1.0 mL/min using 
an isocratic regime of 5% B during the first five minutes, for column equilibration, followed by the 
linear in 30 min at 55 °C. The isocratic regime and the linear gradient are: 
1) isocratic: 5% B, gradient 5-75% B. 
2) isocratic: 5% B, gradient 5-95% B. 
For purity determination, the integrals of the corresponding peaks were set into comparison. Only peaks 




High resolution electrospray ionization mass spectrometry (HR-ESI-MS) was performed on a Finnigan 
LTQ-FT (Thermo Fischer Scientific). The resolution was set to 100.000. HR-EI-MS and HR-CI-MS 
was performed on an AccuTOF GCv 4G (JEOL) Time of Flight (TOF) mass spectrometer. An internal 
or external standard was used for drift time correction. 
 
UV-Vis Spectroscopy 
UV-Vis measurements for concentration determinations were performed on a Tecan 20M at room 
temperature using a quarz cuvette (Hellma Analytics; 104-QS) with a pathlength of 1 cm in a volume 
of 1 mL. 
Thermal melting analysis was performed on a Jasco V-650 UV-Vis spectrophotometer equipped with a 
Jasco PAC-743 temperature controlled cell holder and a Julabo F250 cooling system. The measurements 
were performed in a 1 mL quarz cuvette (Hellma Analytics; 104-QS) with a pathlength of 1 cm, a 
concentration of 1.0 μM of duplex DNA with and without 1.2 μM of polyamide in 10 mM NaH2PO4 pH 
7.4. It was measured at 260 nm, with a medium response, a band width of 20 nm, from 20-95 °C and a 
slope of 0.5 °C/min. Three independent measurements were recorded and the intensity normalized. 
 
FT-IR Spectroscopy 
IR measurements were performed on a Bruker Alpha II Platinum ATR FTIR spectrometer. The 
absorption bands are given in cm-1, intensities are reported as s = strong, m = medium, w = weak. 
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Synthesis in Solution 
 
Synthesis of Pyrrole Monomers Nitro-Py-OMe (10), Fmoc-Py-OH (6) and Fmoc-PyIm-OH 
(8) 
This synthesis was reported before by Dervan et al.,[ii] Sugiyama et al.[iii] Lown et al.[iv] Pindur et al.,[v] 
and König et al.[vi] Such procedure is based in the preparation of the nitro pyrrole methylester 10.[ii] We 
followed the same approach with minor modifications. 
 
Scheme S1: Synthesis route of nitro-Py-OMe (10) and Fmoc-Py-OH (6) and Fmoc-PyIm-OH (8) starting from N-methylpyrrole 
(17). 
 
2,2,2-trichloro-1-(1-methyl-1H-pyrrol-2-yl)ethan-1-one (19): Under inert atmosphere, a 
solution of N- methylpyrrole (2.20 mL, 25.0 mmol) in Et2O (5.0 mL) was added to a 
solution of trichloroacetyl chloride (2.80 mL, 25.0 mmol) in Et2O (5.0 mL) at 0 °C over 1 h. 
The reaction mixture was stirred for 16 h at rt and neutralized with K2CO3 solution (aq). It 
was extracted with Et2O (4 x 200 mL), dried over MgSO4 and the solvent removed under reduced 
pressure to yield the desired product (19, 4.67 g, 20.6 mmol, 82%) as brown solid. The characterization 
is in agreement with the literature.[vii] Rf = 0.60 (n-pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, DMSO-
d6, δ): 7.46 - 7.42 (m, 2H, CH-1 and CH-3), 6.30 (dd, 1H, J = 4.3 Hz, J = 2.5 Hz, CH-2), 3.91 (s, 3H, 
CH-4). 
13
C-NMR (75 MHz, DMSO-d6, δ): 171.8 (C=O), 135.3 (CH), 123.6 (CH), 120.7 (Cq), 109.1 
(CH), 96.0 (CCl3), 36.2 (CH3). HRMS-CI
+
 (m/z): [M+H]+ calcd for C7H6Cl3NOH, 225.95932; found, 
225.95978. 
 
2,2,2-trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)ethan-1-one (20): Under inert 
atmosphere, to a solution of 2,2,2-trichloro-1-(1-methyl-1H-pyrrol-2-yl)ethan-1-one 
(1.50 g, 6.62 mmol) in Ac2O (8.00 mL, 84.6 mmol), conc. HNO3 (0.60 mL, 14.4 mmol) 
was added at -40 °C over 30 min. The reaction mixture was slowly warmed up to rt and 
stirred for 16 h. It was neutralized with Na2CO3 solution (aq), extracted with EtOAc (4 x 150 mL), 
washed with brine (3 x 100 mL), the organic phases dried over MgSO4 and the solvent removed under 
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reduced pressure to yield the desired product (20, 1.24 g, 4.56 mmol, 69%) as brown solid. The 
characterization is in agreement with the literature.[ii] Rf = 0.16 (n-pentane/EtOAc 10:1). 
1
H-NMR 
(300 MHz, DMSO-d6, δ): 8.56 (d, 1H, J = 1.6 Hz, CH-2), 7.80 (d, 1H, J = 1.6 Hz, CH-1), 4.00 (s, 3H, 
CH-3). 
13
C-NMR (75 MHz, DMSO-d6, δ): 172.8 (C=O), 134.2 (Cq), 132.5 (CH), 120.6 (Cq), 116.3 
(CH), 94.5 (CCl3), 50.0 (CH3). HRMS-CI
+
 (m/z): [M+H]+ calcd for C7H5Cl3N2O3H, 270.94440; found, 
270.94291. 
 
methyl 1-methyl-4-nitro-1H-pyrrole-2-carboxylate (10): To a solution of 2,2,2-
trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)ethan-1-one (20, 4.72 g, 17.4 mmol) in 
MeOH (58 mL), DMAP (212 mg, 1.74 mmol) was added and the reaction mixture stirred 
at rt for 72 h. The solvent was removed and the crude product purified by column 
chromatography (silica, n-pentane/EtOAc 4:1 → 1:1) to yield the desired product (10, 2.57 g, 
14.0 mmol, 80%) as yellow solid. The characterization is in agreement with the literature.[ii] Rf = 0.16 
(n-pentane/EtOAc 10:1). 
1
H-NMR (300 MHz, DMSO-d6, δ): 8.27 (d, 1H, J = 2.0 Hz, CH-2), 7.30 (d, 
1H, J = 2.0 Hz, CH-1), 3.92 (s, 3H, CH-3), 3.80 (s, 3H, CH-4). 
13
C-NMR (75 MHz, DMSO-d6, δ): 159.8 
(C=O), 134.2 (Cq), 129.4 (CH), 122.6 (Cq), 111.5 (CH), 51.7 (CH3), 37.4 (CH3). HRMS-ESI
+
 (m/z): 
[M+H]+ calcd for C7H8N2O4H, 185.05623; found, 185.05665. 
 
1-methyl-4-nitro-1H-pyrrole-2-carboxylic acid (21): To a solution of methyl 1-methyl-
4-nitro-1H-pyrrole-2-carboxylate (10 , 2.00 g, 10.9 mmol) in MeOH (25.0 mL) 1 M NaOH 
(aq, 15mL) was added and the reaction mixture stirred at rt for 16 h and heated at 60 °C 
for 1 h. Afterwards, it was extracted with EtOAc (3 x 100 mL) and washed with saturated 
NaHCO3 (aq, 3 x 100 mL). The aqueous phases were acidified with 2 M HCl (aq), extracted with EtOAc 
(4 x 200 mL), the organic phases dried over MgSO4, filtered and the solvent removed under reduced 
pressure to yield the desired product (22, 1.77 g, 10.4 mmol, 95%) as pale yellow solid. The 
characterization is in agreement with the literature.[viii] Rf = 0.33 (EtOAc/formic acid 1:0.02). 
1
H-NMR 
(300 MHz, DMSO-d6, δ): 13.11 (s, 1H, COOH), 8.21 (d, 1H, J = 2.1 Hz, CH-2), 7.25 (d, 1H, J = 2.1 Hz, 
CH-1), 3.91 (s, 3H, CH-3). 
13
C-NMR (75 MHz, DMSO-d6, δ): 160.9 (C=O), 134.0 (Cq), 129.1 (CH), 
123.8 (Cq), 111.4 (CH), 37.4 (CH3). HRMS-ESI
-




carboxylic acid (6): Nitro-Py-OMe (10, 2.56 g, 13.9 mmol) was dissolved in EtOH 
(15 mL) and EtOAc (15 mL). Pd/C (10% dry, 500 mg, 20% w/w) was added and the 
reaction mixture stirred under hydrogen atmosphere. After 3 h and 4 h Pd/C (10% dry, 
500 mg, 20% w/w) was added and the reaction mixture stirred under hydrogen atmosphere. After another 
4 h it was filtered over celite and the solvent removed. The crude was suspended in 2 M LiOH (aq, 
35 mL) and stirred at rt for 1 h. It was neutralized with 4 M HCl (aq), the solvent reduced, the crude 
dissolved in H2O (15 mL) and 1,4-dioxane (15 mL), NaHCO3 (5.86 g, 69.6 mmol) and FmocOSu 
(5.63 g, 16.7 mmol) added. The reaction mixture was stirred under nitrogen atmosphere for 12.5 h at rt. 
It was diluted with water and acidified with 2 M HCl (aq). The product was extracted with EtOAc (4 x 
200 mL), the organic phases dried over MgSO4, filtered and the solvent removed under reduced pressure. 
It was purified by column chromatography (silica, CH2Cl2/MeOH 100:1 → 20:1 → 10:1 → 10:1 
including 1% formic acid) to yield the desired product (6, 3.12 g, 8.61 mmol, 62%) as brown solid. The 
characterization is in agreement with the literature.[vi] Rf = 0.25 (CH2Cl2/MeOH 20:1). 
1
H-NMR 
(300 MHz, DMSO-d6, δ): 12.11 (s, 1H, COOH), 9.41 (s, 1H, NH), 7.90 (d, 2H, J = 7.4 Hz, CHarom.), 
7.72 (d, 2H, J = 7.1 Hz, CHarom.), 7.42 (d, 2H, J = 7.1 Hz, CHarom.), 7.34 (d, 2H, J = 7.4 Hz, CHarom.), 
7.03 (s, 1H, CH-2), 6.62 (s, 1H, CH-1), 4.44 (d, 2H, J = 6.5 Hz, CH2-Fmoc), 4.28 (t, 1H, J = 6.5 Hz, 
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CH-Fmoc), 3.78 (s, 3H, CH3-3). 
13
C-NMR (75 MHz, DMSO-d6, δ): 162.0 (C=O), 153.3 (C=O), 143.8 
(2C, Cq), 140.8 (2C, Cq), 127.6 (2C, CH), 127.1 (2C, CH), 125.0 (2C, CH), 122.3 (Cq), 120.2 (Cq), 120.1 
(2C, CH), 118.6 (CH), 107.5 (CH), 65.4 (CH2), 46.7 (CH), 36.0 (CH3). HRMS-ESI
+
 (m/z): [M+Na]+ 
calcd for C21H18N2O4Na, 385.1159; found, 385.1154. 
 
methyl 1-methyl-4-(1-methyl-4-nitro-1H-pyrrole-2-carboxamido)-1H-
imidazole-2-carboxylate (22): To a solution of nitro-Py-OH (1.04 g, 6.14 mmol) 
in DMF (10.0 mL) it was added HOBt x H2O (1.13 g, 7.41 mmol) followed by 
DCC (1.53 g, 7.41 mmol). The solution was stirred for 16 h and the urea side 
product removed by filtration. Separately, to a solution of nitro-Im-OMe (1.20 g, 
6.48 mmol) in MeOH (11.0 mL) Pd/C (10% dry, 240 mg, 20% w/w) was added and the reaction mixture 
stirred under hydrogen atmosphere for 15.5 h. The catalyst was removed by filtration through celite, the 
solvent removed and the OBt ester solution directly added. DIPEA (1.90 mL, 10.9 mmol) was added 
and the solution stirred at 60 °C for 5.5 h. The DMF was removed under reduced pressure and deionized 
water added to the crude. The formed precipitate was filtered and washed with 1 M HCl (aq, 5 x 50 mL) 
and water (7 x 50 mL). After freeze drying the precipitate, it was purified by column chromatography 
(silica, EtOAc/NEt3 100:1) to yield the desired product (22, 1.04 g, 3.38 mmol, 55%) as pale brown 
solid. The characterization is in agreement with the literature.[ix] Rf = 0.21 (n-pentane/EtOAc 1:1).  
1
H-
NMR (300 MHz, DMSO-d6, δ): 11.15 (s, 1H, NH), 8.20 (d, 1H, J = 2.0 Hz, CH-2), 7.81 (d, 1H, J = 
2.0 Hz, CH-1), 7.69 (s, 1H, CH-4), 3.96 (s, 3H, CH3-3), 3.94 (s, 3H, CH3-5), 3.82 (s, 3H, CH3-6). 
13
C-
NMR (75 MHz, DMSO-d6, δ): 158.9 (C=O), 157.3 (C=O), 137.1 (Cq), 133.9 (Cq), 131.0 (Cq), 128.8 
(CH), 125.2 (Cq), 115.7 (CH), 108.8 (CH), 51.9 (CH3), 37.8 (CH3), 35.5 (CH3). HRMS-ESI
+
 (m/z): 
[M+Na]+ calcd for C12H13N5O5Na, 330.0809; found, 330.0810. 
 
4-(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-1-methyl-1H-pyrrole-
2-carboxamido)-1-methyl-1H-imidazole-2-carboxylic acid (8): To a 
solution of nitro-PyIm-OMe (929 mg, 3.02 mmol) in MeOH (10.0 mL), Pd/C 
(10% dry, 549 mg, 60% w/w) was added and the mixture stirred under hydrogen 
atmosphere for 14 h. The catalyst was removed by filtration through celite, the 
solvent removed and 1 M NaOH (aq, 10.0 mL) added. After 3 h at 45 °C, 1 M NaOH (aq, 5.00 mL) was 
added and the solution stirred for another 1 h. 1 M HCl (aq) was added until pH 7 was reached. The 
water was removed under reduced pressure, the residue dissolved in H2O (8.00 mL) and 1,4-dioxane 
(5.00 mL) and NaHCO3 (1.27 g, 15.1 mmol) and FmocOSu (1.02 g, 3.02 mmol) added. The solution 
was stirred under nitrogen atmosphere at rt for 16 h. H2O (5.00 mL) and 1,4-dioxane (5.00 mL) were 
added and the solution stirred for another 40 min. The dioxane was removed under reduced pressure and 
the formed precipitate filtered and washed with water (6 x 50 mL). The residue was freeze dried and 
purified by column chromatography (silica, CH2Cl2/MeOH 100:1 → 20:1 including 1% formic acid) to 
yield the desired product (8, 734 mg, 1.51 mmol, 50%) as pale brown solid. The characterization is in 
agreement with the literature.[iii] Rf = 0.33 (EtOAc). 
1
H-NMR (300 MHz, DMSO-d6, δ): 10.57 (s, 1H, 
COOH), 9.46 (s, 1H, NH), 8.15 (s, 1H, NH), 7.91 (d, 2H, J = 7.3 Hz, CHarom.), 7.74 (d, 2H, J = 6.5 Hz, 
CHarom.), 7.57 (s, 1H, CH-4), 7.47 – 7.31 (m, 4H, CHarom.), 7.01 (s, 1H, CH-2), 6.95 (s, 1H, CH-1), 4.47 
– 4.37 (m, 2H, CH2-Fmoc.), 4.33 – 4.24 (m, 1H, CH-Fmoc), 3.91 (s, 3H, CH3-3), 3.82 (s, 3H, CH3-5). 
13
C-
NMR (125 MHz, DMSO-d6, δ): 172.8 (C=O), 163.2 (C=O), 153.5 (C=O), 143.9 (2C, Cq), 140.8 (2C, 
Cq), 137.2 (Cq), 132.6 (Cq), 127.7 (2C, CH), 127.1 (2C, CH), 125.2 (2C, CH), 122.6 (Cq), 122.1 (Cq), 
120.2 (2C, CH), 118.1 (CH), 114.6 (CH), 105.0 (CH), 65.5 (CH2), 46.7 (CH), 36.3 (CH3), 35.4 (CH3). 
HRMS-ESI
+
 (m/z): [M+H]+ calcd for C26H23N5O5H, 486.1777; found, 486.1772. 
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Synthesis of Imidazole Monomer Fmoc-Im-OH (7) 
This synthesis was reported before by Dervan et al.,[ii,x] and Shibuya et al.,[xi] Such procedure is based in 
the preparation of the nitro imidazole methylester 12. We followed the same approach with minor 
modifications. 
 
Scheme S2: Synthesis route of nitro-Im-OMe (12) and Fmoc-Im-OH (7) starting from N-methylimidazole (23). 
 
2,2,2-trichloro-1-(1-methyl-1H-imidazol-2-yl)ethan-1-one (24): Under inert 
atmosphere, a solution of N-methylimidazole (5.58 mL, 70.0 mmol) in CH2Cl2 (30 mL) 
was added to a solution of trichloroacetyl chlorid (7.88 mL, 70.2 mmol) in CH2Cl2 (50 mL) 
at 0 °C over 1.5 h. The reaction mixture was stirred for 16 h at rt, CH2Cl2 (40 mL) and 
triethylamine (9.75 mL, 70.2 mmol) were added at 0 °C over 30 min. The crude was purified by flash 
column chromatography (silica, n-pentane/EtOAc 1:1) to yield the desired product (24, 13.0 g, 
57.2 mmol, 82%) as yellow solid. The characterization is in agreement with the literature.[xii] Rf = 0.72 
(n-pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, CD3OD, δ): 7.31 (s, 1H, CH-2), 7.08 (s, 1H, CH-1), 4.01 
(s, 3H, CH3-3). 
13
C-NMR (75 MHz, CD3OD, δ): 160.3 (C=O), 137.8 (Cq), 129.4 (CH), 128.1 (CH), 
119.5 (CCl3), 36.2 (CH3). HRMS-CI
+
 (m/z): [M+H]+ calcd for C6H5Cl3N2O1H, 226.95457; found, 
226.95069. 
 
2,2,2-trichloro-1-(1-methyl-4-nitro-1H-imidazol-2-yl)ethan-1-one (25): Under inert 
atmosphere, Im-CCl3 (24, 12.7 g, 56.0 mmol) was dissolved in Ac2O (72.6 mL, 
768 mmol) and cooled to -40 °C. Fuming HNO3 (15.2 mL, 364 mmol) was added 
carefully dropwise over 1.5 h. The reaction mixture was slowly warmed it up to rt and 
stirred with the flask placed in a water bath for 16 h. Afterwards the reaction was neutralized with 
saturated Na2CO3 (aq), at 0 °C, extracted with CH2Cl2 (4 x 200 mL) and dried over MgSO4. The solvent 
was removed to yield the desired product (25, 6.52 g, 23.9 mmol, 43%) as pale brown solid. The 
characterization is in agreement with the literature.[xii] Rf = 0.55 (n-pentane/EtOAc 1:1). 
1
H-NMR 
(300 MHz, CDCl3, δ): 7.95 (s, 1H, CH-1), 4.16 (s, 3H, CH3-2). 
13
C-NMR (75 MHz, CDCl3, δ): 173.0 
(C=O), 146.0 (Cq), 133.8 (Cq), 126.1 (CH), 93.7 (CCl3), 38.4 (CH3). HRMS-CI
+
 (m/z): [M+H]+ calcd 
for C6H4Cl3N3O3H, 271.93965; found, 271.94021. 
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methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate (12): Nitro-Im-CCl3 (7.17 g, 
26.3 mmol) was suspended in MeOH (145 mL), followed by DMAP (437 mg, 
3.58 mmol) addition. The resulting reaction mixture stirred for 18 h at rt. The crude was 
purified by flash column chromatography (silica, n-pentane/EtOAc: 4:1 → 1:1 → 1:2) to 
yield the desired product (12, 4.87 g, 26.3 mmol, >99%) as pale yellow solid. The characterization is in 
agreement with the literature.[xii] Rf = 0.33 (n-pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, CD3OD, δ): 
8.29 (s, 1H, CH-1), 4.08 (s, 3H, CH3-2), 3.96 (s, 3H, CH3-3). 
13
C-NMR (75 MHz, CD3OD, δ): 159.6 
(C=O), 142.9 (Cq), 136.6 (Cq), 126.9 (CH), 53.2 (CH3), 37.5 (CH3). HRMS-ESI
+
 (m/z): [M+Na]+ calcd 
for C6H7N3O4Na, 208.0329; found, 208.0328. 
 
methyl 4-amino-1-methyl-1H-imidazole-2-carboxylate (26): Nitro-Im-OMe (4.83 g, 
26.1 mmol) was suspended in EtOH (75 mL). EtOAc (75 mL) and Pd/C 10%, 50% wet 
(0.1 w/w%) in a slurry of EtOAc (15 mL) was added and the mixture stirred in the dark 
under hydrogen atmosphere for 18 h. The crude was filtered over celite and the solvent 
removed under reduced pressure to yield the desired product (26, 4.01 g, 25.8 mmol, 
99%) as pale yellow solid. The characterization is in agreement with the literature.[x] Rf = 0.07 (EtOAc). 
1
H-NMR (300 MHz, CD3OD, δ): 6.55 (s, 1H, CH-1), 4.83 (s, 2H, NH2), 3.90 (s, 3H, CH3-2), 3.86 (s, 
3H, CH3-3). 
13
C-NMR (75 MHz, CD3OD, δ): 160.1 (C=O), 147.3 (Cq), 132.2 (Cq), 111.0 (CH), 52.2 
(CH3), 36.0 (CH3). HRMS-ESI
+
 (m/z): [M+Na]+ calcd for C6H9N3O2Na, 178.0587; found, 178.0588. 
 
4-((tert-butoxycarbonyl)amino)-1-methyl-1H-imidazole-2-carboxylic acid (27): 
NH2-Im-OMe (3.97 g, 25.6 mmol) was dissolved in DMF (30 mL). Afterwards 
DIPEA (7.52 mL, 44.3 mmol) and Boc2O (10.9 g, 50.0 mmol) were added. The 
mixture was stirred in the dark for 18 h at rt and heated at 40 °C for other 2 h. The 
reaction mixture was extracted with Et2O (4 x 200 mL) and washed with brine (aq, 
3 x 100 mL), 10% citric acid (aq, 3 x 100 mL), brine (aq, 3 x 100 mL), saturated NaHCO3 (aq, 3 x 
100 mL) and brine (aq, 3 x 100 mL). The organic phases were dried over MgSO4 and the solvent 
removed under reduced pressure. The crude was dissolved in MeOH (80 mL) and 1 M KOH (aq, 50 mL) 
was added at 0 °C and stirred in the dark for 30 min and another 3.5 h at rt. The reaction mixture was 
extracted with Et2O (3 x 150 mL), the aqueous phase cooled to 0 °C and 10% NaHSO4 (aq) added until 
pH 3. The mixture was extracted with EtOAc (4 x 200 mL), the organic phases dried over MgSO4 and 
the solvent removed under reduced pressure to yield the desired product (27, 3.38 g, 14.0 mmol, 55%) 
as pale brown solid. The characterization is in agreement with the literature.[xii] Rf = 0.02 (n-
pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, CD3OD, δ): 7.20 (s, 1H, CH-1), 4.00 (s, 3H, CH3-2), 1.51 (s, 
9H, CH3-3). 
13
C-NMR (75 MHz, CD3OD, δ): 160.9 (C=O), 152.9 (C=O), 137.5 (Cq), 134.5 (Cq), 112.4 
(CH), 79.5 (Cq), 35.7 (CH3), 28.6 (3C, CH3). HRMS-ESI
+
 (m/z): [M+Na]+ calcd for C10H15N3O4Na, 




carboxylate (28): Boc-Im-OH (3.34 g, 10.1 mmol) was suspended in 66% 
EtOH (67 mL) and Cs2CO3 (3.34 g, 10.3 mmol) added. After stirring for 
20 min at rt, the suspension was filtered over glass wool and the solvent 
removed under reduced pressure. The crude was dissolved in DMF (180 mL), BnBr (1.75 mL, 
14.6 mmol) added and the mixture stirred for 13 h. Deionized water was added. It was extracted with 
EtOAc (4 x 200 mL), washed with water (3 x 100 mL) and the organic phases dried over MgSO4. The 
crude was purified by flash column chromatography (silica, n-pentane/EtOAc: 10:1 → 5:1 → 1:1) to 
yield the desired product (28, 3.17 g, 9.57 mmol, 95%) as pale brown solid. The characterization is in 
agreement with the literature.[xiii] Rf = 0.65 (n-pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, CD3OD, δ): 
7.49-7.42 (m, 2H, CHarom.), 7.40-7.32 (m, 3H, CHarom.), 7.25 (s, 1H, CH-1), 5.35 (s, 2H, CH2-4), 3.96 (s, 
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3H, CH3-2), 1.50 (s, 9H, CH3-3). 
13
C-NMR (75 MHz, CD3OD, δ): 159.5 (C=O), 154.8 (C=O), 139.3 
(Cq), 137.2 (Cq), 135.5 (Cq), 129.6 (2C, CH), 129.5 (2C, CH), 129.4 (CH), 115.6 (CH), 81.3 (Cq), 67.9 
(CH2), 36.5 (CH3), 28.6 (3C, CH3). HRMS-ESI
+




1H-imidazole-2-carboxylate (29): Boc-Im-OBn (3.13 g, 9.45 mmol) 
was dissolved in CH2Cl2 (12.5 mL) and a mixture of TFA (8.2 mL), 
CH2Cl2 (4.4 mL) and PhSH (960 µL) was added. After stirring for 2 h in 
the dark, the reaction mixture was added dropwise at 0 °C to 2 M LiOH 
(aq, 100 mL). It was extracted with Et2O (4 x 100 mL), washed with 2 M LiOH (aq, 3 x 80 mL) and the 
organic phases dried over MgSO4. The solvent was removed under reduced pressure. The crude, under 
inert atmosphere, was dissolved in CH2Cl2 (20 mL) and DIPEA (6.4 mL, 36.8 mmol) and Fmoc-Cl 
(2.46 g, 9.52 mmol) were added at 0 °C. It was stirred in the dark for 30 min at 0 °C. It was acidified 
with 1 M HCl (aq), extracted with CH2Cl2 (4 x 150 mL), the organic phases dried over MgSO4 and the 
solvent removed under reduced pressure. The crude was purified by flash column chromatography 
(silica, n-pentane/EtOAc: 10:1 → 4:1 → 0:1) to yield the desired product (29, 2.52 g, 5.56 mmol, 59%) 
as a colorless solid. The characterization is in agreement with the literature.[x] Rf = 0.73 (n-
pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, DMSO-d6, δ): 10.36 (s, 1H, NH), 7.90 (d, 2H, J = 7.5 Hz, 
CHarom.), 7.76 (d, 2H, J = 7.0 Hz, CHarom.), 7.47-7.30 (m, 10H, CHarom- and CH-1), 5.30 (s, 2H, CH2-3), 
4.36-4.23 (m, 3H, CH2-7 and CH-8), 3.92 (s, 3H, CH3-2). 
13
C-NMR (75 MHz, DMSO-d6, δ): 158.1 
(C=O), 153.2 (C=O), 143.7 (2C, Cq), 140.7 (2C, Cq), 137.9 (Cq), 135.7 (Cq), 130.8 (Cq), 128.4 (2C, CH), 
128.3 (2C, CH), 128.2 (CH), 127.6 (2C, CH), 127.0 (2C, CH), 125.3 (2C, CH), 120.0 (2C, CH), 113.9 
(CH), 66.1 (CH2), 66.0 (CH2), 46.4 (CH), 35.4 (CH3). HRMS-ESI
+
 (m/z): [M+Na]+ calcd for 
C27H23N3O4Na, 476.1581; found, 476.1582. 
 
4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-1-methyl-1H-imidazole-2-
carboxylic acid (7): Fmoc-Im-OBn (100 mg, 0.22 mmol) was dissolved in THF 
(2.0 mL) and Pd/C 10% dry (0.25 w/w%) was added. The reaction mixture was 
stirred under hydrogen atmosphere for 4.5 h at rt. The reaction mixture was 
filtered over celite and the solvent removed under reduced pressure to yield the 
desired product (7, 72.7 mg, 0.20 mmol, 91%) as a pale grey solid. The characterization is in agreement 
with the literature.[xiv] Rf = 0.32 (CH2Cl2/MeOH/formic acid 100:10:1). 
1
H-NMR (500 MHz, DMSO-
d6, δ): 11.71 (s, 1H, COOH), 10.30 (s, 1H, NH), 7.91 (d, 2H, J = 7.4 Hz, CHarom.), 7.77 (d, 2H, J = 
7.4 Hz, CHarom.), 7.43 (dd, 2H, J = 7.4 Hz, J = 7.4 Hz, CHarom.), 7.34 (dd, 2H, J = 7.4 Hz, J = 7.4 Hz, 
CHarom.), 7.28 (s, 1H, CH-1), 4.36-4.24 (m, 3H, CH2-3 and CH-4), 3.88 (s, 3H, CH3-2). 
13
C-NMR 
(125 MHz, DMSO-d6, δ): 160.1 (C=O), 153.4 (C=O), 143.7 (2C, Cq), 140.8 (2C, Cq), 137.4 (Cq), 132.3 
(Cq), 127.7 (2C, CH), 127.2 (2C, CH), 125.5 (2C, CH), 120.2 (2C, CH), 113.3 (CH), 66.2 (CH2), 46.5 
(CH), 35.5 (CH3). HRMS-ESI
+







Synthesis of ImPy-OH (31) and Fmoc-γ-OH (9) 
This synthesis was reported before by Sekine et al.,[xv] and Herdewijn et al.[xvi]. We followed the same 
approach with minor modifications. 
 
 
Scheme S3: Synthesis route of ImPy-OH (31) and Fmoc-γ-OH (9). 
 
methyl 1-methyl-4-(1-methyl-1H-imidazole-2-carboxamido)-1H-pyrrole-2-
carboxylate (30): Pd/C (10% dry, 400 mg, 40% w/w) was added to a solution of 
nitro-Py-OMe (1.00 g, 5.43 mmol) in THF (10.0 mL). The mixture was stirred 
under hydrogen atmosphere for 2 h. The catalyst was removed by filtration through 
celite and the solvent removed under reduced pressure. The residue was dissolved in CH2Cl2 (15 mL) 
and Im-CCl3 (24, 1.24 g, 5.43 mmol) and NEt3 (2.27 mL, 16.3 mmol) added. The reaction was stirred 
for 16 h, the solvent removed and the crude purified by column chromatography (silica, CH2Cl2/MeOH 
100:0 → 100:1 → 50:1) to yield the desired product (30, 1.29 g, 4.91 mmol, 90%) as pale brown solid. 
The characterization is in agreement with the literature.[xvii] Rf = 0.27 (n-pentane/EtOAc 1:1). 
1
H-NMR 
(300 MHz, CDCl3, δ): 9.12 (s, 1H, NH), 7.40 (d, 1H, J = 2.0 Hz, CH-2), 7.03 (d, 1H, J = 0.9 Hz, CH-
5), 6.98 (d, 1H, J = 0.9 Hz, CH-4), 6.80 (d, 1H, J = 2.0 Hz, CH-1), 4.09 (s, 3H, CH3-6), 3.90 (s, 3H, 
CH3-3), 3.80 (s, 3H, CH3-7). 
13
C-NMR (75 MHz, CDCl3, δ): 161.6 (C=O), 156.4 (C=O), 139.0 (Cq), 
127.9 (CH), 125.9 (CH), 121.4 (Cq), 120.7 (CH), 120.2 (Cq), 108.4 (CH), 51.2 (CH3), 36.9 (CH3), 35.8 
(CH3). HRMS-ESI
+
 (m/z): [M+H]+ calcd for C12H14N4O3H, 263.1144; found, 263.1139. 
 
1-methyl-4-(1-methyl-1H-imidazole-2-carboxamido)-1H-pyrrole-2-carboxylic 
acid (31): ImPy-OMe (723 mg, 2.75 mmol) was dissolved in EtOH (3.0 mL) and 
0.6 M NaOH (aq, 5.0 mL) and stirred at 70 °C for 2.5 h. The EtOH was removed 
under reduced pressure and the aqueous phase extracted with CH2Cl2. The aqueous 
layers were acidified with 1 M HCl (aq) to pH 3, filtered, washed with deionized H2O and freeze dried 
to yield the desired product (31, 544 mg, 2.19 mmol, 80%) as grey solid. The characterization is in 
agreement with the literature.[xv] Rf = 0.42 (EtOAc). 
1
H-NMR (300 MHz, DMSO-d6, δ): 12.20 (br s, 
1H, COOH), 10.47 (s, 1H, NH), 7.47 (s, 1H, CH-2), 7.39 (s, 1H, CH-5), 7.04 (s, 1H, CH-4), 6.98 (s, 1H, 
CH-1), 3.98 (s, 3H, CH3-6), 3.82 (s, 3H, CH3-3). 
13
C-NMR (75 MHz, DMSO-d6, δ): 161.9 (C=O), 156.0 
(C=O), 138.6 (Cq), 126.9 (CH), 126.3 (CH), 121.9 (Cq), 120.4 (CH), 119.7 (Cq), 108.9 (CH), 36.1 (CH3), 
35.1 (CH3). HRMS-ESI
+
 (m/z): [M+H]+ calcd for C11H12N4O3H, 249.0982; found, 249.0978. 
 
4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid (9): 4-
Aminobutanoic acid (502 mg, 4.87 mmol) was dissolved in deionized water (24 mL) 
and 1,4-dioxane (12 mL). Fmoc-Cl (1.38 g, 5.33 mmol) and NaHCO3 (1.92 g 
22.9 mmol) were added and the mixture stirred at rt for 3.5 h. The mixture was poured into deionized 
water (50 mL) and extracted with Et2O (3 x 50 mL). The aqueous layer was acidified with 2 M HCl (aq) 
to pH 3 and the remaining precipitate filtered and dried in vacuo to yield the desired product (9, 1.25 g, 
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3.85 mmol, 79%) as white solid. The characterization is in agreement with the literature.[xviii] Rf = 0.83 
(CH2Cl2/MeOH 1:1). 
1
H-NMR (300 MHz, DMSO-d6, δ): 11.62 (br s, 1H, COOH), 7.88 (d, 2H, J = 
7.3 Hz, CHarom.), 7.69 (d, 2H, J = 7.3 Hz, CHarom.), 7.45 – 7.37 (m, 2H, CHarom.), 7.36 – 7.29 (m, 3H, 
CHarom., NH), 4.29 (d, 2H, J = 6.7 Hz, CH2-Fmoc), 4.25 – 4.16 (m, 1H, CH-Fmoc), 3.04 – 2.95 (m, 2H, 
CH2-1), 2.20 (t, 2H, J = 7.4 Hz, CH2-3), 1.69 – 1.55 (m, 2H, CH2-2). 
13
C-NMR (75 MHz, DMSO-d6, 
δ): 174.2 (C=O), 156.1 (C=O), 143.9 (2C, Cq), 140.7 (2C, Cq), 127.5 (2C, CH), 127.0 (2C, CH), 125.1 
(2C, CH), 120.1 (2C, CH), 65.2 (CH2), 46.7 (CH), 39.7 (CH2), 31.1 (CH2), 29.9 (CH2). HRMS-ESI
+
 
(m/z): [M+Na]+ calcd for C19H19N1O4Na, 348.1206; found, 348.1201. 
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Synthesis of Mtt-building blocks 
This synthesis is based in the preparation of the Mtt-protected methyl esters to yield the final Mtt-
building blocks 2, 3, 4, and 5, which are used in the solid phase synthesis. 
 
Scheme S4: Synthesis route of Mtt-Py-OH (2), Mtt-Im-OH (3) Mtt-PyIm-OH (4) and Mtt-γ-OH (5).  
 
methyl 4-((diphenyl(p-tolyl)methyl)amino)-1-methyl-1H-pyrrole-2-carboxylate 
(11): Nitro-Py-OMe (10, 300 mg, 1.63 mmol) was dissolved in MeOH (7.0 mL). Pd/C 
(10% dry, 75 mg, 25% w/w) was added and the reaction mixture stirred under hydrogen 
atmosphere. After 3 h, it was filtered over celite and the solvent removed. Under inert 
atmosphere, the residue was dissolved in CH2Cl2 (2.4 mL) and pyridine (2.0 mL). At 0 °C, MttCl 
(477 mg, 1.63 mmol) dissolved in CH2Cl2 (1.2 mL) and pyridine (1.0 mL) was added dropwise for 
30 min. After 1 h at rt, the solvent was removed under reduced pressure, the crude co-evaporated with 
EtOAc (3 x 10 mL) and purified via flash column chromatography (silica, CH2Cl2/NEt3 100:2). Mtt-Py-
OMe (11, 616 mg, 1.50 mmol, 92%) was obtained as pale yellow solid. Rf = 0.52 (CH2Cl2/NEt3 100:1). 
1
H-NMR (300 MHz, CD3OD, δ): 7.41 -7.36 (m, 4H, CHarom.), 7.28 – 7.14 (m, 8H, CHarom.), 7.08 – 7.02 
(m, 2H, CHarom.), 6.12 (d, 1H, J = 2.1 Hz, CH-2), 5.83 (d, 1H, J = 2.1 Hz, CH-1), 3.65 (s, 3H, CH3-4), 
3.55 (s, 3H, CH3-3), 2.28 (s, 3H, CH3-Mtt). 
13
C-NMR (75 MHz, CD3OD, δ): 163.2 (C=O), 147.6 (2C, 
Cq), 144.4 (Cq), 137.1 (Cq), 133.3 (Cq), 130.3 (4C, CH), 130.3 (2C, CH), 129.2 (2C, CH), 128.5 (4C, 
CH), 127.4 (2C, CH), 120.9 (CH), 119.9 (Cq), 111.1 (CH), 73.1 (Cq), 51.1 (CH3), 36.4 (CH3), 21.0 (CH3). 
HRMS-ESI
+
 (m/z): [M+H]+ calcd for C27H26N2O2H, 411.2067; found, 411.2062. FT-IR (neat) ṽ = 3055 
(w), 3022 (w), 2945 (w), 1698 (m), 1571 (w), 1507 (w), 1490 (w), 1443 (s), 1404 (w), 1368 (w), 1255 
(m), 1209 (w), 1185 (w), 1151 (w), 1099 (s), 1054 (w), 1028 (w), 962 (w), 901 (w), 814 (m), 762 (m), 
701 (s), 629 (w), 590 (w), 574 (w), 511 (w), 472 (w), 439 (w). 
 
4-((diphenyl(p-tolyl)methyl)amino)-1-methyl-1H-pyrrole-2-carboxylic acid (2): 
Mtt-Py-OMe (11, 275 mg, 0.67 mmol) was dissolved in 1,4-dioxane (18 mL), 1 M 
LiOH (aq, 5 mL) added and the reaction mixture stirred for 16.5 h at 80 °C. The solvent 
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was removed and the crude purified over reverse phase silica column chromatography (Oasis HLB cc 
Vac Cartridge, 30 µm particle size, Waters, USA; H2O/MeCN/NEt3 100:0:0.1% → 90:10:0.1% → 
75:25:0.1% → 50:50:0.1% → 0:100:0.1%) to yield Mtt-Py-OH (2, 241 mg, 0.61 mmol, 91%) as pale 
yellow solid. Rf = 0.54 (CH2Cl2/MeOH/NEt3 100:10:1). 
1
H-NMR (500 MHz, DMSO-d6, δ): 7.37 -7.34 
(m, 4H, CHarom.), 7.25 – 7.21 (m, 6H, CHarom.), 7.16 – 7.12 (m, 2H, CHarom.), 7.05 – 7.02 (m, 2H, CHarom.), 
5.69 (d, 1H, J = 2.1 Hz, CH-2), 5.39 (d, 1H, J = 2.1 Hz, CH-1), 5.13 (s, 1H, NH), 3.49 (s, 3H, CH3-3), 
2.24 (s, 3H, CH3-Mtt). 
13
C-NMR (125 MHz, DMSO-d6, δ): 166.1 (C=O), 146.6 (2C, Cq), 143.5 (Cq), 
134.8 (Cq), 129.6 (Cq), 129.0 (Cq), 128.8 (6C, CH), 127.9 (2C, CH), 127.2 (4C, CH), 125.9 (2C, CH), 
112.4 (CH), 106.0 (CH), 71.0 (Cq), 35.2 (CH3), 20.5 (CH3). HRMS-ESI
+
 (m/z): [M+Na]+ calcd for 
C26H24N2O2Na, 419.1730; found, 419.1725. FT-IR (neat) ṽ = 3345 (w), 3081 (w), 3056 (w), 3022 (w), 
2975 (w), 2921 (w), 2172 (w), 1562 (m), 1489 (w), 1438 (s), 1402 (w), 1364 (w), 1326 (w), 1284 (w), 
1207 (w), 1185 (w), 1152 (w), 1119 (w), 1030 (w), 901 (w), 814 (w), 771 (m), 700 (s), 626 (w), 576 
(w), 511 (w), 492 (w), 472 (w), 450 (w). 
 
methyl 4-((diphenyl(p-tolyl)methyl)amino)-1-methyl-1H-imidazole-2-carboxylate 
(13): Nitro-Im-OMe (12, 506 mg, 2.96 mmol) was dissolved in EtOH/EtOAc 1:1 
(10 mL). Pd/C (10% dry, 38 mg, 8% w/w) was added and the reaction mixture stirred 
under hydrogen atmosphere. After 19 h, it was filtered over celite and the solvent 
removed. Under inert atmosphere, the residue was dissolved in CH2Cl2 (3.6 mL) and pyridine (2.4 mL) 
and MttCl (867 mg, 2.96 mmol) was added. After 3 h at rt, the solvent was removed under reduced 
pressure, the crude coevaporated with EtOAc (3 x 10 mL) and purified via flash column chromatography 
(silica, CH2Cl2/MeOH/NEt3 100:0:1 → 100:1:1 → 10:1:1). Mtt-Im-OMe (13, 908 mg, 2.21 mmol, 75%) 
was preserved as pale yellow solid. Rf = 0.24 (CH2Cl2/NEt3 100:1). 
1
H-NMR (300 MHz, CD3OD, δ): 
7.40 -7.33 (m, 4H, CHarom.), 7.29 – 7.15 (m, 8H, CHarom.), 7.11 – 7.04 (m, 2H, CHarom.), 5.46 (s, 1H, CH-
1), 3.81 (s, 3H, CH3-3), 3.59 (s, 3H, CH3-2), 2.28 (s, 3H, CH3-Mtt). 
13
C-NMR (75 MHz, CD3OD, δ): 
160.0 (C=O), 147.1 (Cq), 146.7 (2C, Cq), 143.5 (Cq), 137.7 (Cq), 131.6 (Cq), 130.0 (6C, CH), 129.5 (2C, 
CH), 128.9 (4C, CH), 127.9 (2C, CH), 111.7 (CH), 72.1 (Cq), 52.3 (CH3), 35.8 (CH3), 20.9 (CH3). 
HRMS-ESI
+
 (m/z): [M+H]+ calcd for C26H25N3O2H, 412.2031; found, 412.2023. FT-IR (neat) ṽ = 3252 
(w), 3055 (w), 3022 (w), 2947 (w), 1704 (s), 1560 (m), 1485 (w), 1443 (s), 1412 (w), 1271 (m), 1199 
(m), 1121 (s), 1067 (w), 1052 (w), 1014 (w), 966 (w), 928 (w), 900 (w), 843 (w), 816 (m), 788 (w), 749 
(w), 701 (s), 629 (m), 575 (w), 538 (w), 513 (w), 474 (w), 438 (w). 
 
4-((diphenyl(p-tolyl)methyl)amino)-1-methyl-1H-imidazole-2-carboxylic acid (3): 
Mtt-Im-OMe (13, 423 mg, 1.03 mmol) was dissolved in MeOH (3.4 mL), 1 M KOH 
(aq, 1.7 mL) added and the reaction mixture stirred for 20 h at rt. At 0 °C, it was 
acidified until pH 4 with 10% AcOH (aq). The product was extracted with CHCl3 (4 x 
50 mL), washed with 10% AcOH (3 x 50 mL) and the combined organic layers dried over MgSO4. The 
solvent was removed to yield Mtt-Im-OH (3, 368 mg, 0.93 mmol, 90%) as pale yellow solid. Rf = 
0.51(CH2Cl2/MeOH / NEt3 100:10:1). 
1
H-NMR (300 MHz, CDCl3, δ): 8.43 (br s, 1H, NH), 7.41 -7.34 
(m, 4H, CHarom.), 7.27 – 7.16 (m, 8H, CHarom.), 7.07 – 7.00 (m, 2H, CHarom.), 4.87 (s, 1H, CH-1), 3.65 (s, 
3H, CH3-2), 2.28 (s, 3H, CH3-Mtt). 
13
C-NMR (75 MHz, CDCl3, δ): 158.9 (C=O), 144.7 (2C, Cq), 141.4 
(Cq), 139.6 (Cq), 136.5 (Cq), 133.7 (Cq), 129.3 (6C, CH), 128.6 (2C, CH), 127.8 (4C, CH), 126.9 (2C, 
CH), 104.0 (CH), 71.6 (Cq), 34.9 (CH3), 21.1 (CH3). HRMS-ESI
+
 (m/z): [M+H]+ calcd for 
C25H23N3O2H, 398.1863; found, 398.1865. FT-IR (neat) ṽ = 3167 (w), 2921 (w), 1628 (m), 1534 (w), 
1511 (w), 1492 (w), 1444 (w), 1322 (m), 1186 (w), 1159 (w), 1123 (w), 1094 (w), 1070 (w), 1031 (w), 





carboxamido)-1-methyl-1H-imidazole-2-carboxylate (33): To a solution of 
nitro-PyIm-OMe (300 mg, 0.98 mmol) in MeOH (7.0 mL) and DMF (0.5 mL), 
Pd/C (10% dry, 100 mg, 33% w/w) was added and the mixture stirred under 
hydrogen atmosphere for 6.5 h. The catalyst was removed by filtration through 
celite and the solvent removed under reduced pressure. The residue was dissolved in DMF (1.8 mL), 
and DIPEA (268 µL, 1.54 mmol) was added. At 0 °C, Mtt-Cl (220 mg, 0.75 mmol) dissolved in DMF 
(1.2 mL) and DIPEA (137 µL, 0.79 mmol) was added dropwise over 10 min. The reaction was stirred 
at rt for 15.5 h and the solvent removed under reduced pressure. The crude was purified by column 
chromatography (silica, CH2Cl2/NEt3 100:1) to yield the desired product (33, 323 mg, 0.61 mmol, 62%) 
as pale yellow solid. Rf = 0.33 (n-pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, CDCl3, δ): 7.44 (s, 1H, CH-
4), 7.43 -7.39 (m, 4H, CHarom.), 7.31 – 7.27 (m, 2H, CHarom.), 7.25 – 7.20 (m, 4H, CHarom.), 7.17 – 7.13 
(m, 2H, CHarom.), 7.07 – 7.03 (m, 2H, CHarom.), 6.21 (d, 1H, J = 2.0 Hz, CH-2), 5.72 (d, 1H, J = 2.0 Hz, 
CH-1), 3.95 (s, 3H, CH3-5), 3.88 (s, 3H, CH3-6), 3.56 (s, 3H, CH3-3), 2.28 (s, 3H, CH3-Mtt). 
13
C-NMR 
(75 MHz, CDCl3, δ): 161.0 (C=O), 160.2 (C=O), 147.6 (2C, Cq), 144.4 (Cq), 138.6 (Cq), 137.1 (Cq), 
133.2 (Cq), 132.8 (Cq), 130.3 (6C, CH), 129.2 (2C, CH), 128.5 (4C, CH), 127.4 (2C, CH), 122.4 (Cq), 
119.9 (CH), 116.7 (CH), 107.4 (CH), 73.2 (Cq), 52.6 (CH3), 36.4 (2C, CH3), 21.0 (CH3). HRMS-ESI
+
 
(m/z): [M+Na]+ calcd for C32H31N5O3Na, 556.2319; found, 556.2317. FT-IR (neat) ṽ = 3322 (w), 3054 
(w), 3022 (w), 2927 (w), 2851 (w), 1711 (m), 1650 (m), 1559 (w), 1528 (m), 1456 (w), 1431 (s), 1401 
(w), 1368 (w), 1301 (w), 1274 (m), 1247 (w), 1215 (w), 1187 (w), 1124 (s), 1104 (w), 1055 (w), 1017 
(w), 895 (w), 839 (w), 817 (w), 753 (m), 701 (s), 658 (w), 629 (w), 589 (w), 511 (w), 442 (w). 
 
4-(4-((diphenyl(p-tolyl)methyl)amino)-1-methyl-1H-pyrrole-2-
carboxamido)-1-methyl-1H-imidazole-2-carboxylic acid (4): Mtt-PyIm-
OMe (287 mg, 0.55 mmol) was dissolved in 1,4-dioxane (14 mL) and 1 M LiOH 
(aq, 7 mL) and stirred for 1 h at 80 °C and 1.5 h at rt. The dioxane was removed 
under reduced pressure and the crude purified over reverse phase silica column 
chromatography (Oasis HLB cc Vac Cartridge, 30 µm particle size, Waters, USA; H2O/MeCN/NEt3 
100:0:0.1% → 50:50:0.1%). The product fractions were freeze dried to yield the desired product (4, 
242 mg, 0.47 mmol, 85%) as pale yellow solid. Rf = 0.25 (CH2Cl2/MeOH/NEt3 100:10:1). 
1
H-NMR 
(300 MHz, DMSO-d6,, δ): 10.09 (s, 1H, NH), 7.43 -7.36 (m, 4H, CHarom.), 7.31 – 7.24 (m, 6H, CHarom.), 
7.20 – 7.14 (m, 2H, CHarom.), 7.11 – 7.06 (m, 3H, CHarom., CH-4 ), 7.00 (s, 1H, CH-2), 5.40 (s, 1H, CH-
1), 5.24 (s, 1H, NH), 3.90 (s, 3H, CH3-5), 3.50 (s, 3H, CH3-3), 2.25 (s, 3H, CH3-Mtt). 
13
C-NMR 
(75 MHz, DMSO-d6,, δ): 161.7 (C=O), 158.2 (C=O), 146.1 (2C, Cq), 143.0 (Cq), 140.4 (Cq), 135.2 (2C, 
Cq), 131.0 (Cq), 128.8 (4C, CH), 128.7 (2C, CH), 128.2 (2C, CH), 127.5 (4C, CH), 126.2 (2C, CH), 
121.4 (Cq), 116.0 (CH), 109.8 (CH), 106.5 (CH), 71.0 (Cq), 35.7 (CH3), 34.2 (CH3), 20.5 (CH3). HRMS-
ESI
+
 (m/z): [M+Li]+ calcd. for C31H29N5O3Li, 526.2426; found, 526.2423. FT-IR (neat) ṽ = 3324 (w), 
3054 (w), 3022 (w), 2928 (w), 1622 (w), 1574 (w), 1538 (w), 1461 (w), 1427 (s), 1404 (w), 1345 (m), 
1309 (w), 1253 (w), 1217 (w), 1185 (w), 1156 (w), 1105 (w), 1054 (w), 1029 (w), 898 (w), 846 (w), 
813 (w), 753 (m), 702 (s), 663 (w), 632 (w), 587 (w), 508 (w). 
 
4-((diphenyl(p-tolyl)methyl)amino)butanoic acid (5): Methyl 4-aminobutyrate 
hydrochloride (300 mg, 1.95 mmol) was suspended in DMF (4.5 mL) and DIPEA 
(678 µL, 3.89 mmol). At 0 °C, Mtt-Cl (520 mg, 1.78 mmol) dissolved in DMF 
(1.5 mL) and DIPEA (618 µL, 3.55 mmol) was added dropwise over 5 min. After 12.5 h at rt, the solvent 
was removed under reduced pressure and the crude purified by column chromatography (silica, 
CH2Cl2/NEt3 100:1). The product was dissolved MeOH (6.0 mL) and 1 M KOH (aq, 3 mL) and stirred 
at 60 °C for 3 h. The reaction mixture was extracted with n-pentane (3 x 50 mL), MeOH was removed 
from the aqueous phase under reduced pressure and this phase acidified with 20% AcOH (aq) until pH 
4. It was extracted with EtOAc (6 x 50 mL), washed with brine and dried over MgSO4. The solvent was 
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removed to yield the desired product (5, 581 mg, 1.62 mmol, 83%) as colourless solid. Rf = 0.18 (n-
pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, CD3OD, δ): 7.42 -7.32 (m, 10H, CHarom.), 7.29 – 7.20 (m, 
4H, CHarom.), 2.73 (t, 2H, J = 6.3 Hz, CH2-1), 2.45 – 2.38 (m, 2H, CH2-3), 2.35 (s, 3H, CH3-Mtt), 1.90 
– 1.80 (m, 2H, CH2-2). 
13
C-NMR (75 MHz, CD3OD, δ): 179.5 (C=O), 142.9 (2C, Cq), 139.6 (Cq), 139.3 
(Cq), 130.1 (2C, CH), 130.0 (2C, CH), 129.8 (4C, CH), 129.5 (4C, CH), 129.1 (2C, CH), 74.8 (Cq), 46.2 
(CH2), 35.4 (CH2), 24.3 (CH2), 21.0 (CH3). HRMS-ESI
+
 (m/z): [M+Na]+ calcd for C24H25NO2Na, 
382.1778; found, 382.1787. FT-IR (neat) ṽ = 3022 (w), 2920 (w), 2852 (w), 1707 (w), 1562 (w), 1490 
(w), 1446 (m), 1403 (w), 1311 (w), 1190 (w), 1158 (w), 1103 (w), 1031 (w), 1002 (w), 905 (w), 813 
(w), 751 (m), 702 (s), 637 (w), 613 (m), 571 (w), 533 (w), 496 (w). 
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NMR and IR spectra of new compounds  
 
Figure S1: 1H-NMR (300 MHz) spectrum of Mtt-Py-OMe (11). 
 










Figure S3: COSY-NMR (300 MHz) spectrum of Mtt-Py-OMe (11). 
 
 
Figure S4: HSQC-NMR (300 MHz, 75 MHz) spectrum of Mtt-Py-OMe (11). 
187 
 
Figure S5: HMBC-NMR (500 MHz, 125 MHz) spectrum of Mtt-Py-OMe (11). 
 
 





Figure S7: 1H-NMR (300 MHz) spectrum of Mtt-Py-OH (2). 
 
 







Figure S9: COSY-NMR (500 MHz) spectrum of Mtt-Py-OH (2). 
 
 
Figure S10: HSQC-NMR (500 MHz, 125 MHz) spectrum of Mtt-Py-OH (2). 
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Figure S11: HMBC-NMR (500 MHz, 125 MHz) spectrum of Mtt-Py-OH (2). 
 
 





Figure S13: 1H-NMR (300 MHz) spectrum of Mtt-Im-OMe (13). 
 
 










Figure S15: COSY-NMR (300 MHz) spectrum of Mtt-Im-OMe (13). 
 
 
Figure S16: HSQC-NMR (300 MHz, 75 MHz) spectrum of Mtt-Im-OMe (13). 
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Figure S17: HMBC-NMR (500 MHz, 125 MHz) spectrum of Mtt-Im-OMe (13). 
 
 




Figure S19: 1H-NMR (300 MHz) spectrum of Mtt-Im-OH (3). 
 
 









Figure S21: COSY-NMR (300 MHz) spectrum of Mtt-Im-OH (3). 
 
 




Figure S23: HMBC-NMR (500 MHz, 125 MHz) spectrum of Mtt-Im-OH (3). 
 
 




Figure S25: 1H-NMR (500 MHz) spectrum of Mtt-PyIm-OMe (33). 
 
 


















Figure S27: COSY-NMR (500 MHz) spectrum of Mtt-PyIm-OMe (33). 
 
 
Figure S28: HSQC-NMR (500 MHz, 1255 MHz) spectrum of Mtt-PyIm-OMe (33).  
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Figure S29: HMBC-NMR (500 MHz, 125 MHz) spectrum of Mtt-PyIm-OMe (33). 
 
 




Figure S31: 1H-NMR (300 MHz) spectrum of Mtt-PyIm-OH (4). 
 
 









NH CH-2 NH 
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Figure S33: COSY-NMR (500 MHz) spectrum of Mtt-PyIm-OH (4). 
 
 




 Figure S35: HMBC-NMR (500 MHz, 125 MHz) spectrum of Mtt-PyIm-OH (4). 
 
 



















Figure S39: COSY-NMR (500 MHz) spectrum of Mtt-γ-OH (5). 
 
 
Figure S40: HSQC-NMR (500 MHz, 75 MHz) spectrum of Mtt-γ-OH (5).  
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Figure S41: HMBC-NMR (500 MHz, 75 MHz) spectrum of Mtt-γ-OH (5). 
 
 
Figure S42: IR spectrum of Mtt-γ-OH (5). 
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Solid Phase Peptide Synthesis 
Both, Fmoc-SPPS and Mtt-SPPS, follow the same protocol, except the deprotection step. Further 
modifications are described below. 
The polyamide hairpins were synthesized manually in 2 mL polypropylene reactors with plunger and 
frit, (pore size 25 µm, MultiSynTech GmbH; Germany). TG R PHB resin was preloaded with Fmoc-
βAla-OH and the loading determined before further couplings. 
Loading of the first amino acid:[xix] Under inert atmosphere, TG R PHB resin (500 mg, 0.18 - 
0.23 mmol/g) was placed in a flask, covered with DMF (3.0 mL) and swelled for 30 min. In a second 
flask, under inert atmosphere, Fmoc-βAla-OH (358 mg, 1.15 mmol) was dissolved in CH2Cl2 (5.0 mL) 
and DMF (100 µL) and the solution cooled to 0 °C before adding DIC (89.0 µL, 575 µmol). After 
20 min, the solvent was removed, the residue dissolved in DMF (3.0 mL) and added to the swelled resin. 
DMAP (14.0 mg, 115 µmol) dissolved in DMF (50 µL) was added and the mixture was shaken under 
inert atmosphere for 1 h. The resin was filtered off and washed with DMF (5 x 0.5 mL), CH2Cl2 (10 x 
0.5 mL) and DMF (5 x 0.5 mL). Lutidine/Ac2O/DMF 6:5:89 (2.0 mL) was added for 5 min. The resin 
was filtered off and washed with DMF (5 x 0.5 mL) and CH2Cl2 (10 x 0.5 mL). It was dried under 
reduced pressure and the loading determined. 
Determination of the resin loading: The Fmoc-group of a weighted amount of resin (~5.00 mg), 
previously loaded with the first amino acid, Fmoc-βAla-OH, was deprotected by adding twice a solution 
of 20% piperidine in DMF (500 µL) for 5 min. The filtrates were collected and the absorbance measured 
at 300 nm (ε300nm(Fmoc) = 7800 M
-1cm-1)[xx] on a Tecan 20M Spark plate reader and the loading was 
calculated. 
 
Manual Solid Phase Protocol for Peptide Synthesis 
The amounts of reagents of the following synthesis protocol correspond to 10 µmol scale. For higher 
scales, the reagents were scaled up correspondingly. For shaking an Edmund Bühler Swip shaker was 
used.  
Swelling: 10 µmol of resin was swollen in 0.5 mL DMF for 30 min. 
Deprotection of the temporal Fmoc group: Piperidine (20% in DMF, 250 µL) was added to the resin 
and shaken for 5 min. This step was repeated, the resin filtered off and washed with DMF (5 x 0.5 mL), 
CH2Cl2 (5 x 0.5 mL) and DMF (5 x 0.5 mL). 
Deprotection of the temporal Mtt-group: TFA (2% in CH2Cl2, 250 µL) was added to the resin and shaken 
for 20 min. The resin was filtered off and washed with TFA (2% in CH2Cl2, 0.5 mL) until the washing 
solution was no longer coloured yellow. It was washed with CH2Cl2 (8 x 0.5 mL), DMF (8 x 0.5 mL) 
and the resin incubated with DIPEA (10% in DMF, 250 µL) for 5 min to neutralize remaining acid. 
Coupling of amino acids: The amino acid (4.00 eq) was dissolved in NMP (134 µL) and DIPEA (8.00 eq 
for Fmoc-amino acids and 12.0 eq for Mtt-amino acids), and HATU (4.00 eq) was added. The resulting 
solution was activated for 3 min and added to the resin. This mixture was shaken for 1 h in the case of 
Fmoc-Py-OH, Mtt-Py-OH, Fmoc-γ-OH and Mtt-γ-OH and 2 h in the case of Fmoc-Im-OH, Mtt-Im-OH, 
Fmoc-PyIm-OH, Mtt-PyIm-OH and ImPy-OH. For the introduction of the amino acids after the γ-turn, 
DMSO/NMP 1:1 (50 µL) was directly added to the coupling mixture after the corresponding coupling 
time for 30 min. The resin was filtered off and washed with DMF (5 x 0.5 mL), CH2Cl2 (5 x 0.5 mL) 
and DMF (5 x 0.5 mL). 
Capping: After coupling of each amino acid, a solution of Ac2O/pyridine/DMF 5:5:90 (250 µL) was 
added to the resin and it was shaken for 5 min. The resin was filtered off and washed with DMF (5 x 
0.5 mL), CH2Cl2 (5 x 0.5 mL) and DMF (5 x 0.5 mL). 
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Cleavage of the polyamide hairpins: The dried resin was treated with TFA/H2O 9:1 (1.0 mL) for 2 h. 
The resin was filtered off and the filtrate was added to dry ice-cold Et2O (12.0 mL). After 30 min, the 
precipitated polyamide was centrifuged, washed once with dry ice-cold Et2O, centrifuged, the 
supernatant was discarded and the polyamide pellet was dissolved in H2O/MeCN 1:1 including 0.1% 
TFA and freeze-dried. 
Characterization: The freeze-dried products were identified via analytical HPLC-MS on an Agilent 
1260 Series HPLC-system (Agilent Technologies) as described before. Electrospray Ionization Mass 
Spectrometry (ESI-MS) was performed as described before. 
 
Synthesis and Characterization Data of the Polyamides 
Unless otherwise noted, the synthesis of the polyamides was performed manually following the protocol 
described above. The purity of the polyamides was calculated from the integrated peak areas of the 
HPLC chromatograms, taken peaks with an >10% intensity to the highest peak in the chromatogram 
and is given as % for each polyamide. 
 
Im-Py-Py-Im-γ-Py-Im-Im-Py-β-COOH (35): After precipitation and lyophilisation, the crude product 
was obtained from the Fmoc-approach (35, 2.80 µmol, 28%) in form of a brown solid. The yield was 
determined spectroscopically. tR = 19.5 min (gradient 5-75% B). Purity 93%. HRMS-ESI
+
 (m/z): 
[M+2H]2+ calcd for C51H57N21O11H2, 570.7346; found, 570.7359.  
 
Figure S43: HPLC chromatogram of the crude polyamide hairpin 35 resulting from the Fmoc approach. Gradient 5-75% B. 
 
Im-Py-Py-Im-γ-Py-Im-Im-Py-β-COOH (35): After precipitation and lyophilisation, the crude product 
was obtained from the Mtt-approach (35, 1.42 µmol, 14%) in form of a brown solid. The yield was 
determined spectroscopically. tR = 19.5 min (gradient 5-75% B). Purity 83%. HRMS-ESI
+
 (m/z): 
[M+H]+ calcd for C51H57N21O11H, 1140.4625; found, 1140.4688.  
 




Synthesis of Im-Py-Py-Im-γ-Py-Im-Im-Py-β-Dp (1): 
 
Scheme S5: Reaction scheme for the formation Im-Py-Py-Im-γ-Py-Im-Im-Py-β-Dp (1) from Im-Py-Py-Im-γ-Py-Im-Im-Py-β-
COOH (35). 
Im-Py-Py-Im-γ-Py-Im-Im-Py-β-COOH (35, 2.2 mg, 1.93 µmol) was dissolved in DMF (10 µL) and 
HATU (2.9 mg, 7.72 µmol) and DIPEA (2.69 µL, 15.4 µmol) were added. The mixture was shaken for 
5 min before N,N-dimethyl-1,3-diaminopropane (0.97 µL, 7.72 µmol) was added. After shaking for 1 h 
at rt, H2O/MeCN (7:3, 1.0 mL) was added and the solution purified by preparative HPLC as described 
above. The fractions containing Im-Py-Py-Im-γ-Py-Im-Im-Py-β-Dp 1 were lyophilized to give the 
desired product (1, 0.97 µmol, 50%) as pale-brown TFA salt. The yield was determined 
spectroscopically. tR = 18.7 min (gradient 5-75% B ). Purity >95%. HRMS-ESI
+
 (m/z): [M+2H]2+ calcd 
for C56H69N23O10H2, 612.7872; found, 612.7885. 
 
 




Concentrations were measured on a Tecan Spark 20M. Values were background-subtracted. 
For the concentration determination of the ssDNAs, the purchased lyophilized DNA was dissolved in 
milli-Q water. Their molar extinction coefficients were determined by using the following formula:[xxi] 
 
𝜀260𝑛𝑚 = {(8.8 ∗ #𝑇) + (7.3 ∗ #𝐶) + (11.7 ∗ #𝐺) + (15.4 ∗ #𝐴)} ∗  0.9 ∗  10
3 𝑀−1𝑐𝑚−1     (S1) 
 
In the formula # = number of nucleobases determined throughout the DNA sequence, T = thymine, C = 
cytosine, G = guanine, A = adenine. Table S1 summarizes the sequences and the determined extinction 
coefficients of the ssDNAs.  
To form the duplex DNAs, equimolar amounts of the complementary ssDNAs were heated to 95 °C for 
10 min and slowly cooled down to room temperature. Hybridized duplex DNAs serve the target 
sequence (dsDNAAGCCGT) and a single mismatch duplex DNA (dsDNAAGCTGT). The mismatch is marked 
in bold and red. 
 
Table S1. Binding sites, sequences and extinction coefficients of ssDNA, which were used as hybridized duplexes for thermal 
melting analysis. 
DNA binding site sequence (5’ – 3’) extinction 
coefficient at 
260 nm 
ssDNAAGCCGT AGCCGT GGTAGCCGTACC 111960 M
-1 cm-1 
ssDNAACGGCT ACGGCT   GGTACGGCTACC 111960 M
-1 cm-1 
ssDNAAGCTGT AGCTGT GGTAGCTGTACC 113310 M
-1 cm-1 
ssDNAACAGCT ACAGCT GGTACAGCTACC 115290 M
-1 cm-1 
 





Thermal Melting Analysis 
Thermal melting analysis was performed for duplex DNAs serving the target sequence of polyamide 1 
and the target sequence with a single mismatch alone and together with the polyamides. The represented 
data in table S2 shows the calculated mean from three independent measurements and their 
corresponding standard deviations. To calculate the melting temperature, the plots of the thermal melting 
temperature from figure S46 were fitted by applying the Boltzmann equation in the plotting program 
Origin. The figure shows the corresponding normalized thermal melting curves with their standard 
deviations.  
 
Table S2. Melting temperatures of DNA hairpins with and without polyamide hairpins. Represented data are mean values and 
their standard deviation calculated from three independent experiments. 
DNA polyamide Tm ∆Tm 
dsDNAAGCCGT - 36.2 ± 0.3 °C  
dsDNAAGCCGT polyamide 1 42.8 ± 0.6 °C 6.6 °C 
dsDNAAGCTGT - 30.9 ± 0.2 °C  












Figure S46: Melting curves of a 1 µM duplex dsDNA solution in 10 mM NaH2PO4 pH 7.4: 5′-GGTAGCCGTACC-3′ without 
(a) and with (b) addition of 1.2 µM polyamide 1 and 5′-GGTAGCTGTACC-3′ without (c) and with (d) addition of polyamide 
1. Represented data is the mean of three independent measurements including their standard deviation.  
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Stability of the Mtt-building blocks 
For the study of the stability of the Mtt-building blocks via NMR, a solution of 5 mg of Mtt-Py-OMe 
(11) or Mtt-Im-OMe (13) was dissolved in 0.6 mL CDCl3 containing different amounts of TFA to give 
a 12.6 mM solution. Their 1H-NMR spectra was measured 3 min after dissolving the corresponding 
compound and the chemical shifts of the Mtt-methyl group were compared, as this signal shows the 
largest difference upon Mtt-deprotection. Figure 2, S47 and S48 show the comparison of the Mtt-lability 
between protected pyrrole and imidazole. Figure S49 presents the HSQC spectra of Mtt-Py-OMe (11) 








Figure S48: 1H-NMR spectra (300 MHz) of Mtt-Im-OMe (13) in CDCl3 at different TFA concentrations. 
 
 
Figure S49: HSQC-spectra (300 MHz, 75 MHz) of Mtt-Py-OMe (11) in CDCl3 including 2% TFA. The methyl signal of the 
shifted Mtt peak is marked with a circle. 
 
To explain the lowfield shift and the broadening of the signals, the 1H-NMR spectra of 5 mg Mtt-Cl as 
a reference compound in 0.6 mL CDCl3 and increasing amounts of TFA were recorded and are shown 
in figure S50. Figure S51 – S56 show the HSQC, HMBC and APT-spectra of 19 mg Mtt-Cl in 0.6 mL 




Figure S50: 1H-NMR spectra (300 MHz) of Mtt-Cl in CDCl3 at different TFA concentrations. 
 
 
Figure S51: APT-NMR spectra (300 MHz) of Mtt-Cl in CDCl3 without addition of TFA. 
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Figure S52: HSQC-NMR spectra (300 MHz) of Mtt-Cl in CDCl3 without addition of TFA. 
 
 




Figure S54: APT-NMR spectra (300 MHz) of Mtt-Cl in CDCl3 including 5% TFA. 
 
Figure S55: HSQC-NMR spectra (300 MHz) of Mtt-Cl in CDCl3 including 5% TFA. 
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Figure S56: HMBC-NMR spectra (300 MHz) of Mtt-Cl in CDCl3 including 5% TFA. 
 
Figure S57 represents the APT-spectra of a 5% TFA solution in CDCl3. 
 
Figure S57: APT-NMR spectra (300 MHz) of 5% TFA in CDCl3.  
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Additional Experiments 
Further experiments were performed to prove the formation of Mtt-butyrolactam (36) and optimize the 
coupling conditions to implement Mtt-γ-OH (5). 
 
Synthesis of Mtt-butyrolactam (36) 
 
 
Scheme S6: Reaction scheme for the formation of Mtt-butyrolactam (36) from Mtt-γ-OH (5). 
 
1-(diphenyl(p-tolyl)methyl)pyrrolidin-2-one (36): Mtt-γ-OH (50.0 mg, 139 nmol) and HATU 
(52.9 mg, 139 nmol) were dissolved in EtOAc (500 µL) and DIPEA (73 µL, 419 nmol) added. After 
10 min at rt, the solvent was removed under reduced pressure and the crude purified by column 
chromatography (silica, CH2Cl2/NEt3 100:1 and n-pentane/EtOAc 2:1) to yield the desired product (36, 
30.2 mg, 88.4 nmol, 64%) as colourless solid. Rf = 0.42 (n-pentane/EtOAc 1:1). 
1
H-NMR (300 MHz, 
CDCl3, δ): 7.30 -7.17 (m, 10H, CHarom.), 7.16 – 7.06 (m, 4H, CHarom.), 3.46 (t, 2H, J = 6.8 Hz, CH2-3), 
2.37 (t, 2H, J = 8.0 Hz, CH2-1), 2.30 (s, 3H, CH3-Mtt), 2.11 – 1.97 (m, 2H, CH2-2). 
13
C-NMR (75 MHz, 
CDCl3, δ): 178.2 (C=O), 144.3 (2C, Cq), 141.3 (Cq), 137.8 (Cq), 130.8 (2C, CH), 130.7 (4C, CH), 129.1 
(2C, CH), 128.5 (4C, CH), 127.8 (2C, CH), 75.0 (Cq), 51.6 (CH2), 34.2 (CH2), 20.9 (CH3), 19.8 (CH2). 
HRMS-ESI
+
 (m/z): [M+H]+ calcd for C24H23NOH, 342.1852; found, 342.1862. FT-IR (neat) ṽ = 3020 
(w), 2966 (w), 2874 (w), 1692 (s), 1509 (w), 1491 (w), 1443 (w), 1389 (m), 1319 (w), 1282 (w), 1259 
(m), 1190 (w), 1159 (w), 1121 (w), 1086 (w), 1022 (w), 945 (w), 929 (w), 906 (w), 804 (m), 761 (w), 












Figure S58: 1H-NMR (300 MHz) spectrum of Mtt-butyrolactam (36). 
 
 




Figure S60: COSY-NMR (500 MHz) spectrum of Mtt-butyrolactam (36). 
 
 
Figure S61: HSQC-NMR (500 MHz, 75 MHz) spectrum of Mtt-butyrolactam (36).  
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Figure S62: HMBC-NMR (500 MHz, 75 MHz) spectrum of Mtt-butyrolactam (36). 
 
 





Test Implementation of Mtt-γ-OH 
For the introduction of Mtt-γ-OH, Mtt-Py-Im-Im-Py-β was synthesized on solid support. Figure S63 
shows the HPLC chromatogram of the successful coupling with a purity >95%. 
 
 
Figure S64: HPLC chromatogram of the test cleavage of H2N-Py-Im-Im-Py-β-COOH. Gradient 5-95% B. 
In 3 µmol scales, the Mtt group was deprotected as described above and Mtt-γ-OH (5) coupled at 0.3M 
in NMP with different coupling conditions over one hour. After washing, capping and cleavage, HPLC 
analysis revealed the coupling efficiency. Integration of the product peak (H2N-γ-Py-Im-Im-Py-β-
COOH, tR = 17.3 min) in comparison to peaks with an >10% intensity to the highest peak in the 
chromatogram let to the described coupling yields. The corresponding HPLC-chromatograms are shown 
in figure S65. 
Figure S65: HPLC chromatograms of the test couplings for the introduction of Mtt-γ-OH (5). Gradient 5-75% B. Coupling 
conditions were a) 4 eq Mtt-γ-OH, 4 eq HATU, 12 eq DIPEA; b) 4 eq Mtt-γ-OH, 4 eq HATU, 12 eq NMM; c) 4 eq Mtt-γ-OH, 
4 eq HATU, 12 eq pyridine; d) 4 eq Mtt-γ-OH, 4 eq HATU, 8 eq pyridine; e) 4 eq Mtt-γ-OH, 4 eq PyBOP, 12 eq NMM; f) 4 
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4.3.1 Conclusion 
A new toolbox of 4-methyltrityl (Mtt)-monomers and dimers was introduced for the solid phase synthesis 
of DNA-binding pyrrole and imidazole polyamide hairpins. The synthesis of these new building blocks 
was straightforward with excellent yields over two steps: 84% for Mtt-Py-OH and 68% for Mtt-Im-OH. In 
contrast, the previously reported Boc- and Fmoc-building blocks are described with lower yields (64% for 
Boc-Py-OH and 42% for Boc-Im-OH; 58% for Fmoc-Py-OH and 30% for Fmoc-Im-OH).[1,2] The utility of the 
methodology was successfully shown by the synthesis and study of a DNA-binding polyamide employing 
all Mtt-building blocks. It is orthogonal to Fmoc and will allow the implementation of base labile 
compounds and other sensitive groups in Py-Im polyamide chemistry, affording novel bifunctional 
polyamide conjugates. 
Interestingly, in the context of my thesis, whereas the ortho-fluoroazobenzene moiety is not stable under 
Fmoc-deprotection conditions,[3] our new monomers allowed the introduction of this photoswitchable 
compound into the polyamide-hairpin backbone. It will access the introduction of dynamic and spatial 
control in the level of sequence specific DNA binding in biological assays. 
 
4.3.2 Further Developments and Outlook 
Having the Mtt-monomers in hand, we aimed to apply this toolbox to expand the photoswitchable DNA 
binders based on netropsin (chapter 4.2) to sequence-specific polyamide hairpins. A sequence which 
targets the α-satellite nucleosome was chosen to serve as a scaffold to introduce the ortho-
fluorazobenzene in the turn of the hairpin. Successful solid phase synthesis and purification yielded the 
polyamide hairpin represented in Figure 4.3.1.  
 
 
Figure 4.3.1. Structure of the first described photoswitchable polyamide hairpin C1. The sequence was chosen to 
target the α-satellite nucleosome. 
 
Analytical data and a Figure of the RP-HPLC chromatogram, including the mass spectra of the 
photoswitchable polyamide hairpin (Figure 4.3.2) are given below: 
HRMS-ESI+ (m/z): [M+2H]2+ calcd for C67H77F4N23O12H2, 736.8107; found, 736.8107; tR = 13.6 min (trans), 
15.2 min (cis) (gradient 25-40% B). 






Figure 4.3.2. a) RP-HPLC chromatogram of photoswitchable polyamide hairpin C1. Gradient 25-40% B. b) ESI 
spectrum of C1. 
 
The isomerization of the synthesized visible-light switch was studied in H2O / MeCN 1:1 via HPLC and UV-
vis spectroscopy. Both techniques displayed that the photostationary state after 30 s irradiation at 
405 nm for the trans-isomer and after 2 min irradiation at 520 nm for the cis-isomer was reached. HPLC 
analysis demonstrated the dark stability of both forms for up-to at least 11 h (Figure 4.3.3), which turns 






Figure 4.3.3. RP-HPLC chromatograms of F4Azo-polyamide hairpin (C1) showing the dark stability at 20 °C after 
irradiation at a) 405 nm for 30 s and b) 520 nm for 2 min and their corresponding trans/cis-ratio after several time 
points. Gradient 25 – 40% B. Represented data are a representative one of three measurements from independent 
experiments. 
 
By UV-vis spectroscopy, the isosbestic point at 272 nm could be determined (Figure 4.3.4 A) and the 
difference in the absorbance spectra of the two isomers could be shown, which are in agreement with 
the spectra of ortho-fluorazobenzenes from the literature.[4] Subsequent changes of the spectra were 
observed upon stepwise irradiation of the different wavelengths (Figure 4.3.4 B and C) and stability of at 
least 13 cycles could be verified (Figure 4.3.4 D). 












Figure 4.3.4. UV-vis spectra of a 7.0 µM solution of F4Azo-polyamide hairpin (C1) in H2O / MeCN 1:1 after irradiation 
at a) 405 nm for 30 s (blue) and 520 nm for 2 min (green), b) initially irradiated at 405 nm for 30 s and after successive 
irradiation times at 520 nm, c) initially irradiated at 520 nm for 10 min and after successive irradiation times at 
405 nm, d) reversible photochromism upon altering irradiation at 520 nm and 405 nm measured at 299 nm. 
Represented data are the calculated mean from three measurements from independent experiments. 
 
Additional developments will show the exact binding mode of both isomers and their difference in 
binding towards DNA targets. Within a collaboration with Gonzalo Jiménez-Osés and Claudio Navo 
Najera (CICbioGUNE, Spain), molecular dynamics (MD) simulations for the nucleosomal DNA sequence 
(5’-AAA AGTGTA TTT-3’) in the absence and in the presence of several polyamide ligands were 
performed. The studied polyamides had the same sequence than compound C1, but bear different 
photoswitches in their turn-unit. As seen in Figure 4.3.5, it could be observed that the ligand without 
photoswitch (no photoswitch) would show the highest affinity without disturbing the native structure of 
DNA too much. The F4Azo-derivative would display high affinity, but the DNA structure was not 
conserved, especially in the surrounding of the photoswitch due to steric hindrance. The hemithioindigo-
derivative showed very few constructive interactions and low affinity, but disrupted the DNA structure. 
Finally, the diarylethene derivative shows a reasonable binding energy, but effects the native structure 
of the DNA.  
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Figure 4.3.5. Conformational ensembles for each complex show 20 superimposed representative snapshots derived 
from the trajectories (1000 ns). DNA backbone and bases are shown as an orange cartoon and colored lines, 
respectively. A: blue, T: yellow, G: green, C: red. Ligand is shown as turquoise lines. Nonpolar hydrogens have been 
omitted for clarity. The binding energies (ΔGbinding) were estimated using Molecular Mechanics and the Generalized 
Born model with surface area continuum solvation (MM/GBSA).  
 
New photoswitchable polyamide hairpins could allow specific real time manipulation of many DNA based 
processes such as replication, DNA repair or nucleosome based epigenetic phenomena. We envision to 
apply our system in the control of specific epigenetic processes.  
 
4.3.3 Author Contribution 
I synthesized all described Fmoc-monomers and dimers and established their use to access polyamide 
hairpins. The synthesis of the Mtt-building blocks and their stability studies in solution were conducted 
by myself. I could further demonstrate their applicability in solid phase synthesis and their orthogonality 
to Fmoc-SPPS towards the synthesis and study of a DNA-binding polyamide hairpin. I applied the Mtt-
building blocks to synthesize a photoswitchable polyamide. Moreover, I purified and studied the 
photoisomerization of the polyamide by HPLC and UV-vis spectroscopy. Abbas Sajediabkenar (AK 
Vázquez) synthesized some starting materials during his master thesis under my guidance. Gonzalo 
Jiménez-Osés and Claudio Navo Najera performed MD-simulations. Jun.-Prof. Dr. Olalla Vázquez had the 
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4.4 Spicing up an Interdisciplinary Chemical Biology Course with the 






We describe an integrative chemical biology course focused on epigenetics that strives to bring the 
research culture to chemistry and biology Master’s students. The course combines three modules: 
lectures, discovery-based research lab and science communication. Importantly, the outline of our 
course design could be easily adapted to different fields, improving the synergy between research and 
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The complexity of the world’s current grand challenges demands interdisciplinary approaches. The 
education of future scientists must cross the silos of the traditional disciplines; however, there is 
still a strong reluctance to tear such walls down. Here, we describe an integrative chemical biology 
course focused on epigenetics that strives to bring research culture to chemistry and biology 15 
Master’s students. The course, which has been successfully implemented for the past two years, 
combines three modules: lectures, discovery-based research lab and science communication. 
Importantly, the outline of our course design could be easily adapted to different fields, improving 
the synergy between research and teaching in our universities. 
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The study of chemistry is not only for learning chemical concepts, but using them as analytical 
and predictive tools in new situations. Such skills may become even more imperative in the 
interdisciplinary subjects, where contexts change, but the required techniques remain the same. 30 
Interdisciplinary teaching in STEM1,2,3,4,5,6 has been demonstrated to be important for providing 
students with more authentic environments and preparing them for coping with their current 
global challenges.7,8 Accordingly, the number of teaching lab experiments that highlight the 
interplay of multiple disciplines is increasing.9,10,11,12,13,14,15 However, high-level chemistry 
education often remains bound to traditional disciplinary divisions. This lack of interdisciplinary 35 
interactions is evidenced by the relative absence of interdepartmental teaching collaborations, 
despite a wealth of cutting-edge research at the interface of scientific fields. Unfortunately, 
segregation also occurs in laboratory and lecture courses, which often are run independently from 
each other. Traditional laboratory courses are often based on classical ¨cookbook¨ experiments, 
usually without reference to interdisciplinary perspective.16 However, educational research 40 
suggests the academic consequences may be severe.17 For example, many students of discipline-
segregated learning face significant difficulty in finding the connections between the disciplines, 
which prevents meaningful learning. These integrative abilities are crucial to achieving more in-
depth understanding for tackling cross-interdisciplinary challenges. Students should, 
consequently, experience collaborative work between disciplines during their studies, and become 45 
equipped to recognize interdisciplinary links.18 
By definition, chemical biology is an interdisciplinary pursuit toward the understanding of the 
interface of chemistry and biology. This inherently interconnected field19 has significant potential 
as a vehicle for interdisciplinary teaching. However, chemical biology teaching is challenging and 
possesses unique problems for education as it requires, concurrently, both broad and in-depth 50 
knowledge.20,21 Additionally, cultural differences between chemistry and biology departments create 
further challenges for chemical biology educational programs.22 
Here, we report the development, implementation, and evaluation of an interdisciplinary 
chemical biology course in epigenetics between Master’s students from two different disciplines 
(chemistry and biology), that aims to promote the “authentic big picture” of research and the reality 55 
of scientific practice. We have emphasized interdisciplinary collaborative work and created a 
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research experience by the integration of lessons and experiments into a genuine research project, 
which culminates with both the writing of a scientific article and the defense of a joint research 
proposal. An overview of the themes taught during the lectures, the material for the discovery-
based research lab implementation and the evaluation surveys are available in the Supporting 60 
Information. Importantly, this report is intended as a springboard for those who wish to adapt and 
implement interdisciplinary education in their courses. 
CONTEXT AND MOTIVATION 
Our course offers a chemical biology approach to epigenetics. Epigenetics is broadly defined 
as the study of heritable or possibly-heritable variations in gene expression unrelated to changes in 65 
the DNA sequence. Thus, while the genome — the sequence of the DNA — is the blueprint for life, it 
is ultimately epigenetics that influences cell diversity and strongly controls gene expression. These 
changes occur by regulation of chromatin23 via chemical modifications of the DNA and histone 
proteins (histone language24,25,26). Misregulation of epigenetic processes has been linked to many 
disease areas.27 Traditionally, this field has been studied just from a purely biological perspective, 70 
but now its chemical potential has become evident, and consequently, it has emerged as a 
bountiful topic for chemical biologists.28 The fundamental building block of chromatin is the 
nucleosome. This consists of an approximately 150 base pair (bp) DNA chain wrapped in 1.7 left-
handed superhelical turns around a histone protein octamer. Beyond the structural and protective 
functions of the nucleosome, it also plays a dynamic role in epigenetic regulation.29 Hence, the 75 
nucleosome represents an epigenetic target of great potential. In the last decade, a handful of small 
molecules have accessed and targeted the nucleosomal DNA successfully.30,31 Particularly, the 
sequence-specific DNA binders: pyrrole-imidazole polyamides interact with the nucleosome32,33 and 
can control epigenetic processes.34 Apart of inhibition of DNA methylation35 which causes major 
epigenetic changes, polyamide hairpins have been used as nucleosomal clamps32 connecting two 80 
aligned minor grooves. They have further been used as cyanine dye-polyamide conjugates in 
fluorescence studies, such as Förster Resonance Energy Transfer (FRET) on the nucleosome.33 
Recently polyamides conjugated small-molecules like JQ-136 and acetyl lysine mimetics34 have 
allowed to recruit epigenetic proteins. 
Epigenetics was judiciously chosen as the course topic due to its appeal for both disciplines, and 85 
their differing approaches to the subject matter. Additionally, this topic has been under-researched 
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from both a chemistry and biology educational perspective.37,38,39 This theme expediently marries 
our desired to foster reciprocal cross-talk with models that support (and reward) scientists who 
excel simultaneously in teaching and research.40 Finally, the approach of DNA targeting with 
polyamides is applicable to numerous targets other than the nucleosome,41 and to our knowledge, 90 
has never been explored in the context of education, despite its high potential. 
COURSE DESIGN 
Learning Objectives  
The course was envisioned to engage students in authentic research environment. Therefore, 
upon its completion, they will have gained skills in chemical biology (solution / solid phase 95 
synthesis; spectroscopy; electrophoresis; PCR and HPLC) and combined their experimental results 
into a scientific article as well as designed their own research project in epigenetics. Furthermore, 
the students will gain appreciation for the importance of interdisciplinary research.  
Student population 
This course was designed for chemistry and biology Master’s students. The participants were all 100 
from different educational backgrounds and none participated in interdisciplinary discovery-based 
research or science communication courses before. 
Implementation 
The newly-designed course was instituted at Philipps-Universität Marburg as part of the 
chemistry and biology curricula with two cohorts during the 2016/2017 and 2017/2018 winter 105 
semesters (Table 2). 
Table 2. Cohorts of students during the courses. 
Cohort ETCS Total  
students 
m f chem bio ChemBio 
experience 
2016 9 10 7 3 7 3 6 
2017 9 11 3 8 4 7 4 
m = male, f = female, chem = chemistry Master’s student, bio = 
biology Master’s student; ECTS = European Credit Transfer 
System, 1 ECTS equaling 30 study hours; ChemBio experience = 
students who had participated in an introductory undergraduate 
chemical biology lecture.   
 
The shared structure, timeline specifying the face-to-face hours per week, assignment, 
outcomes, and evaluation of both cohorts are illustrated in Figure 1 and specified in Table S1-S4. 
The course comprised three different types of teaching modules: 1) lectures, 2) discovery-based 110 
research lab, and 3) a scientific communication workshop, instructed by a lecturer and a teaching 
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assistant from the chemical biology division. In each week of the lab section and for the proposal, 
we always try to mix biologists and chemists in a group and formed new groups after each week. It 
lasted 14 weeks from which, the final 4 weeks were dedicated to the individual writing of the article 
and preparing the proposal poster in groups. 115 
 
Figure 1. Timeline of the course divided in clusters of 1) lectures; 2) discovery-based research lab, and 3) scientific communication. The 
detailed topics of the lectures and workshop can be found in Box 1 and Table S2, respectively. In addition, assignments, outcomes and 
the time points where the students received feedback or were evaluated are included. NoSP = nature of the scientific practice. The 
smileys represent new group formations, the star indicates an individual assignment and green circles group assignment. 120 
 
Lectures containing integrated technology37 and supported by active learning pedagogies42 (10% 
course time): initially, we started the course with a formative assessment of students’ 
preconceptions in organic chemistry and their perspective of the nature of scientific practice to 
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tailor the lectures accordingly. During these first units, students were exposed to the basics of 125 
epigenetics and chemical biology concepts as listed in Box 1 (Fig 2) using a variety of direct 
interactive teaching resources and peer-instruction activities to maintain cooperation between 
students and increase team-working skills. 
 
Figure 2. Box containing the course material covered during the lectures. 130 
 
Discovery-based research lab (50% course time): this research-inspired lab section was 
organized as a two-week block. Unlike typical laboratory courses, the idea was to explore an 
authentic research project with a clear overarching goal: “the design, synthesis, and study of 
pyrrole-imidazole polyamides as potential nucleosome binders” (Fig 3, Table S5). Thus, the first 135 
three steps of the Fmoc-building blocks were synthesized and the final pyrrole and imidazole 
monomers (supplied by the instructors) were then assembled in solid phase synthesis to yield 
polyamide hairpins. In parallel, nucleosomes were assembled from free DNA and histone octamers 




- Chemical biology versus biochemist-
try 
- Genetics versus epigenetics 
L2: Reminder  
- Basic concepts under a chemical 
biology perspective: resonance, 
specific biological interactions, 
tautomerism, PCR, DNA, proteins, 
nucleophilicity, pKa, arrow pushing 
mechanisms 
L3: Chromatin 
- Chromatin architecture 
- Tailored chromatin in the lab 
L4: Histone Language 
- Post-translational modifications 
- Readers, writers and erasers 
L5: DNA Bases beyond canonical base  
  pairing 
L6: Cutting-edge Examples  
- Chemical biology approaches in 
epigenetics from the literature  
  
235 
by salt gradient dialysis method. The analysis of the DNA and nucleosomal binding properties were 
performed by fluorescence intercalation displacement (FID), CD measurements and footprinting 140 
combined with capillary electrophoresis. 
 
Figure 3. Concept figure of the discovery-based research lab course aiming at the design, synthesis, and study of pyrrole-imidazole 
polyamides as potential nucleosome binders. For the nucleosome representation pdb 1M18 was used. 
 145 
Conducting a meaningful hands-on research project is central to the achievement of 
scientific literacy.43 Thus, the students worked in small groups in the laboratory (biologist/chemist 
pairs) in a project divided in two major parts per week: 1) material preparation and 2) binding 




Figure 4. Overview of the research-inspired laboratory module, which is divided in two main sections by week: week 1) material 
preparation and week 2) binding analysis. The students were divided in three different groups (A1, B1 and C1), which were formed new 
after one week (A2, B2 and C2). Each student relied on the results of all groups to individually write a scientific article.  
 
During the first week, group A1 (week 1, group A1; SI) synthesized in solution the first three steps 155 
of the building blocks needed for the solid-phase peptide synthesis (SPPS) of the polyamides. Due 
to time and safety restrictions, the final steps of the monomers were performed by the instructors 
and provided. Following a literature described synthesis,44,45 the chemistry students could deepen 
their knowledge in synthesis by performing, for instance, reactions under inert atmosphere, 
whereas the biology students gained their first hands-on experience in basic experimental 160 
techniques in organic synthesis, including column chromatography purification, extraction, rotary 
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evaporation, etc. Group B1 (week 1, group B1; SI) was in charge of SPPS of the polyamide 
hairpins.45 The chemistry and biology students developed two novel polyamide hairpins, which 
were characterized by high-performance liquid chromatography (HPLC) and electrospray ionization 
mass spectrometry (ESI-MS). Products were purified by preparative HPLC. The reagents and 165 
monomers needed were supplied by the instructors (Table S5; SI). Group C1 (week 1, group C1; SI) 
was responsible for the preparation of fluorescein (FAM)-labeled DNA by polymerase chain reaction 
(PCR) and used this to assemble nucleosomes.46 Progress and purity were controlled by gel 
electrophoresis. Afterwards, the students reported their results and difficulties in a joint seminar, 
which simulated the regular progress reports of ongoing investigations in research institutions. In 170 
addition, each student was required to keep a lab notebook throughout. During the second week, 
we altered the composition of the groups, to maximize the student interactions and increase the 
collaboration experience.47 All students were introduced to both circular dichroism (CD) and 
fluorescence intercalation displacement (FID) spectroscopy. Then groups A2 and B2 (week 2, group 
A2 and B2; SI) analyzed the binding of the synthesized polyamide hairpins to the target DNA 175 
sequence with these techniques, while group C2 (week 2, group C2; SI) assisted the instructors to 
advance in the development of a new method to study sequence-specific DNA binding on 
nucleosomesA,48,49 (further details in SI). Finally, all groups from week 2 participated in another 
progress-report presentation. All data were made available online to aid writing individual scientific 
articles, instead of using the typical university protocols. Here, it is important to highlight that the 180 
results of each individual group were essential to obtain the overall picture of the topic and 
improve precision in the paper after the laboratory course. Notably, the obtained results were new 
to both students and instructors. Student’s lab course outcomes with examples from individual 
students, as well as an exemplary scientific article are provided (Fig. 5 and “Example of a Student’s 
Scientific Article”, SI) 185 
                                               
A Due to non-published data, the protocol for group C2 is not detailed. Alternative useful references are added 




Figure 5. Front pages of exemplary articles written by students of the course (authors copy).  
 
Scientific communication workshop (40% course time): documenting data, publishing research, 
scientific argumentation, and grant writing standard are authentic practices that researchers are 190 
typically engaged in. Throughout this course, the students were exposed to all these different types 
of scientific communication. Basic notions of scientific writing (Table S2; SI) were introduced in the 
course to enable the students to identify different communication styles and develop their skills 
and confidence to write a research article. This learning was conducted as an interactive, practical 
workshop using epigenetic research papers as guiding frameworks and which led to a scientific 195 
article from the discovery-based research lab. Since in both industrial and academic scientific 
research a permanent day-to-day record of work is established via laboratory notebooks, which are 
even considered legal documents, we consequently trained the students in best practices to keep 




Figure 6. Sample of a laboratory notebook, highlighting the content (authors copy). 
 
The students were divided into small groups of three to four students to design and defend 
their own research project. To maximize the interactions, groupings were altered from the 
discovery-based research lab task, where possible. Bearing their Master’s theses in mind but with 205 
total freedom in the specific research direction (so long as it involved epigenetics) the groups 
developed proposals. During this process they needed to 1) state the general idea they wished to 
address; 2) narrow the problem down to the specific aspect to solve (literature research); 3) state 
the idea (hypothesis); 4) design and plan the experiments. Initially, to find the research gap,50 an 
interactive session based on the Pomodoro technique51,52 and under questionnaire guidance 210 
(“Questions to start the proposal”; SI) was performed. The Pomodoro technique is a time 
management technique, where 25 min working sections are strictly interrupted by short five min 
breaks. The method is based on the idea that regular breaks help to work more efficient and 
creative. In the beginning, the students compared research interests and started the literature 
search using standard academic databases such as Scifinder, over four intervals of 25 min followed 215 
by five min break. We used these five-minute interruptions to brainstorm the findings, providing 
feedback from both peers and instructors.53 We strategically introduced two of these sessions (Fig. 
7). Despite the students were not familiarized with the technique, they adapted fast and 




Figure 7. Research proposal development workflow for a poster format. Each milestones of the students: abstract, raw poster version, 
final poster and poster presentation are highlighted. Each of these milestones were evaluated by the instructors, and feedbac k was 
provided. 
 
Afterwards, each group summarized their initial ideas in an abstract-like draft. This draft 225 
underwent several iterative feedback rounds from the instructors, and then served as a basis for a 
research proposal. At the end of the course, each group presented their results as a poster (Fig. 8; 
“Poster Template”; SI and “Example of a Student’s Research Proposal Poster”; SI), followed by a 
short 15-min explanation and a longer discussion (∼30 min), where other professors from different 
disciplines were invited as referees to select the best proposal. This approach gave the groups the 230 
opportunity to hear about the projects of the other groups, exchange ideas and defend their own 





Figure 8. Example of research proposal posters designed and presented during the course (authors copy).  235 
 
As part of the course grade, the students submitted an individual scientific article for the research-
inspired lab, and an abstract and poster for the joint scientific proposal. Furthermore, they were 
also assessed on the practical work, and oral presentations during both the progress report 
seminars and poster defense.  240 
Instructor’s assessment of the student outcomes 
To assess the outcomes of the students, different criteria were used. For the laboratory part, 
reported data from the literature or analytical measures were accessible for the assessment 
(“Evaluation Criteria for Discovery-based Research Lab”; SI). For the scientific paper and the 
proposal poster, we used criteria such as the scientific content, structure, language (“Evaluation 245 
Criteria for the Scientific Communication”; SI). In addition to the examples of the student’s 
outcomes provided (Fig. 5 and Fig. 8) we include lab course outcomes (“Outcomes of the Discovery-
Based Research Lab”; SI) a student’s article (“Example of a Student’s Scientific Article”; SI), a 
students’ proposal poster (“Example of a Student’s Research Proposal Poster”; SI) and the survey 
results (“Nature of Scientific Practice Survey Results”; “Organic Chemistry Survey Results”; SI). 250 
FITTING OUR COURSE INTO THE COURSE-BASED RESEARCH EXPERIENCE MODEL (CRE) 
The benefits of embedding research experiences into formal laboratory courses has been 
demonstrated by the implementation of course-based research experiences (CREs) in both 
undergraduate (CURE)54 and graduate level.55 Along these lines, our course fulfills the five 
dimensions of a C(U)RE: science practice, discovery, broader relevance, collaboration, and iteration 255 




Table 1. Dimensions of a CRE and 
Connection to our Course.  
Item CRE  
dimension 






Introduction into new topic, 
open inquiry, collecting and 
analyzing data, using 
instruments, reporting 
results, scientific writing and 
oral skills (communication, 
abstract, argumentation, 
presentation), designing the 
research proposal. 
2 Discovery Synthesis of new molecules, 
analysis of properties, finding 
a research gap 
3 Broader  
relevance  
Application in a wider 
biological context.  
4 Collaboration Joint perspectives and 
approaches from different 
disciplines, interdisciplinary 
answer to research questions 
and data interpretation, 
students sharing all data for 
an individual assignment. 
5 Iteration Repeatedly analysis, different 
analysis validation methods, 
similar compound synthesis 
procedures, several rounds of 
feedback during the proposal 
writing. 
 
EVALUATION OF THE OVERALL COURSE EXPERIENCE 
According to our assessment criteria and the presented students’ outputs (Fig. 5; Fig. 8; 260 
“Student’s Outcome”; SI) the overall result was positive. Furthermore, to gain a deeper 
understanding of students’ experience in the class, we used a survey with open-ended and Likert 
scale questions to rate both the overall experience and each teaching module (“Evaluation Results”; 
SI). All students from both cohorts who volunteered for this study were provided with information 
about their rights and the handling of the data beforehand; informed consent was obtained from all 265 
participants. IRB (Institutional Review Board) approval is not required for studies in education at 
German universities, but the recruitment process followed ethical guideline. We ensured that 
students could opt out at any time during data collection and that their privacy and rights were 
protected at any time. Students’ consent included the use of their data (survey answers, interview 
transcripts), including their written work, for research and publication purposes. Interviews were 270 
conducted in German and consequently, translated for this publication. Since nothing was 
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changed between the courses, we combined the evaluations of both cohorts to provide a more 
realistic impression.  
The survey’s results showed that the course was evaluated very positively (Fig. 9): 86% of the 
students rated our new interdisciplinary course as “excellent”, “very good”, or “good”. Notably, no 275 
students rated the course as “very poor”. A deeper analysis of each separate course module 
(“Evaluation Results”; SI) revealed an overall positive impression throughout all the sections. 
Engagement was deemed particularly high: all students rated it as “excellent”, “very good” or 
“good”. The lab sessions (76%), the assignments (81%), the communication (86%), the proposal 
project work (81%), the poster presentation (86%) and the lectures (91%) were also rated highly 280 
positive in the three highest categories. 
 
Figure 9. Students’ opinions of the whole course. 
 
Student perception of the course 285 
In addition to the above evaluation of the course, the positive outcomes were further 
highlighted by answers to open-ended questions (“Evaluation Results”; SI), and post-course 
interviews with some student volunteers. The students described all sections of the course as 
having a positive learning effect. Compared to standard courses, our students appreciated the 
possibility to include their own ideas and felt their effort was valuable. By performing a “real-world 290 
project” (“Evaluation Results”, 14g; SI) they described feeling like an actual scientist. Furthermore, 
the focus on collaboration served as a basis for a productive and friendly working environment. 
Many students highlighted the interaction with students from a different discipline, especially 
during the research proposal. The “power of interdisciplinary” (“Evaluation Results”, 12b; SI) and 
the synergistical integration of biology and chemistry was found to be valuable for future scientific 295 
approaches. This overall positive impression of interdisciplinary work was, additionally highlighted 
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in the three post interviews that we conducted with three students from the 2016 cohort. In 
particular, the students emphasized the positive and open culture between students and 
instructors. Even the biology students, who were sometimes felt overwhelmed by synthesis during 
the lab section, experienced an open-minded collaborative group work that helped them to become 300 
confident in their skills, as shown in the following explanation of a biology student, talking about 
her most valuable moment of the course: 
“Organic synthesis is a bit dirtier than normal synthesis (laughs). I was not prepared for this. I 
thought it might be easier for me to adapt to this situation, because lab is lab, but it wasn’t like that. 
(pause) But the good thing was that I had a chemist in my group and I was just asking him a lot of 305 
questions […] at the end, the last few days, I could do it on my own. When I was unsure, I could 
always ask […] That was different to what I was used to. But now I know that in the future, I could 
do a synthesis, and if I have problems, I can just ask somebody who knows it better (laughs).” 
This collaborative interdisciplinary aspect and the value of having biologists and chemists 
together in a group became apparent when in students’ open-ended answer in the survey, when 310 
they described their process of collecting ideas and writing their proposal. The students valued 
learning about the structure of scientific publications, the use of keywords, and the methodology to 
present their work. Some of them stated that the course improved their self-confidence (“Evaluation 
Results”, 13; SI). Time management was mentioned by some of the students as the most 
challenging part of the course. Importantly, this was not negatively evaluated. On the contrary, 315 
students realized the importance of the cooperative work (“Evaluation Results”, 11g, 16i+k; SI) and 
that the course assignments resemble the real-world research (“Evaluation results”, 11g, 14g; SI). 
This process of exchanging ideas and using what is most suitable for the scientific publications is 
further highlighted in one of the interviews by a biology student who struggled slightly in the lab, but 
could provide her insight into biological processes during the proposal writing process. The quote 320 
illustrates how each discipline contributed their perspective and knowledge to approach the problem 
solution:  
One biology student:  
“Beside the lab, I think when we did the poster I could use my biology background, because we 
picked a rather biological topic and I had more to contribute. Basically, I had the most ideas at the 325 
beginning; I mean we started with an idea and so this was biological. And then we searched how we 
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can use chemical methods, at least in, to combine it. So, we had a synthesis and overexpression and 
protein…something, we used a method to analyze the proteins chemically. And so, this helped a lot. I 
had no idea about the analytical methods, but I knew better how proteins may behave and what would 
work or not.” 330 
These examples, survey results and personal experiences expressed in the interview, during the 
course underpins the overall good impression that the structure and design of the course was well-
received by the students. 
PRACTICAL ADVICE FOR FUTURE INSTRUCTORS: CHALLENGES AND BENEFITS 
A primary challenge is the time commitment required from the students and the organization of 335 
the integrated lab sections. On the one hand, traditional lectures and laboratory courses might seem 
to require less effort. On the other hand, in the traditional learning the research output is always the 
same. Our course design, however, advanced our own research and increased our visibility in our 
own and in a different department. From a student’s perspective, the course enables experience and 
learning of genuine science, allows visualizing the advantages of collaborative work, and promotes 340 
innovative and critical thinking, which will not only be advantageous during their studies but also 
in later life. Our interdisciplinary approach allows learners to tackle broad scope research questions, 
which are not solvable by one discipline alone. Students finishing the course can bring a new 
collaborative spirit into the conservative university system to lower the barriers to interdisciplinary 
collaborations. We envision that the whole concept of the course could be adapted for several 345 
interdisciplinary fields as long as the discovery-based research lab is planned in stages. For instance, 
we foresee feasible adaptability in fields like material science and nanotechnology in which physicists 
and chemists could learn together or in biophysics for biologists and mathematicians or neuroscience 
for chemists and biologists, or drug discovery for chemists and medicine students, etc. 
A challenge from an instructor’s perspective is the difference in prior knowledge. In an 350 
interdisciplinary course, each group of students should be able to equally contribute their knowledge 
to the overall objective, e.g. during the lab section or in the lecture. We tried to involve and support 
all students by teaching highly interdisciplinary topics in the lectures, covering basic concepts of 
both disciplines. In our case, we believe that we succeeded at managing the issue of differing student 
backgrounds because they did not report feeling outperformed by students of the other disciplines. 355 
The reason may be that we carefully mixed biology and chemistry students together and regularly 
  
246 
changed the groupings to stimulate idea exchange and support from each discipline. This 
consequently strengthened the collaborative aspect. 
Sine we were aware that the number of new methods and tasks were challenging, we envisioned 
a small-group course with two fully committed instructors from the chemical biology division. As an 360 
anecdotic point, in the first cohort we were also considering to leave the research project proposal to 
give more time for the communication. We discussed it with the students but gratifyingly for us, the 
students were the ones who asked us for doing the research proposal too. The overall design and the 
implementation of this course in a teaching lab would allow a scale up of this course for larger cohorts 
if the number of methods and required equipment would be reduced. Although further planning and 365 
organization beforehand will be necessary, the research-inspired lab might especially profit from 
larger and mixed cohorts, enabling broader topics and a more screening-oriented approach. 
CONCLUSION 
This course brings the framework of real-world research into a chemical biology course with a 
focus on epigenetics. This interdisciplinary experience for biology and chemistry Master’s students 370 
combines a discovery-based research lab course with scientific communication. Although the time 
investments of students and instructors are relatively high, our output outcompetes traditional 
lecture courses, which was demonstrated by the student’s outcomes, surveys and the positive 
perspective described in course evaluations. Furthermore, a high proportion of group work promoted 
collaborative approaches during the course. 375 
In conclusion, with the growing need for interdisciplinary approaches across scientific research, 
our presented course design can easily be applied to many different fields of science, to empower 
more students to confront the complex societal problems with innovative and collaborative ideas. 
Future approaches will target the long-term impact of these practices, the interdisciplinary 
experience and the involvement in collaborative work.  380 
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APS ammoniumperoxodisulfate  
bp base pair 
CD circular dichroism 
CE capillary electrophoresis 
ddH2O double distilled water 
dNTP nucleoside triphosphate 
EDTA ethylenediaminetetraacetic acid  
FAM fluorescein 
FID fluorescence intercalation displacement 
Fmoc fluorenylmethoxycaarbonyl 
HATU [4,5-b]pyridinium 3-oxid hexafluorophosphate  
HF high fidelity 
ICD induced circular dichroism 
Im imidazole 
KD binding constant 
NoSP nature of scientific writing 
OD optical density 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
Py pyrrole 
RP-HPLC reverse phase high performance liquid chromatography 
SDB salt dialysis buffer 
SPPS solid phase peptide synthesis 
TBE Tris-Borate-EDTA buffer 
TEMED tetramethylethylenediamine  
test cl. test cleavage 
TO thiazole orange 




COURSE TIMETABLES AND TOPIC DESCRIPTIONS 
The timetables show the plan of the whole course (Table S1) and the specific topics covered during the scientific communication workshop (Table 
S2). The lecture topics are shown in the manuscript in Box 1 (Figure 2).  
 
Table S1. General course timetable. 50 
time duration event description assignment(s) (outcome/observation) 
week -10 1h information meeting basic description of the course to interested master  
   students from chemistry and biology   
week -3  sign up deadline students had to sign up for the course  signing in 
week 1 2h lecture 1 topic L1  







group formation for research proposal, rounds of 
brainstorming and group feedback I  
brainstorming and topic idea finding in 
groups 
week 4 2h lecture 3, workshop 2 topic L3, topic W2  
week 5 2h lecture 4 topic L4  
week 6 2h Pomodoro 2 rounds of brainstorming and group feedback II group work on proposal abstract 
week 7 2h lecture 5, workshop 3 topic L5, topic W3  
week 8 full days lab course week 1 introduction, security introduction, lab exercises  hand in proposal abstract 
   (see extra lab course plan)  
 2h lecture 6, workshop 4 topic L6, topic W4  
week 9 full days lab course week 2 lab exercises (see extra lab course plan)  




scientific writing  
 
students received group feedback about submitted 
proposal abstract  
week 10 2h workshop 6 topic W6 by an Scientific English expert   
week 10 flexible scientific writing communication individual writing of communication 







poster of proposal 
 
hand in communication, group design of 







poster of proposal, group feedback on draft poster 
version 
hand in draft of the poster version, group 







poster presentation and individual feedback by 
external referees 
group poster presentation 
 







Table S2. Course material covered during the scientific communication workshops.  55 
topic topic description  
topic W1  Overview: types of scientific writing; structure; writing elements by analyzing articles 
topic W2  Drafting: importance of the outline; practical exercises 
topic W3  
abstract, title and keywords; practical exercises  
From introduction to conclusions 
topic W4  Referring an article and in-class writing exercises 
topic W5  Effective use of figures and tables 
topic W6  Use of English by a Scientific English expert 
 
DISCOVERY-BASED RESEARCH LAB DESIGN 
Tables S3 and S4 summarize a detailed plan for each day of the discovery-based research lab. Table S5 shows the parameters, which were on 
the research question and experimental techniques to answer them. 
 60 
Table S3. Plan of the first week for the discovery-based research lab. 
group Monday Tuesday Wednesday Thursday Friday 
A1: monomer get glassware, purify acetylation  purify nitration purify esterification  purify esterification  
 start acetylation  of Py + Im of Py + Im of Py of Im 
 of Py + Im start nitration  start esterification   
  of Py + Im of Py + Im   
B1: hairpin 
 




analyze test cl. 
continue hairpin 
analyze test cl. 
continue hairpin 
analyze test cl. 
final cleavage 
 start hairpin synthesis test cleavage synthesis, synthesis, and purification 
   test cleavage test cleavage  
C1: nucleosome get glassware ,  PCR W601,  start nucleosome test check nucleosome purity, check nucleosome  
 prepare buffers gel for purity assembly nucleosome big scale  purity 








Table S4. Plan of the second week for discovery-based research lab. 
group Monday Tuesday Wednesday Thursday Friday 
A2: analysis of presentation meeting 1 CD measurement CD measurement analysis of data presentation meeting 2 
      hairpins by CD finish rest of 1. week    finish rest, clean all 
 introduction in all     give glassware back 
 new devices     
B2: analysis of presentation meeting 1 fluorescence fluorescence analysis of data presentation meeting 2 
      hairpins by FID finish rest of 1. week displacement displacement  finish rest, clean all 
 introduction in all  measurement measurement  give glassware back 
 new devices     
C2: analysis of presentation meeting 1 prepare sample CE measurement analysis of data presentation meeting 2 
      sequence specific finish rest of 1. week    finish rest, clean all 
      nucleosome  introduction in all     give glasware back 
      binding 
      (footprinting)  
new devices 
         
 
Table S5. Parameters, which were on the research question and experimental techniques to answer them. 
Parameter (research question) Experimental technique (answer) 
Binding affinity to free DNA CD spectroscopy (induced circular dichroism) 
 fluorescence spectroscopy (fluorescence intercalation displacement) 
 capillary electrophoresis 





LIST OF REAGENTS 
Table S6 summarizes the used reagents, including its corresponding CAS-number and the used 
supplier. For non-commercial reagents, procedures and references for preparations are given. 
Table S6. List of used reagents including their CAS-number and the used supplier. 
Chemical CAS-number supplier 
trichloroacetyl chloride 76-02-8 Sigma Aldrich (USA) 
N-methylpyrrole 96-54-8 Acros Organics (Belgium) 
potassium carbonate 584-08-7 Carl Roth (Germany) 
magnesium sulfate anhydrous 7487-88-9 Carl Roth (Germany) 
acetic anhydride 108-24-7 Carl Roth (Germany) 
conc. Nitric acid 7697-37-2 Merck (Germany) 
sodium carbonate 497-19-8 Carl Roth (Germany) 
sodium chloride 7647-14-5 VWR (USA) 
4-dimethylaminopyridine (DMAP) 1122-58-3 Fluka (USA) 
N-methylimidazole 616-47-7 Sigma Aldrich (USA) 
triethylamine 121-44-8 VWR (USA) 
sodium hydrogen carbonate 144-55-8 Carl Roth (Germany) 
dimethylformamid (DMF) 68-12-2 Iris Biotech (Germany) 
N-methyl-2-pyrrolidone (NMP) 872-50-4 Iris Biotech (Germany) 
N,N-diisopropylethylamine (DIPEA) 7087-68-5 Carl Roth (Germany) 
1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo-   
[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) 148893-10-1 Iris Biotech (Germany) 
Rink amide (RAM) MBHA-resin 431041-83-7 Fluorochem (UK) 
Fmoc-βAla-OH 35737-10-1 TCI (Japan) 
Fmoc-γ-OH 116821-47-7 Iris Biotech (Germany) 
piperidine 110-89-4 Iris Biotech (Germany) 
pyridine 110-86-1 VWR (USA) 
DMSO biomolecular grade 67-68-5 Sigma Aldrich (USA) 
triisopropylsilane (TIS) 6485-79-6 Sigma Aldrich (USA) 
trifluoroacetic acid (TFA) 76-05-1 abcr (Germany) 
5XHF buffer  - New England Biolabs (USA) 
dNTPs  - Invitrogen (USA) 
primers  - Sigma Aldrich (USA) 
phusion polymerase  - New England Biolabs (USA) 
40% 19:1 acrylamide : bisacrylamide  - Carl Roth (Germany) 
tetramethylethylenediamine (TEMED) 110-18-9 Carl Roth (Germany) 
ammoniumperoxodisulfate (APS) 7727-54-0 Carl Roth (Germany) 
tris(hydroxymethyl)aminomethane (Tris) 77-86-1 Carl Roth (Germany) 
ethylenediaminetetraacetic acid (EDTA) 60-00-4 Merck (Germany) 
boric acid 10043-35-3 Carl Roth (Germany) 
sodium dihydrogen phosphate monohydrate 10049-21-5 Merck (Germany) 
thiazole orange (TO) 107091-89-4 Sigma Aldrich (USA) 
hairpin DNAs  - Sigma Aldrich (USA) 
Fmoc-βAla-RAM resin Load RAM-MBHA-resin following reference [1] 
Fmoc-Py-OH Synthesized following reference [2,3] 
  
259 
Fmoc-Im-OH Synthesized following reference [2,3,4] 
Fmoc-Im-Py-OH Synthesized following reference [5] 
plasmid pGEM-3z/601 Addgene plasmid #26656, deposited by Jonathan 
Widom  
chicken erythrocyte histone octamers Prepared following reference [6] 
HAZARDS 75 
Within each lab assignment the hazards varied. Especially in the synthesis stations, the most 
common hazards were flammable liquids and toxic reagents, which were reduced to a minimum 
amount and replaced when alternatives were possible. All hazardous work was performed in fume 
hoods and protective coats and googles were compulsory during the whole two weeks of the 
practical course. Before the course, all students received a basic security introduction considering 80 
the inexperience of the biologists. The main security issues were highlighted and hazardous steps 
were mentioned and discussed during the course too. 
PRIMER SEQUENCES AND DNA PREPARATION 
Table S7 shows the primer sequences that were used in the polymerase chain reaction of Widom 601 
DNA. 85 
 
Table S7. Primer sequences used in the polymerase chain reaction of Widom 601 DNA. 
primer Sequence 5’-3’ 
forward primer FAM601_F [6FAM] CCT GGA GAA TCC CGG TGC 
reverse primer 601_R CAG GAT GTA TAT ATC TGA CAC GTG CC 
 
The DNA hairpins for the CD-spectroscopy and fluorescence intercalation displacement (FID) were 
prepared prior to the laboratory course. The two DNA strands from Table S8 were dissolved in ddH2O 
and each mixture was heated to 95 °C for 10 min and then slowly cooled to r.t. Their concentration 90 
was determined spectroscopically on a Tecan Spark 20M. Their molar extinction coefficients were 
determined by using the following formula:7 
 
𝜀260𝑛𝑚 = {(8.8 ∗ #𝑇) + (7.3 ∗ #𝐶) + (11.7 ∗ #𝐺) + (15.4 ∗ #𝐴)} ∗  0.8 ∗  10
3 𝑀−1𝑐𝑚−1      (S1) 
 95 
In the formula # = number of nucleobases determined throughout the DNA sequence, T = thymine, 
C = cytosine, G = guanine, A = adenine. 
 
Table S8. DNA sequences used for the CD and FID analysis. 
DNA name DNA sequence 5’-3’ 
Nucleosome_1 GGC AGTGTA CGC TTTTT GCG TACACT GCC 
Nucleosome_2 GGC AGACTA CGC TTTTT GCG TAGTCT GCC 
 
  100 
  
260 
EXPERIMENTAL DESCRIPTION FOR EACH GROUP 
Week 1, group A1 – Pyrrole (Py) and imidazole (Im) monomer synthesis: 
 
References:  Proc. Natl. Acad. Sci. USA  2004, 101, 6864.; Org. Lett. 2001, 3, 1201.; J. Am.Chem. 
Soc. 1996, 118, 6141.; J. Am.Chem. Soc.  2006, 8766.; Heterocycles 1988, 27, 1945.; 105 
Patent  
 WO 199703975 A2. 
Questions:   Why do we need to go two different ways of synthesis for the imidazole and the pyrrole 
monomer? What do we need all the chemicals in each reaction for? What are the 
mechanisms of the reactions? With which chemicals do we need to work carefully?  110 
Retrosynthetic pathway of the monomer synthesis: 
 
Scheme S1. Retrosynthetic pathway for the imidazole monomer. Synthesis steps which were performed by the 
students are highlighted with a red box. The final green-highlighted Fmoc-monomer was previously prepared 
and supplied by the instructors. 115 
 
 
Scheme S2. Retrosynthetic pathway for the pyrrole monomer. Synthesis steps which were performed by the 
students are marked with a red box. The final green-highlighted Fmoc-monomer was previously prepared and 
supplied by the lab instructors. 120 
 
Below, the detailed synthetic procedures for the synthesis steps which were performed by the 
students is shown. The remaining steps until the final Fmoc-building blocks were conducted and 
supplied by the instructors, due to time restrictions and dangerous and complicated synthesis steps. 




Synthesis of Py-C(O)CCl3 
 
Under nitrogen atmosphere, trichloroacetylchlorid (50.0 mmol) was dissolved in Et2O (10 mL) and 
cooled to 0 °C. N-Methylpyrrole (50.0 mmol) was dissolved in Et2O (10 mL) and added dropwise over 130 
30 min. The reaction mixture was warmed up to r.t. and stirred for another 3 h. At 0 °C, the reaction 
was quenched with K2CO3 (26 mmol) dissolved in H2O (14 mL). It was extracted with Et2O, dried over 
MgSO4, filtered and the solvent removed. Analysis was performed (1H, 13C, CI). 
 
Synthesis of NO2-Py-C(O)CCl3 135 
 
Under nitrogen atmosphere, Py-C(O)CCl3 (1 eq) was dissolved in Ac2O (13 eq) and cooled down 
to -40 °C. 65% HNO3 (2.2 eq) was added dropwise. The reaction mixture was slowly warmed up to 
r.t. and stirred overnight. At 0 °C, the reaction mixture was carefully neutralized with Na2CO3 (sat.) to 
pH 7. It was extracted 4 x with EtOAc and washed 3 x with brine. The organic layers were dried over 140 
MgSO4, filtered and the solvent removed. Analysis was performed (1H, 13C, CI). 
 
Synthesis of NO2-Py-OMe 
 
NO2-Py-C(O)CCl3 (1 eq) was dissolved in MeOH to give a 0.3 M solution. DMAP (0.1 eq) was added 145 
and the solution stirred overnight. The solvent was removed in a dryload and the crude purified by 










Synthesis of Im-C(O)CCl3 155 
 
Under nitrogen atmosphere, trichloroacetylchlorid (35.1 mmol) was dissolved in CH2Cl2 (25 mL) and 
cooled to 0 °C. N-Methylimidazole (35.0 mmol) was dissolved in CH2Cl2 (15 mL) and added dropwise 
over 1.5 h. The reaction mixture was warmed up to r.t. and stirred until full conversion (at least 3 h). 
At 0 °C, freshly destilled NEt3 (35.1 mmol) was added dropwise over 30 min. The solvent was removed 160 
in a dryload and the crude purified by flash column chromatography (pentane/EtOAc 1:1). Analysis 
was performed (1H, 13C in CDCl3, CI). 
 
Synthesis of NO2-Im-C(O)CCl3 
 165 
Under nitrogen atmosphere, Im-C(O)CCl3 (1 eq) was dissolved in Ac2O (13 eq) and cooled down 
to -40 °C. Fuming HNO3 (6.5 eq) was added dropwise over 1.5 h. The reaction mixture was slowly 
warmed up to r.t. and stirred overnight. The reaction mixture was neutralized carefully with 
saturated NaHCO3 under cooling and extracted with CH2Cl2, dried over MgSO4, filtered and the 
solvent removed. Analysis was performed (1H, 13C in CDCl3, CI). 170 
 
Synthesis of NO2-Im-OMe 
 
Under nitrogen atmosphere, NO2-Im-C(O)CCl3 (1 eq) was dissolved in MeOH to give a 0.3 M solution. 
DMAP (0.1 eq) was added and the solution stirred overnight. The solvent was removed in a dryload 175 
and the crude purified by flash column chromatography (pentane/EtOAc 4:1 → 1:1 → 1:4). The 
gradient was not increased too fast, as with this column the 4-NO2- and 5-NO2-isomer were 




Week 1, group B1 - Polyamide Hairpin Synthesis: 180 
 
General procedure for the polyamide hairpin coupling 
The hairpins were synthesised manually in a 20 µmol scale in 2 mL polypropylene syringes equipped 
with a filter and plunger (pore size 25 µm, MultiSynTech GmbH; Germany). All solutions needed were 
freshly prepared in the morning of use. 185 
The needed amount of preloaded Fmoc-βAla-RAM-resin (loading = 0.54 mmol/g) was weighted into 
a filter-syringe and the resin swelled in 1.5 mL DMF for 30 min. 
Solutions were prepared in 50 mL falcon tubes and refilled to 1.5 mL reaction tubes: 
    deprotection solution: 20% piperidine in DMF, 500 µL (24x) /1.5 mL reaction tubes (12 mL in 
total) 190 
    capping solution: 5% Ac2O, 5% pyridine in DMF, 500 µL (12x) /1.5 mL reaction tubes (6 mL in 
total) 
 
It was followed the procedure of the table at the end of this protocol: 
deprotection:  Deprotection was performed twice for 5 min.  195 
coupling: Coupling of Fmoc-Py-OH was performed with 4 eq of the amino acid and 4 eq HATU 
dissolved in DMF to give a 0.3 M solution. DIPEA (8 eq) was added and the mixture 
preincubated for 3 min before addition to the resin. Coupling was performed for 1 h. 
After introduction of Fmoc-γ-OH, after 1 h of coupling, DMSO/DMF 1:1 (100 µL) was 
added for 30 min. 200 
Coupling of Fmoc-Im-Py-OH and Fmoc-Im-OH was performed with 4 eq of the amino 
acid and 4 eq HATU dissolved in NMP to give a 0.3 M solution. DIPEA (12 eq) was 
added and the mixture preincubated for 3 min before addition to the resin. Coupling 
was performed for 2 h. After introduction of Fmoc-γ-OH, after 2 h of coupling, 
DMSO/DMF 1:1 (100 µL) was added for 30 min. 205 
capping: Capping was performed once for 5 min. 
test cleavage: After the capping step, a little sample of resin, which was washed with CH2Cl2 last, 
was transferred to an 1.5 mL reaction tubes and 180 µL cleavage mixture 
(TFA/CH2Cl2/H2O/TIS 90/5/2.5/2.5) were added and shacked at r.t. for 1.5 to 2 h. 
The solvent was transferred into another 1.5 mL reaction tube without the resin balls, 210 
the solvent was removed under nitrogen flow, and the crude dried under vacuum for 
10 min. The sample was re-dissolved in H2O/MeCN 7/3 0.1% TFA and the OD304 was 
determined on the nanodrop and the sample injected in the HPLC to verify the 
successful couplings. The injected amount was calculated by V = 3.6 µL / OD304. 
  
264 
final cleavage: To the resin, cleavage mixture (1 mL /10 µmol, TFA/CH2Cl2/H2O/TIS 90/5/2.5/2.5) 215 
was added and stirred at r.t. for 2 h. The solvent was transferred into a filter syringe, 
filtered and washed once with 1 mL TFA, to remove the resin balls. The solvent was 
removed under nitrogen flow and the crude dried under vacuum for 10 min. The crude 




Synthesize the two following hairpins: 
- Nucleosome 1:  Ac-Im-Py-Im-Py-γ-Py-Py-Py-Py-β-NH2 (20 µmol)  (targets the α-satellite nucleosome) 
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Pairing rules for Dervan-polyamide hairpins 
Pairing rules for polyamides, which bind sequence-specific to the DNA, were nicely summarized by 
Dervan and Bürli.8 By designing the right polyamide, many different sequences can be addressed. 230 
For the design of a sequence, some rules needs to be followed: a pyrrole opposite of an imidazole 
(Py/Im) targets a C-G basepair, whereas an imidazole opposite of a pyrrole (Im/Py) targets a G-C 
basepair. A pyrrole pyrrole pair (Py/Py) targets both, A-T and T-A. The C-terminal β-alanine linker 
and the γ-turn both are specific for an A/T or T/A pair on the flanking sides of the polyamide. β-
alanine can be introduced instead of pyrrole and reveals the same binding selectivity’s. However, 235 
their introduction gives a less rigid polyamide hairpin, which results in less truncations during 
coupling and therefore higher yields. The orientation of the polyamide upon binding to the DNA 
orientates the N→C of the polyamide in the 5’→3’ direction of the DNA. The table below summarizes 
the pairing rules of all building block combinations. The example polyamide in the figure below 
illustrates its pairing rules to a 6-bp DNA. 240 
Table S9. Pairing rules of all building block combinations for the synthesis of polyamides.  
pair G-C C-G T-A A-T 
Im/Py + - - - 
Py/Im - + - - 
Py/Py - - + + 
Im/Im - - - - 
Im/β + - - - 
β/Im - + - - 
Py/β - - + + 
β/Py - - + + 
β/β - - + + 
 
 
Figure S1. Example of polyamide hairpin binding to a 6 bp DNA to visualize the pairing rules. 
  245 
  
267 
Week 1, group C1 - Nucleosome Assembly: 
 
PCR for DNA601 and FAM-DNA601: 
Questions:   What does PCR stands for? How does PCR works? What do we need each component  
of the PCR for? How does the purification of the produced DNA work? 250 
Procedure for W601-DNA:  
During the PCR, all components were always stored on ice. The phusion polymerase was stored in 
the cooling block and only shortly taken out of the freezer when needed. 
  amount [µL] final concentration 
ddH2O 532.2   
5xHF 160 1X 
DMSO 100% 24 3% 
dNTP(10 mM) 16 each 200 µM each 
primer 601_R (HPLC, 100 µM) 4 0.5 µM 
primer FAM601_F (100 µM) 4 0.5 µM 
plasmid pGEM-601 (211 ng/µL) 3.8 1 ng/µL 
phusion polymerase (2 U/µL)  8 1 U/ 50 µL 
 
The mixtures were prepared twice. All components except the phusion polymerase were combined 255 
and mixed gently with a pipette. The mixture was stored on ice and it was checked for the free PCR 
cycler. At last, the phusion polymerase was added, mixed again gently and portions of 50 µL were 
filled in each PCR tube. All the liquid was shortly spinned down and placed into the PCR cycler. The 
program of the table below was started: 
98 °C 30 s 
98 °C 8 s 
60 °C 20 s 
72 °C 10 s 
72 °C 4 min 
4 °C hold 
 260 
After the program was finished, two PCR tubes were combined in one 1.5 mL reaction tubes and 
the procedure of the PCR & DNA Clean Up Kit (New England Biolabs) provided was followed, but 
600 µL loading buffer used and the columns loaded twice. 5 columns in total were used. 
The DNA was eluted from the column with 10 µL ddH2O and all eluents collected in one 1.5 mL 
reaction tube. It was re-eluted with 25 µL elution buffer. Afterwards, the DNA concentration was 265 




Determination of DNA purity 
To determine the purity of prepared DNA, a 2% agarose gel was run. To prepare the gel, 1.2 g of 
agarose was added to 60 g of 1X TBE buffer in an Erlenmeyer flask. The mixture was heated until 270 
all particles were completely dissolved and the solution was gently boiling. The solution was cooled 
down for 3 min and 2 µL of midori green were added. It was shaked again gently, poored into a gel 
caster and the comb placed into it. After polymerisation was finished the comb was removed carefully 
and the gel transferred into the running chamber filled with 1X TBE and the pockets were filled with: 
1) 5 µL of DNA ladder CSL 1kb 275 
2) 0.3 µg of the prepared DNA in a total volume of 6 µL TBE buffer and 1 µL 6x DNA loading dye 
The gel was run for 40 min at 90 V. The gel was analyzed with a ChemiDoc MP by Biorad. 
 
Nucleosome assembly:9 
Questions: Which of the used chemicals are dangerous? Are all nucleosomes the same? – check for 280 
alpha-satellite, widom601 and the composition of the histone core. What are PTMs? How does the 
reconstitution of nucleosomes work? 
 
Buffer preparation 
Nucleosome Core Particles (NCPs) were reconstituted by the salt-gradient-dialysis method. Different 285 
buffers were prepared: 
 1 L 20X TE buffer:  200 mM Tris, 20 mM EDTA, pH 8.0 
 1 L 10X TBE buffer:  40 mL 0.5 M EDTA pH 8.0, 108 g Tris, 55g boric acid → filled up to 1 L 
 250 mL SDB buffer (“salt dialysis buffer”): 10 mM Tris, 1 mM EDTA, 2 M NaCl, pH 8.0 
(12.5 mL 20X TE, 29.22g NaCl → filled up to 125 mL, took out 1 mL 290 
and filled up to a total volume of 250 mL) 
 1L of 1X TE-buffer (10 mM Tris, 1 mM EDTA, pH 8.0) 
All buffers were stored at 4°C 
Reconstitution of NCPs 
It was reconstituted in a volume of 30 µL, which contained 1 µg of DNA (90876 Da) and varying 295 
amounts of histone octamers prepared from chicken erythrocytes. To assemble this 1 µg of DNA, 
about 2.4 µL of the 1:10 glycerol stock of histones in 1X SDB were needed. It was planned to prepare 
a titration row with 11.0 / 11.5 / 12.0 / 12.5 µL of the 1:50 stock to determine the exact ratio needed.  




The used histone dilution in low binding tubes was: 1:50 glycerol stock in 1X SDB 
Histone and DNA mixtures were prepared in low binding tubes by adding 1.0 µg DNA and the 
volumes given above of the 1:50 histone stock into a total volume of 30 µL SDB 
 
Dialysis chambers: Samples were pipetted into cut 1.5 ml reaction tube caps and a small membrane 305 
was added (The membrane was placed in water before and shortly put into the beaker (2 M NaCl). 
The membranes were separated from each other, put with the inside face onto the cap rim and the 
other part stored) and the chamber closed with the cut tube piece. The dialysis cells were put into 
the beaker filled with 250 mL 1X SDB (2 M NaCl) and shaked in a way that the liquid came into 
contact with the membrane. All solutions were kept at 4 °C all the time. It was stirred for 1 h at about 310 
60 rpm. After 1 h 250 mL TE were added → 1 M NaCl. After 1 h 250 mL were discarded from the 
beaker and 250 mL TE were added → 500 mM NaCl. After 1 h all but 50 mL were discarded and 
450 mL TE were added → 50 mM NaCl. Stirring was continued for at least 1 h. The dialysis cells 
were removed from the beaker and dried on top with a pipette tip. The samples were pipetted from 
the dialysis cells by perforating the membrane on the non-liquid side, then sucked up and transferred 315 
into a low binding tube. A gel was poured to check the purity and the best conditions. As a reference 
100 ng free DNA and half of the amount of each nucleosome titration was loaded. 
To pour the 5% native PAGE gel 0.5X TBE, 1.875 mL 40% acrylamide and 750 µL 10X TBE were 
added into a 50 mL falcon tube. It was filled up to 15 mL with water, mixed and 150 µL 10% APS 
and 7.5 µL TEMED were added. It was mixed again, the gel poured into the cassette, the comb 320 
inserted and polymerized for about 40 min. After polymerization the chamber was rinsed to remove 
all SDS, the comb removed and the chambers washed with Millipore water. The gel was placed into 
the chamber and filled up with 0.5X TBE. For sample preparation, half of the nucleosome amount 
was mixed with 2 µL glycerol (cut tip end) and the chambers loaded. A 100 ng DNA sample as 
reference was also loaded. The gel was run at 90 V for 40 min. DNA bands in the gels were visualized 325 
using post-staining by allowing the gel to float in 100 mL 0.5X TBE and 10 μL SYBR Safe DNA Gel 
Stain (10000X) for 30 min. The bands were visualized with Chemidoc instruments.  
For large scale assembly a reaction volume of 50 µL was used.  
  
270 




References: Curr. Protein Pept. Sci. 2000, 1, 349.; Biochemistry, 1999, 38, 2143.; Bioconjugate 
Chem. 2015, 26, 2054. 
Questions: What does CD stands for? How does a CD measurement works? What do we use CD 335 
measurements for? Why do we get a CD signal, although or molecule is not chiral? 
What is an ICD? 
How the CD spectrometer was turned on and off: 
Turn on: 
- the nitrogen flow was turned on 340 
- the nitrogen monitor (Afristo) was turned on and the gas flow checked (at least >2.5 L/min; 
best 5-10 L/min) 
- the computer and screen were turned on 
- the water bath (Haake WKL 26) and peltier controller (CDF426) were turned on 
- the CD-spectrometer JASCO J810s was turned on 345 
- the software SpectraManager was started: spectrum measurement was chosen from the list 
on the right 
- It was waited for at least 20 min before the first measurement, to let the lamp heat up and 
stabilize  
- it was proceeded by clicking measurement – accessory – Temperature: Jasco Peltier 350 
Controller – ok 
- it was proceeded by clicking control – accessory – put the desired temperature – apply – 
close 
- it was proceeded by clicking measurement – parameters – put the desired settings 
 355 
Turn off: 
- all data were saved (also as.txt file) and downloaded onto an USB-stick 
- the software was closed and in the Spectra Manager “Instrument STOP” was chosen 
- the JASCO J810s, water bath and peltier controller were shut down 
- the nitrogen gas was turned off 360 
- the nitrogen monitor was turned off 
- the computer and the screen was shut down 
 
How concentrations of a stock solution were determined: 
  
271 
A little bit of the polyamide hairpin sample was dissolved in 100 µL ddH2O. It was vortexed well and 365 
all centrifuged down.  
On the photometer, a 500 µL absorbance cuvette was filled with 500 µL of ddH2O and a blank 
measured. 3 µL of the stock was added, well mixed and the absorbance at the wavelength given 
measured. Three data point between an absorbance between 0.3 and 1.0 were recorded. The solution 
was kept from the cuvette and from the stock and freeze dried on the lysophylizer after finishing with 370 
the measurements. The concentration of the stock was calculated with the equation:10 







It was used:11  ε310nm(unmodified polyamide hairpin) in ddH2O = 69200 M-1cm-1  
 
 375 
How CD measurements were performed: 
The following settings were used: 20°C, 0.2 cm pathlength, start: 380 nm, end: 220 nm, scanning 
speed 100 nm/min, response 0.25 s, data pitch 1 nm, accumulations 3, bandwidth 2 nm, sensitivity: 
high, scanning mode: continuous. 
To have a 10 µM DNA solution in the end, it was calculated how much of the DNA stock was needed 380 
to get this final concentration in a volume of 500 µL. The 0.2 cm pathlength CD cuvette was filled 
with (500 µL – V (DNA stock)) 20 mM NaH2PO4 100 mM NaCl pH 7.4, the cuvette placed in the 
spectrometer, 5 min waited and the blank measured. The calculated DNA amount was added, 
carefully mixed while avoiding to produce bubbles in the cuvette, 3 min waited and measured. 
Increasing amounts (250 µM) of polyamide hairpin stock were added, carefully mixed while avoiding 385 
to produce bubbles in the cuvette, 3 min waited and measured. It was continued until the recorded 
spectra reached a saturation.  
 
The data was exported from the CD-spectrometer and plotted in θ x 10-4 [deg/M*cm] versus the 
wavelength. The maxima of the ICD signal was plotted against the concentration of polyamide hairpin 390 




Week 2, group B2 - Analysis of the New DNA Binder by Fluorescence Intercalation Displacement 
(FID): 
 395 
References: Org. Lett. 2010, 12, 216.; Acc. Chem. Res. 2004, 37, 61-69. 
Questions: What is fluorescence? Why do we need two different types of cuvettes when we 
measure absorbance and fluorescence? What is a stokes shift? What is an absorbance, 
emission and excitation spectra? Why do we expect a change of fluorescence when we 
increase the concentration of DNA in our fluorophore stock? Why do we expect a 400 
decrease in fluorescence when we add our polyamide hairpin to the mixture? 
 
How concentrations of a stock solution were determined: 
It was followed the protocols of the CD measurements. 
 405 
How the spectrometer settings were set: 
To use the fluorimeter, first the computer was turned on, then the fluorimeter and the water bath. 
When all sounds of the fluorimeter were finished, the program was started and then the lamps turned 
on by using the program. It was waited for at least 20 min before the first measurement to let the 
lamp stabilize. Then only the emission lamp was turned on and auto scale pressed. Then only the 410 
excitation lamp was turned on and auto scale pressed. In the end, only the emission lamp was turned 
on. For measurements it was proceeded by clicking on file – properties and the setting typed in. Ok 
was pressed, the measurement started and the results saved. Then, it was continued with the next 
measurement.  
 415 
How the polyamide hairpin titrations were performed: 
Measurements were performed in a volume of 1 ml at a concentration of 6 µM thiazole orange and 
1 µM DNA duplex with the right target sequence in 20 mM NaH2PO4 100 mM NaCl pH 7.4 with 
increasing amounts of polyamide hairpin.  
 420 
The following settings were used: 20°C, excitation wavelength: 490 nm, excitation slidth: 3 nm, 
emission wavelength: 510 - 700 nm, emission slidth: 3 nm, scanning speed 500 nm/min, response 
0.2 s, sensitivity: medium, data pitch: 1 nm. 
 
To have a 6 µM thiazole orange and 1 µM DNA hairpin solution in the end, it was calculated how 425 
much of the stocks were need, to achieve this final concentration in a volume of 1 mL. The cuvette 
was filled with (1 mL – V (DNA stock) – V (thiazole orange stock)) 20 mM NaH2PO4 100 mM NaCl pH 
7.4 buffer, the cuvette placed into the spectrometer, 5 min waited and the blank measured. The 
  
273 
calculated thiazole orange amount was added, carefully mixed while avoiding to produce bubbles in 
the cuvette, 1 min waited and measured. The calculated DNA amount was added, carefully mixed 430 
while avoiding to produce bubbles in the cuvette, 3 min waited and measured. Increasing amounts 
(250 µM and 1 mM) of polyamide hairpin stock were added, carefully mixed while avoiding to produce 
bubbles in the cuvette, 3 min waited and measured. It was continued until the recorded spectra were 
nearly absent.  
 435 
To plot the fluorescence intensity versus the wavelength the data from the spectrometer was 
exported. The maxima of the fluorescence signal was plotted against the concentration of polyamide 
hairpin and the KD calculated by using the program DynaFit.12 
 
 440 
Week 2, group C2 - Analysis of the New DNA binder by Footprinting Combined with Capillary 
Electrophoresis (CE): 
 
For this methodology only references, questions and the procedure and data of the final sample 
preparation are given due to non-published data.  445 
 
References: ChemBioChem 2018, 19, 664-668.; Org. Biol. Chem. 2019, 17, 1827-1833. 
 
Questions: What is capillary electrophoresis? On which methods is it based on? Which are the 
most common applications? How can a nucleosome dissemble? Why do we use different reagents for 450 
CE of free DNA and nucleosomes? Can potential minor groove binders bind at any position of the 
nucleosome? How does the common footprinting methodology works? What are advantages and 
disadvantages? 
 
How concentrations of a stock solution were determined: 455 
It was followed the protocols of the CD measurements. 
 
Sample preparation: 
The freeze-dried DNA amount was dissolved in 12 µL Formamid and 0.5 µL size standard (550 BTO, 
Biotype). 460 
The CE samples were run on an ABI PRISM 310 genetic analyzer by Applied Biosystems. All samples 
were separated on denaturing POP-4 polymer (Applied Biosystems) in a capillary with a length of 
47 cm (36 cm well-to-read) and a diameter of 50 µm. After an electrokinetical injection of 5 s at 15 kV 





QUESTIONS TO START THE PROPOSAL 
Before starting with the Pomodoro-technique, the students filled in a questionnaire to guide their 
own ideas and facilitate initial introduction among students. The questions in the questionnaire 
were:13 470 
- What are your research interests? 
- What are the problems in your interested fields? Why are they important? 
- With what sources of data can you validate the importance of the proposed project? 
- How is the existing knowledge inadequate? 
- Why are your ideas better? 475 
- What makes your project new / unique / different? 





For the proposal poster, the students were supplied with the poster template below as a guide. They 480 
were free to choose the template or use other approaches to present their idea. 
 
Figure S1: Poster template, which was provided for the students.   
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EVALUATION CRITERIA FOR DISCOVERY-BASED RESEARCH LAB  




All synthesized monomer precursors were literature described.[3] Therefore, the access of the 
molecules, yields and characterization by 1H and 13C NMR spectroscopy and CI or ESI mass 490 
spectrometry can be easily evaluated. 
The synthesized polyamide hairpins were novel. To judge the success of the synthesis HPLC-MS 
analysis was performed. The number of peaks revealed how many truncations and other side 
products were formed and mass analysis helped to assign the chromatograms. In the ideal case, the 
HPLC-chromatogram would show a single peak and a mass spectra containing only masses, which 495 
belong to the product polyamide.  
 
PCR and nucleosome assembly 
The success of the PCR and nucleosome assembly as well as their purity was tested by native 
polyacrylamide gel electrophoresis (PAGE). Supplying free DNA and nucleosome reference samples 500 
and/or the addition of DNA ladder validated the size of the bands in the gel and allowed the 
assessment of the results. 
 
CD measurements 
To assess the results of the CD measurements we compared the observed signals with the literature 505 
reported of known similar compounds. After addition of dsDNA hairpin to the buffer the typical bands 
for B-DNA: minimum at 250 nm and a maximum at 280 nm were expected.[9] Addition of increasing 
amounts of polyamide resulted in an induced CD signal at the absorbance range of the polyamide 
(300-360 nm).[14] Absence of contamination by the students could be evaluated by initial 
measurements of the buffer in which no distinct signal was expected. Overlay of the buffer- and DNA-510 
spectra with previous ones, performed by the instructors helped to assess the results. 
Final calculation of the binding constant allowed the students and the instructors to compare their 
results to known literature values in the nM-region[14] and judge their measurements.  
 
FID measurements 515 
FID measurements were performed with 6-TramTO-3.[15] In the first cohort we used this fluorescent 
dye, which was developed in our own laboratory. After finding out with the help of the students that 
it was not a suitable dye for FID measurements, we changed to thiazole orange for the second cohort. 
To assess the results of the FID measurements it was checked, if the observed signals align with the 
expectations in comparison to known compounds. Fluorescence measurements of the buffer alone 520 
and of the buffer and the dye gave the expected weak fluorescence intensity signals. After addition 
of the DNA to the dye solution, the typical strong fluorescence signals at 645 nm for 6-TramTO-3[15] 
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and 530 nm for TO[16,17] was anticipated. Addition of subsequent amounts of polyamide resulted in 
a decreasing fluorescence signal.[16,17] Absence of contamination by the students could be evaluated 
by initial measurements of the buffer in which no distinct signal was expected. 525 
Final calculation of the binding constant allowed the students and the instructors to compare their 
results to known literature values in the nM-region[16] and judge their measurements.  
 
General evaluation  
The discovery-based research lab was evaluated following the criteria given below: 530 
 
 Did the students achieve the synthesis/PCR and nucleosome assembly/CD 
measurements/FID measurements?  
 How do the students work in the lab? 
 Does the analysis data of the synthesis fit the reported ones from the literature? 535 
 How are the yields and the purity? 
 Do the measurements look as expected? 
 Do the calculated data fit the region from the literature? 





EVALUTATION CRITERIA FOR THE SCIENTIFIC COMMUNICATION  
The scientific article and the research proposal poster, including the presentation were evaluated 
following the given guidelines: 
 545 
Scientific article: 
 Was the communication prepared using the journal template? 
 How is the general / first impression? 
 Does the communication follow the general structure and addresses each content 
appropriately? 550 
o Title: does the title suits to the content? 
o Abstract: appropriated structured and summarizing the relevant content? 
o Introduction: scope of background info? Connection between precedents and new 
results?  
o Is there a scientific gap to highlight the importance of the article? 555 
o Discussion: well discussed results? Importance of bigger picture? 
o Methods: clear and complete? 
o References: complete and following the right style? 
 What data were used? 
 Does it have scientific rigor?  560 
 Is the used language clear and understandable? 
 Are the figures coherent with the data? 
 
Research Proposal Poster: 
 Is it well structured? 565 
 How is the general / first impression? 
 Does the topic cover the field of epigenetics? 
 Is it a novel project? 
 Is the timeline and methodology feasible?  
 Is it visual and understandable? 570 
 How do the students present their poster: 
o Did they understand the topic and the precedents? 
o Do they present their poster well? 
o Are all students taking part equally? 





In this section, examples of student’s outcomes for the lab course, the scientific article and the poster 
are given. Tables which describe the criteria, which were used to evaluate and rate the outcomes, 
are further supplied.  580 
 
OUTCOMES OF THE DISCOVERY-BASED RESEARCH LAB 
Synthesis: 
Below, students’ results of the 1H-NMR, 13C-NMR and HRMS are noted and exemplary a figure of the 
corresponding 1H-NMR spectra is shown. 585 
 
Py-CCl3: 
1H-NMR (300 MHz, DMSO-d6, δ): 7.46 - 7.42 (m, 2H, CH-1 and CH-3), 6.30 (dd, 1H, J = 4.3 Hz, J = 
2.5 Hz, CH-2), 3.91 (s, 3H, CH-4).  
13C-NMR (75 MHz, DMSO-d6, δ): 171.8 (C=O), 135.3 (CH), 123.6 (CH), 120.7 (Cq), 109.1 (CH), 96.0 590 
(CCl3), 36.2 (CH3).  
HRMS-CI+ (m/z): [M+H]+ calcd for C7H6Cl3NOH, 225.95932; found, 225.95978. 
 
Figure S3. 1H-NMR spectra of Py-CCl3. 
 595 
NO2-Py-CCl3: 
1H-NMR (300 MHz, DMSO-d6, δ): 8.56 (d, 1H, J = 1.6 Hz, CH-2), 7.80 (d, 1H, J = 1.6 Hz, CH-1), 4.00 
(s, 3H, CH-3).  
13C-NMR (75 MHz, DMSO-d6, δ): 172.8 (C=O), 134.2 (Cq), 132.5 (CH), 120.6 (Cq), 116.3 (CH), 94.5 
(CCl3), 50.0 (CH3).  600 




Figure S4. 1H-NMR spectra of NO2-Py-CCl3. 
 
NO2-Py-OMe: 605 
1H-NMR (300 MHz, DMSO-d6, δ): 8.27 (d, 1H, J = 2.0 Hz, CH-2), 7.30 (d, 1H, J = 2.0 Hz, CH-1), 3.92 
(s, 3H, CH-3), 3.80 (s, 3H, CH-4).  
13C-NMR (75 MHz, DMSO-d6, δ): 159.8 (C=O), 134.2 (Cq), 129.4 (CH), 122.6 (Cq), 111.5 (CH), 51.7 
(CH3), 37.4 (CH3).  
HRMS-ESI+ (m/z): [M+H]+ calcd for C7H8N2O4H, 185.05623; found, 185.05665. 610 
 
 











1H-NMR (300 MHz, CD3OD, δ): 7.31 (s, 1H, CH-2), 7.08 (s, 1H, CH-1), 4.01 (s, 3H, CH3-3).  
13C-NMR (75 MHz, CD3OD, δ): 160.3 (C=O), 137.8 (Cq), 129.4 (CH), 128.1 (CH), 119.5 (CCl3), 36.2 
(CH3).  
HRMS-CI+ (m/z): [M+H]+ calcd for C6H5Cl3N2O1H, 226.95457; found, 226.95069. 625 
 
 
Figure S6. 1H-NMR spectra of Im-CCl3. 
NO2-Im-CCl3: 
1H-NMR (300 MHz, CDCl3, δ): 7.95 (s, 1H, CH-1), 4.16 (s, 3H, CH3-2).  630 
13C-NMR (75 MHz, CDCl3, δ): 173.0 (C=O), 146.0 (Cq), 133.8 (Cq), 126.1 (CH), 93.7 (CCl3), 38.4 (CH3). 
HRMS-CI+ (m/z): [M+H]+ calcd for C6H4Cl3N3O3H, 271.93965; found, 271.94021. 
 
 







1H-NMR (300 MHz, CD3OD, δ): 8.29 (s, 1H, CH-1), 4.08 (s, 3H, CH3-2), 3.96 (s, 3H, CH3-3).  640 
13C-NMR (75 MHz, CD3OD, δ): 159.6 (C=O), 142.9 (Cq), 136.6 (Cq), 126.9 (CH), 53.2 (CH3), 37.5 (CH3). 
HRMS-ESI+ (m/z): [M+Na]+ calcd for C6H7N3O4Na, 208.0329; found, 208.0328. 
 
 
Figure S8. 1H-NMR spectra of NO2-Im-OMe. 645 
 
 
Polyamide Hairpin Synthesis: 
Figure S9 shows an exemplary HPLC-chromatogram of polyamide 1 after 4 couplings from the 
students’ progress report. 650 
 
Figure S9. HPLC chromatogram of a test cleavage of polyamide 1 after 4 couplings with marked mass, which 









PCR and nucleosome assembly 660 
In the figure below, lane-1 shows the free DNA-W601 from the PCR. Lane 2-8 are the results of 




Figure S10. Native PAGE analysis of free DNA-W601 in lane-1 and nucleosome test assemblies in lane 2-8 
with increasing amounts of histone octamers.  
 
CD-measurements 




Figure S11. Exemplary CD titration of DNA with polyamide hairpin 1. CD signal increase upon addition of 
more polyamide.  675 
 
FID-measurements 
Figure S12 presents an example of a student’s result of the FID titration of polyamide 1 with  
6-TramTO-3.  
 680 
Figure S12. Exemplary FID titration of 6-TramTO-3 and DNA. Subsequent addition of polyamide resulted in a 
decrease of fluorescence signal intensity. 
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At the end of the course, the students were asked to evaluate the course. We used Likert scale and 
open-ended questions to collect the answers. The results and answers from the cohort in 695 
2016/2017 and 2017/2018 were combined and are represented in the following. In the open-ended 
questions, the answers of the individual students were marked in italic from a to l. 
 
1) Please rate the lecture period 
 700 





















































please rate the lab period
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3) Please rate the assignments during the lecture 
 710 
4) Please rate your engagement in the course 
 









































































please rate writing a coomunication 
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6) Please rate the project work (proposal) 
 
7) Please rate the presentation (proposal) 720 
 
 
8) What do you think was the most valuable part of the course for you personally? 
a. Learn how to write scientifically and communicate. 
b. Doing the proposal. 725 
c. Communication. 
d. The lessons about the scientific writing. 
e. Interacting with students of other disciplines and the writing of a paper and a 
communication. 
f. To work interdisciplinary and to get to know a new research field. 730 
g. The whole course felt more like a group project, which is very nice. We got to learn how 
to work as a group on different topics in the lab course and designing the fictitious 
project was a fun and also very valuable experience, because finding a research gap 














































please rate the presentation (proposal)
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h. I really like to have the interdisciplinary part of the course. Working together with 735 
chemists and biologists was really interesting and I got some new insights in some 
biologic work and thinking. 
i. This course really guide us to know how real research works (writing a paper, design 
experiment, developing ideas, create and present poster). Discussing ideas within an 
interdisciplinary group was also a great experience. 740 
j. Refreshing some basic chemistry not used often in biological courses outside of 
mandatory chemistry lessons at the start of the bachelor. Additionally the use of 
language when writing scientific articles or protocols. It is expected of the students to 
write in English but the specific terminology is never focused on in any of the usual 
courses. 745 
 
9) Can you describe your experience interacting with the other students? 
a. Was a lot of teamwork, we wrote a lot, skyped, the others were fine. We helped us, 
was a good atmosphere. 
b. Very good, one of the best thing of the course. 750 
c. Very productive and friendly working environment. 
d. Interaction was very valuable as well, because it felt like all students had different 
backgrounds and knowledge that could really come together in the proposal. 
e. It was really nice to work in groups and get new contacts and discuss also with other 
students from another department and see their point of few to different themes. 755 
f. It was a really great experience to discuss the ideas, the project with the teammate. It 
really push us to think how we can make the project better, we really complete each 
other and managed to create a project for the poster. 
g. Everything went really well, everyone was helping each other to understand the 
lectures, the lab work etc. 760 
 
10) What was the biggest challenge for you in the course? 
a. Writing and formulating the thoughts about the research for everybody in the course 
understandable. 




11) What would you recommend, what we should definitely keep in the future? 
a. The lab work and Poster session. 770 
b. Communication, Proposal, lab course and maybe theoretical lessons within the 
semester. 
c. The combination of writing a communication and presenting the proposal as a poster. 
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d. Mixing chemistry and biology students, since we see the things from "the other side". 
e. The way that you interact with the pupils. 775 
f. The writing part was good. Keep that. 
g. Changing the groups - although it is sometimes hard, but this is how it's going to be in 
the future, we cannot always choose who we are working with, so it really close to 
reality. Also the poster - much work, but definitely worth it because I learnt so much 
about the other discipline and chemical biology and had the chance to ask any 780 
question that came in my mind and discuss it in the group. 
 
12) To what extend do you think, did the course change your perspective on interdisciplinary 
research? 
a. It reinforced my opinion on the importance of interdisciplinary research. 785 
b. It will definitely. I saw the power of interdisciplinarity. Also it was very inspiring 
during the work on the proposal. 
c. It changed it, I am now not as "afraid" as before to read a chemical paper and I 
learned and read about chemical methods which I didn’t have in my head as helpful 
for biology. 790 
d. Beside the benefits of different point of view as well as different methodology for the 
same research question, communications between the fields seem to be a bigger topic 
than I thought. 
e. I would like to work in an interdisciplinary research field in the future. 
f. Interdisciplinary research is the future science. 795 
g. The course got me really interested on the chemical biology and even more on the 
epigenetic topic and by designing our own project, we got to get an understanding of 
how you could apply knowledges from both disciplines. 
h. I have learned new things and other ways of thinking. 
i. Before I didn't pay much attention to the application of chemical methods for biology 800 
but the course introduced me to the ideas of using small molecules and chemical 
reactions in biological systems. 
 
13) To what extend do you think, did the course change your perspective on scientific writing? 
a. I really learned what "keywords" are useful in scientific writing. This helped a lot. 805 
b. It has improved during the course a lot, because now I understand how is a paper 
structured and where to get the information. How to argue and present myself and my 
results. 
c. It clarified the processes of writing and gave strategies not only for writing but also for 
reading. 810 
d. A lot. It was always something I was scared of but now after finishing this course, I 
think that with practice it will get a lot better. 
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e. More self-confident. 
f. No one has ever taught us the method of scientific writing. This is my first contact with 
and learning about science writing. Thank you very much. 815 
 
14) Do you think that this course is different from what you have done before? If yes, what are 
the main differences? 
a. The overall system is way better than normal lab courses or lectures, especially the 
poster session is a new part, because one has the possibility of thinking about new 820 
ideas and not repeating old scripts. 
b. Yes. The interaction between students and the teachers were much more intensive. 
Somehow for me it was like giving a sense for what I am actually doing, it increased 
my motivation a lot. The combination of Theory, practical stuff and in the end the 
communication was in my point of view perfect. 825 
c. A lot of teamwork. 
d. Yes! More interactive working, learning of scientific writing, theoretical and practical 
work together with the same content. 
e. Yes, the active involvement of the students was bigger. The interconnection between 
practical course and lab was new. 830 
f. Yes it is. Different approaches with students from chemistry and biology working 
together and different theme (dealing with how to write scientific texts in a proper 
way). 
g. Yes, it felt more like a real world project, more like we are actual scientists. I really 
enjoyed actually using my knowledge and not just following instructions! 835 
h. It was different in that part that chemists and biologists work together in groups and 
see the different ways of thinking, which are varying between the two sciences. 
i. Yes. Before we only knew how to write protocol, which actually in real research we 
are not going to write protocol, but mostly paper, poster, and presentation. 
j. Yes, a lot more team work, a lot more support of the professors and supervisors. 840 
k. Yes, real improvement in skills and learning. In the process of completing the poster, I 
really understood how to do scientific research by discussing and reading the 
literature. 
l. Yes, usually in courses the students either work alone on a topic or in set groups that 
won't change during the course. The constant changing of groups allowed to work with 845 
different people throughout the course and related subjects. 
15) Does this course changed your perspective of biology and chemistry as separated 
disciplines? Why? 
a. During the course I really experienced how colleagues from other departments 
contributed to the way of solving a problem. It was nice and inspiring to see their 850 
ways of approaching a problem with their methods. 
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b. Yes, it all depends more than I thought. 
c. Yes, a lot. 
d. I think they are very much connected and you can't look at them as separate 
disciplines. 855 
e. Yes, because you learns how to combine both. 
f. I don't think so. On the contrary, for the first time, I realized how interdisciplinary 
research links two different disciplines. Although the course was over, I continued to 
read the literature in the related field and the book the professor had recommended 
because it benefited a lot. 860 
g. No, before I also thought it is not a great gap between biology and chemistry. 
 
16) Do you think that both divisions (chemistry and biology) can work in a synergistic way? 
Why? 
a. Sure they can... biologist work with "living" systems they observe the whole organism, 865 
they have a broader view on things... but when it comes to molecular levels chemists 
can explain things a lot more in detail. 
b. Yes because they can complement each other really well. 
c. Of course, better overview of the whole subject, resulting in a better understanding. 
d. Yes, because there is a need of new perspectives to solve. 870 
e. I think the synergistic way is the only way for future. 
f. It feels like the biggest research topics are in medical science/biology. By applying 
chemical methods like synthesis or analysis methods, you can really help to solve 
problems that are not as easy from the biological standpoint. 
g. Yes, because the two disciplines are really close and can learn a lot from each other. 875 
Problems can be solved in the one discipline with the help of the other. 
h. Yes, because the challenges are seen from different ways. 
i. Of course they can, there is basically no real separation and if both parties are 
enthusiastic and able, the cooperation will bear rich scientific yield. 
j. Yes, it is proven already by our research proposal (poster) that we can solve problem 880 
with chemical biology approach. 
k. Yes, I think not only chemistry and biology can work together, but even more cross-
cooperation with pharmacy or physics. For example, the intracellular binding sites can 
be better detected by different electron microscopy methods. Many problems in 
biochemical synergy research can solve pharmaceutical applications. 885 
l. Yes. During the development of the research proposal has shown that we often 
approached a task from different perspectives. The biologists were often focused on 
the 'bigger picture', which part of a biological system to target or which organism for 
example. The chemistry students however were very helpful in finding the specific 




17) Do you have the feeling that interactions and problems solving between chemists and 
biologists went in both directions or just in one? 
a. In both directions. 
b. In both. 895 
 
18) Do you think that writing the communication give you a better overview than the traditional 
separate protocols? Why? 
a. Yes, a communications gives one a "big picture" of a research project. 
b. Yes! By writing a paper I learned a lot about the way of doing research, informed and 900 
get an overview of the recent research topic. 
c. Yes because you were confronted to really make something out of the data we got and 
not just write it down and if something didn’t work just write that also. 
d. Yes because it's not just writing down the results, it is a kind of presenting the results. 
e. Yes it does since one is forced to think a bit more about what was done in the course. 905 
f. Yes, communication gives you an overview about the problem and how you solve it. 
g. Yes. In separate protocols you only concentrate on the results you get and what they 
mean. In a communication you also have to combine everything in a bigger picture. 
 
  910 
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NATURE OF SCIENTIFIC PRACTICE SURVEY RESULTS 
The students performed a nature of scientific practise survey in the beginning and at the end of the 
course. The results from before and after the course are represented in the following:  
 
1) Research articles do not affect the reputation of a scientist. 915 
     
 
2) Research articles are meant to convey information that are worth reporting.  
     
 920 
3) Research proposals describe project outlines. 
     
4) A research article should persuade the reader of its importance.  
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 925 
5) Lab notebooks should be written to document the ongoing work. 
     
 
6) Research articles need to be written in a clear and appropriate language. 




ORGANIC CHEMISTRY SURVEY RESULTS 
The students performed an organic chemistry survey in the beginning and at the end of the course. 
The results from before and after the course are represented in the following:  
1) Indicate the direction of the reaction step. 935 
 
    
 
2) Which molecule is aromatic? 
 940 










3) Which interaction is more favoured? 
 950 
    
 
4) Which property are you expecting from the amino acid lysine? 
a. Acidic 
b. Basic 955 
c. Nonpolar (hydrophobic) 
d. Polar (uncharged)+ 
e. Other 










5) Which amino acid is shown in the picture? 
a. Cystein 
b. Methionine 
c. Serine 970 
d. Other 
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4.4.1 Conclusion 
The implementation of a new master course for chemistry and biology students with a focus on 
epigenetics brought the authentic big picture of research into the classroom and promoted collaborative 
work. The combination of lectures, a discovery-based research lab and scientific communication tried to 
break down the classical borders between disciplines, and also between traditionally separated course 
and lab structures. This course fosters cooperative research relationships between biology and chemistry 
students, provides a unique and genuine research experience and emphasizes the importance of science 
communication. Even though time investment of students and instructors was relatively high, 
evaluations and student outcomes clearly proved the aimed learning effect and the advance in our own 
research and, therefore, a successful implementation of the course and the overall positive outcomes. 
Future perspectives could target the long-term impact of these practices, the interdisciplinary approach 
and the collaborative work. Evaluations in two or three years could provide us with information about 
such issues.  
In conclusion, following the need to tackle real-world problems, our course design and the 
interdisciplinary approach could easily be applied in many different fields of research, resulting in 
students with critical thinking minds and capable to solve the modern challenges with innovative and 
collaborative solutions. 
 
4.4.2 Author Contribution 
The overall design of the innovative master course, which serves the basis to this manuscript, was 
developed by Jun.-Prof. Dr. Olalla Vázquez as awarded proposal for the Cottrell-Fulbright Prize in 2016. 
In 2016 and 2017, we implemented the course together. I was designing and conducting the discovery-
based research lab following my current research achievements under Jun.-Prof. Dr. Olalla Vázquez 
supervision. I prepared all necessary material (experimental procedures as hand-outs) and guided the 
students during the research lab. Moreover, I helped to correct and evaluate the outcoming of the 
articles elaborated by the students. As part of the scientific communication section of this course, I was 
leading the Pomodoro technique and guided the students to find their own research gap. Afterwards, I 
contributed in the correction, feedback and evaluation of the proposal products. The evaluation 
assessments were designed by Olalla Vázquez and Nicole Graulich (JLU, Gießen), but I also analyzed the 
surveys of the students. I contributed to write the manuscript and prepared several of the figures. Jun.-
Prof. Dr. Olalla Vázquez had the role of corresponding author, was leading or involved in all the 14-role 
taxonomy for author-contribution assignment.[1] 
 
Marburg,  
     Jun. Prof. Dr. Olalla Vázquez  Benedikt Heinrich 
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